diff --git a/CVO/cvo.owl b/CVO/cvo.owl
index 0f96a4a..466baf4 100644
--- a/CVO/cvo.owl
+++ b/CVO/cvo.owl
@@ -16,7 +16,7 @@
xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#"
xmlns:ncbitaxon="http://purl.obolibrary.org/obo/ncbitaxon#">
-
+
en
Chris mungall
Erica Marcos
@@ -62,7 +62,7 @@
OWL-DL
Vaccine Ontology Cancer Vaccine View
- 2024-12-29
+ 2025-02-26
@@ -527,7 +527,9 @@ WHERE {
Jie Zheng
Oliver He
Penny Pan
- status of vaccine development
+
+ obsolete status of vaccine development
+ true
@@ -1215,6 +1217,23 @@ A continuant cannot have an occurrent as part: use 'participates in'.
+
+
+
+
+
+ w 'has component' p if w 'has part' p and w is such that it can be directly disassembled into into n parts p, p2, p3, ..., pn, where these parts are of similar type.
+ The definition of 'has component' is still under discussion. The challenge is in providing a definition that does not imply transitivity.
+ For use in recording has_part with a cardinality constraint, because OWL does not permit cardinality constraints to be used in combination with transitive object properties. In situations where you would want to say something like 'has part exactly 5 digit, you would instead use has_component exactly 5 digit.
+
+
+
+ has component
+
+
+
+
+
@@ -1226,6 +1245,22 @@ A continuant cannot have an occurrent as part: use 'participates in'.
+
+
+
+
+
+ A shortcut relation that is equivalent to:
+('vaccine') and ('has component' some ('vaccine organism' and 'has quality' some 'organismal quality').
+The domain of this relation is a vaccine.
+The range of this relation is a organismal quality.
+ Jie Zheng
+ Oliver He
+ has vaccine organism with quality
+
+
+
+
@@ -1320,6 +1355,22 @@ Ranges: organism and 'has role' some 'pathogen role'
+
+
+
+
+ A shortcut relation that is equivalent to:
+('vaccine' and 'has function' some ('vaccine function' and ('is realized by' some ('vaccine immunization' and 'has participant' some ('organism' and 'has role' some 'laboratory animal model role'))))).
+The domain of this relation is a vaccine.
+The range of this relation is a organism.
+ Jie Zheng
+ Oliver He
+ test in laboratory model
+
+
+
+
+
+
+
+
+
+ GC_ID:1
+ PMID:11214318
+ PMID:11214319
+ PMID:12878460
+ ncbi_taxonomy
+ Laurasiatheria
+
+
+
+
@@ -5369,6 +5436,21 @@ Request that IAO either clarify these or change definitions not to use them
+
+
+
+
+
+ GC_ID:1
+ carnivores
+ ncbi_taxonomy
+ carnivores
+ Carnivora
+
+
+
+
@@ -5457,6 +5539,41 @@ Request that IAO either clarify these or change definitions not to use them
+
+
+
+
+
+ GC_ID:1
+ ncbi_taxonomy
+ Felis
+
+
+
+
+
+
+
+
+
+
+ NCBITaxon:36475
+ GC_ID:1
+ PMID:17600185
+ PMID:8581300
+ PMID:8603894
+ cat
+ cats
+ domestic cat
+ ncbi_taxonomy
+ Felis domesticus
+ Felis silvestris catus
+ Felis catus
+
+
+
+
@@ -6334,9 +6451,9 @@ https://sourceforge.net/p/obi/obi-terms/738/
Melanie Courtot
Oliver He
Ronak Sutariya
+ MeSH: D014612
vaccine
vaccine
- MeSH: D014612
@@ -6484,29 +6601,29 @@ https://sourceforge.net/p/obi/obi-terms/738/
-
+
-
+
-
-
+
+
-
+
-
-
+
+
@@ -6536,7 +6653,7 @@ https://sourceforge.net/p/obi/obi-terms/738/
Kallan Roan
Oliver He
BCG Live
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=351
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=351
351
TICE BCG
For the treatment and prophylaxis of carcinoma in situ (CIS) of the urinary bladder. For the prophylaxis of primary or recurrent state Ta and/or T1 papillary tumors following transurethral resection (TUR).
@@ -6548,11 +6665,40 @@ https://sourceforge.net/p/obi/obi-terms/738/
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ a vaccine organism that is live and attenuated
+ Oliver He
+ organism
+ live attenuated vaccine organism
+
+
+
+
-
- a vaccine component role that inheres in a recombinant vaccine vector as a vaccine component. The combination of a recombinant vaccine vector and a heterogenous protective antigen(s) inserted inside the vector for a recombinant vector vaccine.
+
+ A vaccine vector role that inheres in a recombinant vaccine vector as a vaccine component. The combination of a recombinant vaccine vector and a heterogenous protective antigen(s) inserted inside the vector for a recombinant vector vaccine.
Asiyah Yu Lin
Oliver He
role
@@ -6584,9 +6730,9 @@ https://sourceforge.net/p/obi/obi-terms/738/
A vaccine that targets against a bacterial disease.
Oliver He
+ MeSH: D001428
vaccine
bacterial vaccine
- MeSH: D001428
@@ -6624,6 +6770,12 @@ https://sourceforge.net/p/obi/obi-terms/738/
+
+
+
+
+
+
Vaccine that prevents or treats cancer.
Anna Maria Masci
Barry Smith
@@ -6743,6 +6895,18 @@ https://sourceforge.net/p/obi/obi-terms/738/
+
+
+
+
+ A vaccine role that is not licensed or in clinical trial; instead, it has been experimently approved to induce protection or treatment effect in vivo in at least an experimental animal model.
+ Oliver He
+ role
+ vaccine in research role
+
+
+
+
@@ -6791,7 +6955,7 @@ https://sourceforge.net/p/obi/obi-terms/738/
-
+
@@ -6800,7 +6964,7 @@ https://sourceforge.net/p/obi/obi-terms/738/
-
+
@@ -6910,7 +7074,7 @@ https://sourceforge.net/p/obi/obi-terms/738/
-
+
@@ -6919,7 +7083,7 @@ https://sourceforge.net/p/obi/obi-terms/738/
-
+
@@ -6932,6 +7096,38 @@ https://sourceforge.net/p/obi/obi-terms/738/
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ Allen Xiang
+ Asiyah Yu Lin
+ Oliver He
+ a vaccine organism that is inactived/killed
+ killed vaccine organism
+ organism
+ inactivated vaccine organism
+
+
+
+
@@ -7019,6 +7215,12 @@ https://sourceforge.net/p/obi/obi-terms/738/
+
+
+
+
+
+
@@ -7027,8 +7229,8 @@ https://sourceforge.net/p/obi/obi-terms/738/
Mixed Bacterial Vaccine (MBV, Coley's Toxins) is a historical, vaguely defined preparation of heat-inactivated Streptococcus pyogenes and Serratia marcescens used as non-specific immunotherapy in the treatment of cancer.
Oliver He
- PubMed:22847809
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=6314
+ PMID:22847809
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6314
6314
cancer vaccine
Mixed Bacterial Vaccine
@@ -7083,12 +7285,6 @@ https://sourceforge.net/p/obi/obi-terms/738/
-
-
-
-
-
-
a vaccine that is used for prevention against a disease.
Oliver He
vaccine
@@ -7114,14 +7310,14 @@ https://sourceforge.net/p/obi/obi-terms/738/
-
-
+
+
-
-
+
+
A vaccine that uses a modified virus or bacterium as the vector to deliver vaccine antigen(s) to the cells of the host body.
@@ -7262,7 +7458,7 @@ https://sourceforge.net/p/obi/obi-terms/738/
-
+
@@ -7271,7 +7467,7 @@ https://sourceforge.net/p/obi/obi-terms/738/
-
+
an organism that is used as part of a vaccine
@@ -7339,12 +7535,6 @@ https://sourceforge.net/p/obi/obi-terms/738/
-
-
-
-
-
-
A vaccine that is used for treatment for a disease.
Oliver He
vaccine
@@ -7517,14 +7707,16 @@ https://sourceforge.net/p/obi/obi-terms/738/
-
+
+ Vaccine vector that is a genetically engineered virus or bacterium used to deliver genetic code into the cells within the body.
a vaccine component that uses a microbe (e.g., bacterium, virus, and parasitic organism) as a vector that is inserted with the DNA(s) of a heterologous protective antigen(s) to generate a "recombinant vector vaccine". The microorganism used as a vector generally has a stable non or low pathogenic phenotype for the species the vaccine is intended for.
+ Jie Zheng
Oliver He
recombinant vector
WEB: http://en.wikipedia.org/wiki/Vaccine
@@ -7559,9 +7751,9 @@ https://sourceforge.net/p/obi/obi-terms/738/
A vaccine that targets against a viral disease.
Oliver He
+ MeSH: D014765
vaccine
viral vaccine
- MeSH: D014765
@@ -7649,6 +7841,19 @@ https://sourceforge.net/p/obi/obi-terms/738/
+
+
+
+
+ A vaccine in clinical trial role is a regulation-assigned role that inheres in a vaccine that is currently in clinical trial.
+ In medical research, clinical trials are conducted to allow safety and efficacy data to be collected for new drugs or devices.
+ Oliver He
+ role
+ vaccine in clinical trial role
+
+
+
+
@@ -7700,6 +7905,41 @@ https://sourceforge.net/p/obi/obi-terms/738/
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ Oliver He
+ vaccine
+ licensed cat vaccine
+
+
+
+
@@ -7723,10 +7963,10 @@ https://sourceforge.net/p/obi/obi-terms/738/
a vaccine against human papillomavirus infection
Oliver He
+ SNOMEDCT: 424519000
+ UMLS_CUI: C1512511
vaccine
human papillomavirus vaccine
- SNOMEDCT: 424519000
- UMLS_CUI: C1512511
@@ -7751,7 +7991,7 @@ https://sourceforge.net/p/obi/obi-terms/738/
-
+
@@ -7761,7 +8001,7 @@ https://sourceforge.net/p/obi/obi-terms/738/
-
+
@@ -7857,7 +8097,7 @@ https://sourceforge.net/p/obi/obi-terms/738/
- the vaccine component that is used as antigen to produce an immune responce protect against the specific pathogen or disease.
+ Vaccine component that is used as antigen to produce an immune responce protect against the specific pathogen or disease.
This is a modified or partial form of the virus, bacteria or the toxin that causes the disease against which the vaccine protects. The vaccine antigen is altered from its original form so it no longer causes disease but it can produce an immune response.(Vaccine components FactSheet of NCIRS)
Asiyah Yu Lin
Oliver He
@@ -7869,64 +8109,6 @@ https://sourceforge.net/p/obi/obi-terms/738/
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- a live attenuated quality of a bacterial vaccine strain.
- Oliver He
- quality
- bacterial vaccine organism live attenuated
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- a live attenuated quality of a virus vaccine strain.
- Oliver He
- quality
- viral vaccine organism live attenuated
-
-
-
-
@@ -7944,7 +8126,7 @@ https://sourceforge.net/p/obi/obi-terms/738/
- PubMed:23969885
+ PMID:23969885
cancer vaccine
autologous dendritic cell melanoma vaccine
@@ -7972,7 +8154,7 @@ https://sourceforge.net/p/obi/obi-terms/738/
-
+
@@ -7982,7 +8164,7 @@ https://sourceforge.net/p/obi/obi-terms/738/
-
+
@@ -8002,7 +8184,7 @@ https://sourceforge.net/p/obi/obi-terms/738/
-
+
@@ -8012,7 +8194,7 @@ https://sourceforge.net/p/obi/obi-terms/738/
-
+
@@ -8024,6 +8206,18 @@ https://sourceforge.net/p/obi/obi-terms/738/
+
+
+
+
+ Vaccine that is used for animals (excluding humans), for example, pet, domestic, wildlife, and livestock animals.
+ Oliver He
+ vaccine
+ veterinary vaccine
+
+
+
+
@@ -8032,7 +8226,7 @@ https://sourceforge.net/p/obi/obi-terms/738/
-
+
@@ -8042,18 +8236,13 @@ https://sourceforge.net/p/obi/obi-terms/738/
-
+
a viral vaccine that is live attenuated
Oliver He
vaccine
- This term has an equivalent class:
-'viral vaccine' and ('has quality at some time' some 'vaccine organism live attenuated')
-
-However, running the reasoner takes time. As a way to reducing the time, I have tentatively made tern two subclasses instead of equivalent class. If needed, the equivalent class can be used in SPARQL or converted back in VO. --Oliver
-
live attenuated viral vaccine
@@ -8102,7 +8291,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
+
+
+
+
+
+
@@ -8128,17 +8323,46 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:8306370
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3066
+ PMID:8306370
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3066
https://github.com/vaccineontology/VO/issues/295
3066
- Research
cancer vaccine
B16 Vaccine adjuvanted by Loxoribine
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ Vaccine that used for immunizing cat (felis catus).
+ Asiyah Yu Lin
+ Jie Zheng
+ vaccine
+ cat vaccine
+
+
+
+
@@ -8241,9 +8465,22 @@ However, running the reasoner takes time. As a way to reducing the time, I have
A non-small cell lung cancer mRNA-derived vaccine that contains modified mRNAs encoding cancer-testis antigen NY-ESO-1, melanoma-associated antigens C1 (MAGE-C1/CT7) and C2 (MAGE-C2/CT10), survivin, and the oncofetal antigen 5T4 with potential antitumor and immunomodulatory activities.
Oliver He
Randi Vita
+ CV9201
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/non-small-cell-lung-cancer-mrna-derived-vaccine-cv9201
cancer vaccine
- CV9201
+ CV9201 vaccine
+
+
+
+
+
+
+
+
+ Vaccine component role inheres in a vaccine vector.
+ Jie Zheng
+ role
+ vaccine vector role
@@ -8273,9 +8510,38 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Oliver He
vaccine against Papillomaviridae
https://en.wikipedia.org/wiki/Papillomaviridae
+ MeSH: D053918
vaccine
Papillomaviridae vaccine
- MeSH: D053918
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ Vaccine component that is used to deliver genetic code into the cells to produce antigen.
+ Jie Zheng
+ vaccine component
+ vaccine vector
@@ -8292,6 +8558,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -8320,15 +8592,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:9725239
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3053
+ PMID:9725239
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3053
https://github.com/vaccineontology/VO/issues/369
1489079
3053
- Clinical trial
cancer vaccine
Gene name: E7
- Cancer Vaccine using E7 protein of human papillomavirus 16 and Algammulin
+ cancer vaccine using E7 protein of human papillomavirus 16 and Algammulin
@@ -8345,6 +8616,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -8365,7 +8642,7 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
@@ -8373,16 +8650,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:10931134
- PubMed:9725239
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3054
+ PMID:10931134
+ PMID:9725239
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3054
https://github.com/vaccineontology/VO/issues/370
1489079
3054
- Licensed
cancer vaccine
Gene name: E7
- Cancer Vaccine using E7 protein of human papillomavirus 16 and Quil-A
+ cancer vaccine using E7 protein of human papillomavirus 16 and Quil-A
@@ -8399,6 +8675,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -8420,7 +8702,7 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ningxian Fan
Oliver He
Ronak Sutariya
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3074
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3074
3074
cancer vaccine
Recombinant Colorectal cancer antigen GA733 Vaccine
@@ -8440,6 +8722,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -8461,10 +8749,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ningxian Fan
Oliver He
Ronak Sutariya
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3078
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3078
3078
cancer vaccine
- Recombinant NY-ESO-1 Protein vaccine adjuvanted with Imiquimod
+ recombinant NY-ESO-1 protein vaccine adjuvanted with imiquimod
@@ -8484,8 +8772,8 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
-
+
+
@@ -8494,6 +8782,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -8508,20 +8802,19 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
-
+
+
Eliyas Asfaw
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:28706878
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3081
+ PMID:28706878
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3081
https://github.com/vaccineontology/VO/issues/241
1489079
3081
- Clinical trial
cancer vaccine
Gene name: E7
attenuated Listeria expressing cancer antigen vaccine
@@ -8541,6 +8834,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -8562,10 +8861,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ningxian Fan
Oliver He
Ronak Sutariya
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3085
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3085
3085
cancer vaccine
- Recombinant NY-ESO-1 ISCOMATRIX Vaccine
+ recombinant NY-ESO-1 ISCOMATRIX vaccine
@@ -8580,6 +8879,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -8595,10 +8900,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ningxian Fan
Oliver He
Ronak Sutariya
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3091
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3091
3091
cancer vaccine
- Synthetic MUC1 Peptide Vaccine
+ synthetic MUC1 peptide vaccine
@@ -8615,6 +8920,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -8633,12 +8944,17 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
Ningxian Fan
Oliver He
Ronak Sutariya
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3617
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3617
3617
- VO:0007471
cancer vaccine
Lymphoma DNA vaccine V-Alpha-V-Beta-V-Beta-FrC
@@ -8656,6 +8972,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -8679,10 +9001,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3643
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3643
https://github.com/vaccineontology/VO/issues/175
3643
- Clinical trial
cancer vaccine
Glypican-3-derived peptide vaccine for human hepatocellular carcinoma
@@ -8701,6 +9022,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -8722,25 +9049,24 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
Eliyas Asfaw
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:15879128
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3695
+ PMID:15879128
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3695
https://github.com/vaccineontology/VO/issues/316
8132375
3695
- Research
cancer vaccine
Gene name: Fragment C from tetanus toxin
Cancer DNA vaccine p.DOM-AH1 encoding fragment C
@@ -8760,6 +9086,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -8780,20 +9112,19 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
-
+
+
Eliyas Asfaw
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:18273615
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3696
+ PMID:18273615
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3696
https://github.com/vaccineontology/VO/issues/378
21423
3696
- Research
cancer vaccine
Gene name: E2A
Carcinoma DNA vaccine pVAX/E2A
@@ -8813,6 +9144,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -8834,25 +9171,24 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
Eliyas Asfaw
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:12384547
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3698
+ PMID:12384547
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3698
https://github.com/vaccineontology/VO/issues/292
1945467
3698
- Clinical trial
cancer vaccine
Gene name: Immunoglobulin
B-cell lymphoma DNA vaccine VCL-1642.XXX encoding a chimeric immunoglobulin molecule onsisting of tumor-specific variable (Id) regions
@@ -8872,6 +9208,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -8900,15 +9242,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:12231517
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3699
+ PMID:12231517
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3699
https://github.com/vaccineontology/VO/issues/387
1048
128168861
3699
- Research
cancer vaccine
- Gene name: S|CEA
+ CEA
+ Gene name: S
Colorectal cancer DNA vaccine pCEA/HBsAg encoding carcinoembryonic antigen and hepatitis B surface antigen
@@ -8926,6 +9268,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -8940,7 +9288,7 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
@@ -8948,15 +9296,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:12496961
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3700
+ PMID:12496961
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3700
https://github.com/vaccineontology/VO/issues/294
22178
7306
3700
- Research
cancer vaccine
- Gene name: TYRP1|Gene name: Tyrp1
+ Gene name: TYRP1
+ Gene name: Tyrp1
B16 melanoma DNA vaccine pSin-hTRP-1 encoding TRP-1
@@ -8974,6 +9322,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -8988,7 +9342,7 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
@@ -8996,15 +9350,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:12496961
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3701
+ PMID:12496961
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3701
https://github.com/vaccineontology/VO/issues/293
22178
7306
3701
- Research
cancer vaccine
- Gene name: TYRP1|Gene name: Tyrp1
+ Gene name: TYRP1
+ Gene name: Tyrp1
B16 melanoma DNA vaccine pCMV-hTRP-1 encoding TRP-1
@@ -9022,6 +9376,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -9044,7 +9404,7 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Oliver He
Ronak Sutariya
Melanoma DNA vaccine TA2M(TM) encoding tyrosinase peptides
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3705
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3705
7299
3705
cancer vaccine
@@ -9065,6 +9425,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -9083,11 +9449,17 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
Jie Zheng
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3713
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3713
https://github.com/vaccineontology/VO/issues/518
3713
cancer vaccine
@@ -9109,6 +9481,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -9127,11 +9505,17 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
Jie Zheng
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3717
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3717
https://github.com/vaccineontology/VO/issues/512
2922
3717
@@ -9154,6 +9538,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -9172,17 +9562,24 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
Jie Zheng
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3718
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3718
https://github.com/vaccineontology/VO/issues/514
12981
4100
3718
cancer vaccine
- Gene name: GM-CSF|Gene name: MAGEA1
+ Gene name: GM-CSF
+ Gene name: MAGEA1
Melanoma DNA vaccine pNL3-MAGE-1-GM
@@ -9200,6 +9597,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -9218,17 +9621,24 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
Jie Zheng
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3719
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3719
https://github.com/vaccineontology/VO/issues/513
12981
4100
3719
cancer vaccine
- Gene name: GM-CSF|Gene name: MAGEA1
+ Gene name: GM-CSF
+ Gene name: MAGEA1
Melanoma DNA vaccine pN4a-MAGE-1-GM
@@ -9246,6 +9656,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -9264,11 +9680,17 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
Jie Zheng
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3720
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3720
https://github.com/vaccineontology/VO/issues/516
84004
3720
@@ -9291,6 +9713,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -9315,18 +9743,24 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
Jie Zheng
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3723
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3723
https://github.com/vaccineontology/VO/issues/485
17829
4582
3723
- Clinical trial
cancer vaccine
- Gene name: MUC1|Gene name: Muc1
+ Gene name: MUC1
+ Gene name: Muc1
Lung metastasis DNA vaccine pCEP4-MUC1 encoding MUC1
@@ -9344,6 +9778,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -9362,11 +9802,17 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
Jie Zheng
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3724
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3724
https://github.com/vaccineontology/VO/issues/511
6490
3724
@@ -9389,6 +9835,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -9407,11 +9859,17 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
Jie Zheng
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3726
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3726
https://github.com/vaccineontology/VO/issues/519
20431
3726
@@ -9434,6 +9892,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -9446,17 +9910,24 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
Jie Zheng
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3727
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3727
https://github.com/vaccineontology/VO/issues/509
1067130
1638
3727
cancer vaccine
- Gene name: HUMGP 75|Gene name: TRP-2
+ Gene name: HUMGP 75
+ Gene name: TRP-2
Melanoma DNA vaccine gp75 DNA encoding melanosomal membrane glycoproteins, gp75 Vaccine
@@ -9474,6 +9945,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -9492,11 +9969,17 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
Jie Zheng
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3728
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3728
https://github.com/vaccineontology/VO/issues/521
22178
3728
@@ -9519,6 +10002,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -9531,11 +10020,17 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
Jie Zheng
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3729
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3729
https://github.com/vaccineontology/VO/issues/510
6490
3729
@@ -9558,6 +10053,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -9576,17 +10077,24 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
Jie Zheng
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3730
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3730
https://github.com/vaccineontology/VO/issues/515
104042
55118
3730
cancer vaccine
- Gene name: Ubiquitin|Gene name: Trp2
+ Gene name: Trp2
+ Gene name: Ubiquitin
Melanoma DNA vaccine pUB-TRP-2 encoding a fusion protein linking murine ubiquitin (UB) to the N-terminus of the full-length mTRP-2
@@ -9603,6 +10111,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -9621,10 +10135,16 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
Ningxian Fan
Oliver He
Ronak Sutariya
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3731
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3731
3731
cancer vaccine
Neuroblastoma DNA vaccine HuDsec
@@ -9644,6 +10164,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -9662,10 +10188,16 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
Ningxian Fan
Oliver He
Ronak Sutariya
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3736
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3736
3736
cancer vaccine
Prostate cancer DNA vaccine pcDNA3-STEAP encoding six-transmembrane epithelial antigen
@@ -9685,6 +10217,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -9706,7 +10244,7 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ningxian Fan
Oliver He
Ronak Sutariya
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3737
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3737
3737
cancer vaccine
Prostate cancer DNA vaccine hPSMAt encoding PSMA
@@ -9726,6 +10264,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -9747,7 +10291,7 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ningxian Fan
Oliver He
Ronak Sutariya
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3738
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3738
3738
cancer vaccine
Prostate cancer DNA vaccine rPSMAt encoding PSMA
@@ -9767,6 +10311,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -9785,10 +10335,16 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
Ningxian Fan
Oliver He
Ronak Sutariya
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3740
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3740
3740
cancer vaccine
Prostate cancer DNA vaccine pVax-PSA
@@ -9808,6 +10364,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -9820,10 +10382,16 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
Ningxian Fan
Oliver He
Ronak Sutariya
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3742
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3742
3742
cancer vaccine
Prostate cancer DNA vaccine psig-3P-Fc encoding 3P(hPSM, hPAP, or hPSA)-Fc fusion protein
@@ -9843,6 +10411,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -9861,10 +10435,16 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
Ningxian Fan
Oliver He
Ronak Sutariya
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3744
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3744
3744
cancer vaccine
Prostate cancer DNA vaccine PSCA-HSP encoding PSCA and HSP
@@ -9884,6 +10464,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -9896,10 +10482,16 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
Ningxian Fan
Oliver He
Ronak Sutariya
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3745
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3745
3745
cancer vaccine
Prostate cancer DNA vaccine encoding PSCA
@@ -9919,6 +10511,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -9937,10 +10535,16 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
Ningxian Fan
Oliver He
Ronak Sutariya
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3746
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3746
3746
cancer vaccine
Prostate cancer DNA vaccine pmPSCA encoding PSCA
@@ -9960,6 +10564,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -9982,7 +10592,7 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3768
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3768
https://github.com/vaccineontology/VO/issues/520
7299
3768
@@ -10005,6 +10615,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -10017,10 +10633,16 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
Ningxian Fan
Oliver He
Ronak Sutariya
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3869
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3869
3869
cancer vaccine
B16 melanoma DNA vaccine pSin-mTRP-1
@@ -10040,6 +10662,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -10063,7 +10691,7 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5238
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5238
https://github.com/vaccineontology/VO/issues/286
4102
51438
@@ -10073,10 +10701,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
959
970
5238
- Clinical trial
cancer vaccine
- Gene name: gp100 (PMEL)|Gene name: MAGEA3|Gene name: MAGEC2|Gene name: CD40LG|Gene name: Tyrosinase|Gene name: TLR4|Gene name: CD70
- Autologous TriMix-DC Melanoma Vaccine
+ Gene name: CD40LG
+ Gene name: CD70
+ Gene name: MAGEA3
+ Gene name: MAGEC2
+ Gene name: TLR4
+ Gene name: Tyrosinase
+ Gene name: gp100 (PMEL)
+ autologous TriMix-DC melanoma vaccine
@@ -10092,6 +10725,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -10107,10 +10746,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ningxian Fan
Oliver He
Ronak Sutariya
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3987
+ pCR3.1-VS-HSP65-TP-GRP6-M2
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3987
3987
cancer vaccine
- pCR3.1-VS-HSP65-TP-GRP6-M2
+ pCR3.1-VS-HSP65-TP-GRP6-M2 vaccine
@@ -10126,6 +10766,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -10141,10 +10787,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ningxian Fan
Oliver He
Ronak Sutariya
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4001
+ SRL172
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4001
4001
cancer vaccine
- SRL172
+ SRL172 vaccine
@@ -10160,6 +10807,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -10175,10 +10828,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ningxian Fan
Oliver He
Ronak Sutariya
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4019
+ VMCL
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4019
4019
cancer vaccine
- VMCL
+ VMCL vaccine
@@ -10194,6 +10848,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -10209,10 +10869,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ningxian Fan
Oliver He
Ronak Sutariya
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4025
+ Newcastle disease virus lysate
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4025
4025
cancer vaccine
- Newcastle disease virus lysate
+ Newcastle disease virus lysate vaccine
@@ -10228,6 +10889,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -10243,7 +10910,7 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ningxian Fan
Oliver He
Ronak Sutariya
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4044
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4044
4044
cancer vaccine
smallpox vaccine
@@ -10263,6 +10930,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -10285,8 +10958,8 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Oliver He
Ronak Sutariya
Yuanyi (Penny) Pan
- PubMed:22896657
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4054
+ PMID:22896657
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4054
4054
cancer vaccine
mRNA-electroporated dendritic cells encoding gp100 and tyrosinase as melanoma vaccine
@@ -10305,6 +10978,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -10320,10 +10999,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ningxian Fan
Oliver He
Ronak Sutariya
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4057
+ pcDNA3-MCC/ST
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4057
4057
cancer vaccine
- pcDNA3-MCC/ST
+ pcDNA3-MCC/ST vaccine
@@ -10339,6 +11019,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -10356,13 +11042,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4064
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4064
https://github.com/vaccineontology/VO/issues/557
2315
6490
4064
cancer vaccine
- Gene name: MLANA|Gene name: gp100
+ Gene name: MLANA
+ Gene name: gp100
Multivalent immunotherapeutic vaccine
@@ -10381,6 +11068,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -10408,10 +11101,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ningxian Fan
Oliver He
Ronak Sutariya
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4079
+ short overlapping peptides and full-length recombinant protein
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4079
4079
cancer vaccine
- short overlapping peptides and full-length recombinant protein
+ short overlapping peptides and full-length recombinant protein vaccine
@@ -10428,6 +11122,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -10449,10 +11149,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ningxian Fan
Oliver He
Ronak Sutariya
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4190
+ Poliovirus vector expressing model antigen H2-Kb-restricted CTL epitope
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4190
4190
cancer vaccine
- Poliovirus vector expressing model antigen H2-Kb-restricted CTL epitope
+ poliovirus vector expressing model antigen H2-Kb-restricted CTL epitope vaccine
@@ -10469,6 +11170,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -10491,13 +11198,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4193
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4193
https://github.com/vaccineontology/VO/issues/496
727897
4193
cancer vaccine
Gene name: MUC5B
- Maraba virus MG1 Vaccine
+ Maraba virus MG1 vaccine
@@ -10512,6 +11219,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -10527,10 +11240,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ningxian Fan
Oliver He
Ronak Sutariya
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4198
+ rMeV- SCD
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4198
4198
cancer vaccine
- rMeV- SCD
+ rMeV- SCD vaccine
@@ -10546,6 +11260,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -10561,10 +11281,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ningxian Fan
Oliver He
Ronak Sutariya
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4201
+ rMCMV-TRP2
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4201
4201
cancer vaccine
- rMCMV-TRP2
+ rMCMV-TRP2 vaccine
@@ -10581,6 +11302,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -10610,11 +11337,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:12006514
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4225
+ PMID:12006514
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4225
7157
4225
- Clinical trial
cancer vaccine
Gene name: TP53 (P53)
ALVAC-P53 Vaccine
@@ -10633,6 +11359,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -10654,10 +11386,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ningxian Fan
Oliver He
Ronak Sutariya
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4251
+ rMVTT- HPV16-E6/E7
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4251
4251
cancer vaccine
- rMVTT- HPV16-E6/E7
+ rMVTT- HPV16-E6/E7 vaccine
@@ -10673,6 +11406,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -10685,17 +11424,23 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
Jie Zheng
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4255
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4255
https://github.com/vaccineontology/VO/issues/527
4100
4255
cancer vaccine
Gene name: MAGEA1
- MG1-hDCT Vaccine
+ MG1-hDCT vaccine
@@ -10759,6 +11504,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -10782,10 +11533,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5304
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5304
https://github.com/vaccineontology/VO/issues/77
5304
- Clinical trial
cancer vaccine
(H115D)VHL35 Peptide Vaccine
@@ -10847,7 +11597,7 @@ However, running the reasoner takes time. As a way to reducing the time, I have
A cancer vaccine that is used against colorectal cancer
Oliver He
Yuanyi (Penny) Pan
- PubMed:35990683
+ PMID:35990683
cancer vaccine
colorectal cancer vaccine
@@ -11464,7 +12214,7 @@ However, running the reasoner takes time. As a way to reducing the time, I have
- a grouping class for vaccines for specific diseases
+ Vaccine that prevents or treats specific disease.
Barry Smith
Charles Tapley Hoyt
Jie Zheng
@@ -11546,7 +12296,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
- a grouping class for vaccines for specific platforms
+ Vaccine that is developed and produced by specific technology or method.
+ Barry Smith
+ Charles Tapley Hoyt
+ Jie Zheng
+ Oliver He
+ Xingxian Li
+ https://github.com/vaccineontology/VO/issues/619
vaccine
vaccine by platform type
@@ -11581,6 +12337,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -11596,13 +12358,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A recombinant oncolytic adenovirus encoding the immunohematopoietic cytokine granulocyte-macrophage colony stimulating factor (GM-CSF) with potential antineoplastic activity. Upon administration, the oncolytic adenovirus selectively infects and replicates in tumor cells, which may result in tumor cells lysis. Synergistically, GM-CSF (sargramostim) expressed by the oncolytic adenovirus may promote a cytotoxic T cell response against tumor cells harboring the oncolytic adenovirus, resulting in an immune-mediated tumor cell death.
@@ -11612,12 +12374,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C48412
NCT: https://clinicaltrials.gov/ct2/show/NCT00109655
- PubMed:28530155
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5475
+ PMID:28530155
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5475
https://github.com/vaccineontology/VO/issues/75
1437
5475
- Clinical trial
cancer vaccine
Gene name: CSF-2
Oncolytic Adenovirus Encoding GM-CSF Vaccine
@@ -11637,6 +12398,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -11652,13 +12419,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A non-replicating recombinant adenovirus type 5 (Ad5)-vector encoding the gene for interferon alpha-2b (IFN_2b) and the gene transfer enhancement agent Syn 3, with potential antineoplastic activity. Upon intravesical administration, recombinant adenovirus-interferon with Syn3 transfects both cancerous and normal bladder cells, and the adenovirus secretes interferon (IFN_2b) into the bladder. IFN exerts a direct antitumor killing effect and a bystander effect, thereby killing adjacent, non-transfected cancerous bladder cells. Syn 3 enhances the ability of the adenoviral vector to transfect cells.
@@ -11668,12 +12435,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C104743
NCT: https://clinicaltrials.gov/ct2/show/NCT02773849
- PubMed:28834453
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5047
+ PMID:28834453
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5047
https://github.com/vaccineontology/VO/issues/322
3440
5047
- Clinical trial
cancer vaccine
Gene name: IFNA2
Recombinant Adenovirus-Interferon/Syn3 Vaccine
@@ -11693,6 +12459,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -11708,13 +12480,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A cancer vaccine adjuvant consisting of a recombinant fowlpox virus encoding human granulocyte-macrophage colony-stimulating factor (GM-CSF). GM-CSF binds to specific cell surface receptors on various immuno-hematopoietic cell types, enhancing their proliferation and differentiation and stimulating macrophage and dendritic cell functions in antigen presentation and antitumor cell-mediated immunity. Administration of recombinant fowlpox GM-CSF vaccine adjuvant may induce an immune response against tumor cells. Fowlpox virus is an attractive vector because its genome is easy to manipulate and it is replication incompetent in mammalian cells.
@@ -11724,12 +12496,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2686
NCT: https://clinicaltrials.gov/ct2/show/NCT00072137
- PubMed:15780740
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4994
+ PMID:15780740
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4994
https://github.com/vaccineontology/VO/issues/328
1437
4994
- Clinical trial
cancer vaccine
Gene name: GM-CSF
Recombinant Fowlpox GM-CSF Vaccine Adjuvant
@@ -11749,6 +12520,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -11764,13 +12541,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A peptide vaccine derived from cytomegalovirus (CMV) antigens with potential immunostimulating activity. Intradermal administration of the PEP-CMV vaccine may stimulate the immune system to mount a specific helper and cytotoxic T-lymphocyte (CTL) response against CMV-infected tumor cells. Infection with the herpesvirus CMV may play a significant role in tumor cell initiation and progression as well as chemoresistance.
@@ -11780,12 +12557,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C107243
NCT: https://clinicaltrials.gov/ct2/show/NCT02864368
- PubMed:31806885
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5259
+ PMID:31806885
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5259
https://github.com/vaccineontology/VO/issues/118
18826
5259
- Clinical trial
cancer vaccine
Gene name: pp65(Lcp 1)
PEP-CMV Vaccine
@@ -11805,6 +12581,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -11820,13 +12602,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A cancer vaccine consisting of a human epidermal growth factor receptor variant III (EGFRvIIi)-specific peptide conjugated to the non-specific immunomodulator keyhole limpet hemocyanin (KLH) with potential antineoplastic activity. Vaccination with rindopepimut may elicit a cytotoxic T-lymphocyte (CTL) immune response against tumor cells expressing EGFRvIII. EGFRvIII, a functional variant of EGFR that is not expressed in normal tissues, was originally discovered in glioblastoma multiforme (GBM) and has also been found in various other cancers such as breast, ovarian, metastatic prostate, colorectal, and head and neck cancers. EGFRvIII contains an 83 amino acid deletion in its extracellular domain and has been shown to transform NIH/3T3 mouse embryonic fibroblast cells in vitro.
@@ -11836,12 +12618,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C69076
NCT: https://clinicaltrials.gov/ct2/show/NCT01498328
- PubMed:28844499
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5032
+ PMID:28844499
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5032
https://github.com/vaccineontology/VO/issues/120
1956
5032
- Clinical trial
cancer vaccine
Gene name: EGFR
PF-04948568 Vaccine
@@ -11861,6 +12642,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -11876,13 +12663,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
Jie Zheng
@@ -11890,12 +12677,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Oliver He
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C29786
- PubMed:21078216
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5192
+ PMID:21078216
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5192
https://github.com/vaccineontology/VO/issues/324
945006
5192
- Clinical trial
cancer vaccine
Gene name: lacZ
Recombinant Adenovirus-LacZ Vaccine
@@ -11915,6 +12701,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -11940,9 +12732,8 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C116332
NCT: https://clinicaltrials.gov/ct2/show/NCT02149225
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5086
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5086
5086
- Clinical trial
cancer vaccine
Synthetic Glioblastoma Mutated Tumor-specific Peptides Vaccine Therapy APVAC2
@@ -11961,6 +12752,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -11986,10 +12783,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C116331
NCT: https://clinicaltrials.gov/ct2/show/NCT02149225
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5231
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5231
1956
5231
- Clinical trial
cancer vaccine
Gene name: EGFR
Synthetic Glioblastoma Tumor-associated Peptides Vaccine Therapy APVAC1
@@ -12015,6 +12811,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -12034,11 +12836,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C99378
NCT: https://clinicaltrials.gov/ct2/show/NCT02718443
- PubMed:29632710
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5521
+ PMID:29632710
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5521
3791
5521
- Clinical trial
cancer vaccine
Gene name: KDR
VEGFR-2 DNA Vaccine VXM01
@@ -12058,6 +12859,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -12073,13 +12880,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A cancer peptide vaccine comprised of a human leukocyte antigen (HLA) A2/A3 restricted HER2/neu (ERBB2) peptide from the extracellular domain of the HER2 protein (E75 peptide) and combined with the immunoadjuvant granulocyte-macrophage colony-stimulating factor (GM-CSF), with potential immunomodulating and antineoplastic activity. Upon intradermal injection, nelipepimut-S plus GM-CSF vaccine may induce a specific cytotoxic T-lymphocyte (CTL) response against HER2/neu-expressing tumor cell types. HER2/neu, a tumor-associated antigen and a member of the epidermal growth factor receptor family of tyrosine kinases, is overexpressed in various tumor cell types. GM-CSF potentiates the antitumor immune response.
@@ -12089,12 +12896,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C99228
NCT: https://clinicaltrials.gov/ct2/show/NCT02636582
- PubMed:33485895
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5363
+ PMID:33485895
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5363
https://github.com/vaccineontology/VO/issues/54
2064
5363
- Clinical trial
cancer vaccine
Gene name: ERBB2
Nelipepimut-S Plus GM-CSF Vaccine
@@ -12114,6 +12920,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -12129,13 +12941,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A cancer vaccine consisting of one or more long, synthetic peptides derived from patient-specific breast cancer tumor-associated antigens (TAAs), with potential immunomodulating and antineoplastic activities. Upon intramuscular administration of the personalized synthetic long peptide breast cancer vaccine, the peptides stimulate the host immune system to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing the TAAs, which results in tumor cell lysis.
@@ -12145,9 +12957,8 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C121947
NCT: https://clinicaltrials.gov/ct2/show/NCT02427581
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5348
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5348
5348
- Clinical trial
cancer vaccine
Personalized Synthetic Long Peptide Breast Cancer Vaccine
@@ -12172,6 +12983,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -12181,13 +12998,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A plasmid DNA cancer vaccine encoding the intracellular domain (ICD) of the HER-2/neu proto-oncogene. Upon administration and after cellular uptake by skin or muscle cells, the pNGVL3-hICD vaccine plasmid expresses the HER-2/neu protein, which, after intracellular processing, may elicit both antigen-specific cytotoxic T-lymphocyte (CTL) and humoral immune responses against tumor cells expressing HER-2. The HER-2/neu ICD protein is highly immunogenic and, as a subdominant epitope, may be associated with decreased immune tolerance.
@@ -12197,11 +13014,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C61146
NCT: https://clinicaltrials.gov/ct2/show/NCT05163223
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5040
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5040
https://github.com/vaccineontology/VO/issues/122
2064
5040
- Clinical trial
cancer vaccine
Gene name: ERBB2
pNGVL3-hICD Vaccine
@@ -12221,6 +13037,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -12236,13 +13058,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
Jie Zheng
@@ -12250,11 +13072,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Oliver He
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C29785
- PubMed:11590241
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5530
+ PMID:11590241
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5530
https://github.com/vaccineontology/VO/issues/320
5530
- Clinical trial
cancer vaccine
Recombinant Adenovirus-Cre Recombinase Vaccine
@@ -12273,6 +13094,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -12288,13 +13115,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
An immunotherapeutic composed of the Wilms tumor 1 (WT1) and an as of yet undisclosed adjuvant, with potential antineoplastic activity. Upon administration, the immune system may be stimulated to exert a cytotoxic T-lymphocyte (CTL) response against WT1-expressing tumor cells. The adjuvant stimulates the immune system's response to WT1. WT1, a tumor-associated antigen (TAA) and transcription factor, is overexpressed in a variety of tumor cell types.
@@ -12304,12 +13131,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C116880
NCT: https://clinicaltrials.gov/ct2/show/NCT01220128
- PubMed:30562862
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5297
+ PMID:30562862
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5297
https://github.com/vaccineontology/VO/issues/326
7490
5297
- Clinical trial
cancer vaccine
Gene name: WT1
Recombinant Anti-WT1 Immunotherapeutic GSK2302024A Vaccine
@@ -12335,6 +13161,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -12354,11 +13186,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C49177
NCT: https://clinicaltrials.gov/ct2/show/NCT00140738
- PubMed:26975189
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5241
+ PMID:26975189
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5241
2064
5241
- Clinical trial
cancer vaccine
Gene name: ERBB2
Recombinant dHER2 Vaccine
@@ -12378,6 +13209,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -12403,11 +13240,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C102782
NCT: https://clinicaltrials.gov/ct2/show/NCT00004156
- PubMed:9656453
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5077
+ PMID:9656453
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5077
4582
5077
- Clinical trial
cancer vaccine
Gene name: MUC1
Recombinant Human MUC1-Oxidized Polymannose-pulsed Autologous Dendritic Cell Vaccine
@@ -12427,6 +13263,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -12442,13 +13284,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A cancer vaccine comprised of a recombinant modified vaccinia Ankara (MVA) viral vector encoding the 5T4 fetal oncoprotein (MVA-h5T4). Vaccination with recombinant modified vaccinia Ankara-5T4 vaccine may stimulate the host immune system to mount a humoral and cytotoxic T lymphocyte (CTL) response against tumor cells expressing 5T4 fetal oncoprotein antigen, resulting in tumor cell lysis. The MVA viral vector, derived from the replication-competent strain Ankara, is a highly attentuated, replication-defective vaccinia strain incapable of virion assembly.
@@ -12458,12 +13300,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C49087
NCT: https://clinicaltrials.gov/ct2/show/NCT00227474
- PubMed:18990081
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5058
+ PMID:18990081
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5058
https://github.com/vaccineontology/VO/issues/337
7162
5058
- Clinical trial
cancer vaccine
Gene name: TPBG
Recombinant Modified Vaccinia Ankara-5T4 Vaccine
@@ -12483,6 +13324,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -12498,13 +13345,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A vaccinia virus based vaccine expressing human tumor associated epithelial mucin (DF3 antigen; MUC1). MUC1 antigen, a membrane bound glycoprotein expressed by most glandular and ductal epithelial cells, is overexpressed in various tumors such as breast, prostate, and ovarian cancers. This vaccine could be used in development of immunotherapeutics against cancers expressing MUC1.
@@ -12514,15 +13361,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2510
NCT: https://clinicaltrials.gov/ct2/show/NCT00071942
- PubMed:9101412
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5281
+ PMID:9101412
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5281
https://github.com/vaccineontology/VO/issues/338
354
4582
5281
- Clinical trial
cancer vaccine
- Gene name: MUC1|Gene name: KLK3
+ Gene name: KLK3
+ Gene name: MUC1
Recombinant Vaccinia DF3/MUC1 Vaccine
@@ -12540,6 +13387,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -12555,13 +13408,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A vaccine containing a recombinant vaccinia virus that encodes the gene for human mucin-1, a tumor-associated antigen. Upon administration, recombinant vaccinia-MUC-1 vaccine may elicit a MUC-1-specific cytotoxic T cell response against tumor cells bearing MUC-1.
@@ -12571,12 +13424,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2732
NCT: https://clinicaltrials.gov/ct2/show/NCT00071942
- PubMed:12898638
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5321
+ PMID:12898638
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5321
https://github.com/vaccineontology/VO/issues/347
4582
5321
- Clinical trial
cancer vaccine
Gene name: MUC1
Recombinant Vaccinia-MUC-1 Vaccine
@@ -12602,6 +13454,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -12611,13 +13469,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A vaccine containing a pancarcinoma carbohydrate antigen conjugated with keyhole limpet hemocyanin (KLH), with potential antineoplastic activity. Sialylated Tn antigen (sTn) is a monosaccharide glycan usually O-linked to serine or threonine residues of mucins found on most epithelial cancers. Conjugation with KLH, a hapten carrier and an immunostimulant, improves host immune responses. Vaccination with sTn-KLH vaccine may produce antibodies and elicit a cytotoxic T lymphocyte (CTL) response against those tumor cells expressing sTn, resulting in decreased tumor growth.
@@ -12627,11 +13485,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1690
NCT: https://clinicaltrials.gov/ct2/show/NCT00003638
- PubMed:23983823
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5425
+ PMID:23983823
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5425
https://github.com/vaccineontology/VO/issues/361
5425
- Clinical trial
cancer vaccine
Gene name: sialyl-Tn
Sialyl Tn-KLH Vaccine
@@ -12657,6 +13514,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -12666,13 +13529,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A vaccine comprised of a synthetic Sialyl-Tn antigen linked to the protein carrier, keyhole limpet hemocyanin (KLH), administered with immunostimulant, Detox. Vaccination with STn-KLH plus Detox may elicit an IgG-based anti-STn antibody response and ultimately a cytotoxic T-cell response against STn-expressing cancer cells.
@@ -12682,11 +13545,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2501
NCT: https://clinicaltrials.gov/ct2/show/NCT00003638
- PubMed:7690215
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5061
+ PMID:7690215
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5061
https://github.com/vaccineontology/VO/issues/363
5061
- Clinical trial
cancer vaccine
Gene name: sialyl-Tn
STn-KLH plus Detox Vaccine
@@ -12707,6 +13569,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -12738,10 +13606,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C61076
NCT: https://clinicaltrials.gov/ct2/show/NCT00304096
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5271
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5271
6007
5271
- Clinical trial
cancer vaccine
Gene name: RHD
Synthetic Breast Cancer Peptides-Tetanus Toxoid-Montanide ISA-51 Vaccine
@@ -12774,6 +13641,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -12793,10 +13666,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2474
NCT: https://clinicaltrials.gov/ct2/show/NCT00030823
- PubMed:9579798
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5025
+ PMID:9579798
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5025
5025
- Clinical trial
cancer vaccine
Tn(c)-KLH Conjugate Vaccine
@@ -12815,6 +13687,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -12840,12 +13718,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C85466
NCT: https://clinicaltrials.gov/ct2/show/NCT00900809
- PubMed:18425107
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5026
+ PMID:18425107
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5026
https://github.com/vaccineontology/VO/issues/50
107653060
5026
- Clinical trial
cancer vaccine
Gene name: IL12
Natural Killer Cells ZRx101 vaccine
@@ -12867,6 +13744,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -12894,13 +13777,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A cancer vaccine consisting of an immunogenic peptide derived from the cancer-testis antigen (NY-ESO-1), an antigen found in normal testis and various tumors. Vaccination with NY-ESO-1 peptide vaccine may stimulate the host immune system to mount a humoral and cytotoxic T lymphocyte (CTL) response to cells expressing NY-ESO-1 antigen, resulting in tumor cell lysis.
@@ -12910,12 +13793,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2657
NCT: https://clinicaltrials.gov/ct2/show/NCT05479045
- PubMed:24397899
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5206
+ PMID:24397899
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5206
https://github.com/vaccineontology/VO/issues/55
1485
5206
- Clinical trial
cancer vaccine
Gene name: CTAG1B
NY-ESO-1 peptide vaccine
@@ -12945,6 +13827,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -12978,13 +13866,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A plasmid DNA encoding an immunogenic peptide derived from the cancer-testis antigen NY-ESO-1 with potential immunostimulating and antitumor activities. Upon administration, NY-ESO-1 plasmid DNA cancer vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells expressing the NY-ESO-1 antigen, resulting in tumor cell lysis. NY-ESO-1 is a tumor associated antigen (TAA) found in normal testes and expressed on the surfaces of various tumor cells, including melanoma, breast, bladder, prostate, lung, ovarian, and hepatocellular tumor cells.
@@ -12994,14 +13882,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C62452
NCT: https://clinicaltrials.gov/ct2/show/NCT00199849
- PubMed:15102697
- PubMed:21900253
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5283
+ PMID:15102697
+ PMID:21900253
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5283
https://github.com/vaccineontology/VO/issues/56
https://github.com/vaccineontology/VO/issues/58
1485
5283
- Clinical trial
cancer vaccine
Gene name: CTAG1B
NY-ESO-1 plasmid DNA cancer vaccine
@@ -13025,6 +13912,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -13064,13 +13957,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A cancer vaccine composed of a recombinant form of the tumor antigen NY-ESO-1 and glucopyranosyl lipid adjuvant (GLA)-stable emulsion (GLA-SE), with potential antineoplastic and immunomodulating activities. Upon intramuscular injection, the adjuvant portion of the NY-ESO-1/GLA-SE vaccine ID-G30 binds to toll-like receptor subtype 4 (TLR-4) expressed on dendritic cells (DCs), monocytes, macrophages and B cells. The activated DCs present the NY-ESO-1 antigen to Th1 CD4 T-lymphocytes. This leads to the induction of cytotoxic T lymphocytes (CTLs) and the killing of NY-ESO-1-expressing tumor cells. This vaccine also induces specific antibody responses and increases the production of inflammatory cytokines.
@@ -13080,15 +13973,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C113432
NCT: https://clinicaltrials.gov/ct2/show/NCT02015416
- PubMed:31069460
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5445
+ PMID:31069460
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5445
https://github.com/vaccineontology/VO/issues/85
1485
7099
5445
- Clinical trial
cancer vaccine
- Gene name: CTAG1B|Gene name: TLR4
+ Gene name: CTAG1B
+ Gene name: TLR4
NY-ESO-1/GLA-SE vaccine ID-G305AmN
@@ -13106,6 +13999,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -13127,13 +14026,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A recombinant nonapeptide used as an antineoplastic vaccine. NY-ESO-1b peptide vaccine contains the amino acid sequence SLLMWITQC, derived from the cancer-testis tumor antigen (NY-ESO-1), which is expressed on tumor cells of many different types, including melanomas. Vaccination with this peptide vaccine may elicit strong humoral and cellular immune responses to NY-ESO-1-expressing cancers.
@@ -13143,12 +14042,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C68999
NCT: https://clinicaltrials.gov/ct2/show/NCT00199836
- PubMed:15501973
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5428
+ PMID:15501973
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5428
https://github.com/vaccineontology/VO/issues/112
1485
5428
- Clinical trial
cancer vaccine
Gene name: CTAG1B
NY-ESO-1b peptide vaccine
@@ -13178,6 +14076,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -13211,13 +14115,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A tumor-associated antigen belonging to the family of immunogenic testicular proteins that are aberrantly expressed in human cancers in a lineage-nonspecific fashion. Reverse transcription-PCR analysis showed NY-ESO-1 mRNA expression in a variable proportion of a wide array of human cancers, including melanoma, breast cancer, bladder cancer, prostate cancer, and hepatocellular carcinoma; and restricted expression in normal tissues, with high-level mRNA expression found only in testis and ovary tissues. The gene for NY-ESO-1 maps to Xq28 and codes for an 18-kDa protein having no homology with any known protein. NY-ESO-1 elicits a strong, integrated humoral and cellular immune response in a high proportion of patients with NY-ESO-1-expressing tumors and is under investigation as a cancer immunotherapy agent.
@@ -13226,14 +14130,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Oliver He
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C26680
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5182
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5182
https://github.com/vaccineontology/VO/issues/76
1485
5182
- Clinical trial
cancer vaccine
Gene name: CTAG1B
- NY-ESO-B Vaccine
+ NY-ESO-B vaccine
@@ -13250,6 +14153,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -13277,13 +14186,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
An E1B-55kDa-deleted adenovirus that is able to selectively replicate in and lyse TP53-deficient human tumor cells. After tumor cell lysis, released viruses infect neighboring tumor cells, tripping a chain of ONYX-015-mediated tumor cell cytotoxicity.
@@ -13293,15 +14202,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2830
NCT: https://clinicaltrials.gov/ct2/show/NCT00006106
- PubMed:11892945
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5486
+ PMID:11892945
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5486
https://github.com/vaccineontology/VO/issues/73
7157
5486
- Clinical trial
cancer vaccine
Gene name: TP53
- ONYX-015 Vaccine
+ ONYX-015 vaccine
@@ -13319,6 +14227,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -13340,13 +14254,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A peptide-based cancer vaccine composed of amino acids 264 to 272 of the wild-type protein encoded by the P53 gene. p53 peptide vaccine may elicit an HLA-A2.1-restricted cytotoxic T lymphocyte immune response against tumor cells that overexpress p53 protein.
@@ -13356,14 +14270,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1986
NCT: https://clinicaltrials.gov/ct2/show/NCT00001827
- PubMed:24583792
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5255
+ PMID:24583792
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5255
7157
5255
- Clinical trial
cancer vaccine
Gene name: TP53
- p53 Peptide Vaccine
+ p53 peptide vaccine
@@ -13379,6 +14292,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -13394,13 +14313,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A peptide-based vaccine containing a pan HLA DR-binding epitope (PADRE) fused to a cytomegalovirus (CMV) peptide epitope, with potential anti-viral and immunomodulating activities. Upon administration, PADRE-CMV fusion peptide may stimulate a cytotoxic T-lymphocyte (CTL) response against CMV in the CMV-infected host. The synthetic peptide PADRE is a universal helper T cell epitope.
@@ -13410,12 +14329,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C78820
NCT: https://clinicaltrials.gov/ct2/show/NCT00722839
- PubMed:22402037
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5441
+ PMID:22402037
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5441
5441
- Clinical trial
cancer vaccine
- PADRE-CMV Fusion Peptide Vaccine
+ PADRE-CMV fusion peptide vaccine
@@ -13431,6 +14349,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -13446,13 +14370,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A synthetic HIV-1 envelope peptide that was developed for use as a vaccine. Vaccination with PCLUS 3-18MN may stimulate the host immune system to mount cytotoxic T lymphocyte (CTL) and T helper cell responses, and induce the production of neutralizing antibodies.
@@ -13462,13 +14386,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2786
NCT: https://clinicaltrials.gov/ct2/show/NCT00001386
- PubMed:10546852
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5451
+ PMID:10546852
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5451
https://github.com/vaccineontology/VO/issues/115
5451
- Clinical trial
cancer vaccine
- PCLUS 3-18MN Vaccine
+ PCLUS 3-18MN vaccine
@@ -13484,6 +14407,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -13499,13 +14428,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A synthetic HIV-1 envelope peptide that was developed for use as a vaccine. Vaccination with PCLUS 6.1-18MN may stimulate the host immune system to mount cytotoxic T lymphocyte (CTL) and T helper cell responses, and induce the production of neutralizing antibodies.
@@ -13515,13 +14444,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2787
NCT: https://clinicaltrials.gov/ct2/show/NCT00001386
- PubMed:10546852
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5443
+ PMID:10546852
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5443
https://github.com/vaccineontology/VO/issues/116
5443
- Clinical trial
cancer vaccine
- PCLUS 6.1-18MN Vaccine
+ PCLUS 6.1-18MN vaccine
@@ -13539,6 +14467,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -13570,14 +14504,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2718
NCT: https://clinicaltrials.gov/ct2/show/NCT02795988
- PubMed:29448628
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5176
+ PMID:29448628
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5176
2064
5176
- Clinical trial
cancer vaccine
Gene name: ERBB2
- Poly Microsphere Encapsulated HER2/neu Oral Vaccine
+ poly microsphere encapsulated HER2/neu oral vaccine
@@ -13596,6 +14529,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -13623,13 +14562,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A cancer vaccine containing a RAS oncogene-encoded peptide with potential antineoplastic activity. RAS peptide cancer vaccine may stimulate a RAS peptide-specific antitumoral T-cell cytotoxic immune response, resulting in an inhibition of tumor cell proliferation and tumor cell death.
@@ -13639,15 +14578,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2438
NCT: https://clinicaltrials.gov/ct2/show/NCT00019006
- PubMed:33016924
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5320
+ PMID:33016924
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5320
https://github.com/vaccineontology/VO/issues/189
3845
5320
- Clinical trial
cancer vaccine
Gene name: KRAS
- RAS Peptide Cancer Vaccine
+ RAS peptide cancer vaccine
@@ -13663,6 +14601,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -13678,13 +14622,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A cancer vaccine comprised of a recombinant fowlpox virus vector encoding the stimulatory molecule transgene B7-1. Recombinant fowlpox-B7.1 (rF-B7.1) vaccine may enhance antigen presentation and activate antitumoral cytotoxic T-cells.
@@ -13694,15 +14638,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2666
NCT: https://clinicaltrials.gov/ct2/show/NCT00030693
- PubMed:12969559
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5424
+ PMID:12969559
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5424
https://github.com/vaccineontology/VO/issues/329
941
5424
- Clinical trial
cancer vaccine
Gene name: CD80
- Recombinant Fowlpox-B7.1 Vaccine
+ recombinant Fowlpox-B7.1 vaccine
@@ -13718,6 +14661,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -13733,13 +14682,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A cancer vaccine comprised of a recombinant fowlpox virus vector encoding the carcinoembryonic antigen (CEA) and a TRIad of COstimulatory Molecules (B7-1, ICAM-1 and LFA-3) (TRICOM). This agent may enhance CEA presentation to antigen presenting cells (APC) and activate cytotoxic T-cells against CEA-expressing tumors.
@@ -13749,14 +14698,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2620
NCT: https://clinicaltrials.gov/ct2/show/NCT00028496
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5049
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5049
https://github.com/vaccineontology/VO/issues/330
1048
5049
- Clinical trial
cancer vaccine
Gene name: CEACAM5
- Recombinant Fowlpox-CEA(6D)/TRICOM Vaccine
+ recombinant Fowlpox-CEA(6D)/TRICOM vaccine
@@ -13772,6 +14720,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -13797,14 +14751,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C82371
NCT: https://clinicaltrials.gov/ct2/show/NCT00924092
- PubMed:22862954
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5152
+ PMID:22862954
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5152
1048
5152
- Clinical trial
cancer vaccine
Gene name: CEACAM5 (CEA)
- Recombinant Saccharomyces Cerevisia-CEA(610D)-Expressing Vaccine GI-6207
+ recombinant Saccharomyces Cerevisia-CEA(610D)-expressing vaccine GI-6207
@@ -13820,6 +14773,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -13835,13 +14794,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A vaccine consisting of recombinant vaccinia virus encoding the tumor-associated antigen carcinoembryonic antigen (CEA) and a TRIad of COstimulatory Molecules (B7-1, ICAM-1, and LFA-3; also called TRICOM). Vaccination with recombinant vaccinia-CEA(6D)-TRICOM vaccine stimulates the host immune system to mount a T-cell response against tumor cells expressing the CEA antigen. The use of TRICOM in the vaccine may elicit a greater antitumor cytotoxic T lymphocyte (CTL) immune response compared to the use of vaccinia-CEA alone.
@@ -13851,15 +14810,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2619
NCT: https://clinicaltrials.gov/ct2/show/NCT00217373
- PubMed:27581603
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5037
+ PMID:27581603
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5037
https://github.com/vaccineontology/VO/issues/342
111518
5037
- Clinical trial
cancer vaccine
Gene name: Cea-Mouse
- Recombinant Vaccinia-CEA(6D)-TRICOM Vaccine
+ recombinant Vaccinia-CEA(6D)-TRICOM vaccine
@@ -13879,6 +14837,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -13912,13 +14876,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
An admixture of recombinant vaccinia virus encoding MUC-1 and recombinant vaccinia virus encoding the murine T-cell co-stimulatory molecule B7.1. MUC-1 is a glycosylated mucin that is overexpressed in breast, lung, pancreatic, prostate, stomach, colon, and ovarian carcinomas. Vaccination with MUC-1 in combination with B7.1 may enhance the cytotoxic T cell (CTL) immune response to tumors expressing MUC-1, compared to vaccination with MUC-1 alone.
@@ -13927,16 +14891,16 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Oliver He
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29409
- PubMed:9101412
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5326
+ PMID:9101412
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5326
https://github.com/vaccineontology/VO/issues/348
12519
4582
5326
- Clinical trial
cancer vaccine
- Gene name: MUC1|Gene name: Cd80
- Recombinant Vaccinia-MUC1-B7 Vaccine
+ Gene name: Cd80
+ Gene name: MUC1
+ recombinant Vaccinia-MUC1-B7 vaccine
@@ -13952,6 +14916,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -13967,13 +14937,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A cancer vaccine consisting of a recombinant vaccinia viral vector encoding an immunogenic peptide derived from the cancer-testis antigen NY-ESO-1, an antigen found in normal testis and various tumors, including bladder, breast, hepatocellular, melanoma, and prostate cancers. Vaccination with recombinant vaccinia- NY-ESO-1 peptide vaccine may stimulate the host immune system to mount a humoral and cytotoxic T lymphocyte (CTL) response against tumor cells expressing NY-ESO-1 antigen, resulting in tumor cell lysis.
@@ -13983,15 +14953,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C48419
NCT: https://clinicaltrials.gov/ct2/show/NCT00112957
- PubMed:29773080
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5389
+ PMID:29773080
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5389
https://github.com/vaccineontology/VO/issues/349
1485
5389
- Clinical trial
cancer vaccine
Gene name: CTAG1B
- Recombinant Vaccinia-NY-ESO-1 Vaccine
+ recombinant Vaccinia-NY-ESO-1 vaccine
@@ -14016,6 +14985,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -14037,13 +15012,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A replication-incompetent, pathotropic, tumor matrix (collagen)-targeted, retroviral vector encoding an N-terminal deletion mutant form of the cyclin G1 gene with potential antineoplastic activity. Under the control of a hybrid long-terminal repeat/cytomegalovirus (CMV) promoter, retrovector encoding mutant anti-cyclin G expresses the mutant cyclin G1 construct, resulting in disruption of tumor cell cyclin G1 activity and decreased cellular proliferation and angiogenesis. This agent preferentially targets collagen of the tumor matrix because of the incorporation of the collagen-binding domain of von Willebrand factor (vWF) on the retrovector surface. Exploiting the collagen-targeting mechanism of vWF permits delivery of the retrovector to tumor sites where angiogenesis and collagen matrix exposure occur.
@@ -14053,14 +15028,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C49082
NCT: https://clinicaltrials.gov/ct2/show/NCT00505271
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5437
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5437
https://github.com/vaccineontology/VO/issues/355
900
5437
- Clinical trial
cancer vaccine
Gene name: CCNG1
- Retrovector Encoding Mutant Anti-Cyclin G1 Vaccine
+ retrovector encoding mutant Anti-Cyclin G1 vaccine
@@ -14084,6 +15058,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -14109,16 +15089,17 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C114285
NCT: https://clinicaltrials.gov/ct2/show/NCT00978913
- PubMed:16096014
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5180
+ PMID:16096014
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5180
2064
373110
7157
5180
- Clinical trial
cancer vaccine
- Gene name: Survivin|Gene name: ERBB2|Gene name: p53
- Survivin/p53/HER2 Antigen-loaded Autologous Dendritic Cell Vaccine
+ Gene name: ERBB2
+ Gene name: Survivin
+ Gene name: p53
+ survivin/p53/HER2 antigen-loaded autologous dendritic cell vaccine
@@ -14136,6 +15117,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -14157,13 +15144,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A peptide vaccine containing a 15-mer peptide (DLAQMFFCFKELEGW), with C to M alteration at amino acid position 57, derived from the anti-apoptosis protein survivin, and conjugated with keyhole limpet hemocyanin (KLH), with potential immunopotentiating and antineoplastic activities. Upon subcutaneous administration of SVN53-67/M57-KLH peptide vaccine, this peptide is able to bind both HMC class I and II molecules and may activate the immune system to mount a cytotoxic T-lymphocyte (CTL) as well as a T-helper cell response against survivin-expressing cancer cells. This may result in decreased tumor cell proliferation and ultimately tumor cell death. Survivin, a member of the inhibitor of apoptosis (IAP) family, expressed during embryonic development while absent in most normal adult cells, is upregulated in a variety of human cancers; its expression in tumors is associated with a more aggressive phenotype, decreased survival, and increased resistance to chemotherapy. KLH may enhance immune recognition and may promote an enhanced response. As SVN53-67 is weakly immunogenic in humans, the M57 alteration may lead to greater affinity towards HLA-A*0201 and thus an enhanced antitumor immune response.
@@ -14173,15 +15160,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C95705
NCT: https://clinicaltrials.gov/ct2/show/NCT02334865
- PubMed:27576783
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5008
+ PMID:27576783
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5008
https://github.com/vaccineontology/VO/issues/405
373110
5008
- Clinical trial
cancer vaccine
Gene name: Survivin
- SVN53-67/M57-KLH Peptide Vaccine
+ SVN53-67/M57-KLH peptide vaccine
@@ -14196,6 +15182,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -14205,13 +15197,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A DNA vaccine consisting of a plasmid encoding the full-length sequence of the tumor-associated antigen (TAA) human telomerase reverse transcriptase (hTERT), which is the catalytic subunit of human telomerase and synthesizes telomeric DNA at the chromosome ends, containing two immunogenic mutations, with potential immunostimulating and antineoplastic activities. Upon intradermal vaccination of the hTERT-encoding DNA vaccine INO-1400 in combination with electroporation, hTERT protein is expressed and activates the immune system to mount a cytotoxic T-cell (CTL) response against telomerase-expressing tumor cells, which may result in tumor cell death. Telomerase prolongs the functional lifespan of cells via the restoration and maintenance of telomere length. Abnormally activated in tumorigenesis, telomerase is expressed in the majority of human cancer cells, but its expression is low or non-existent in normal cells.
@@ -14221,15 +15213,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C120118
NCT: https://clinicaltrials.gov/ct2/show/NCT02960594
- PubMed:34230114
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5171
+ PMID:34230114
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5171
https://github.com/vaccineontology/VO/issues/409
7015
5171
- Clinical trial
cancer vaccine
Gene name: TERT
- Synthetic hTERT DNA Vaccine INO-1400
+ synthetic hTERT DNA vaccine INO-1400
@@ -14245,6 +15236,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -14260,13 +15257,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A cancer vaccine consisting of E-PRA and E-PSM, two synthetic peptide analogs of PRAME (PReferential Antigen MElanoma) and PSMA (Prostate Specific Membrane Antigen), with potential immunostimulating activity. Upon direct administration into lymph nodes, synthetic peptides E-PRA and E-PSM vaccine may sitmulate a cytotoxic T-lymphocyte (CTL) response against PRAME- and PSMA-expressing tumor cells. PRAME and PSMA are tumor-associated antigens upregulated and expressed on the cell surfaces of certain tumor cell types.
@@ -14276,15 +15273,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C67098
NCT: https://clinicaltrials.gov/ct2/show/NCT00423254
- PubMed:21760528
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5496
+ PMID:21760528
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5496
https://github.com/vaccineontology/VO/issues/412
6277
5496
- Clinical trial
cancer vaccine
Gene name: S100A6
- Synthetic Peptides E-PRA And E-PSM Vaccine
+ synthetic peptides E-PRA and E-PSM vaccine
@@ -14300,6 +15296,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -14315,13 +15317,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A peptide-based cancer vaccine, containing amino acid residues 27 through 35 of T cell receptor gamma alternate reading frame protein (TARP), with potential immunostimulatory and antineoplastic activities. Upon administration, TARP 27-35 peptide vaccine may stimulate a host cytotoxic T-cell (CTL) response against TARP-expressing tumor cells, resulting in tumor cell cytotoxicity. The nuclear protein TARP is commonly expressed on prostate and breast cancer cells and is highly immunogenic.
@@ -14331,15 +15333,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C85462
NCT: https://clinicaltrials.gov/ct2/show/NCT00972309
- PubMed:27622067
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5448
+ PMID:27622067
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5448
https://github.com/vaccineontology/VO/issues/413
445347
5448
- Clinical trial
cancer vaccine
Gene name: TARP
- TARP 27-35 Peptide Vaccine
+ TARP 27-35 peptide vaccine
@@ -14355,6 +15356,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -14370,13 +15377,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A peptide-based cancer vaccine, consisting of amino acid residues 29 through 37 of T cell receptor gamma alternate reading frame protein (TARP) with a leucine-to-valine substitution at position 9, with potential immunostimulatory and antineoplastic activities. Upon administration, TARP 29-37-9V peptide vaccine may induce a cytotoxic T-lymphocyte (CTL) response against TARP-expressing tumor cells, which may result in decreased tumor cell proliferation. The leucine-to-valine substitution at position 9 of this peptide improves its immunogenicity. The nuclear protein TARP is commonly expressed on prostate and breast cancer cells and is highly immunogenic.
@@ -14386,15 +15393,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C85463
NCT: https://clinicaltrials.gov/ct2/show/NCT02362464
- PubMed:27622067
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5242
+ PMID:27622067
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5242
https://github.com/vaccineontology/VO/issues/414
445347
5242
- Clinical trial
cancer vaccine
Gene name: TARP
- TARP 29-37-9V Peptide Vaccine
+ TARP 29-37-9V peptide vaccine
@@ -14410,6 +15416,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -14425,13 +15437,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A cancer vaccine consisting of a recombinant vector encoding the tumor-associated carcinoembryonic antigen (CEA) that isÊcontaminatedÊwith bovine viral diarrhea virus (BVDV). The carcinoembryonic antigen (CEA) is a prevalent tumor marker expressed by a number of different cancers such as colorectal, breast, lung and ovarian carcinomas; vaccination with vaccinia virus genetically engineered to expressÊCEAÊmay generate antitumoral T-cell responses.ÊBVDVÊis an RNA pestivirus that may contaminate vaccines due to its presence in fetal calf serum used as a growth supplement in the tissue culture of mammalian cells used in vaccine production.
@@ -14440,15 +15452,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Oliver He
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29476
- PubMed:35380920
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5295
+ PMID:35380920
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5295
https://github.com/vaccineontology/VO/issues/415
4153
5295
- Clinical trial
cancer vaccine
Gene name: MBL2
- TBC-CEA-Contaminated W/ BVDV Vaccine
+ TBC-CEA-Contaminated W/ BVDV vaccine
@@ -14467,6 +15478,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -14504,8 +15521,8 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C91077
NCT: https://clinicaltrials.gov/ct2/show/NCT01095848
- PubMed:22862954
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5458
+ PMID:22862954
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5458
10134
27
3696
@@ -14514,10 +15531,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
7153
780
5458
- Clinical trial
cancer vaccine
- Gene name: BCAP31|Gene name: TOP2A|Gene name: ADAM17|Gene name: ABL2|Gene name: JUP|Gene name: DDR1|Gene name: IGTB8
- Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907
+ Gene name: ABL2
+ Gene name: ADAM17
+ Gene name: BCAP31
+ Gene name: DDR1
+ Gene name: IGTB8
+ Gene name: JUP
+ Gene name: TOP2A
+ therapeutic Breast/Ovarian/Prostate peptide cancer vaccine DPX-0907
@@ -14533,6 +15555,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -14558,14 +15586,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C74087
NCT: https://clinicaltrials.gov/ct2/show/NCT00624182
- PubMed:29568993
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5115
+ PMID:29568993
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5115
54742
5115
- Clinical trial
cancer vaccine
Gene name: LY6K
- URLC10 Peptide Vaccine
+ URLC10 peptide vaccine
@@ -14582,6 +15609,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -14607,16 +15640,17 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C74088
NCT: https://clinicaltrials.gov/ct2/show/NCT00632333
- PubMed:24708624
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5001
+ PMID:24708624
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5001
10643
54742
7422
5001
- Clinical trial
cancer vaccine
- Gene name: LY6K|Gene name: VEGFA|Gene name: IGF2BP3
- URLC10-TTK-KOC1-VEGFR1-VEGFR2 Multipeptide Vaccine
+ Gene name: IGF2BP3
+ Gene name: LY6K
+ Gene name: VEGFA
+ URLC10-TTK-KOC1-VEGFR1-VEGFR2 multipeptide vaccine
@@ -14632,6 +15666,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -14657,14 +15697,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C74089
NCT: https://clinicaltrials.gov/ct2/show/NCT00574977
- PubMed:27203445
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5296
+ PMID:27203445
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5296
45091589
5296
- Clinical trial
cancer vaccine
Gene name: cdsR
- Vaccinia Virus DD-CDSR Vaccine
+ Vaccinia virus DD-CDSR vaccine
@@ -14688,6 +15727,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -14713,14 +15758,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C61327
NCT: https://clinicaltrials.gov/ct2/show/NCT00285259
- PubMed:22237175
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5390
+ PMID:22237175
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5390
3077579
5390
- Clinical trial
cancer vaccine
Gene name: UL83
- VCL-CB01 Vaccine
+ VCL-CB01 vaccine
@@ -14739,6 +15783,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -14775,14 +15825,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Oliver He
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C104738
- PubMed:16220325
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5430
+ PMID:16220325
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5430
7490
5430
- Clinical trial
cancer vaccine
Gene name: WT1
- WT1 124-138 Peptide Vaccine
+ WT1 124-138 peptide vaccine
@@ -14800,6 +15849,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -14831,14 +15886,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C61442
NCT: https://clinicaltrials.gov/ct2/show/NCT01842139
- PubMed:26492414
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5089
+ PMID:26492414
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5089
7490
5089
- Clinical trial
cancer vaccine
Gene name: WT1
- WT1 126-134 Peptide Vaccine
+ WT1 126-134 peptide vaccine
@@ -14855,6 +15909,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -14879,14 +15939,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Oliver He
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C104734
- PubMed:23225417
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5029
+ PMID:23225417
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5029
7490
5029
- Clinical trial
cancer vaccine
Gene name: WT1
- WT1 235-243 Peptide Vaccine
+ WT1 235-243 peptide vaccine
@@ -14905,6 +15964,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -14941,14 +16006,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Oliver He
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C104737
- PubMed:16220325
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5468
+ PMID:16220325
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5468
7490
5468
- Clinical trial
cancer vaccine
Gene name: WT1
- WT1 247-261 Peptide Vaccine
+ WT1 247-261 peptide vaccine
@@ -14971,6 +16035,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -14980,13 +16050,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A cancer vaccine consisting of the DNA plasmid pNGVL4a-A encoding calreticulin (CRT) linked to a detox form of human papillomavirus (HPV) type 16 E7 antigen, with potential immunomodulating and antineoplastic activities. Upon administration, this vaccine may generate a potent cytotoxic T-lymphocyte (CTL) response against E7-expressing tumor cells, resulting in tumor cell death. For E7(detox), the amino acids in E7 at positions 24 (cysteine to glycine) and 26 (glutamic acid to glycine) were substituted. CRT, a 46 kDa protein located in the lumen of the cell's endoplasmic reticulum (ER), may potentiate MHC class I presentation of HPV-16 E7 to E7-specific CD8-positive T cells. In addition, pNGVL4a-A contains two short immunostimulatory DNA sequences (ISS) in the noncoding region, which may elicit the production of IFN- and IL-12 in transfected keratinocytes and dermal antigen presenting cells (APCs), resulting in a potent T helper cell type 1 response.
@@ -14996,15 +16066,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C88289
NCT: https://clinicaltrials.gov/ct2/show/NCT00988559
- PubMed:26616223
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5011
+ PMID:26616223
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5011
https://github.com/vaccineontology/VO/issues/123
1489079
5011
- Clinical trial
cancer vaccine
Gene name: HPV16 E7
- pNGVL4a-CRT/E7(detox) DNA Vaccine
+ pNGVL4a-CRT/E7(detox) DNA vaccine
@@ -15027,6 +16096,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -15036,13 +16111,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
An antigen-specific DNA cancer vaccine consisting of the coding sequences of a signal peptide (pNGVL4a-Sig), a detox form of the human papillomavirus type 16 (HPV-16) antigen E7, and the heat shock protein 70 (HSP70). Upon administration, this vaccine may generate potent cytotoxic CD8(+) T-cell responses against E7-expressing tumor cells, resulting in tumor cell death.
@@ -15052,15 +16127,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C48418
NCT: https://clinicaltrials.gov/ct2/show/NCT00121173
- PubMed:30296681
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5069
+ PMID:30296681
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5069
https://github.com/vaccineontology/VO/issues/124
1489079
5069
- Clinical trial
cancer vaccine
Gene name: HPV16 E7
- pNGVL4a-Sig/E7(detox)/HSP70 DNA Vaccine
+ pNGVL4a-Sig/E7(detox)/HSP70 DNA vaccine
@@ -15077,6 +16151,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -15102,11 +16182,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C61087
NCT: https://clinicaltrials.gov/ct2/show/NCT00411749
- PubMed:35997582
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5406
+ PMID:35997582
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5406
25479185
5406
- Clinical trial
cancer vaccine
Gene name: L1
Quadrivalent Human Papillomavirus (types 6, 11, 16, 18) Recombinant Vaccine
@@ -15126,6 +16205,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -15150,14 +16235,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Oliver He
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C119664
- PubMed:26772631
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5342
+ PMID:26772631
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5342
25479185
7162
5342
- Clinical trial
cancer vaccine
- Gene name: L1|Gene name: TPBG
+ Gene name: L1
+ Gene name: TPBG
Recombinant Human Papillomavirus Nonavalent Vaccine
@@ -15175,6 +16260,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -15190,13 +16281,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A cancer vaccine comprised of a modified, replication-defective, vaccinia virus Ankara (MVA) strain encoding the tumor-associated antigens (TAAs) human papillomavirus type 16 (HPV16) subtypes E6 and E7, and human interleukin-2 (IL-2), with potential immunostimulating and antineoplastic activities. Vaccination with MVA-HPV16E6/E7-IL2 vaccine TG4001 stimulates the host immune system to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing HPV16 E6 and E7, resulting in tumor cell lysis. Expression of IL-2 augments the specific CTL response against HPV16 E6- and E7-expressing tumor cells.
@@ -15206,14 +16297,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C88326
NCT: https://clinicaltrials.gov/ct2/show/NCT01022346
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5208
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5208
https://github.com/vaccineontology/VO/issues/340
1489078
1489079
5208
- Clinical trial
cancer vaccine
- Gene name: E6|Gene name: E7
+ Gene name: E6
+ Gene name: E7
Recombinant Vaccinia Viral Vector RO5217790 Vaccine
@@ -15231,6 +16322,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -15246,13 +16343,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A therapeutic peptide vaccine consisting of thirteen synthetic long peptides (SLPs), which are 25-35 amino acids in size, derived from the human papillomavirus (HPV) type 16 oncoproteins E6 and E7, with potential immunostimulating and antitumor activities. Upon administration, synthetic long E6/E7 peptides vaccine HPV-01 is taken up and degraded into small pieces by dendritic cells. The processed viral epitopes are presented by dendritic cells, which may stimulate the host immune system to mount both cytotoxic T-cell lymphocyte (CTL) and helper T cell responses against HPV E6/E7-expressing tumor cells. This results in the destruction of tumor cells and leads to decreased tumor growth. The E6 and E7 oncoproteins are implicated in the tumorigenesis in a variety of cancers. The SLPs allow for optimal presentation by antigen-presenting cells.
@@ -15262,14 +16359,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C111037
NCT: https://clinicaltrials.gov/ct2/show/NCT02128126
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5186
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5186
https://github.com/vaccineontology/VO/issues/410
1489078
1489079
5186
- Clinical trial
cancer vaccine
- Gene name: E6|Gene name: E7
+ Gene name: E6
+ Gene name: E7
Synthetic Long E6/E7 Peptides Vaccine HPV-01
@@ -15287,6 +16384,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -15312,14 +16415,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2811
NCT: https://clinicaltrials.gov/ct2/show/NCT00493545
- PubMed:16691066
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5542
+ PMID:16691066
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5542
1489079
3329
5542
- Clinical trial
cancer vaccine
- Gene name: E7|Gene name: HSPD1
+ Gene name: E7
+ Gene name: HSPD1
Verpasep Caltespen Vaccine
@@ -15337,6 +16440,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -15352,13 +16461,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A synthetic vaccine used for cancer immunotherapy also known as Ras(cis 12)-Vaccinia Vaccine, RASVAC-C is based on a mutant peptide epitope of the Ras oncoprotein at codon 12 that induces recognition and induction of tumor-specific, cell-mediated immune responses. Ras is an intracellular GTP-binding protein involved in signal transduction and regulation of proliferation and differentiation.
@@ -15368,11 +16477,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29401
NCT: https://clinicaltrials.gov/ct2/show/NCT00019591
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5504
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5504
https://github.com/vaccineontology/VO/issues/190
3845
5504
- Clinical trial
cancer vaccine
Gene name: KRAS
RASVAC-C Vaccine
@@ -15392,6 +16500,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -15407,13 +16521,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A synthetic vaccine used for cancer immunotherapy also known as Ras(val 12)-Vaccinia Vaccine, RASVAC-V is based on a mutant peptide epitope of the Ras oncoprotein at codon 12 (valine instead of glycine) that induces recognition and induction of tumor-specific, cell-mediated immune responses. Ras is an intracellular GTP-binding protein involved in signal transduction and regulation of proliferation and differentiation.
@@ -15423,11 +16537,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29402
NCT: https://clinicaltrials.gov/ct2/show/NCT00019591
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5497
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5497
https://github.com/vaccineontology/VO/issues/191
3845
5497
- Clinical trial
cancer vaccine
Gene name: KRAS
RASVAC-V Vaccine
@@ -15447,6 +16560,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -15462,13 +16581,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A genetically-engineered adenovirus that contains the gene that encodes the human tumor-suppressor protein p53 with potential antineoplastic activity. Recombinant adenovirus-p53 SCH-58500 delivers p53 into tumor cells, which may result in p53-mediated cell cycle arrest and apoptosis.
@@ -15478,16 +16597,17 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2423
NCT: https://clinicaltrials.gov/ct2/show/NCT00002960
- PubMed:16082381
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5470
+ PMID:16082381
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5470
https://github.com/vaccineontology/VO/issues/325
4771
7157
7490
5470
- Clinical trial
cancer vaccine
- Gene name: NF2|Gene name: WT1|Gene name: TP53 (P53)
+ Gene name: NF2
+ Gene name: TP53 (P53)
+ Gene name: WT1
Recombinant Adenovirus-p53 SCH-58500 Vaccine
@@ -15505,6 +16625,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -15520,13 +16646,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
An immunocytokine consisting of human pro-inflammatory cytokine tumor necrosis factor alpha (TNFalpha) fused to a human single-chain variable fragment (scFv) directed against the extra-domain B (ED-B) of fibronectin (L19), with potential immunopotentiating and antineoplastic activities. Upon adinistration, the L19 moiety of onfekafusp alfa binds to the ED-B domain of fibronectin on tumor cells in the tumor neovasculature. In turn, the TNFalpha moiety may locally induce an immune response against ED-B fibronectin-expressing tumor cells and may specifically decrease the proliferation of ED-B-expressing tumor cells. ED-B is predominantly expressed during angiogenesis and tumor growth.
@@ -15536,12 +16662,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C166939
NCT: https://clinicaltrials.gov/ct2/show/NCT01253837
- PubMed:12810649
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5219
+ PMID:12810649
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5219
https://github.com/vaccineontology/VO/issues/336
100136034
5219
- Clinical trial
cancer vaccine
Gene name: tnf-alpha
Recombinant Human Fusion Protein L19TNFalpha Vaccine
@@ -15561,6 +16686,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -15586,15 +16717,16 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C95212
NCT: https://clinicaltrials.gov/ct2/show/NCT00681577
- PubMed:27720136
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5350
+ PMID:27720136
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5350
10643
54742
83540
5350
- Clinical trial
cancer vaccine
- Gene name: LY6K|Gene name: NUF2|Gene name: IGF2BP3
+ Gene name: IGF2BP3
+ Gene name: LY6K
+ Gene name: NUF2
URLC10-CDCA1-KOC1 Multipeptide Vaccine
@@ -15618,6 +16750,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -15627,13 +16765,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A fusion DNA vaccine containing the first domain of fragment C (FrC) of tetanus toxin (TT865-1120) (p.DOM) fused to the human Wilms' Tumor gene-1 (WT1)-derived MHC class I-binding epitope WT1.126, with potential antitumor activity. Upon vaccination with p.DOM-WT1-126 DNA and subsequent electroporation, this vaccine may induce a WT1 epitope-specific cytotoxic T-lymphocyte (CTL) response against WT1 expressing cells, resulting in cell lysis and inhibition of cancer cell proliferation in WT1-overexpressing cancer cells. WT1, a tumor associated antigen, is overexpressed in most types of leukemia and in a variety of solid cancers. The FrC of tetanus toxin contains the MHC II-binding sequence, p30, which induces T-helper cell activation for long-lasting immunity.
@@ -15643,12 +16781,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C96738
NCT: https://clinicaltrials.gov/ct2/show/NCT01334060
- PubMed:27099895
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5165
+ PMID:27099895
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5165
https://github.com/vaccineontology/VO/issues/69
7490
5165
- Clinical trial
cancer vaccine
Gene name: WT1
p.DOM-WT1-126 DNA Vaccine
@@ -15674,6 +16811,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -15683,13 +16826,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A fusion DNA vaccine containing the first domain of fragment C (FrC) of tetanus toxin (TT865-1120) (p.DOM) fused to the human Wilms' Tumor gene-1 (WT1)-derived MHC class I-binding epitope WT1.37, with potential antitumor activity. Upon vaccination with p.DOM-WT1-37 DNA and subsequent electroporation, this vaccine may induce a WT1 epitope-specific cytotoxic T-lymphocyte (CTL) response against WT1 expressing cells, resulting in cell lysis and inhibition of cancer cell proliferation in WT1-overexpressing cancer cells. WT1, a tumor associated antigen, is overexpressed in most types of leukemia and in a variety of solid cancers. The FrC of tetanus toxin contains the MHC II-binding sequence, p30, which induces T-helper cell activation for long-lasting immunity.
@@ -15699,13 +16842,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C96737
NCT: https://clinicaltrials.gov/ct2/show/NCT01334060
- PubMed:27099895
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5471
+ PMID:27099895
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5471
https://github.com/vaccineontology/VO/issues/61
https://github.com/vaccineontology/VO/issues/62
7490
5471
- Clinical trial
cancer vaccine
Gene name: WT1
p.DOM-WT1-37 DNA Vaccine
@@ -15725,6 +16867,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -15740,13 +16888,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A cancer vaccine containing PR1, a 9 amino-acid human leukocyte antigen (HLA)-A2 restricted peptide derived from proteinase 3, with potential immunotherapeutic activity. Vaccination with PR1 leukemia peptide vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells expressing proteinase 3, resulting in tumor cell lysis. Often overexpressed in leukemic cells, proteinase 3 is a serine proteinase that activates progelatinase A and is involved in angiogenesis and metastasis.
@@ -15756,12 +16904,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2235
NCT: https://clinicaltrials.gov/ct2/show/NCT00004918
- PubMed:27654852
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5140
+ PMID:27654852
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5140
https://github.com/vaccineontology/VO/issues/139
140738
5140
- Clinical trial
cancer vaccine
Gene name: TMEM37
PR1 Leukemia Peptide Vaccine
@@ -15780,6 +16927,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -15799,10 +16952,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2341
NCT: https://clinicaltrials.gov/ct2/show/NCT00100971
- PubMed:30348199
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5387
+ PMID:30348199
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5387
5387
- Clinical trial
cancer vaccine
Tumor Cell Derivative Vaccine
@@ -15821,6 +16973,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -15846,11 +17004,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C106257
NCT: https://clinicaltrials.gov/ct2/show/NCT01961882
- PubMed:28321480
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5330
+ PMID:28321480
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5330
7490
5330
- Clinical trial
cancer vaccine
Gene name: WT1
WT1 Peptide Vaccine OCV-501
@@ -15870,6 +17027,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -15895,11 +17058,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C78865
NCT: https://clinicaltrials.gov/ct2/show/NCT00725283
- PubMed:16117707
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5354
+ PMID:16117707
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5354
7490
5354
- Clinical trial
cancer vaccine
Gene name: WT1
WT1-A10/AS01B Immunotherapeutic GSK2130579A Vaccine
@@ -15919,6 +17081,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -15934,13 +17102,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A recombinant vaccinia virus encoding carcinoembryonic antigen (CEA). CEA is overexpressed in several cancer cell types, including gastrointestinal, breast, and non-small cell lung cancers. Attenuated vaccinia virus is a highly effective immunizing agent that evokes both humoral and cell-mediated responses. Vaccination with this agent may evoke a cytotoxic immune response to CEA-expressing cells.
@@ -15950,12 +17118,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2809
NCT: https://clinicaltrials.gov/ct2/show/NCT00081848
- PubMed:7629885
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5401
+ PMID:7629885
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5401
https://github.com/vaccineontology/VO/issues/341
1048
5401
- Clinical trial
cancer vaccine
Gene name: CEACAM5
Recombinant Vaccinia-CEA Vaccine
@@ -15974,6 +17141,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -15983,13 +17156,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
Human mesenchymal stem cells (MSCs) harvested from bone marrow of healthy adult donors and expanded ex vivo, with potential immunosuppressive activity. Remestemcel-L cells are hypo-immunogenic due to lack of major histocompatibility II (MHC II) molecule expression, eliciting little, if any, host immune response upon intravenous infusion. Infusion of allogeneic MSCs may result in: a) increased production of anti-inflammatory cytokines, such as interleukin-10, prostaglandin E, and hepatocyte growth factor; b) decreased mononuclear phagocyte expression of indoleamine 2,3,-dioxygenase, which catabolizes L-tryptophan into its pro-inflammatory metabolites; and c) modulated dendritic cell (DC)maturation and disrupted activities of natural killer (NK) cells and CD8+ and CD4+ T cells. In addition, pluripotent MSCs, upon administration, may be recruited to damaged tissue sites, differentiating along specific lineages when stimulated.
@@ -15998,11 +17171,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Oliver He
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C67082
- PubMed:32018062
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4993
+ PMID:32018062
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4993
https://github.com/vaccineontology/VO/issues/353
4993
- Clinical trial
cancer vaccine
Remestemcel-L Vaccine
@@ -16021,6 +17193,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -16046,11 +17224,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C119617
NCT: https://clinicaltrials.gov/ct2/show/NCT02293850
- PubMed:27673332
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5072
+ PMID:27673332
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5072
7015
5072
- Clinical trial
cancer vaccine
Gene name: TERT
Telomerase-specific Type 5 Adenovirus OBP-301 Vaccine
@@ -16076,6 +17253,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -16085,13 +17268,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A proprietary cancer DNA vaccine that contains multiple natural and modified epitopes derived from the four tumor associated antigens, CEA, HER2/neu, p53, and MAGE 2/3. OSE 2101 also includes CAP1-6D, a heteroclitic CEA analog, and PADRE, a proprietary universal T-cell epitope that serves to enhance the immunogenicity of the epitopes. This agent has been shown to elicit cytotoxic T-lymphocyte responses against tumor cells expressing these multiple epitopes.
@@ -16101,8 +17284,8 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C26645
NCT: https://clinicaltrials.gov/ct2/show/NCT02654587
- PubMed:18382135
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5528
+ PMID:18382135
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5528
https://github.com/vaccineontology/VO/issues/72
1048
2064
@@ -16110,9 +17293,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
4102
7157
5528
- Clinical trial
cancer vaccine
- Gene name: TP53|Gene name: CEACAM5|Gene name: ERBB2|Gene name: MAGEA2|Gene name: MAGEA3
+ Gene name: CEACAM5
+ Gene name: ERBB2
+ Gene name: MAGEA2
+ Gene name: MAGEA3
+ Gene name: TP53
EP-2101 Vaccine
@@ -16130,6 +17316,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -16145,13 +17337,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A tumor-specific peptide encoded by patient-specific mutant p53 oncogene with potential immunostimulatory properties. The peptide (LPTGQDL) contains a frame shift mutation at amino acid position 134. It was used to pulse dendritic cells, which are then used in the adoptive immunotherapy setting and may stimulate the host immune system to mount a specific cytotoxic T lymphocyte response against tumor cells expressing the p35 mutation.
@@ -16161,13 +17353,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C38121
NCT: https://clinicaltrials.gov/ct2/show/NCT00049218
- PubMed:29301826
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5272
+ PMID:29301826
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5272
https://github.com/vaccineontology/VO/issues/125
https://github.com/vaccineontology/VO/issues/193
7157
5272
- Clinical trial
cancer vaccine
Gene name: TP53
PR-151 Peptide Vaccine
@@ -16193,6 +17384,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -16202,13 +17399,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
An anti-idiotype murine monoclonal antibody (MoAb) specific to P3 MoAb with anti-metastatic effect. Racotumomab binds to the idiotype region of P3 MoAb and functionally mimics the three-dimensional structure of N-glycolyl ceramides of mono-sialyl lactose, the antigenic target of P3. As a result, this anti-idiotype antibody may stimulate the host immune system to elicit humoral and cellular immune responses against tumor cells expressing NeuGc-GM3 gangliosides, which are expressed in a wide variety of tumor cells.
@@ -16218,16 +17415,17 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C95024
NCT: https://clinicaltrials.gov/ct2/show/NCT01598454
- PubMed:26903265
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5201
+ PMID:26903265
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5201
https://github.com/vaccineontology/VO/issues/188
3265
3845
4893
5201
- Clinical trial
cancer vaccine
- Gene name: HRAS|Gene name: NRAS|Gene name: KRAS
+ Gene name: HRAS
+ Gene name: KRAS
+ Gene name: NRAS
Racotumomab Vaccine
@@ -16245,6 +17443,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -16260,13 +17464,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A replication-defective adenovirus containing a gene that encodes the human protein L523S with potential antineoplastic activity. Upon administration, recombinant adenovirus-L523S vaccine expresses L523S, which may stimulate antibody and cytotoxic T lymphocyte (CTL) responses against tumor cells expressing L523S. L523S is an RNA-binding protein that belongs to the KOC (K homology domain containing protein over-expressed in cancer) family of proteins. As an oncofetal protein, L523S is normally expressed in early embryonic tissues and certain normal adult tissues such as colon, fallopian tube, gall bladder, and ovary tissues but may be overexpressed in squamous cell cancers of the lung.
@@ -16276,12 +17480,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C49289
NCT: https://clinicaltrials.gov/ct2/show/NCT00062907
- PubMed:16581300
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5074
+ PMID:16581300
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5074
https://github.com/vaccineontology/VO/issues/323
10643
5074
- Clinical trial
cancer vaccine
Gene name: IGF2BP3
Recombinant Adenovirus-L523S Vaccine
@@ -16308,6 +17511,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -16323,13 +17532,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A plasmid DNA encoding human L523S, an RNA-binding protein that belongs to the KOC (K homology domain containing protein overexpressed in cancer) family, with potential antineoplastic activity. Vaccination with L523S DNA may stimulate a cytotoxic T lymphocyte (CTL) response against tumor cells that express the L523S protein. As an oncofetal protein, L523S is normally expressed in early embryonic tissue, but is overexpressed in certain cancer cell types.
@@ -16339,12 +17548,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C49290
NCT: https://clinicaltrials.gov/ct2/show/NCT00062907
- PubMed:12750279
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5156
+ PMID:12750279
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5156
https://github.com/vaccineontology/VO/issues/327
10643
5156
- Clinical trial
cancer vaccine
Gene name: IGF2BP3
Recombinant DNA-L523S Vaccine
@@ -16365,6 +17573,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -16396,11 +17610,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C70674
NCT: https://clinicaltrials.gov/ct2/show/NCT00516685
- PubMed:29661145
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5190
+ PMID:29661145
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5190
25003478
5190
- Clinical trial
cancer vaccine
Gene name: LV28_RS26095 transcriptional regulator RegF
Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine
@@ -16419,6 +17632,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -16438,10 +17657,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C66985
NCT: https://clinicaltrials.gov/ct2/show/NCT02460367
- PubMed:28238782
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5527
+ PMID:28238782
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5527
5527
- Clinical trial
cancer vaccine
Tergenpumatucel-L Vaccine
@@ -16460,6 +17678,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -16485,11 +17709,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C61073
NCT: https://clinicaltrials.gov/ct2/show/NCT02439450
- PubMed:27364122
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5513
+ PMID:27364122
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5513
7184
5513
- Clinical trial
cancer vaccine
Gene name: HSP90B1
Viagenpumatucel-L Vaccine
@@ -16515,6 +17738,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -16524,13 +17753,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A cancer vaccine consisting of a mixture of a murine lymphoma-derived idiotype and interleukin-2 (IL-2) encapsulated in dimyristoylphosphatidylcholine liposomes. The use of a liposomal carrier confers immunogenicity to the naturally non-immunogenic idiotype.
@@ -16539,11 +17768,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Oliver He
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2783
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5541
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5541
https://github.com/vaccineontology/VO/issues/74
107653060
5541
- Clinical trial
cancer vaccine
Gene name: IL12
Oncovax-ID/IL-2 Vaccine
@@ -16563,6 +17791,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -16578,13 +17812,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A lipid depot-based therapeutic cancer vaccine composed of survivin epitopes, a universal T Helper peptide and a polynucleotide adjuvant encapsulated in liposomes and then formulated in the hydrophobic carrier Montanide ISA51 VG, with potential immunopotentiating and antineoplastic activities. Upon injection of the maveropepimut-S, a depot is created at the injection site from which the antigens and adjuvant are released. This vaccine may elicit a long lasting cellular response against survivin-expressing cancers, resulting in a decrease in tumor cell proliferation and an induction of tumor cell death. Survivin, a member of the inhibitor of apoptosis (IAP) family expressed during embryonic development, is upregulated in a variety of human cancers while absent in most normal adult cells; its expression in tumors is associated with a more aggressive phenotype, decreased survival, and increased resistance to chemotherapy.
@@ -16594,12 +17828,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C97951
NCT: https://clinicaltrials.gov/ct2/show/NCT02323230
- PubMed:26405584
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5371
+ PMID:26405584
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5371
https://github.com/vaccineontology/VO/issues/364
373110
5371
- Clinical trial
cancer vaccine
Gene name: Survivin
Survivin Antigen Vaccine DPX-Survivac
@@ -16619,6 +17852,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -16643,10 +17882,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Oliver He
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2821
- PubMed:18715553
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5046
+ PMID:18715553
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5046
5046
- Clinical trial
cancer vaccine
Unconjugated Lymphoma Ig Id Vaccine
@@ -16671,6 +17909,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -16680,13 +17924,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A peptide cancer vaccine consisting of peptides derived from the melanoma antigen NA-17, the human leukocyte antigen HLA-A2-restricted human melanoma antigen 3 (MAGE-3.A2) and the cancer-testis antigen (NY-ESO-1), with potential immunostimulating and antineoplastic activities. Upon administration, the NA-17/MAGE-3.A2/NY-ESO-1 peptide vaccine may stimulate the immune system to mount a cytotoxic T-cell (CTL) response against tumor cells expressing NA-17, MAGE-3.A2 and NY-ESO-1, resulting in tumor cell lysis. The tumor-associated antigens (TAAs) NA-17, MAGE-3.A2 and NY-ESO-1 are overexpressed in a variety of cancer cell types.
@@ -16696,16 +17940,16 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C96042
NCT: https://clinicaltrials.gov/ct2/show/NCT01308294
- PubMed:25941588
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5305
+ PMID:25941588
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5305
https://github.com/vaccineontology/VO/issues/48
1485
4102
5305
- Clinical trial
cancer vaccine
- Gene name: MAGEA3|Gene name: CTAG1B
- NA-17/MAGE-3.A2/NY-ESO-1 Peptide Vaccine
+ Gene name: CTAG1B
+ Gene name: MAGEA3
+ NA-17/MAGE-3.A2/NY-ESO-1 peptide vaccine
@@ -16722,6 +17966,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -16737,13 +17987,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A peptide cancer vaccine comprised of human leukocyte antigen HLA-A2-restricted peptide derived from a metastatic melanoma cell line of patient NA17, with potential immunomodulating and antineoplastic activity. NA17. A2 peptide vaccine may stimulate a cytotoxic T lymphocyte (CTL) response against tumors that express this antigen, which may result in a reduction in tumor size. This NA17 specific antigen, encoded by an intron sequence of N-acetylglucosaminyltransferase V (GnT-V) gene, is expressed in about 50% of melanomas.
@@ -16753,17 +18003,19 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2680
NCT: https://clinicaltrials.gov/ct2/show/NCT01307618
- PubMed:16133111
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5323
+ PMID:16133111
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5323
https://github.com/vaccineontology/VO/issues/49
107653060
2315
4102
6490
5323
- Clinical trial
cancer vaccine
- Gene name: IL12|Gene name: MAGEA3|Gene name: MLANA|Gene name: PMEL
+ Gene name: IL12
+ Gene name: MAGEA3
+ Gene name: MLANA
+ Gene name: PMEL
NA17.A2 peptide vaccine
@@ -16787,6 +18039,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -16796,13 +18054,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with a peptide derived from the tumor associated antigen human cancer-testis antigen NY-ESO-1 (NY-ESO-1(157-165)), with potential immunostimulatory and antineoplastic activities. Upon administration, the NY-ESO-1(157-165) peptide-pulsed autologous dendritic cell vaccine may stimulate the immune system to mount both an anti-tumoral cytotoxic T-lymphocyte (CTL) and an antibody-mediated immune response against NY-ESO-1-expressing tumor cells, which may result in tumor cell lysis. NY-ESO-1 is expressed both in normal testes and on the surfaces of various tumor cells, and plays a key role in tumor cell proliferation and survival.
@@ -16812,18 +18070,21 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C114380
NCT: https://clinicaltrials.gov/ct2/show/NCT00313508
- PubMed:16311731
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5100
+ PMID:16311731
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5100
1485
2315
4102
6490
7299
5100
- Clinical trial
cancer vaccine
- Gene name: MAGEA3|Gene name: MLANA|Gene name: PMEL|Gene name: CTAG1B|Gene name: TYR
- NY-ESO-1(157-165) Peptide-pulsed Autologous Dendritic Cell Vaccine
+ Gene name: CTAG1B
+ Gene name: MAGEA3
+ Gene name: MLANA
+ Gene name: PMEL
+ Gene name: TYR
+ NY-ESO-1(157-165) peptide-pulsed autologous dendritic cell vaccine
@@ -16840,6 +18101,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -16865,15 +18132,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C120129
NCT: https://clinicaltrials.gov/ct2/show/NCT00798629
- PubMed:16311731
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5366
+ PMID:16311731
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5366
1485
2315
5366
- Clinical trial
cancer vaccine
- Gene name: CTAG1B|Gene name: MLANA
- NY-ESO-1/MART-1 Peptide-pulsed Dendritic Cell Vaccine
+ Gene name: CTAG1B
+ Gene name: MLANA
+ NY-ESO-1/MART-1 peptide-pulsed dendritic cell vaccine
@@ -16896,6 +18163,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -16905,13 +18178,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A cancer vaccine consisting of PEP-3, a synthetic peptide encompassing a tumor-specific mutated segment of the epidermal growth factor receptor type vIII (EGFRvIII), conjugated to the naturally-occurring immunoadjuvant keyhole limpet hemocyanin (KLH) with potential immunostimulating and antineoplastic activities. Upon administration, PEP-3-KLH conjugate vaccine may induce a cytotoxic immune response against tumor cells that overexpress EGFRvIII; this antitumoral immune response may involve antibody-dependent cellular cytotoxicity (ADCC).
@@ -16921,15 +18194,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C74070
NCT: https://clinicaltrials.gov/ct2/show/NCT00626015
- PubMed:14519652
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5480
+ PMID:14519652
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5480
https://github.com/vaccineontology/VO/issues/117
1956
5480
- Clinical trial
cancer vaccine
Gene name: EGFR
- PEP-3-KLH Conjugate Vaccine
+ PEP-3-KLH conjugate vaccine
@@ -16946,6 +18218,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -16961,13 +18239,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A whole cell vaccine derived from a distinct subset of dendritic cells (DCs) with a plasma cell-like morphology that exhibits immunomodulating activity. Plasmacytoid dendritic cells (pDCs) express a characteristic set of surface markers, such as CD123 (interleukin-3 receptor alpha chain), BDCA-2 (blood dendritic cell antigen 2; CD303) and BDCA-4 (CD304), as well as intracellular toll-like receptors 7 and 9. Upon stimulation, the activated pDCs produce substantial amounts of interferon (IFN) alpha, and to a lesser degree IFN-beta, as well as other cytokines and chemokines, such as tumor necrosis factor alpha and interleukins 1, 6 and 8. In addition, these pDCs, directly or indirectly stimulate T-cells, B-cells and natural killer cells. This may potentially lead to increased immunity against tumor cells.
@@ -16977,8 +18255,8 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C103192
NCT: https://clinicaltrials.gov/ct2/show/NCT01690377
- PubMed:30049538
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5006
+ PMID:30049538
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5006
https://github.com/vaccineontology/VO/issues/121
170482
3598
@@ -16986,10 +18264,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
54106
8829
5006
- Clinical trial
cancer vaccine
- Gene name: IL13RA2|Gene name: CLEC4C|Gene name: NRP1|Gene name: TLR9|Gene name: TLR7
- Plasmacytoid Dendritic Cell Vaccine
+ Gene name: CLEC4C
+ Gene name: IL13RA2
+ Gene name: NRP1
+ Gene name: TLR7
+ Gene name: TLR9
+ plasmacytoid dendritic cell vaccine
@@ -17005,6 +18286,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -17034,11 +18321,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jimmy Guo
Oliver He
Virginia He
- PubMed:23539449
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4074
+ PMID:23539449
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4074
https://github.com/vaccineontology/VO/issues/140
4074
- Research
cancer vaccine
prime/boost DC-TRP-2 melanoma vaccine
@@ -17057,6 +18343,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -17072,13 +18364,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A melanoma vaccine comprised of a recombinant fowlpox vector construct encoding a modified epitope of the melanoma antigen glycoprotein 100 (gp100), ES-2092M(gp100), containing an endoplasmic reticulum signal sequence targeted to the endoplasmic reticulum apparatus. Vaccination with recombinant fowlpox-gp100p209 vaccine may stimulate the host immune system more efficiently to mount a cytotoxic T lymphocyte response against tumor cells expressing the gp100 antigen.
@@ -17088,13 +18380,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2806
NCT: https://clinicaltrials.gov/ct2/show/NCT00080353
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5274
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5274
6490
5274
- Clinical trial
cancer vaccine
Gene name: gp100 (PMEL)
- Recombinant Fowlpox-gp100p209 Vaccine
+ recombinant Fowlpox-gp100p209 vaccine
@@ -17111,6 +18402,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -17126,13 +18423,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A cancer vaccine consisting of a replication-defective recombinant fowlpox virus that encodes for the murine melanoma antigen glycoprotein 100 (mgp100) with potential antineoplastic activity. Vaccination with recombinant fowlpox-mgp100 vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells positive for the gp100 antigen, resulting in decreased tumor growth.
@@ -17141,12 +18438,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Oliver He
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2805
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5499
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5499
https://github.com/vaccineontology/VO/issues/332
5499
- Clinical trial
cancer vaccine
- Recombinant Fowlpox-Mgp100 Vaccine
+ recombinant Fowlpox-Mgp100 vaccine
@@ -17163,6 +18459,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -17178,13 +18480,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A recombinant fowlpox virus vaccine with potential antineoplastic activity. Binding to the melanoma antigen tyrosinase, recombinant fowlpox-tyrosinase vaccine generates cellular immune responses against melanoma cells expressing the tyrosinase antigen; this effect is enhanced by the co-administration of interleukin 2 (IL-2). Fowlpox virus is an attractive vector because its genome is easy to manipulate and it is replication incompetent in mammalian cells.
@@ -17194,14 +18496,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2807
NCT: https://clinicaltrials.gov/ct2/show/NCT00054535
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5518
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5518
https://github.com/vaccineontology/VO/issues/335
7299
5518
- Clinical trial
cancer vaccine
Gene name: Tyrosinase
- Recombinant Fowlpox-Tyrosinase Vaccine
+ recombinant Fowlpox-Tyrosinase vaccine
@@ -17224,6 +18525,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -17243,14 +18550,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C103830
NCT: https://clinicaltrials.gov/ct2/show/NCT01744171
- PubMed:12750279
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5359
+ PMID:12750279
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5359
6490
5359
- Clinical trial
cancer vaccine
Gene name: gp100 (PMEL)
- Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine
+ recombinant human Hsp110-gp100 chaperone complex vaccine
@@ -17267,6 +18573,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -17282,13 +18594,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A recombinant vaccinia virus encoding a modified peptide of the gp100 melanoma-melanocyte antigen with potential use in cancer immunotherapy. gp100 human antigen is a wild type self-antigen expressed by melanocytes, pigmented retinal cells and most melanomas. gp100p209 is a fragment epitope of gp100 in which the threonine in position 2 is replaced with methionine; this modification may stimulate tumor infiltrating lymphocytes (TIL) more efficiently.Ê
@@ -17298,15 +18610,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29566
NCT: https://clinicaltrials.gov/ct2/show/NCT00116597
- PubMed:15133631
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5393
+ PMID:15133631
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5393
https://github.com/vaccineontology/VO/issues/344
6490
5393
- Clinical trial
cancer vaccine
Gene name: gp100 (PMEL)
- Recombinant Vaccinia-gp100:209-217 Vaccine
+ recombinant Vaccinia-gp100:209-217 vaccine
@@ -17323,6 +18634,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -17338,13 +18655,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A recombinant vaccinia virus encoding a modified peptide of the gp100 melanoma-melanocyte antigen with potential use in cancer immunotherapy. gp100 human antigen is a wild type self-antigen expressed by melanocytes, pigmented retinal cells and most melanomas. This recombinant vaccinia Mgp100 encodes a fragment epitope of gp100 bearing 2 amino acids substitution; T->M at position 210 and 288 A ->V at position 210. This modification may stimulate tumor infiltrating lymphocytes (TIL) more efficiently.
@@ -17353,15 +18670,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Oliver He
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C51978
- PubMed:12912944
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5505
+ PMID:12912944
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5505
https://github.com/vaccineontology/VO/issues/346
6490
5505
- Clinical trial
cancer vaccine
Gene name: gp100 (PMEL)
- Recombinant Vaccinia-Mgp100 Vaccine
+ recombinant Vaccinia-Mgp100 vaccine
@@ -17378,6 +18694,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -17402,17 +18724,19 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Oliver He
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C48638
- PubMed:30626434
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5232
+ PMID:30626434
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5232
12524
2315
6490
941
5232
- Clinical trial
cancer vaccine
- Gene name: Cd86|Gene name: MLANA-Dupli|Gene name: CD80|Gene name: gp100 (PMEL)
- Recombinant Vaccinia-Multiepitope Melanoma Peptides-B7.1-B7.2 Vaccine
+ Gene name: CD80
+ Gene name: Cd86
+ Gene name: MLANA-Dupli
+ Gene name: gp100 (PMEL)
+ recombinant Vaccinia-multiepitope melanoma peptides-B7.1-B7.2 vaccine
@@ -17429,6 +18753,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -17444,13 +18774,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A recombinant vaccinia virus encoding the melanocyte differentiation antigen tyrosinase-related protein-1 (TRP-1) with potential use in cancer immunotherapy.
@@ -17459,15 +18789,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Oliver He
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29564
- PubMed:19047169
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5063
+ PMID:19047169
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5063
https://github.com/vaccineontology/VO/issues/352
22178
5063
- Clinical trial
cancer vaccine
Gene name: TRP-1
- Recombinant Vaccinia-TRP1 Vaccine
+ recombinant Vaccinia-TRP1 vaccine
@@ -17490,6 +18819,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -17499,13 +18834,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A vaccine adjuvant consisting of a plasmid DNA encoding sargramostim (a granulocyte macrophage-colony stimulating factor). Upon administration, expressed sargramostim may stimulate a cytotoxic T cell response enhancing the host immune response to a concomitantly administered melanoma vaccine.
@@ -17515,15 +18850,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2430
NCT: https://clinicaltrials.gov/ct2/show/NCT01216436
- PubMed:26241951
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5194
+ PMID:26241951
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5194
https://github.com/vaccineontology/VO/issues/360
1493
8784
5194
- Clinical trial
cancer vaccine
- Gene name: CTLA4|Gene name: TNFRSF18
+ Gene name: CTLA4
+ Gene name: TNFRSF18
Sargramostim Plasmid DNA Melanoma Vaccine Adjuvant
@@ -17532,58 +18867,16 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
A recombinant plasmid DNA vaccine that encodes two peptides, tyrosinase 207-216 and tyrosinase 1-17, both of which are derived from human tyrosinase.
Jie Zheng
Jimmy Guo
Oliver He
Virginia He
- NCT: https://clinicaltrials.gov/ct2/show/NCT00023647
- PubMed:12833467
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4002
- https://github.com/vaccineontology/VO/issues/406
- 4002
- Research
- cancer vaccine
- Synchotrope TA2M Vaccine
+
+
+
+ obsolete Synchotrope TA2M vaccine
+ true
@@ -17606,6 +18899,18 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
+
+
+
+
+
+
@@ -17615,31 +18920,32 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
- A recombinant plasmid DNA vaccine encoding epitopes of tyrosinase with potential antineoplastic activity. Synchrotope TA2M vaccine contains a plasmid encoding 2 epitopes, amino acid sequences 207-216 and 1-17 of tyrosinase, a protein frequently expressed by melanoma cells. Vaccination with the TA2M plasmid DNA vaccine may induce the production of anti-tyrosinase antibodies as well as elicit a cytotoxic T-lymphocyte (CTL) response against tyrosinase-expressing tumor cells, resulting in decreased tumor growth.
+ A recombinant plasmid DNA vaccine encoding epitopes of tyrosinase with potential antineoplastic activity. Synchotrope TA2M vaccine contains a plasmid encoding 2 epitopes, amino acid sequences 207-216 and 1-17 of tyrosinase, a protein frequently expressed by melanoma cells. Vaccination with the TA2M plasmid DNA vaccine may induce the production of anti-tyrosinase antibodies as well as elicit a cytotoxic T-lymphocyte (CTL) response against tyrosinase-expressing tumor cells, resulting in decreased tumor growth.
Jie Zheng
Jimmy Guo
Oliver He
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2650
NCT: https://clinicaltrials.gov/ct2/show/NCT00023647
- PubMed:12833467
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5218
+ PMID:12833467
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4002
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5218
https://github.com/vaccineontology/VO/issues/407
7299
+ 4002
5218
- Clinical trial
cancer vaccine
Gene name: Tyrosinase
- Synchrotope TA2M Plasmid DNA Vaccine
+ Synchotrope TA2M DNA vaccine
@@ -17662,6 +18968,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -17671,13 +18983,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A bivalent DNA vaccine encoding epitopes for both Melan-A (MART-1) and tyrosinase with potential antineoplastic activity. Synchrovax SEM plasmid DNA vaccine contains a plasmid pSEM that encodes 4 epitopes: Melan-A (26-35), Melan-A (31-96), tyrosinase (1-9), and tyrosinase (369-377). Both Melan-A and tyrosinase are tumor antigens associated with melanoma. Vaccination with this plasmid DNA vaccine may induce both humoral and cytotoxic lymphocyte (CTL) responses against cells expressing either or both of these antigens, resulting in decreased tumor growth.
@@ -17687,15 +18999,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C28549
NCT: https://clinicaltrials.gov/ct2/show/NCT00033228
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5506
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5506
https://github.com/vaccineontology/VO/issues/408
2315
7299
5506
- Clinical trial
cancer vaccine
- Gene name: MLANA-Dupli|Gene name: Tyrosinase
- Synchrovax SEM Plasmid DNA Vaccine
+ Gene name: MLANA-Dupli
+ Gene name: Tyrosinase
+ Synchrovax SEM plasmid DNA vaccine
@@ -17712,6 +19024,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -17727,13 +19045,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
-
+
+
A cancer vaccine containing synthetic epitope peptides derived from melanoma tumor-associated antigens (TAAs), including melanoma-melanocyte antigen gp100(280-288), melanoma-associated antigen tyrosinase(1-9), and melanoma-associated antigen melan-A(27-35). Upon administration, synthetic melanoma-associated antigens vaccine may stimulate a cytotoxic T-lymphocyte immune response against melanoma cells that express TAAs which share epitopes with the vaccine epitope peptides, resulting in tumor cell lysis.
@@ -17743,15 +19061,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C48639
NCT: https://clinicaltrials.gov/ct2/show/NCT00116597
- PubMed:11874634
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5217
+ PMID:11874634
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5217
https://github.com/vaccineontology/VO/issues/411
6490
5217
- Clinical trial
cancer vaccine
Gene name: PMEL - obsolete
- Synthetic Melanoma-Associated Antigens Vaccine
+ synthetic melanoma-associated antigens vaccine
@@ -17774,6 +19091,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -17793,14 +19116,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C122396
NCT: https://clinicaltrials.gov/ct2/show/NCT02410733
- PubMed:21093980
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5114
+ PMID:21093980
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5114
416115
5114
- Clinical trial
cancer vaccine
Gene name: MAGE-1
- Tetravalent RNA-lipoplex Cancer Vaccine
+ tetravalent RNA-lipoplex cancer vaccine
@@ -17817,6 +19139,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -17845,16 +19173,17 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jimmy Guo
Oliver He
Virginia He
- PubMed:23090079
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4004
+ PMID:23090079
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4004
2315
6409
7299
4004
- Research
cancer vaccine
- Gene name: MLANA|Gene name: PMEL|Gene name: Tyrosinase
- TLR-9/GM Vaccine
+ Gene name: MLANA
+ Gene name: PMEL
+ Gene name: Tyrosinase
+ TLR-9/GM vaccine
@@ -17870,6 +19199,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -17892,10 +19227,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jimmy Guo
Oliver He
Virginia He
- PubMed:23509826
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4075
+ PMID:23509826
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4075
4075
- Clinical trial
cancer vaccine
TriMixDC-MEL Vaccine
@@ -17914,6 +19248,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -17939,14 +19279,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2815
NCT: https://clinicaltrials.gov/ct2/show/NCT00022438
- PubMed:16906394
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5325
+ PMID:16906394
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5325
1638
5325
- Clinical trial
cancer vaccine
Gene name: TRP-2
- TRP-2: 180-188 Peptide Vaccine
+ TRP-2: 180-188 peptide vaccine
@@ -17963,6 +19302,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -17988,14 +19333,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2816
NCT: https://clinicaltrials.gov/ct2/show/NCT00019383
- PubMed:8027058
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5487
+ PMID:8027058
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5487
22178
5487
- Clinical trial
cancer vaccine
Gene name: TRP-1
- TRP1(0RF3):1-9 Peptide Vaccine
+ TRP1(0RF3):1-9 peptide vaccine
@@ -18012,6 +19356,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -18037,14 +19387,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2384
NCT: https://clinicaltrials.gov/ct2/show/NCT00028431
- PubMed:21143299
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5060
+ PMID:21143299
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5060
7299
5060
- Clinical trial
cancer vaccine
Gene name: Tyrosinase
- Tyrosinase-KLH Vaccine
+ tyrosinase-KLH vaccine
@@ -18061,6 +19410,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -18083,13 +19438,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jimmy Guo
Oliver He
Virginia He
- PubMed:14581425
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3999
+ PMID:14581425
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3999
tyrosinase240-251s, 368-376d vaccine
3999
- Research
cancer vaccine
- tyrosinase240-251S, 368-376D Vaccine
+ tyrosinase240-251S, 368-376D vaccine
@@ -18105,6 +19459,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -18122,10 +19482,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jimmy Guo
Oliver He
Virginia He
- PubMed:12377961
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4007
+ PMID:12377961
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4007
4007
- Research
cancer vaccine
vaccinia melanoma cell lysates (VMCL) vaccine
@@ -18143,6 +19502,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -18159,12 +19524,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jimmy Guo
Oliver He
Virginia He
- PubMed:3155379
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4023
+ PMID:3155379
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4023
4023
- Research
cancer vaccine
- Vaccinia Melanoma Oncolysates (VMO) Vaccine
+ Vaccinia melanoma oncolysates (VMO) vaccine
@@ -18181,6 +19545,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -18206,14 +19576,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2674
NCT: https://clinicaltrials.gov/ct2/show/NCT00002817
- PubMed:8894677
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5508
+ PMID:8894677
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5508
12981
5508
- Clinical trial
cancer vaccine
Gene name: Csf2-Mouse
- Vaccinia-GM-CSF Vaccine
+ Vaccinia-GM-CSF vaccine
@@ -18230,6 +19599,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -18255,13 +19630,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2531
NCT: https://clinicaltrials.gov/ct2/show/NCT00019734
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5223
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5223
7299
5223
- Clinical trial
cancer vaccine
Gene name: Tyrosinase
- Vaccinia-Tyrosinase Vaccine
+ Vaccinia-Tyrosinase vaccine
@@ -18284,6 +19658,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -18303,14 +19683,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C68839
NCT: https://clinicaltrials.gov/ct2/show/NCT00471133
- PubMed:4019903
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5416
+ PMID:4019903
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5416
7299
5416
- Clinical trial
cancer vaccine
Gene name: Tyrosinase
- Xenogeneic Tyrosinase DNA Vaccine
+ Xenogeneic Tyrosinase DNA vaccine
@@ -18327,6 +19706,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -18351,6 +19736,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
A recombinant replication-defective adenovirus which encodes the gene for the cytokine human interferon-beta (IFN-beta). Once inserted into and replicating in host tumor cells, recombinant adenovirus-hIFN-beta expresses human IFN-beta, which may stimulate an antiproliferative natural killer (NK) cell response against tumor cells and induce caspase-mediated tumor cell apoptosis.
Jie Zheng
Jimmy Guo
@@ -18358,12 +19749,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C28550
NCT: https://clinicaltrials.gov/ct2/show/NCT00066404
- PubMed:19893592
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5510
+ PMID:19893592
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5510
https://github.com/vaccineontology/VO/issues/321
3456
5510
- Clinical trial
cancer vaccine
Gene name: IFNB1
Recombinant Adenovirus-hIFN-beta Vaccine
@@ -18383,6 +19773,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -18407,6 +19803,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
A modified recombinant nonapeptide (LMLGEFLKL) derived from the anti-apoptosis protein survivin with potential immunopotentiating and antineoplastic activities. Upon administration, survivin Sur1M2 peptide vaccine may elicit humoral and cellular immune responses against survivin-expressing cancers, resulting in decreased tumor cell proliferation and tumor cell death. The survivin protein inhibits caspase activation and apoptosis; it is undetectable in normal adult tissues but is expressed by several human cancers including lung, colon, breast, pancreas, and prostate cancer as well as hematopoietic malignancies and skin cancers.
Jie Zheng
Jimmy Guo
@@ -18414,12 +19816,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C71741
NCT: https://clinicaltrials.gov/ct2/show/NCT00499577
- PubMed:29057249
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5265
+ PMID:29057249
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5265
https://github.com/vaccineontology/VO/issues/365
7015
5265
- Clinical trial
cancer vaccine
Gene name: TERT
Survivin Sur1M2 Peptide Vaccine
@@ -18439,6 +19840,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -18464,10 +19871,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2822
NCT: https://clinicaltrials.gov/ct2/show/NCT00001561
- PubMed:4108872
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5391
+ PMID:4108872
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5391
5391
- Clinical trial
cancer vaccine
Unconjugated Myeloma Ig Id Vaccine
@@ -18486,6 +19892,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -18511,11 +19923,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C64635
NCT: https://clinicaltrials.gov/ct2/show/NCT01827137
- PubMed:25802083
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5341
+ PMID:25802083
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5341
7490
5341
- Clinical trial
cancer vaccine
Gene name: WT1
WT1 Analog Peptide Vaccine
@@ -18535,6 +19946,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -18560,10 +19977,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C102751
NCT: https://clinicaltrials.gov/ct2/show/NCT01621542
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5027
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5027
7490
5027
- Clinical trial
cancer vaccine
Gene name: WT1
WT1 Peptide Vaccine WT2725
@@ -18583,6 +19999,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -18608,15 +20030,16 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C103823
NCT: https://clinicaltrials.gov/ct2/show/NCT01718899
- PubMed:30128502
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5415
+ PMID:30128502
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5415
22433
57823
6382
5415
- Clinical trial
cancer vaccine
- Gene name: Xbp1|Gene name: SDC1|Gene name: SLAMF7
+ Gene name: SDC1
+ Gene name: SLAMF7
+ Gene name: Xbp1
XBP1-US/XBP1-SP/CD138/CS1 Multipeptide Vaccine PVX-410
@@ -18634,6 +20057,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -18658,6 +20087,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
A cancer vaccine consisting of autologous dendritic cells (DCs) loaded with autologous, lethally irradiated cancer cells and mixed with the cytokine granulocyte-macrophage colony stimulating factor (GM-CSF), with potential immunostimulatory and antineoplastic activities. Upon vaccination, ovapuldencel-T may stimulate the immune system to exert a cytotoxic T-lymphocyte (CTL) immune response against the repertoire of tumor associated antigens (TAAs) found in the irradiated cancer cells. GM-CSF enhances the activation of dendritic cells (DCs) and promotes antigen presentation to both B- and T-lymphocytes.
Jie Zheng
Jimmy Guo
@@ -18665,10 +20100,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C113651
NCT: https://clinicaltrials.gov/ct2/show/NCT02033616
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5481
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5481
https://github.com/vaccineontology/VO/issues/71
5481
- Clinical trial
cancer vaccine
Ovapuldencel-T Vaccine
@@ -18687,6 +20121,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -18711,6 +20151,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
A cancer vaccine comprised of synthetic peptides corresponding to naturally-occurring peptides derived from ovarian cancer cell antigens. Ovarian cancer peptide vaccine may elicit a cytotoxic T-cell response against tumor cells expressing the related ovarian cancer cell antigens.
Jie Zheng
Jimmy Guo
@@ -18718,10 +20164,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C48414
NCT: https://clinicaltrials.gov/ct2/show/NCT00091273
- PubMed:20445345
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5502
+ PMID:20445345
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5502
5502
- Clinical trial
cancer vaccine
Ovarian Cancer Peptide Vaccine
@@ -18741,6 +20186,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -18772,10 +20223,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C96739
NCT: https://clinicaltrials.gov/ct2/show/NCT01334047
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5403
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5403
7015
5403
- Clinical trial
cancer vaccine
Gene name: TERT
Ovarian Cancer Stem Cell/hTERT/Survivin mRNAs-loaded Autologous Dendritic Cell Vaccine
@@ -18795,6 +20245,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -18820,15 +20276,16 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C115105
NCT: https://clinicaltrials.gov/ct2/show/NCT02107950
- PubMed:22862954
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5280
+ PMID:22862954
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5280
3696
3728
780
5280
- Clinical trial
cancer vaccine
- Gene name: ITGB8|Gene name: JUP|Gene name: DDR1
+ Gene name: DDR1
+ Gene name: ITGB8
+ Gene name: JUP
Ovarian Tumor Antigen-activated Autologous Dendritic Cell Vaccine
@@ -18846,6 +20303,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -18870,6 +20333,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
A peptide vaccine consisting of 10 synthetic long peptides (SLPs), 25-30 amino acids in size and derived from the middle portion of p53 (amino acids 70-251), mixed with the adjuvant Montanide ISA-51 with potential immunostimulatory and antitumor activities. Upon administration, p53 synthetic long peptide (70-251) vaccine may stimulate the host immune system to mount a cytotoxic T-cell lymphocyte (CTL) response against p53-expressing tumor cells. p53, a tumor associated antigen (TAA), may be overexpressed in variety of cancer cell types.
Jie Zheng
Jimmy Guo
@@ -18877,12 +20346,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C82420
NCT: https://clinicaltrials.gov/ct2/show/NCT00844506
- PubMed:26334096
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5278
+ PMID:26334096
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5278
https://github.com/vaccineontology/VO/issues/59
7157
5278
- Clinical trial
cancer vaccine
Gene name: TP53
P53-Synthetic Long Peptides Vaccine
@@ -18902,6 +20370,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -18926,6 +20400,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
A cell-based cancer vaccine with potential antineoplastic activity. PA-1-STK ovarian carcinoma vaccine is produced by transducing the ovarian cancer cell line, PA-1, with the herpes simplex thymidine kinase (HSV-tk) gene, resulting in a cell line, PA-1-STK, that permanently expresses the HSV tk gene. Upon transfection into malignant cells, this vaccine is capable of sensitizing tumor cells in response to an antiviral drug such as ganciclovir, which is readily phosphorylated by the TK enzyme to its active form. Administration of ganciclovir following PA-1 STK transfection results in enhanced cytotoxicity of the transfected tumor cells. Additionally, adjacent non-transfected cells are also killed by the activated antiviral drug, a phenomenon referred to as the bystander effect that occurs with this type of suicide-gene transfer technique.
Jie Zheng
Jimmy Guo
@@ -18933,12 +20413,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2428
NCT: https://clinicaltrials.gov/ct2/show/NCT00006216
- PubMed:7578411
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5245
+ PMID:7578411
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5245
https://github.com/vaccineontology/VO/issues/57
79447
5245
- Clinical trial
cancer vaccine
Gene name: PAGR1
PA-1-STK Ovarian Carcinoma Vaccine
@@ -18958,6 +20437,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -18982,6 +20467,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
An oncolytic thymidine kinase (TK)-deleted vaccinia poxvirus expressing human GM-CSF (hGM-CSF) with antineoplastic activity. Upon intratumoral or intravenous administration, pexastimogene devacirepvec selectively infects and lyses tumor cells. While vaccinia displays a natural tumor cell tropism, deletion of the TK gene increases the tumor selectivity of vaccinia by limiting viral replication to cells expressing high levels of TK, such as certain cancer cells. hGM-CSF expression by this agent helps recruit antigen presenting cells (APCs), such as dendritic cells (DCs) and macrophages, to virally infected tumor cells, thereby initiating an antitumoral immune response.
Jie Zheng
Jimmy Guo
@@ -18989,12 +20480,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C71533
NCT: https://clinicaltrials.gov/ct2/show/NCT02562755
- PubMed:31413923
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5078
+ PMID:31413923
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5078
https://github.com/vaccineontology/VO/issues/119
1437
5078
- Clinical trial
cancer vaccine
Gene name: hGM-CSF
Pexastimogene-devacirepvec Vaccine
@@ -19020,6 +20510,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -19038,6 +20534,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
A plasmid DNA vaccine containing mammalian expression vector pUMVC3, encoding epitopes of human insulin-like growth factor-binding protein 2 (hIGFBP-2) with potential immunostimulating and antineoplastic activities. Upon vaccination, pUMVC3-hIGFBP-2 multi-epitope plasmid DNA vaccine may activate the immune system to mount a cytotoxic T-lymphocyte (CTL) response against hIGFBP-2-expressing cells. The tumor associated antigen (TAA) hIGFBP-2, a member of the insulin like growth factor receptor family, is overexpressed in a number of cancer cell types and its expression has been associated with increased invasiveness.
Jie Zheng
Jimmy Guo
@@ -19045,12 +20547,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C95727
NCT: https://clinicaltrials.gov/ct2/show/NCT01322802
- PubMed:17102977
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5365
+ PMID:17102977
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5365
https://github.com/vaccineontology/VO/issues/186
3484
5365
- Clinical trial
cancer vaccine
Gene name: hIGFBP-2
pUMVC3-hIGFBP-2 Multi-Epitope Plasmid DNA Vaccine
@@ -19070,6 +20571,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -19094,17 +20601,22 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
A recombinant retrovirus containing the modified murine retroviral vector MFG-S encoding a chimeric construct, MOv18-gamma. MOv18 is a murine monoclonal antibody developed against epitope of human folate binding protein, which is overexpressed on more than 90% of non-mucinous epithelial ovarian neoplasms. The chimeric construct (MOv18-gamma) encodes the variable region of MOv18 antibody, and the gamma chain of human T-cell receptor. This virion might be used to transduce autologous T lymphocytes, and reintroduced back to the patient after expansion ex vivo to invoke specific immune response against ovarian cancer cells.
Jie Zheng
Jimmy Guo
Oliver He
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29192
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5131
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5131
https://github.com/vaccineontology/VO/issues/356
2348
5131
- Clinical trial
cancer vaccine
Gene name: FOLR1
Retroviral Vector MFGS-MOv18-gamma Vaccine
@@ -19124,6 +20636,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -19148,17 +20666,22 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
A fowlpox vaccine containing the tumor-associated antigen mucin-1 (MUC1), found in pancreatic tumor cells, and a TRIad of COstimulatory Molecules (B7-1, ICAM-1 and LFA-3; TRICOM), which is designed to enhance antigen presentation and activation of immune responses critical for tumor destruction. Vaccination with this agent may elicit a host immune response against MUC1-expressing tumor cells.
Jie Zheng
Jimmy Guo
Oliver He
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29558
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5477
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5477
https://github.com/vaccineontology/VO/issues/357
4582
5477
- Clinical trial
cancer vaccine
Gene name: MUC1
rF-MUC1(DF3)/TRICOM Vaccine
@@ -19184,6 +20707,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -19202,6 +20731,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
A whole cell vaccine comprised of irradiated allogenic pancreatic tumor cells transfected with a plasmid DNA encoding human sargramostim (GM-CSF). Vaccination results in expression of GM-CSF, which induces proliferation and differentiation hematopoietic lineage cells as well as stimulating macrophage and dendritic cell functions in antigen presentation and antitumor cell-mediated immunity. Furthermore, administration of this pancreatic tumor cell vaccine may elicit a cytotoxic T lymphocyte (CTL) response against similar host tumor cells, resulting in decreased tumor growth.
Jie Zheng
Jimmy Guo
@@ -19209,10 +20744,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2445
NCT: https://clinicaltrials.gov/ct2/show/NCT00389610
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5340
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5340
100137216
5340
- Clinical trial
cancer vaccine
Gene name: GM-CSF
Sargramostim Plasmid DNA Pancreatic Tumor Cell Vaccine
@@ -19232,6 +20766,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -19257,11 +20797,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C77895
NCT: https://clinicaltrials.gov/ct2/show/NCT00655785
- PubMed:26190488
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5214
+ PMID:26190488
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5214
2321
5214
- Clinical trial
cancer vaccine
Gene name: FLT1
VEGFR1-1084 Peptide Vaccine
@@ -19281,6 +20820,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -19306,11 +20851,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C74090
NCT: https://clinicaltrials.gov/ct2/show/NCT00639925
- PubMed:15930316
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5419
+ PMID:15930316
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5419
16542
5419
- Clinical trial
cancer vaccine
Gene name: Kdr
VEGFR2-169 Peptide Vaccine
@@ -19330,6 +20874,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -19354,6 +20904,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
A cancer vaccine containing HLA class I- and II-binding peptides derived from the NY-ESO-1/LAGE-1 cancer/testis antigen with potential immunostimulatory and antineoplastic activities. Upon administration, NY-ESO-1/LAGE-1 HLA class I/II peptide vaccine may induce a cytotoxic immune response against tumor cells that over-express NY-ESO-1/LAGE-1. Rarely expressed by normal cells, the NY-ESO-1/LAGE-1 cancer/testis antigen has been shown to be preferentially expressed on the surface of some cancer cell types.
Jie Zheng
Jimmy Guo
@@ -19361,15 +20917,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C74066
NCT: https://clinicaltrials.gov/ct2/show/NCT00616291
- PubMed:21131422
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5379
+ PMID:21131422
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5379
https://github.com/vaccineontology/VO/issues/111
1485
30848
5379
- Clinical trial
cancer vaccine
- Gene name: CTAG1B|Gene name: CTAG2
+ Gene name: CTAG1B
+ Gene name: CTAG2
NY-ESO-1/LAGE-1 peptide vaccine
@@ -19388,6 +20944,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -19419,11 +20981,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C95771
NCT: https://clinicaltrials.gov/ct2/show/NCT00345293
- PubMed:30505813
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5205
+ PMID:30505813
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5205
7015
5205
- Clinical trial
cancer vaccine
Gene name: TERT
Primary Prostate Cancer Tissue/hTERT/Survivin mRNA-loaded Autologous Dendritic Cell Vaccine
@@ -19443,6 +21004,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -19472,10 +21039,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jimmy Guo
Oliver He
Virginia He
- PubMed:22729556
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3710
+ PMID:22729556
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3710
3710
- Research
cancer vaccine
Prostate cancer DNA vaccine pDOM-PSMA27 encoding PSMA
@@ -19494,6 +21060,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -19518,6 +21090,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
A cell-based vaccine derived from prostate cancer with potential immunopotentiating and antineoplastic activities. Prostate cancer vaccine ONY-P1 is derived from three irradiated allogeneic prostate cancer cell lines that represent different stages of prostate cancer and express a broad range of prostate and prostate cancer antigens. Upon administration, this vaccine may stimulate a host immune response against prostate cancer cells; in the vaccination schedule, the first two vaccinations are co-administered with bacillus Calmette-Guerin (BCG) as an adjuvant.
Jie Zheng
Jimmy Guo
@@ -19525,12 +21103,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C71723
NCT: https://clinicaltrials.gov/ct2/show/NCT00514072
- PubMed:22932804
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5351
+ PMID:22932804
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5351
https://github.com/vaccineontology/VO/issues/141
959
5351
- Clinical trial
cancer vaccine
Gene name: CD40
Prostate Cancer Vaccine ONY-P1
@@ -19550,6 +21127,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -19575,11 +21158,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C115106
NCT: https://clinicaltrials.gov/ct2/show/NCT02111577
- PubMed:27683469
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5132
+ PMID:27683469
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5132
354
5132
- Clinical trial
cancer vaccine
Gene name: KLK3
Prostate Tumor Antigen-activated Autologous Dendritic Cell Vaccine
@@ -19598,6 +21180,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -19616,18 +21204,23 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
A vaccinia virus carrying a copy of the human gene encoding prostate-specific antigen (PSA), contaminated with bovine viral diarrhea virus (BVDV).
Jie Zheng
Jimmy Guo
Oliver He
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29334
- PubMed:27683469
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5260
+ PMID:27683469
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5260
https://github.com/vaccineontology/VO/issues/142
354
5260
- Clinical trial
cancer vaccine
Gene name: KLK3
PROSTVAC-Contaminated W/ BVDV vaccine
@@ -19647,6 +21240,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -19671,6 +21270,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
A peptide vaccine containing the prostate specific antigen (PSA) with potential antineoplastic activity. PSA, a glycoprotein secreted by prostatic epithelial and ductal cells, is overexpressed in prostate cancer cells and is used as a tumor marker for both diagnosis and treatment evaluation. Vaccination with PSA peptide vaccine may produce anti-PSA antibodies as well as elicit a cytotoxic T-cell (CTL) response against prostate cancer cells expressing this antigen, thereby decreasing tumor cell growth.
Jie Zheng
Jimmy Guo
@@ -19678,12 +21283,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2497
NCT: https://clinicaltrials.gov/ct2/show/NCT00015977
- PubMed:27683469
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5087
+ PMID:27683469
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5087
https://github.com/vaccineontology/VO/issues/143
354
5087
- Clinical trial
cancer vaccine
Gene name: KLK3
PSA Prostate Cancer Vaccine
@@ -19704,6 +21308,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -19734,6 +21344,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
An autologous dendritic cell vaccine with potential immunostimulatory activity. Dendritic cells harvested from a prostate cancer patient are transfected with the mRNA encoding for prostate specific antigen (PSA), a tumor marker secreted by prostatic epithelial and ductal cells. When reintroduced back to the patient, these PSA RNA pulsed autologous dendritic cells may elicit a cytotoxic T-cell (CTL) response against PSA-positive prostate cancer cells.
Jie Zheng
Jimmy Guo
@@ -19741,12 +21357,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2236
NCT: https://clinicaltrials.gov/ct2/show/NCT00004211
- PubMed:14711334
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5022
+ PMID:14711334
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5022
https://github.com/vaccineontology/VO/issues/144
354
5022
- Clinical trial
cancer vaccine
Gene name: KLK3
PSA RNA-Pulsed Dendritic Cell Vaccine
@@ -19766,6 +21381,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -19790,18 +21411,23 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
A 30-residue prostate specific antigen (PSA) oligoepitope peptide (OP) vaccine with potential antineoplastic activity. PSA-OP peptide vaccine contains the PSA-1 and PSA-3 HLA-A2 epitopes and the PSA-9 HLA-class I-A3 epitope joined by peptide linker sequences. In an animal model, vaccination with this agent has been shown to elicit a cytotoxic T-lymphocyte immune response.
Jie Zheng
Jimmy Guo
Oliver He
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C29337
- PubMed:9743387
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5234
+ PMID:9743387
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5234
https://github.com/vaccineontology/VO/issues/179
354
5234
- Clinical trial
cancer vaccine
Gene name: KLK3
PSA-OP Peptide Vaccine
@@ -19821,6 +21447,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -19846,11 +21478,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C92573
NCT: https://clinicaltrials.gov/ct2/show/NCT01171729
- PubMed:12487060
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5353
+ PMID:12487060
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5353
56318
5353
- Clinical trial
cancer vaccine
Gene name: Acpp
PSA-PAP/KLH-pulsed Autologous Dendritic Cell Vaccine
@@ -19876,6 +21507,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -19894,6 +21531,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
A prostate cancer vaccine containing prostate specific antigen (PSA) combined with the cytokines, interleukin-2 (IL-2) and granulocyte macrophage-colony-stimulating factor (GM-CSF), with potential antineoplastic activity. Upon intradermal vaccination, PSA/IL-2/GM-CSF vaccine may activate the immune system to induce a cytotoxic T-cell (CTL) response against prostate cancer cells expressing this antigen, thereby decreasing tumor cell growth. PSA, a glycoprotein secreted by prostatic epithelial and ductal cells, is overexpressed by prostate cancer cells. IL-2 stimulates natural killer (NK) cells and cytotoxic T-cells against the PSA-expressing tumor cells. GM-CSF promotes antigen presentation to dendritic cells and further stimulates a tumor-specific cytotoxic T-lymphocyte (CTL) response.
Jie Zheng
Jimmy Guo
@@ -19901,15 +21544,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C114289
NCT: https://clinicaltrials.gov/ct2/show/NCT02058680
- PubMed:12487060
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5109
+ PMID:12487060
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5109
https://github.com/vaccineontology/VO/issues/180
1437
3558
5109
- Clinical trial
cancer vaccine
- Gene name: IL-2|Gene name: GM-CSF
+ Gene name: GM-CSF
+ Gene name: IL-2
PSA/IL-2/GM-CSF Vaccine
@@ -19933,6 +21576,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -19951,6 +21600,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
A plasmid DNA vaccine encoding the tumor-associated antigens (TAAs) prostate-specific antigen (PSA) and prostate-specific membrane antigen (PSMA), with potential immunoactivating and antineoplastic activities. Upon intramuscular delivery and electroporation of the PSA/PSMA DNA plasmid INO-5150, both PSA and PSMA are translated in cells which then activate the immune system. This induces cytotoxic T-lymphocyte (CTL) responses against tumor cells expressing PSA and PSMA. This may result in both immune-mediated tumor cell death and the inhibition of tumor cell proliferation. PSA and PSMA are overexpressed on a variety of cancer cell types. The DNA encoding the TAAs in INO-5150 is based on both human and other primate antigen gene sequences. As the plasmid genes differ from the human gene sequences encoding these antigens, INO-5150 may overcome immune tolerance to human TAAs.
Jie Zheng
Jimmy Guo
@@ -19958,12 +21613,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C123283
NCT: https://clinicaltrials.gov/ct2/show/NCT02514213
- PubMed:32208168
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5252
+ PMID:32208168
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5252
https://github.com/vaccineontology/VO/issues/181
2346
5252
- Clinical trial
cancer vaccine
Gene name: FOLH1
PSA/PSMA DNA Plasmid INO-5150 vaccine
@@ -19983,6 +21637,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -20007,6 +21667,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
A synthetic peptide based on sequence corresponding to positions 154-163 of the amino acids of prostate-specific antigen (PSA), VISNDVCAQV. Upon administration, PSA:154-163 peptide vaccine may elicit a cytotoxic T-cell response against tumor cells that express PSA.
Jie Zheng
Jimmy Guo
@@ -20014,12 +21680,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2798
NCT: https://clinicaltrials.gov/ct2/show/NCT00004156
- PubMed:19483644
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5106
+ PMID:19483644
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5106
https://github.com/vaccineontology/VO/issues/182
4582
5106
- Clinical trial
cancer vaccine
Gene name: MUC1
PSA:154-163 Peptide vaccine
@@ -20039,6 +21704,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -20063,6 +21734,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
A cancer vaccine comprised of a synthetic peptide with an amino acid sequence corresponding to positions 154-163 of the amino acid sequence for prostate-specific antigen (PSA) with a leucine substitution at position 155. Upon administration, PSA:154-163(155L) peptide vaccine may elicit a cytotoxic T-cell response against tumor cells that express PSA.
Jie Zheng
Jimmy Guo
@@ -20070,12 +21747,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C29338
NCT: https://clinicaltrials.gov/ct2/show/NCT00109811
- PubMed:19483644
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5155
+ PMID:19483644
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5155
https://github.com/vaccineontology/VO/issues/183
354
5155
- Clinical trial
cancer vaccine
Gene name: KLK3
PSA:154-163(155L) Peptide Vaccine
@@ -20095,6 +21771,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -20119,6 +21801,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
A peptide-based cancer vaccine containing epitopes of T cell receptor gamma-chain alternate reading frame protein (TARP) and prostate-specific membrane antigen (PSMA) in combination with a Poly IC-LC immunoadjuvant, with potential antineoplastic activity. Upon administration, PSMA/TARP peptide vaccine may stimulate a host cytotoxic T-cell (CTL) response against TARP- and PSMA-expressing tumor cells, resulting in tumor cell cytotoxicity. The nuclear protein TARP and PSMA are commonly expressed in prostate cancer cells.
Jie Zheng
Jimmy Guo
@@ -20126,12 +21814,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C78819
NCT: https://clinicaltrials.gov/ct2/show/NCT00694551
- PubMed:34494382
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5052
+ PMID:34494382
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5052
https://github.com/vaccineontology/VO/issues/184
354
5052
- Clinical trial
cancer vaccine
Gene name: KLK3
PSMA/TARP Peptide Vaccine
@@ -20157,6 +21844,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -20175,6 +21868,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
A cancer vaccine containing plasmid DNA encoding human prostatic acid phosphatase (PAP) (pTVG-HP) with potential immunostimulatory and antineoplastic activities. Upon administration, pTVG-HP plasmid DNA vaccine may stimulate the host immune system to generate a cytotoxic T lymphocyte (CTL) response against PAP-expressing prostate cancer cells. PAP or prostatic specific acid phosphatase (PSAP) is a tumor associated antigen (TAA) that may be overexpressed in prostate cancer.
Jie Zheng
Jimmy Guo
@@ -20182,12 +21881,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C82407
NCT: https://clinicaltrials.gov/ct2/show/NCT02499835
- PubMed:17102977
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5535
+ PMID:17102977
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5535
https://github.com/vaccineontology/VO/issues/185
55
5535
- Clinical trial
cancer vaccine
Gene name: ACP3
pTVG-HP Plasmid DNA Vaccine
@@ -20213,6 +21911,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -20231,6 +21935,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
A cancer vaccine containing xenogenic DNA from rhesus macaque (Macaca mulatta) that encodes prostate specific antigen (PSA) with potential immunostimulating and antineoplastic activities. Upon repeated intradermal administration via electroporation, pVAXrcPSAv53l vaccine may induce a cytotoxic T-lymphocyte (CTL) response against PSA-expressing prostate cancer cells. Rhesus PSA is 89% homologous to human PSA.
Jie Zheng
Jimmy Guo
@@ -20238,11 +21948,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C82352
NCT: https://clinicaltrials.gov/ct2/show/NCT00859729
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5092
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5092
https://github.com/vaccineontology/VO/issues/187
354
5092
- Clinical trial
cancer vaccine
Gene name: KLK3
pVAXrcPSAv53l DNA Vaccine
@@ -20262,6 +21971,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -20286,6 +22001,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
A cancer vaccine consisting of a recombinant fowlpox virus encoding human prostate-specific antigen (PSA). Administration of this agent may stimulate a cytotoxic T cell response against PSA-expressing tumor cells. Fowlpox virus is an attractive vector because its genome is easy to manipulate and it is replication incompetent in mammalian cells.
Jie Zheng
Jimmy Guo
@@ -20293,12 +22014,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2675
NCT: https://clinicaltrials.gov/ct2/show/NCT00005039
- PubMed:17707059
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4988
+ PMID:17707059
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4988
https://github.com/vaccineontology/VO/issues/333
354
4988
- Clinical trial
cancer vaccine
Gene name: KLK3
Recombinant Fowlpox-Prostate Specific Antigen Vaccine
@@ -20318,6 +22038,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -20342,6 +22068,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
A cancer vaccine consisting of a recombinant fowlpox virus encoding fragment of human prostate-specific antigen (PSA), PSA:154-163 (155L), and a TRIad of COstimulatory Molecules (B7-1, ICAM-1 and LFA-3) (TRICOM). Administration of this agent may induce a cytotoxic T cell response against PSA-expressing tumor cells. Dendritic cells infected with TRICOM vectors greatly enhance naive T-cell activation and peptide-specific T-cell stimulation. Fowlpox virus is an attractive vector because its genome is easy to manipulate and it is replication incompetent in mammalian cells.
Jie Zheng
Jimmy Guo
@@ -20349,17 +22081,19 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C38708
NCT: https://clinicaltrials.gov/ct2/show/NCT00108732
- PubMed:16390546
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5434
+ PMID:16390546
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5434
https://github.com/vaccineontology/VO/issues/333
12519
3383
354
965
5434
- Clinical trial
cancer vaccine
- Gene name: KLK3|Gene name: Cd80|Gene name: ICAM1|Gene name: CD58
+ Gene name: CD58
+ Gene name: Cd80
+ Gene name: ICAM1
+ Gene name: KLK3
Recombinant Fowlpox-PSA(L155)/TRICOM Vaccine
@@ -20377,6 +22111,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -20401,6 +22141,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
A cancer vaccine comprised of a recombinant fowlpox virus vector encoding TRICOM. TRICOM is comprised of three co-stimulatory molecule transgenes (B7-1, ICAM-1 and LFA-3) that may enhance antigen presentation and activate cytotoxic T-cells. Fowlpox virus is an attractive vector because its genome is easy to manipulate and it is replication incompetent in mammalian cells.
Jie Zheng
Jimmy Guo
@@ -20408,15 +22154,16 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2667
NCT: https://clinicaltrials.gov/ct2/show/NCT00450619
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5253
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5253
https://github.com/vaccineontology/VO/issues/132
12519
3383
965
5253
- Clinical trial
cancer vaccine
- Gene name: Cd80|Gene name: ICAM1|Gene name: CD58
+ Gene name: CD58
+ Gene name: Cd80
+ Gene name: ICAM1
Recombinant Fowlpox-TRICOM Vaccine
@@ -20434,6 +22181,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -20458,6 +22211,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
A vaccine consisting of recombinant vaccinia virus encoding prostate specific antigen (PSA). Vaccination with recombinant vaccinia prostate-specific antigen vaccine stimulates the host immune system to mount a cytotoxic T-cell response against tumor cells expressing PSA.
Jie Zheng
Jimmy Guo
@@ -20465,12 +22224,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2433
NCT: https://clinicaltrials.gov/ct2/show/NCT02649439
- PubMed:12242725
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5154
+ PMID:12242725
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5154
https://github.com/vaccineontology/VO/issues/339
354
5154
- Clinical trial
cancer vaccine
Gene name: KLK3
Recombinant Vaccinia PSA Vaccine
@@ -20490,6 +22248,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -20514,6 +22278,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
A recombinant vaccinia virus encoding prostate-specific antigen (PSA). Vaccination with recombinant vaccinia-PSA may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells positive for PSA, which may decrease tumor growth.
Jie Zheng
Jimmy Guo
@@ -20521,12 +22291,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29945
NCT: https://clinicaltrials.gov/ct2/show/NCT00005039
- PubMed:12242725
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5302
+ PMID:12242725
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5302
https://github.com/vaccineontology/VO/issues/350
354
5302
- Clinical trial
cancer vaccine
Gene name: KLK3
Recombinant Vaccinia-Prostate Specific Antigen Vaccine
@@ -20546,6 +22315,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -20570,20 +22345,26 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
A recombinant vaccinia virus encoding prostate-specific antigen (PSA) and prostate-specific membrane antigen (PSMA) with potential use in cancer immunotherapy.
Jie Zheng
Jimmy Guo
Oliver He
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29563
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5307
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5307
https://github.com/vaccineontology/VO/issues/351
2346
354
5307
- Clinical trial
cancer vaccine
- Gene name: KLK3|Gene name: Prostate-specific membrane antigen
+ Gene name: KLK3
+ Gene name: Prostate-specific membrane antigen
Recombinant Vaccinia-PSA/PSMA Vaccine
@@ -20601,6 +22382,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -20625,17 +22412,22 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
A synthetic fowlpox viral vaccine containing the tumor-associated antigens prostate specific antigen (PSA), prostate specific membrane antigen (PSMA), and a TRIad of COstimulatory Molecules (B7-1, ICAM-1 and LFA-3; TRICOM). Vaccination with this viral vaccine may enhance antigen presentation and activate cytotoxic T-cells against PSA- or PSMA-expressing tumor cells.
Jie Zheng
Jimmy Guo
Oliver He
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29559
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5005
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5005
https://github.com/vaccineontology/VO/issues/358
354
5005
- Clinical trial
cancer vaccine
Gene name: KLK3
rF-PSA/PSMA/TRICOM Vaccine
@@ -20655,6 +22447,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -20679,6 +22477,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
A vaccine formulation consisting of recombinant vaccinia virus encoding prostate specific antigen (PSA) and recombinant vaccinia virus encoding three co-stimulatory molecule transgenes B7.1, ICAM-1, and LFA-3 (TRICOM). Vaccination with PSA in combination with TRICOM may enhance antigen presentation, resulting in the augmentation of a cytotoxic T cell (CTL) immune response against tumor cells expressing PSA.
Jie Zheng
Jimmy Guo
@@ -20686,16 +22490,18 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C38681
NCT: https://clinicaltrials.gov/ct2/show/NCT02772562
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5183
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5183
https://github.com/vaccineontology/VO/issues/359
12519
3383
354
965
5183
- Clinical trial
cancer vaccine
- Gene name: ICAM1|Gene name: Cd80|Gene name: KLK3|Gene name: CD58
+ Gene name: CD58
+ Gene name: Cd80
+ Gene name: ICAM1
+ Gene name: KLK3
Rilimogene-galvacirepvec Vaccine
@@ -20713,6 +22519,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -20737,6 +22549,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
A cell-based vaccine composed of autologous antigen-presenting peripheral blood mononuclear cells (enriched for a dendritic cell fraction) that have been exposed to a recombinant protein consisting of granulocyte-macrophage colony-stimulating factor (GM-CSF) fused to prostatic-acid phosphatase (PAP), a protein expressed by prostate cancer cells. Upon administration, the vaccine may stimulate an antitumor T-cell response against tumor cells expressing PAP.
Jie Zheng
Jimmy Guo
@@ -20744,12 +22562,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1985
NCT: https://clinicaltrials.gov/ct2/show/NCT02159950
- PubMed:20818862
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5216
+ PMID:20818862
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5216
https://github.com/vaccineontology/VO/issues/362
55
5216
- Clinical trial
cancer vaccine
Gene name: ACP3
Sipuleucel-T Vaccine
@@ -20769,6 +22586,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -20793,6 +22616,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
A synthetic peptide vaccine, containing 16 amino acid residues (611-626) of the human telomerase reverse transcriptase catalytic subunit (hTERT), with potential antineoplastic activity. Telomerase, a reverse transcriptase normally repressed in healthy cells, is overexpressed in most cancer cells and plays a key role in cellular proliferation. Vaccination with tertomotide may activate the immune system to mount a cytotoxic T-lymphocyte (CTL) response against telomerase-expressing cells.
Jie Zheng
Jimmy Guo
@@ -20800,12 +22629,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C62756
NCT: https://clinicaltrials.gov/ct2/show/NCT02855892
- PubMed:27941629
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5101
+ PMID:27941629
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5101
https://github.com/vaccineontology/VO/issues/416
22059
5101
- Clinical trial
cancer vaccine
Gene name: Trp53
Telomerase Peptide Vaccine GV1001
@@ -20825,6 +22653,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -20849,11 +22683,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Oliver He
Virginia He
NCT: https://clinicaltrials.gov/ct2/show/NCT01784913
- PubMed:28391357
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5478
+ PMID:28391357
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5478
7015
5478
- Clinical trial
cancer vaccine
Gene name: TERT
UV1 Telomerase Peptide Vaccine
@@ -20873,6 +22706,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -20897,10 +22736,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Oliver He
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C116879
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5397
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5397
8743
5397
- Clinical trial
cancer vaccine
Gene name: TNFSF10
Recombinant Adenovirus 5 Encoding Tumor Necrosis Factor-related Apoptosis-Inducing Ligand Vaccine
@@ -20920,6 +22758,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -20944,6 +22788,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
A multipeptide cancer vaccine targeting renal cell carcinoma with potential immunopotentiating activity. Renal cell carcinoma peptides vaccine IMA901 consists of 10 different synthetic tumor-associated peptide (TUMAP) antigens (9 HLA-class I-binding and 1 HLA class II-binding); endogenously, these TUMAPs are expressed by the majority of renal cell carcinomas. Vaccination with this agent may significantly increase host cytotoxic T-lymphocyte (CTL) immune responses against tumor cells expressing these peptide antigens.
Jie Zheng
Jimmy Guo
@@ -20951,15 +22801,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C70968
NCT: https://clinicaltrials.gov/ct2/show/NCT00523159
- PubMed:23899354
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5013
+ PMID:23899354
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5013
https://github.com/vaccineontology/VO/issues/354
3105
3106
5013
- Clinical trial
cancer vaccine
- Gene name: HLA-A|Gene name: HLA-B
+ Gene name: HLA-A
+ Gene name: HLA-B
Renal Cell Carcinoma Peptides Vaccine IMA901
@@ -20978,6 +22828,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -21009,11 +22865,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C129522
NCT: https://clinicaltrials.gov/ct2/show/NCT02170389
- PubMed:25901286
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5373
+ PMID:25901286
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5373
958
5373
- Clinical trial
cancer vaccine
Gene name: CD40
Renal Cell Carcinoma/CD40L RNA-Transfected Autologous Dendritic Cell Vaccine AGS-003
@@ -21033,6 +22888,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -21057,10 +22918,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Oliver He
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C48816
- PubMed:33408117
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5196
+ PMID:33408117
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5196
5196
- Clinical trial
cancer vaccine
Renal Tumor-Reactive Autologous Peripheral Blood Lymphocyte Vaccine
@@ -21079,6 +22939,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -21103,11 +22969,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Oliver He
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C38122
- PubMed:20109232
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5097
+ PMID:20109232
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5097
7428
5097
- Clinical trial
cancer vaccine
Gene name: VHL
VHL-42: 65-76(V74G) Peptide Vaccine
@@ -21127,6 +22992,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -21151,10 +23022,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Oliver He
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C38123
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5172
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5172
7428
5172
- Clinical trial
cancer vaccine
Gene name: VHL
VHL-59: 116-128 Peptide Vaccine
@@ -21174,6 +23044,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -21198,10 +23074,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Oliver He
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2741
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5012
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5012
7428
5012
- Clinical trial
cancer vaccine
Gene name: VHL
VHL14 Peptide Vaccine
@@ -21221,6 +23096,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -21245,10 +23126,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Oliver He
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2740
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5333
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5333
7428
5333
- Clinical trial
cancer vaccine
Gene name: VHL
VHL16 Peptide Vaccine
@@ -21268,6 +23148,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -21292,10 +23178,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Oliver He
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2824
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5490
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5490
7428
5490
- Clinical trial
cancer vaccine
Gene name: VHL
VHL2 (Y12M) Peptide Vaccine
@@ -21315,6 +23200,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -21340,11 +23231,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2492
NCT: https://clinicaltrials.gov/ct2/show/NCT00001703
- PubMed:20109232
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5127
+ PMID:20109232
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5127
7428
5127
- Clinical trial
cancer vaccine
Gene name: VHL
Von Hippel-Lindau Peptide Vaccine
@@ -21364,6 +23254,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -21388,6 +23284,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
A synthetic peptide vaccine based on the sequences of a translocation mutation of 2 transcriptional factor genes, PAX3 and FKHR. PAX3/FKHR fusion proteins are frequently found in patients with rhabdomyosarcomas. Vaccination with PAX3/FKHR peptide may stimulate the host immune response to elicit a cytotoxic T-cell response against tumor cells that express this PAX3/FKHR fusion protein.
Jie Zheng
Jimmy Guo
@@ -21395,16 +23297,17 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C49023
NCT: https://clinicaltrials.gov/ct2/show/NCT00001564
- PubMed:15838707
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5484
+ PMID:15838707
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5484
https://github.com/vaccineontology/VO/issues/114
2308
5077
7422
5484
- Clinical trial
cancer vaccine
- Gene name: PAX3|Gene name: FOXO1|Gene name: VEGFA
+ Gene name: FOXO1
+ Gene name: PAX3
+ Gene name: VEGFA
PAX3/FKHR Peptide Vaccine
@@ -21422,6 +23325,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -21446,17 +23355,22 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
A recombinant retroviral virus derived from SR-A strain of Rous sarcoma virus carrying a constitutively active form of the AKT Gene. The viral vector RCAS harbors a Replication Competent ALV Splice acceptor. This recombinant virus was use in animal model to study gliomagenesis.
Jie Zheng
Jimmy Guo
Oliver He
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29908
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5044
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5044
https://github.com/vaccineontology/VO/issues/192
207
5044
- Clinical trial
cancer vaccine
Gene name: AKT1
RCAS-Akt Vaccine
@@ -21476,6 +23390,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -21500,10 +23420,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Oliver He
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29910
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5500
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5500
3845
5500
- Clinical trial
cancer vaccine
Gene name: KRAS
RCAS-Ras Vaccine
@@ -21524,6 +23443,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -21555,14 +23480,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Virginia He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2640
NCT: https://clinicaltrials.gov/ct2/show/NCT00069940
- PubMed:11536162
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5098
+ PMID:11536162
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5098
7015
5098
- Clinical trial
cancer vaccine
Gene name: TERT
- Telomerase: 540-548 Peptide Vaccine
+ telomerase: 540-548 peptide vaccine
@@ -21578,6 +23502,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -21601,13 +23531,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:23643168
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4071
+ 1(SOCS1)-silenced dendritic cell (DC) Vaccine
+ PMID:23643168
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4071
https://github.com/vaccineontology/VO/issues/78
4071
- Research
cancer vaccine
- 1(SOCS1)-silenced dendritic cell (DC) Vaccine
+ 1(SOCS1)-silenced dendritic cell vaccine
@@ -21624,6 +23554,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -21647,10 +23583,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5414
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5414
https://github.com/vaccineontology/VO/issues/79
5414
- Clinical trial
cancer vaccine
117-126:FGF-5 Peptide Vaccine
@@ -21685,6 +23620,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -21714,14 +23655,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- 12 Melanoma Peptide vaccine
- PubMed:21690475
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3978
+ 12MP vaccine
+ PMID:21690475
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3978
https://github.com/vaccineontology/VO/issues/81
3978
- Research
cancer vaccine
- 12MP Vaccine
+ 12 melanoma peptide vaccine
@@ -21738,6 +23678,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -21767,13 +23713,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:23653149
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4070
+ PMID:23653149
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4070
https://github.com/vaccineontology/VO/issues/82
4070
- Clinical trial
cancer vaccine
- 12MP, 12MP/Tet, 12MP/6MHP, or 6MHP Vaccine
+ 12MP, 12MP/Tet, 12MP/6MHP, or 6MHP vaccine
@@ -21790,6 +23735,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -21813,17 +23764,18 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:22495394
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5290
+ PMID:22495394
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5290
https://github.com/vaccineontology/VO/issues/83
2315
6490
7299
5290
- Clinical trial
cancer vaccine
- Gene name: Tyrosinase|Gene name: gp100|Gene name: MLANA
- 27-35(27L):MART-1 Peptide Vaccine
+ Gene name: MLANA
+ Gene name: Tyrosinase
+ Gene name: gp100
+ 27-35(27L):MART-1 peptide vaccine
@@ -21840,6 +23792,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -21863,11 +23821,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4986
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4986
https://github.com/vaccineontology/VO/issues/84
4986
cancer vaccine
- 851B Gel Vaccine
+ 851B Gel vaccine
@@ -21890,6 +23848,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -21907,15 +23871,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:17000686
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5244
+ Abagovomab
+ PMID:17000686
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5244
https://github.com/vaccineontology/VO/issues/86
94025
5244
- Clinical trial
cancer vaccine
Gene name: MUC16
- Abagovomab
+ Abagovomab vaccine
@@ -21930,6 +23894,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -21946,16 +23916,16 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:11860704
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5543
+ PMID:11860704
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5543
https://github.com/vaccineontology/VO/issues/87
2875
7124
5543
- Research
cancer vaccine
- Gene name: TNF|Gene name: GPT
- Ad CMV I kappaB alpha Vaccine
+ Gene name: GPT
+ Gene name: TNF
+ Ad CMV I kappaB alpha vaccine
@@ -21976,6 +23946,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -22023,16 +23999,16 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5179
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5179
https://ascopubs.org/doi/10.1200/JCO.2018.36.15_suppl.3098
https://github.com/vaccineontology/VO/issues/88
4582
959
5179
- Clinical trial
cancer vaccine
- Gene name: MUC1|Gene name: CD40LG
- Ad-sig-hMUC-1/ecdCD40L Vaccine
+ Gene name: CD40LG
+ Gene name: MUC1
+ Ad-sig-hMUC-1/ecdCD40L vaccine
@@ -22065,6 +24041,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -22088,11 +24070,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:15300212
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5523
+ PMID:15300212
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5523
https://github.com/vaccineontology/VO/issues/92
5523
- Clinical trial
cancer vaccine
Adenovector Encoding MDA7 Vaccine
@@ -22111,6 +24092,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -22134,11 +24121,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4999
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4999
https://github.com/vaccineontology/VO/issues/93
2346
4999
- Clinical trial
cancer vaccine
Gene name: Prostate-specific membrane antigen
Adenovector-transduced AP1903-inducible MyD88/CD40-expressing Autologous PSMA-specific Prostate Cancer Vaccine BPX-201
@@ -22158,6 +24144,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -22181,12 +24173,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:25956394
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5137
+ PMID:25956394
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5137
https://github.com/vaccineontology/VO/issues/94
1048
5137
- Clinical trial
cancer vaccine
Gene name: CEACAM5
Adenoviral Vector Ad5-CEA(6D) Vaccine
@@ -22206,6 +24197,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -22220,7 +24217,7 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
@@ -22229,11 +24226,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:15153545
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5529
+ PMID:15153545
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5529
https://github.com/vaccineontology/VO/issues/95
5529
- Research
cancer vaccine
Adenovirus 5-CD40 Ligand Vaccine
@@ -22252,6 +24248,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -22269,12 +24271,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:16709032
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5489
+ PMID:16709032
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5489
https://github.com/vaccineontology/VO/issues/96
2247
5489
- Research
cancer vaccine
Gene name: FGF2
Adenovirus 5-Fibroblast Growth Factor 2 Vaccine
@@ -22294,6 +24295,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -22318,14 +24325,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jie Zheng
Oliver He
NCT: https://clinicaltrials.gov/ct2/show/NCT04111172
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5147
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5147
https://github.com/vaccineontology/VO/issues/97
2984
5147
- Clinical trial
cancer vaccine
Gene name: GUCY2C
- Adenovirus 5-Human Guanylyl Cyclase C-PADRE Vaccine
+ Adenovirus 5-Human Guanylyl Cyclase C-PADRE vaccine
@@ -22341,6 +24347,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -22364,14 +24376,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5435
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5435
https://github.com/vaccineontology/VO/issues/98
941
5435
- Research
cancer vaccine
Gene name: CD80
- Adenovirus B7-1 Vaccine
+ Adenovirus B7-1 vaccine
@@ -22388,6 +24399,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -22412,11 +24429,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jie Zheng
Oliver He
NCT: https://clinicaltrials.gov/ct2/show/NCT00307229
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5388
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5388
https://github.com/vaccineontology/VO/issues/99
24337
5388
- Clinical trial
cancer vaccine
Gene name: Erbb2
Adenovirus Encoding Rat HER-2/neu Vaccine
@@ -22436,6 +24452,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -22459,16 +24481,17 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:22737604
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5370
+ PMID:22737604
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5370
https://github.com/vaccineontology/VO/issues/100
2315
4105
7299
5370
- Clinical trial
cancer vaccine
- Gene name: Tyrosinase|Gene name: MLANA|Gene name: MAGEA6
+ Gene name: MAGEA6
+ Gene name: MLANA
+ Gene name: Tyrosinase
Adenovirus Encoding Tyrosinase/MART-1/MAGEA6-transduced Autologous Dendritic Cell Vaccine
@@ -22486,6 +24509,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -22510,11 +24539,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jie Zheng
Oliver He
NCT: https://clinicaltrials.gov/ct2/show/NCT00197522
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5082
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5082
https://github.com/vaccineontology/VO/issues/101
2064
5082
- Clinical trial
cancer vaccine
Gene name: ERBB2
Adenovirus HER2-Transduced Autologous Dendritic Cell Vaccine
@@ -22534,6 +24562,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -22557,13 +24591,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:/8985364
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5122
+ PMID:/8985364
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5122
https://github.com/vaccineontology/VO/issues/102
5122
- Clinical trial
cancer vaccine
- Adenovirus RSV-TK Vaccine
+ Adenovirus RSV-TK vaccine
@@ -22580,6 +24613,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -22603,12 +24642,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:33575474
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5285
+ PMID:33575474
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5285
https://github.com/vaccineontology/VO/issues/103
2346
5285
- Clinical trial
cancer vaccine
Gene name: Prostate-specific membrane antigen gene engineering
Adenovirus-mediated Human Interleukin-12 Vaccine
@@ -22629,6 +24667,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -22658,16 +24702,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:20420527
- PubMed:29515795
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5256
+ PMID:20420527
+ PMID:29515795
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5256
https://github.com/vaccineontology/VO/issues/104
7157
5256
- Clinical trial
cancer vaccine
Gene name: TP53 (P53)
- Adenovirus-p53 Transduced Dendritic Cell Vaccine
+ Adenovirus-p53 transduced dendritic cell vaccine
@@ -22684,6 +24727,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -22707,11 +24756,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5010
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5010
https://github.com/vaccineontology/VO/issues/105
2346
5010
- Clinical trial
cancer vaccine
Gene name: Prostate-specific membrane antigen gene engineering
Adenovirus-PSA Prostate Cancer Vaccine
@@ -22731,6 +24779,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -22754,11 +24808,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5203
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5203
https://github.com/vaccineontology/VO/issues/106
11010
5203
- Clinical trial
cancer vaccine
Gene name: GLIPR1
AdRTVP-1-Transduced Prostate Cancer Cell-Based Vaccine
@@ -22778,6 +24831,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -22801,15 +24860,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:32323103
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5436
+ PMID:32323103
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5436
https://github.com/vaccineontology/VO/issues/107
1437
2064
5436
- Clinical trial
cancer vaccine
- Gene name: GM-CSF|Gene name: ERBB2
+ Gene name: ERBB2
+ Gene name: GM-CSF
AE37 Peptide/GM-CSF Vaccine
@@ -22833,6 +24892,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -22850,11 +24915,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5275
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5275
https://github.com/vaccineontology/VO/issues/108
174
5275
- Clinical trial
cancer vaccine
Gene name: AFP
AFP Gene Hepatocellular Carcinoma Vaccine
@@ -22874,6 +24938,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -22909,15 +24979,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:C5941317
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3991
+ PMID:C5941317
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3991
https://github.com/vaccineontology/VO/issues/109
1485
3991
- Clinical trial
cancer vaccine
Gene name: NY-ESO-1
- Ag NY-ESO-1 Vaccine
+ Ag NY-ESO-1 vaccine
@@ -22934,6 +25003,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -22958,15 +25033,16 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jie Zheng
Oliver He
NCT: https://clinicaltrials.gov/ct2/show/NCT01461148
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5402
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5402
https://github.com/vaccineontology/VO/issues/110
28990
9014
9447
5402
- Clinical trial
cancer vaccine
- Gene name: AIM2|Gene name: TAF1B|Gene name: ASTE1
+ Gene name: AIM2
+ Gene name: ASTE1
+ Gene name: TAF1B
AIM2(-1)/HT001(-1)/TAF1B(-1) Frameshift Peptide Vaccine
@@ -22983,6 +25059,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -23000,15 +25082,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:26787078
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5422
+ PMID:26787078
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5422
https://github.com/vaccineontology/VO/issues/145
1048
111518
5422
- Clinical trial
cancer vaccine
- Gene name: CEACAM5|CEA
+ CEA
+ Gene name: CEACAM5
Algenpantucel-L Vaccine
@@ -23026,6 +25108,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -23049,14 +25137,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5020
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5020
https://github.com/vaccineontology/VO/issues/146
5788
945
5020
- Clinical trial
cancer vaccine
- Gene name: CD33|Gene name: PTPRC
+ Gene name: CD33
+ Gene name: PTPRC
Allogeneic AML Antigen-expressing Dendritic Cell Vaccine
@@ -23074,6 +25162,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -23097,12 +25191,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:15254047
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4998
+ PMID:15254047
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4998
https://github.com/vaccineontology/VO/issues/147
941
4998
- Clinical trial
cancer vaccine
Gene name: CD80
Allogeneic B7.1/HLA-A1 Transfected Tumor Cell Vaccine
@@ -23121,6 +25214,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -23138,15 +25237,16 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5257
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5257
https://github.com/vaccineontology/VO/issues/148
1048
4101
7490
5257
- Clinical trial
cancer vaccine
- Gene name: CEACAM5|Gene name: WT1|Gene name: MAGEA2
+ Gene name: CEACAM5
+ Gene name: MAGEA2
+ Gene name: WT1
Allogeneic Cellular Vaccine 1650-G
@@ -23163,6 +25263,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -23188,15 +25294,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Oliver He
NCT: https://clinicaltrials.gov/ct2/show/NCT01525017
NCT: https://clinicaltrials.gov/ct2/show/NCT01974661
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5446
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5446
https://github.com/vaccineontology/VO/issues/149
3458
7124
5446
- Clinical trial
cancer vaccine
- Gene name: IFNG|Gene name: TNF
- Allogeneic Dendritic Cell Vaccine COMBIG-DC
+ Gene name: IFNG
+ Gene name: TNF
+ allogeneic dendritic cell vaccine COMBIG-DC
@@ -23213,6 +25319,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -23236,10 +25348,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5102
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5102
https://github.com/vaccineontology/VO/issues/150
5102
- Clinical trial
cancer vaccine
Allogeneic Dendritic Cell-Myeloma Idiotype Vaccine
@@ -23259,6 +25370,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -23288,11 +25405,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5023
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5023
https://github.com/vaccineontology/VO/issues/151
7070
5023
- Clinical trial
cancer vaccine
Gene name: CD90
Allogeneic Glioblastoma Stem-like Cell Line Lysate-pulsed Autologous Dendritic Cell Vaccine
@@ -23318,6 +25434,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -23335,16 +25457,18 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5327
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5327
https://github.com/vaccineontology/VO/issues/152
1437
4102
7490
9947
5327
- Clinical trial
cancer vaccine
- Gene name: GM-SCF|Gene name: MAGEA3|Gene name: WT1|Gene name: MAGEC1
+ Gene name: GM-SCF
+ Gene name: MAGEA3
+ Gene name: MAGEC1
+ Gene name: WT1
Allogeneic GM-CSF-Based Myeloma Cell Vaccine
@@ -23368,6 +25492,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -23385,11 +25515,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5059
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5059
https://github.com/vaccineontology/VO/issues/153
2064
5059
- Clinical trial
cancer vaccine
Gene name: ERBB2
Allogeneic GM-CSF-Secreting Breast Cancer Vaccine
@@ -23415,6 +25544,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -23433,10 +25568,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jie Zheng
Oliver He
NCT: https://clinicaltrials.gov/ct2/show/NCT01088789
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5075
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5075
https://github.com/vaccineontology/VO/issues/154
5075
- Clinical trial
cancer vaccine
Allogeneic GM-CSF-secreting Tumor Vaccine PANC 10.05 pcDNA-1/GM-Neo
@@ -23461,6 +25595,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -23478,11 +25618,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5515
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5515
https://www.cancer.gov/about-cancer/treatment/clinical-trials/search/v?id=NCI-2010-01868&r=1
https://github.com/vaccineontology/VO/issues/155
5515
- Clinical trial
cancer vaccine
Allogeneic GM-CSF-secreting Tumor Vaccine PANC 6.03 pcDNA-1/GM-Neo
@@ -23501,6 +25640,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -23524,11 +25669,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5269
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5269
https://github.com/vaccineontology/VO/issues/156
1493
5269
- Clinical trial
cancer vaccine
Gene name: CTLA4
Allogeneic Large Multivalent Immunogen Breast Cancer Vaccine
@@ -23547,6 +25691,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -23565,14 +25715,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jie Zheng
Oliver He
NCT: https://clinicaltrials.gov/ct2/show/NCT00726739
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5423
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5423
https://github.com/vaccineontology/VO/issues/157
2315
6490
5423
- Clinical trial
cancer vaccine
- Gene name: MLANA|Gene name: gp100 (PMEL)
+ Gene name: MLANA
+ Gene name: gp100 (PMEL)
Allogeneic Large Multivalent Immunogen Melanoma Vaccine LP2307
@@ -23589,6 +25739,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -23606,12 +25762,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:32002306
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5376
+ PMID:32002306
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5376
https://github.com/vaccineontology/VO/issues/158
216
5376
- Clinical trial
cancer vaccine
Gene name: ALDH1A1
Allogeneic Melanoma Vaccine AGI-101H
@@ -23631,6 +25786,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -23654,11 +25815,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5440
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5440
https://github.com/vaccineontology/VO/issues/159
10232
5440
- Clinical trial
cancer vaccine
Gene name: MSLN
Allogeneic Mesothelioma Tumor Lysate-pulsed Autologous Dendritic Cell Vaccine
@@ -23677,6 +25837,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -23700,12 +25866,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5054
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5054
https://github.com/vaccineontology/VO/issues/160
5054
- Clinical trial
cancer vaccine
- Allogeneic Multipotent Adult Progenitor Cells Vaccine
+ allogeneic multipotent adult progenitor cells vaccine
@@ -23722,6 +25887,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -23745,15 +25916,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5358
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5358
https://www.cell.com/molecular-therapy-family/molecular-therapy/fulltext/S1525-0016(16)36654-0
https://github.com/vaccineontology/VO/issues/161
941
959
5358
- Clinical trial
cancer vaccine
- Gene name: CD80|Gene name: CD40LG
+ Gene name: CD40LG
+ Gene name: CD80
Allogeneic Renal Cell Carcinoma Vaccine MGN1601
@@ -23772,6 +25943,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -23801,13 +25978,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5339
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5339
https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/allogeneic-tumor-cell-vaccine
https://github.com/vaccineontology/VO/issues/162
5339
- Clinical trial
cancer vaccine
- Allogeneic Tumor Cell Vaccine
+ allogeneic tumor cell vaccine
@@ -23823,6 +25999,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -23840,11 +26022,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:24829761
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5119
+ PMID:24829761
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5119
https://github.com/vaccineontology/VO/issues/163
5119
- Clinical trial
cancer vaccine
Allogenic Glioma Cancer Vaccine
@@ -23863,6 +26044,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -23886,12 +26073,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:25041030
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5313
+ PMID:25041030
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5313
https://github.com/vaccineontology/VO/issues/164
149
5313
- Clinical trial
cancer vaccine
Gene name: AFP
Alpha Fetoprotein Adenoviral Vector Vaccine
@@ -23910,6 +26096,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -23927,11 +26119,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5349
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5349
https://github.com/vaccineontology/VO/issues/165
11605
5349
- Clinical trial
cancer vaccine
Gene name: Gla
Alpha-1,3-galactosyltransferase-expressing Allogeneic Renal Cell Carcinoma Vaccine
@@ -23951,6 +26142,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -23974,12 +26171,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:16675576
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5315
+ PMID:16675576
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5315
https://github.com/vaccineontology/VO/issues/166
174
5315
- Clinical trial
cancer vaccine
Gene name: AFP
Alpha-fetoprotein Peptide-Pulsed Autologous Dendritic Cell Vaccine
@@ -23999,6 +26195,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -24022,11 +26224,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:32188702
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5288
+ PMID:32188702
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5288
https://github.com/vaccineontology/VO/issues/167
5288
- Clinical trial
cancer vaccine
Alpha-Galactosylceramide-Pulsed Autologous Dendritic Cell Vaccine
@@ -24046,6 +26247,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -24081,17 +26288,18 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5198
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5198
https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/alpha-type-1-polarized-dendritic-cells
https://github.com/vaccineontology/VO/issues/168
2315
6490
7299
5198
- Clinical trial
cancer vaccine
- Gene name: MLANA|Gene name: gp100 (PMEL)|Gene name: Tyrosinase
- Alpha-type-1 Polarized Dendritic Cell Vaccine
+ Gene name: MLANA
+ Gene name: Tyrosinase
+ Gene name: gp100 (PMEL)
+ Alpha-type-1 polarized dendritic cell vaccine
@@ -24114,6 +26322,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -24131,15 +26345,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:16061912
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5334
+ PMID:16061912
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5334
https://github.com/vaccineontology/VO/issues/169
3458
5334
- Clinical trial
cancer vaccine
Gene name: IFNG -Obselete
- ALVAC Vaccine
+ ALVAC vaccine
@@ -24156,6 +26369,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -24179,16 +26398,16 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:12596363
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5444
+ PMID:12596363
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5444
https://github.com/vaccineontology/VO/issues/210
1048
941
5444
- Clinical trial
cancer vaccine
- Gene name: CD80|Gene name: CEACAM5 (CEA)
- ALVAC-B7-CEA Vaccine
+ Gene name: CD80
+ Gene name: CEACAM5 (CEA)
+ ALVAC-B7-CEA vaccine
@@ -24204,6 +26423,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -24227,14 +26452,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5003
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5003
https://github.com/vaccineontology/VO/issues/212
1048
5003
- Clinical trial
cancer vaccine
Gene name: CEACAM5 (CEA)
- ALVAC-CEA (VCP248) Vaccine
+ ALVAC-CEA (VCP248) vaccine
@@ -24251,6 +26475,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -24274,12 +26504,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:18676757
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5125
+ PMID:18676757
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5125
https://github.com/vaccineontology/VO/issues/213
941
5125
- Clinical trial
cancer vaccine
Gene name: CD80
ALVAC-CEA B7.1 Vaccine
@@ -24297,6 +26526,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -24314,14 +26549,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5051
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5051
https://github.com/vaccineontology/VO/issues/214
1048
5051
- Clinical trial
cancer vaccine
Gene name: CEACAM5 (CEA)
- ALVAC-CEA Vaccine
+ ALVAC-CEA vaccine
@@ -24337,6 +26571,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -24361,14 +26601,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jie Zheng
Oliver He
NCT: https://clinicaltrials.gov/ct2/show/NCT01982487
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5332
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5332
https://github.com/vaccineontology/VO/issues/215
1485
5332
- Clinical trial
cancer vaccine
Gene name: NY-ESO-1
- ALVAC-ESO-1 Vaccine
+ ALVAC-ESO-1 vaccine
@@ -24385,6 +26624,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -24409,14 +26654,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jie Zheng
Oliver He
NCT: https://clinicaltrials.gov/ct2/show/NCT00003556
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5181
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5181
https://github.com/vaccineontology/VO/issues/216
1493
5181
- Clinical trial
cancer vaccine
Gene name: CTLA4
- ALVAC-hB7.1 Vaccine
+ ALVAC-hB7.1 vaccine
@@ -24433,6 +26677,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -24457,14 +26707,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jie Zheng
Oliver He
NCT: https://clinicaltrials.gov/ct2/show/NCT00612222
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5124
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5124
https://github.com/vaccineontology/VO/issues/217
2315
5124
- Clinical trial
cancer vaccine
Gene name: MLANA
- ALVAC-MART-1 Vaccine
+ ALVAC-MART-1 vaccine
@@ -24481,6 +26730,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -24504,15 +26759,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5394
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5394
https://github.com/vaccineontology/VO/issues/170
1485
6490
5394
- Clinical trial
cancer vaccine
- Gene name: gp100 (PMEL)|Gene name: CTAG1B
- ALVAC(2) Melanoma Multi-antigen Vaccine
+ Gene name: CTAG1B
+ Gene name: gp100 (PMEL)
+ ALVAC(2) Melanoma multi-antigen vaccine
@@ -24528,6 +26783,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -24552,17 +26813,19 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jie Zheng
Oliver He
NCT: https://clinicaltrials.gov/ct2/show/NCT01982487
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5268
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5268
https://github.com/vaccineontology/VO/issues/171
1485
3383
941
965
5268
- Clinical trial
cancer vaccine
- Gene name: NY-ESO-1|Gene name: ICAM1|Gene name: CD80|Gene name: CD58
- ALVAC(2)-NY-ESO-1 (M)/TRICOM Vaccine
+ Gene name: CD58
+ Gene name: CD80
+ Gene name: ICAM1
+ Gene name: NY-ESO-1
+ ALVAC(2)-NY-ESO-1 (M)/TRICOM vaccine
@@ -24580,6 +26843,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -24609,10 +26878,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5533
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5533
https://github.com/vaccineontology/VO/issues/219
5533
- Clinical trial
cancer vaccine
AML mRNA Positive Lysate Loaded Autologous Dendritic Cell Vaccine
@@ -24637,6 +26905,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -24654,12 +26928,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:19051140
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5243
+ PMID:19051140
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5243
https://github.com/vaccineontology/VO/issues/220
1489079
5243
- Clinical trial
cancer vaccine
Gene name: E7
Amolimogene Bepiplasmid Vaccine
@@ -24685,6 +26958,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -24702,12 +26981,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:32513836
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5331
+ PMID:32513836
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5331
https://github.com/vaccineontology/VO/issues/221
367
5331
- Clinical trial
cancer vaccine
Gene name: AR
Androgen Receptor Ligand-binding Domain-encoding Plasmid DNA Vaccine MVI-118
@@ -24727,6 +27005,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -24756,13 +27040,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:15627214
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3994
+ PMID:15627214
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3994
https://github.com/vaccineontology/VO/issues/222
3994
- Clinical trial
cancer vaccine
- Ankara (MVA) Vaccine
+ Ankara (MVA) vaccine
@@ -24779,6 +27062,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -24808,13 +27097,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:15627214
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4073
+ PMID:15627214
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4073
https://github.com/vaccineontology/VO/issues/223
4073
- Clinical trial
cancer vaccine
- Ankara (MVA) and ALVAC(2) Vaccine
+ Ankara (MVA) and ALVAC(2) vaccine
@@ -24830,6 +27118,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -24847,10 +27141,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5199
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5199
https://github.com/vaccineontology/VO/issues/224
5199
- Clinical trial
cancer vaccine
Anti-CD19/CD3 Tetravalent Antibody AFM11 Vaccine
@@ -24868,6 +27161,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -24885,12 +27184,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5411
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5411
https://www.targetedonc.com/view/cd20-cd3-bispecific-antibodies-can-revolutionize-b-cell-lymphoma-therapy
https://github.com/vaccineontology/VO/issues/225
931
5411
- Clinical trial
cancer vaccine
Gene name: MS4A1
Anti-CD3 x Anti-CD20 Bispecific Antibody-Armed Activated T Cells Cancer Vaccine
@@ -24910,6 +27208,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -24933,14 +27237,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5536
+ Anti-CEA TCR Retroviral Vector-Transduced Autologous Peripheral Blood Lymphocytes
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5536
https://github.com/vaccineontology/VO/issues/226
1048
5536
- Clinical trial
cancer vaccine
Gene name: CEACAM5 (CEA)
- Anti-CEA TCR Retroviral Vector-Transduced Autologous Peripheral Blood Lymphocytes
+ anti-CEA TCR retroviral vector-transduced autologous peripheral blood lymphocyte vaccine
@@ -24957,6 +27261,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -24986,14 +27296,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5375
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5375
https://github.com/vaccineontology/VO/issues/227
1493
5375
- Clinical trial
cancer vaccine
Gene name: CTLA4
- Anti-CTLA4 MoAb RNA-transfected Autologous Dendritic Cell Vaccine
+ anti-CTLA4 MoAb RNA-transfected autologous dendritic cell vaccine
@@ -25010,6 +27319,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -25039,14 +27354,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5149
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5149
https://github.com/vaccineontology/VO/issues/228
1493
5149
- Clinical trial
cancer vaccine
Gene name: CTLA4
- Anti-CTLA4 MoAb RNA/GITRL RNA-transfected Autologous Dendritic Cell Vaccine
+ anti-CTLA4 MoAb RNA/GITRL RNA-transfected autologous dendritic cell vaccine
@@ -25063,6 +27377,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -25087,11 +27407,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jie Zheng
Oliver He
NCT: https://clinicaltrials.gov/ct2/show/NCT00895466
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5405
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5405
https://github.com/vaccineontology/VO/issues/229
14714
5405
- Clinical trial
cancer vaccine
Gene name: Gnhr1
Anti-GnRH Vaccine PEP223
@@ -25116,6 +27435,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -25133,15 +27458,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:15550589
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5175
+ PMID:15550589
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5175
https://github.com/vaccineontology/VO/issues/230
4582
5175
- Clinical trial
cancer vaccine
Gene name: MUC1
- Anti-idiotype MUC-1 Monoclonal Antibody Vaccine
+ anti-idiotype MUC-1 monoclonal antibody vaccine
@@ -25163,6 +27487,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -25180,12 +27510,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5301
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5301
https://github.com/vaccineontology/VO/issues/231
5301
- Clinical trial
cancer vaccine
- Anti-Idiotype Specified Monoclonal Antibody Vaccine
+ anti-Idiotype specified monoclonal antibody vaccine
@@ -25201,6 +27530,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -25223,13 +27558,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:9816036
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4015
+ anti-idiotypic mAb MK2-23+BCG
+ PMID:9816036
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4015
https://github.com/vaccineontology/VO/issues/232
4015
- Clinical trial
cancer vaccine
- anti-idiotypic mAb MK2-23+BCG
+ anti-idiotypic mAb MK2-23+BCG vaccine
@@ -25252,6 +27587,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -25269,10 +27610,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5433
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5433
https://github.com/vaccineontology/VO/issues/233
5433
- Clinical trial
cancer vaccine
anti-idiotypic monoclonal antibody BEC2 vaccine
@@ -25290,6 +27630,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -25307,14 +27653,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5485
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5485
https://github.com/vaccineontology/VO/issues/234
1485
5485
- Clinical trial
cancer vaccine
Gene name: NY-ESO-1
- anti-NY-ESO-1 Immunotherapeutic GSK-2241658A Vaccine
+ anti-NY-ESO-1 Immunotherapeutic GSK-2241658A vaccine
@@ -25330,6 +27675,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -25353,15 +27704,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5081
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5081
https://github.com/vaccineontology/VO/issues/235
1485
30484
5081
- Clinical trial
cancer vaccine
- Gene name: NY-ESO-1|Gene name: CTAG2
- anti-NY-ESO1 TCR-transduced Autologous CD62L+-derived T-Lymphocytes Vaccine
+ Gene name: CTAG2
+ Gene name: NY-ESO-1
+ anti-NY-ESO1 TCR-transduced Autologous CD62L+-derived T-Lymphocytes vaccine
@@ -25377,6 +27728,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -25401,14 +27758,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jie Zheng
Oliver He
NCT: https://clinicaltrials.gov/ct2/show/NCT00393029
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5447
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5447
https://github.com/vaccineontology/VO/issues/236
7157
5447
- Clinical trial
cancer vaccine
Gene name: TP53 (P53)
- anti-p53 T-Cell Receptor-Transduced Peripheral Blood Lymphocytes Vaccine
+ anti-p53 T-Cell Receptor-Transduced peripheral blood lymphocytes vaccine
@@ -25424,6 +27780,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -25442,11 +27804,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jie Zheng
Oliver He
NCT: https://clinicaltrials.gov/ct2/show/NCT01853878
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5361
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5361
https://github.com/vaccineontology/VO/issues/237
23532
5361
- Clinical trial
cancer vaccine
Gene name: PRAME
anti-PRAME Immunotherapeutic GSK2302032A Vaccine
@@ -25472,6 +27833,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -25489,11 +27856,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5138
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5138
https://github.com/vaccineontology/VO/issues/238
6490
5138
- Clinical trial
cancer vaccine
Gene name: gp100 (PMEL)
antigen-targeted Personalized Breast Cancer Vaccine
@@ -25513,6 +27879,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -25537,15 +27909,16 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jie Zheng
Oliver He
NCT: https://clinicaltrials.gov/ct2/show/NCT01133704
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5420
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5420
https://github.com/vaccineontology/VO/issues/239
2346
354
55
5420
- Clinical trial
cancer vaccine
- Gene name: ACPP|Gene name: Prostate|Gene name: KLK3
+ Gene name: ACPP
+ Gene name: KLK3
+ Gene name: Prostate
APC8015F vaccine
@@ -25563,6 +27936,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -25586,11 +27965,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:21509164
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5222
+ PMID:21509164
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5222
https://github.com/vaccineontology/VO/issues/240
5222
- Clinical trial
cancer vaccine
Apoptotic Autologous Tumor Cells-pulsed Alpha-type-1 Polarized Dendritic Cells Vaccine
@@ -25608,6 +27986,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -25625,12 +28009,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5319
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5319
https://www.clincosm.com/trial/recurrent-ovarian-epithelial-cancer-houston-alvac-hb71-recombinant
https://github.com/vaccineontology/VO/issues/242
155971
5319
- Clinical trial
cancer vaccine
Gene name: env
AUT-OV-ALVAC-hB7.1 Vaccine
@@ -25650,6 +28033,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -25674,11 +28063,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jie Zheng
Oliver He
NCT: https://clinicaltrials.gov/ct2/show/NCT00779883
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5053
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5053
https://github.com/vaccineontology/VO/issues/243
959
5053
- Clinical trial
cancer vaccine
Gene name: CD40LG
Autologous Ad-CD154-Transduced CLL B Cells Vaccine
@@ -25698,6 +28086,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -25722,14 +28116,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jie Zheng
Oliver He
NCT: https://clinicaltrials.gov/ct2/show/NCT00509496
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5507
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5507
https://github.com/vaccineontology/VO/issues/244
6490
5507
- Clinical trial
cancer vaccine
Gene name: gp100 (PMEL)
- Autologous Anti-gp100:154-162 T-Cell Receptor Gene-Engineered Peripheral Blood Lymphocytes Vaccine
+ autologous anti-gp100:154-162 T-cell receptor gene-engineered peripheral blood lymphocytes vaccine
@@ -25746,6 +28139,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -25770,14 +28169,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jie Zheng
Oliver He
NCT: https://clinicaltrials.gov/ct2/show/NCT00509288
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5293
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5293
https://github.com/vaccineontology/VO/issues/245
2315
5293
- Clinical trial
cancer vaccine
Gene name: MLANA
- Autologous Anti-MART-1 F5 T-Cell Receptor Gene-Engineered Peripheral Blood Lymphocytes Vaccine
+ autologous anti-mart-1 f5 T-cell receptor gene-engineered peripheral blood lymphocytes vaccine
@@ -25795,6 +28193,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -25824,12 +28228,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5463
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5463
https://mhlw-grants.niph.go.jp/system/files/2013/134041/201328051A/201328051A0017.pdf
https://github.com/vaccineontology/VO/issues/246
8842
5463
- Clinical trial
cancer vaccine
Gene name: PROM1
Autologous CD133-Positive BTSC mRNA-Pulsed Autologous Dendritic Cell Vaccine
@@ -25849,6 +28252,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -25872,11 +28281,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5174
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5174
https://github.com/vaccineontology/VO/issues/247
959
5174
- Clinical trial
cancer vaccine
Gene name: CD40LG
Autologous CD40L-expressing B-CLL Vaccine
@@ -25896,6 +28304,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -25919,11 +28333,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5150
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5150
https://github.com/vaccineontology/VO/issues/248
174
5150
- Clinical trial
cancer vaccine
Gene name: AFP
Autologous Colorectal Tumor Antigen-pulsed Dendritic Cell Vaccine
@@ -25944,6 +28357,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -25974,11 +28393,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jie Zheng
Oliver He
NCT: https://clinicaltrials.gov/ct2/show/NCT01995708
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5128
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5128
https://github.com/vaccineontology/VO/issues/249
7490
5128
- Clinical trial
cancer vaccine
Gene name: WT1
Autologous CT7/MAGE-A3/WT1 mRNA-Electroporated Langerhans-Type Dendritic Cells Vaccine
@@ -25998,6 +28416,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -26032,15 +28456,16 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:22774527
- PubMed:31771601
- PubMed:34862245
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3967
+ autologous DCV
+ autologous dendritic cell vaccine (DCV)
+ PMID:22774527
+ PMID:31771601
+ PMID:34862245
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3967
https://github.com/vaccineontology/VO/issues/250
3967
- Clinical trial
cancer vaccine
- autologous dendritic cell vaccine (DCV)
+ autologous dendritic cell vaccine
@@ -26057,6 +28482,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -26081,12 +28512,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jie Zheng
Oliver He
NCT: https://clinicaltrials.gov/ct2/show/NCT02649829
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5085
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5085
https://github.com/vaccineontology/VO/issues/251
958
5085
- Clinical trial
- VO:0007576
cancer vaccine
Gene name: CD40
Autologous Dendritic Cell Vaccine ACT2001
@@ -26106,6 +28535,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -26130,11 +28565,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jie Zheng
Oliver He
NCT: https://clinicaltrials.gov/ct2/show/NCT03546361
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5030
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5030
https://github.com/vaccineontology/VO/issues/252
6366
5030
- Clinical trial
cancer vaccine
Gene name: CCL21
Autologous Dendritic Cell-Adenovirus CCL21 Vaccine
@@ -26155,6 +28589,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -26184,16 +28624,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:20420527
- PubMed:29515795
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5088
+ PMID:20420527
+ PMID:29515795
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5088
https://github.com/vaccineontology/VO/issues/253
7157
5088
- Clinical trial
cancer vaccine
Gene name: TP53 (P53)
- Autologous Dendritic Cell-Adenovirus P53 Vaccine
+ autologous dendritic cell-Adenovirus P53 vaccine
@@ -26210,6 +28649,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -26233,16 +28678,17 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5495
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5495
https://github.com/vaccineontology/VO/issues/254
2315
4102
6490
5495
- Clinical trial
cancer vaccine
- Gene name: MLANA|Gene name: gp100 (PMEL)|Gene name: MAGEA3
- Autologous Dendritic Cell-Allogeneic Melanoma Tumor Cell Lysate Vaccine
+ Gene name: MAGEA3
+ Gene name: MLANA
+ Gene name: gp100 (PMEL)
+ autologous dendritic cell-allogeneic melanoma tumor cell lysate vaccine
@@ -26260,6 +28706,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -26289,12 +28741,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:20884622
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5066
+ PMID:20884622
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5066
https://github.com/vaccineontology/VO/issues/255
6490
5066
- Clinical trial
cancer vaccine
Gene name: gp100 (PMEL)
Autologous Dendritic Cell-Autologous Tumor mRNA-Human CD40L Vaccine
@@ -26314,6 +28765,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -26337,11 +28794,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5284
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5284
https://ascopubs.org/doi/10.1200/jco.2014.32.15_suppl.2052
https://github.com/vaccineontology/VO/issues/256
5284
- Clinical trial
cancer vaccine
Autologous Dendritic Cell-based Immunotherapeutic AV0113 Vaccine
@@ -26360,6 +28816,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -26383,17 +28845,17 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:23685836
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5056
+ PMID:23685836
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5056
https://github.com/vaccineontology/VO/issues/257
4582
6382
952
5056
- Clinical trial
- VO:0007577
cancer vaccine
- Gene name: MUC1|Gene name: CD38|Gene name: SDC1
+ Gene name: CD38
+ Gene name: MUC1
+ Gene name: SDC1
Autologous Dendritic Cell-Tumor Fusion Vaccine
@@ -26410,6 +28872,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -26427,13 +28895,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:/9400626
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5537
+ PMID:/9400626
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5537
https://github.com/vaccineontology/VO/issues/258
5537
- Clinical trial
cancer vaccine
- Autologous Dinitrophenyl Vaccine
+ autologous dinitrophenyl vaccine
@@ -26456,6 +28923,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -26473,10 +28946,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5459
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5459
https://github.com/vaccineontology/VO/issues/259
5459
- Clinical trial
cancer vaccine
Autologous Dinitrophenyl-Modified Ovarian Cancer Vaccine
@@ -26495,6 +28967,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -26518,10 +28996,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5118
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5118
https://github.com/vaccineontology/VO/issues/260
5118
- Clinical trial
cancer vaccine
Autologous EBV-Transformed B Lymphoblastoid-Tumor Fusion Cell Vaccine
@@ -26540,6 +29017,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -26563,11 +29046,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5225
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5225
https://github.com/vaccineontology/VO/issues/261
1880
5225
- Clinical trial
cancer vaccine
Gene name: GPR183
Autologous Epstein-Barr Virus-Transformed B-Lymphoblastoid Cell Vaccine
@@ -26586,6 +29068,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -26603,10 +29091,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5491
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5491
https://github.com/vaccineontology/VO/issues/262
5491
- Clinical trial
cancer vaccine
Autologous Expanded Mesenchymal Stem Cells OTI-010 Vaccine
@@ -26625,6 +29112,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -26648,11 +29141,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5250
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5250
https://github.com/vaccineontology/VO/issues/263
2064
5250
- Clinical trial
cancer vaccine
Gene name: ERBB2
Autologous GM-CSF-Secreting Breast Cancer Vaccine
@@ -26672,6 +29164,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -26695,11 +29193,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5188
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5188
https://github.com/vaccineontology/VO/issues/264
10232
5188
- Clinical trial
cancer vaccine
Gene name: MSLN
Autologous GM-CSF-secreting Lethally Irradiated Colorectal Cancer Cell Vaccine
@@ -26719,6 +29216,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -26742,14 +29245,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5240
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5240
https://github.com/vaccineontology/VO/issues/265
1437
7490
5240
- Clinical trial
cancer vaccine
- Gene name: GM-CSF|Gene name: WT1
+ Gene name: GM-CSF
+ Gene name: WT1
Autologous GM-CSF-Secreting Lethally Irradiated Leukemia Cell Vaccine
@@ -26767,6 +29270,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -26790,11 +29299,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5266
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5266
https://github.com/vaccineontology/VO/issues/266
3308
5266
- Clinical trial
cancer vaccine
Gene name: HSPA4
Autologous Heat-Shock Protein 70 Peptide Vaccine AG-858
@@ -26821,6 +29329,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -26845,14 +29359,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jie Zheng
Oliver He
NCT: https://clinicaltrials.gov/ct2/show/NCT02211027
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5043
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5043
https://github.com/vaccineontology/VO/issues/267
6375
5043
- Clinical trial
cancer vaccine
Gene name: XLC1
- Autologous HNSCC DNA-transfected Semi-allogeneic Fibroblasts MRC-5 Vaccine
+ autologous HNSCC DNA-transfected semi-allogeneic fibroblasts MRC-5 vaccine
@@ -26869,6 +29382,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -26893,15 +29412,16 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jie Zheng
Oliver He
NCT: https://clinicaltrials.gov/ct2/show/NCT00458679
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5228
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5228
https://github.com/vaccineontology/VO/issues/268
12519
3383
942
5228
- Clinical trial
cancer vaccine
- Gene name: Cd80|Gene name: CD86|Gene name: ICAM1
+ Gene name: CD86
+ Gene name: Cd80
+ Gene name: ICAM1
Autologous IL-2-expressing B-CLL Vaccine
@@ -26925,6 +29445,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -26943,12 +29469,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jie Zheng
Oliver He
NCT: https://clinicaltrials.gov/ct2/show/NCT00104819
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5057
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5057
https://github.com/vaccineontology/VO/issues/269
3123
5057
- Clinical trial
- VO:0007579
cancer vaccine
Gene name: HLA-DRB1
Autologous Immunoglobulin Idiotype-KLH Conjugate Vaccine
@@ -26968,6 +29492,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -26991,10 +29521,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5248
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5248
https://github.com/vaccineontology/VO/issues/270
5248
- Clinical trial
cancer vaccine
Autologous Lymphoma Cell Lysate-Pulsed Autologous Dendritic Cell Vaccine
@@ -27013,6 +29542,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -27036,16 +29571,18 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5503
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5503
https://github.com/vaccineontology/VO/issues/272
1638
2315
6490
7299
5503
- Clinical trial
cancer vaccine
- Gene name: gp100 (PMEL)|Gene name: MLANA|Gene name: DCT|Gene name: Tyrosinase
+ Gene name: DCT
+ Gene name: MLANA
+ Gene name: Tyrosinase
+ Gene name: gp100 (PMEL)
Autologous Lymphoma Cell/Allogeneic Dendritic Cell Electrofusion Hybrid Vaccine
@@ -27063,6 +29600,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -27086,10 +29629,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5431
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5431
https://github.com/vaccineontology/VO/issues/273
5431
- Clinical trial
cancer vaccine
Autologous Lymphoma Cell/Autologous Dendritic Cell Electrofusion Hybrid Vaccine
@@ -27108,6 +29650,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -27131,15 +29679,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5148
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5148
https://github.com/vaccineontology/VO/issues/274
1485
2315
5148
- Clinical trial
cancer vaccine
- Gene name: NY-ESO-1|Gene name: MLANA-Dupuli
- Autologous Melanoma Lysate-Pulsed Autologous Dendritic Cell Vaccine
+ Gene name: MLANA-Dupuli
+ Gene name: NY-ESO-1
+ autologous melanoma lysate-pulsed autologous dendritic cell vaccine
@@ -27156,6 +29704,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -27179,14 +29733,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5213
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5213
https://github.com/vaccineontology/VO/issues/275
3123
5213
- Clinical trial
cancer vaccine
Gene name: HLA-DRB1
- Autologous Melanoma Lysate/KLH-Pulsed Autologous Dendritic Cell Vaccine
+ autologous melanoma Lysate/KLH-pulsed autologous dendritic cell vaccine
@@ -27203,6 +29756,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -27226,14 +29785,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5158
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5158
https://github.com/vaccineontology/VO/issues/276
1485
5158
- Clinical trial
cancer vaccine
Gene name: NY-ESO-1
- Autologous Melanoma Lysate/NY-ESO-1-pulsed Autologous Dendritic Cell Vaccine
+ autologous melanoma Lysate/NY-ESO-1-pulsed autologous dendritic cell vaccine
@@ -27257,6 +29815,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -27280,10 +29844,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5377
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5377
https://github.com/vaccineontology/VO/issues/277
5377
- Clinical trial
cancer vaccine
Autologous NSCLC DNA-Transfected Semi-Allogeneic Fibroblasts MRC-5 Vaccine
@@ -27302,6 +29865,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -27325,10 +29894,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5311
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5311
https://github.com/vaccineontology/VO/issues/278
5311
- Clinical trial
cancer vaccine
Autologous NSCLC Peptide-specific Dendritic Cell Vaccine
@@ -27348,6 +29916,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -27378,11 +29952,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jie Zheng
Oliver He
NCT: https://clinicaltrials.gov/ct2/show/NCT00715832
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5368
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5368
https://github.com/vaccineontology/VO/issues/279
16785
5368
- Clinical trial
cancer vaccine
Gene name: Rspa
Autologous OFA-iLRP RNA-Transfected Dendritic Cell Vaccine
@@ -27402,6 +29975,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -27425,11 +30004,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5427
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5427
https://github.com/vaccineontology/VO/issues/280
5427
5427
- Clinical trial
cancer vaccine
Gene name: ERBB2
Autologous Ovarian Tumor Cell Lysate-Pulsed Dendritic Cell Vaccine
@@ -27448,6 +30026,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -27465,15 +30049,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5220
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5220
https://discovery.lifemapsc.com/regenerative-medicine/cell-therapy-applications/brain-ald451-bone-marrow-derived-cells-for-malignant-glioma
https://github.com/vaccineontology/VO/issues/281
216
217
5220
- Clinical trial
cancer vaccine
- Gene name: ALDH1A1|Gene name: ALDH2
+ Gene name: ALDH1A1
+ Gene name: ALDH2
Autologous Pluripotent ALDHbr Stem Cells ALD-451 Vaccine
@@ -27491,6 +30075,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -27514,14 +30104,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5282
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5282
https://github.com/vaccineontology/VO/issues/282
2346
928
5282
- Clinical trial
cancer vaccine
- Gene name: CD40|Gene name: Prostate
+ Gene name: CD40
+ Gene name: Prostate
Autologous Prostate Cancer Antigen-expressing Dendritic Cell Vaccine BPX-101
@@ -27539,6 +30129,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -27562,14 +30158,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5018
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5018
https://github.com/vaccineontology/VO/issues/283
2315863
7015
5018
- Clinical trial
cancer vaccine
- Gene name: Survivin|Gene name: TERT
+ Gene name: Survivin
+ Gene name: TERT
Autologous Renal Cell Carcinoma Tumor Lysate-Pulsed Dendritic Cell Vaccine
@@ -27587,6 +30183,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -27610,10 +30212,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5189
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5189
https://github.com/vaccineontology/VO/issues/284
5189
- Clinical trial
cancer vaccine
Autologous Sarcoma Lysate-pulsed Dendritic Cell Vaccine
@@ -27632,6 +30233,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -27656,11 +30263,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jie Zheng
Oliver He
NCT: https://clinicaltrials.gov/ct2/show/NCT02362451
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5024
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5024
https://github.com/vaccineontology/VO/issues/285
6862
5024
- Clinical trial
cancer vaccine
Gene name: TBXT
Autologous TARP Peptide-Pulsed Dendritic Cell Vaccine
@@ -27679,6 +30285,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -27696,11 +30308,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5108
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5108
https://github.com/vaccineontology/VO/issues/287
3558
5108
- Clinical trial
cancer vaccine
Gene name: IL2
Autologous Tumor Cell Proteoliposome Chronic Lymphocytic Leukemia Vaccine
@@ -27721,6 +30332,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -27750,16 +30367,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:22854664
- PubMed:32558897
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5396
+ PMID:22854664
+ PMID:32558897
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5396
https://github.com/vaccineontology/VO/issues/288
942
5396
- Clinical trial
cancer vaccine
Gene name: CD86
- Autologous Tumor Cell Vaccine
+ autologous tumor cell vaccine
@@ -27777,6 +30393,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -27806,9 +30428,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:18528294
- PubMed:23482679
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5035
+ PMID:18528294
+ PMID:23482679
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5035
https://github.com/vaccineontology/VO/issues/289
53340
54763
@@ -27816,10 +30438,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
8852
9232
5035
- Clinical trial
cancer vaccine
- Gene name: SPA17|Gene name: ROPN1|Gene name: AKAP4|Gene name: PTTG1|Gene name: SPANXB1
- Autologous Tumor-associated Peptide Antigen-pulsed Dendritic Cell Vaccine
+ Gene name: AKAP4
+ Gene name: PTTG1
+ Gene name: ROPN1
+ Gene name: SPA17
+ Gene name: SPANXB1
+ autologous tumor-associated peptide antigen-pulsed dendritic cell vaccine
@@ -27838,7 +30463,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
+
+
+
+
+
+
@@ -27859,14 +30490,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5404
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5404
https://github.com/vaccineontology/VO/issues/290
2315
4102
5404
- Clinical trial
cancer vaccine
- Gene name: MAGEA3|Gene name: MLANA
+ Gene name: MAGEA3
+ Gene name: MLANA
Autologous-Cell Leukemia Vaccine
@@ -27883,6 +30514,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -27900,12 +30537,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5110
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5110
https://github.com/vaccineontology/VO/issues/291
5110
- Clinical trial
cancer vaccine
- Autologous-Cell Melanoma Vaccine
+ autologous-cell melanoma vaccine
@@ -27914,6 +30550,7 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
@@ -27924,7 +30561,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
+
+
+
+
+
+
@@ -27944,11 +30587,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:21036724
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5230
+ PMID:21036724
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5230
https://github.com/vaccineontology/VO/issues/296
5230
- Clinical trial
cancer vaccine
BCG, Cell Wall Skeleton Vaccine
@@ -27966,6 +30608,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -27983,17 +30631,16 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:7479929
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5399
+ PMID:7479929
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5399
https://github.com/vaccineontology/VO/issues/297
598
7306
5399
- Clinical trial
- VO:0007589
cancer vaccine
- Gene name: BCL2L1|Gene name: TYRP1
- Bcl-Xs Adenovirus Vaccine
+ Gene name: BCL2L1
+ Gene name: TYRP1
+ Bcl-Xs adenovirus vaccine
@@ -28010,6 +30657,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -28033,12 +30686,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:26211534
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5374
+ PMID:26211534
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5374
https://github.com/vaccineontology/VO/issues/298
7042
5374
- Clinical trial
cancer vaccine
Gene name: TGFB2
Belagenpumatucel-L Vaccine
@@ -28057,6 +30709,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -28080,15 +30738,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:15983396
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4992
+ PMID:15983396
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4992
https://github.com/vaccineontology/VO/issues/299
7157
4992
- Clinical trial
cancer vaccine
Gene name: TP53 (P53)
- Berzofsky Ras/P53 Peptide Vaccine
+ Berzofsky Ras/P53 peptide vaccine
@@ -28107,7 +30764,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
+
+
+
+
+
+
@@ -28128,12 +30791,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5439
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5439
https://www.cancer.gov/about-cancer/treatment/clinical-trials/search/v?id=NCI-2022-05711&r=1
https://github.com/vaccineontology/VO/issues/310
925
5439
- Clinical trial
cancer vaccine
Gene name: CD8A
Brachyury-expressing Modified Vaccinia Ankara-TRICOM Vaccine
@@ -28152,6 +30814,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -28169,15 +30837,16 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5210
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5210
https://github.com/vaccineontology/VO/issues/311
3383
941
965
5210
- Clinical trial
cancer vaccine
- Gene name: CD58|Gene name: ICAM1|Gene name: CD80
+ Gene name: CD58
+ Gene name: CD80
+ Gene name: ICAM1
Brain Tumor Initiating Cell Vaccine
@@ -28194,6 +30863,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -28212,10 +30887,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jie Zheng
Oliver He
NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C29561
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5309
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5309
https://github.com/vaccineontology/VO/issues/312
5309
- Clinical trial
cancer vaccine
rMVA-PSA/PSMA/TRICOM vaccine
@@ -28234,6 +30908,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -28257,14 +30937,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5544
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5544
https://github.com/vaccineontology/VO/issues/313
2521
5544
- Clinical trial
cancer vaccine
Gene name: FUS
- Canarypox-hIL-12 Melanoma Vaccine
+ Canarypox-hIL-12 melanoma vaccine
@@ -28280,6 +30959,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -28302,13 +30987,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:/7629885
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5329
+ PMID:/7629885
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5329
https://github.com/vaccineontology/VO/issues/372
5329
- Clinical trial
cancer vaccine
- CAP-2 (CEA Peptide 9-mer) Vaccine
+ CAP-2 (CEA peptide 9-mer) vaccine
@@ -28325,6 +31009,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -28347,11 +31037,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5380
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5380
https://link.springer.com/article/10.1007/s11888-014-0250-5
https://github.com/vaccineontology/VO/issues/373
5380
- Clinical trial
cancer vaccine
CAP-3 (CEA Peptide 9-mer) Vaccine
@@ -28370,6 +31059,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -28394,11 +31089,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jie Zheng
Oliver He
NCT: https://clinicaltrials.gov/ct2/show/NCT00203892
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5356
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5356
https://github.com/vaccineontology/VO/issues/374
1048
5356
- Clinical trial
cancer vaccine
Gene name: CEACAM5 (CEA)
Carcinoembryonic Antigen Peptide 1-6D Vaccine
@@ -28418,6 +31112,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -28447,15 +31147,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:22630596
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5129
+ PMID:22630596
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5129
https://github.com/vaccineontology/VO/issues/375
1048
5129
- Clinical trial
cancer vaccine
Gene name: CEACAM5 (CEA)
- Carcinoembryonic Antigen Peptide 1-6D Virus-Like Replicon Particles Vaccine
+ carcinoembryonic antigen peptide 1-6D virus-like replicon particles vaccine
@@ -28471,6 +31170,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -28494,15 +31199,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:22630596
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5209
+ PMID:22630596
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5209
https://github.com/vaccineontology/VO/issues/376
1048
5209
- Clinical trial
cancer vaccine
Gene name: CEACAM5 (CEA)
- Carcinoembryonic Antigen Peptide-1 Vaccine
+ carcinoembryonic antigen peptide-1 vaccine
@@ -28520,6 +31224,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -28549,12 +31259,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:21187495
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5041
+ PMID:21187495
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5041
https://github.com/vaccineontology/VO/issues/377
1048
5041
- Clinical trial
cancer vaccine
Gene name: CEACAM5 (CEA)
Carcinoembryonic Antigen RNA-pulsed DC Cancer Vaccine
@@ -28580,6 +31289,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -28597,7 +31312,7 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5193
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5193
https://github.com/vaccineontology/VO/issues/379
1001
2022
@@ -28605,9 +31320,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
4904
6657
5193
- Clinical trial
cancer vaccine
- Gene name: ENG|Gene name: YBX1|Gene name: SOX2|Gene name: CDH3|Gene name: MDM2
+ Gene name: CDH3
+ Gene name: ENG
+ Gene name: MDM2
+ Gene name: SOX2
+ Gene name: YBX1
CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
@@ -28625,6 +31343,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -28649,11 +31373,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jie Zheng
Oliver He
NCT: https://clinicaltrials.gov/ct2/show/NCT02049489
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5107
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5107
https://github.com/vaccineontology/VO/issues/380
8842
5107
- Clinical trial
cancer vaccine
Gene name: PROM1
CD133 Antigen Peptide-pulsed Autologous Dendritic Cell Vaccine
@@ -28672,6 +31395,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -28689,15 +31418,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5476
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5476
https://github.com/vaccineontology/VO/issues/381
2064
941
5476
- Clinical trial
- VO:0007592
cancer vaccine
- Gene name: CD80|Gene name: ERBB2
+ Gene name: CD80
+ Gene name: ERBB2
CD80 Breast Cancer Vaccine
@@ -28716,6 +31444,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -28745,12 +31479,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:21187495
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5045
+ PMID:21187495
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5045
https://github.com/vaccineontology/VO/issues/382
1048
5045
- Clinical trial
cancer vaccine
Gene name: CEACAM5 (CEA)
CEA RNA-pulsed Autologous Human Cultured Dendritic Cells Vaccine
@@ -28777,6 +31510,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -28792,7 +31531,7 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
A plasmid vaccine encoding wild type human carcinoembryonic antigen (CEA) fused to a tetanus toxoid T helper epitope, with potential antineoplastic activity. Upon vaccination and subsequent intradermal electroporation, CEA/tetanus toxoid T helper epitope fusion protein-expressing DNA plasmid vaccine may stimulate the immune system to mount a cytotoxic T-lymphocyte (CTL) response against CEA-expressing tumor cells. CEA, a tumor associated antigen, is overexpressed in a variety of cancer cell types. The tetanus toxoid helper peptide epitope, obtained from the bacterial Clostridium tetani toxoid, binds to class II MHC molecules and increases the helper T-cell response thereby inducing an increased and long-term immune response.
@@ -28800,11 +31539,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5367
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5367
https://github.com/vaccineontology/VO/issues/383
1048
5367
- Research
cancer vaccine
Gene name: CEACAM5 (CEA)
CEA/Tetanus Toxoid T Helper Epitope Fusion Protein-Expressing DNA Plasmid Vaccine
@@ -28824,6 +31562,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -28847,11 +31591,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5316
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5316
https://www.cell.com/molecular-therapy-family/molecular-therapy/fulltext/S1525-0016(05)00564-2
https://github.com/vaccineontology/VO/issues/384
5316
- Clinical trial
cancer vaccine
Chimeric Ad11p/Ad3 Oncolytic Virus Vaccine
@@ -28870,6 +31613,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -28893,12 +31642,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4985
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4985
https://academic.oup.com/neuro-oncology/article/22/Supplement_3/iii306/6018727
https://github.com/vaccineontology/VO/issues/385
3077579
4985
- Clinical trial
cancer vaccine
Gene name: UL83
CMV pp65 Peptide-pulsed Autologous Dendritic Cell Vaccine
@@ -28923,6 +31671,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -28940,14 +31694,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5306
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5306
https://github.com/vaccineontology/VO/issues/386
3077579
5306
- Clinical trial
cancer vaccine
Gene name: UL83
- CMVpp65/gB Plasmid Vaccine ASP0113
+ CMVpp65/gB plasmid vaccine ASP0113
@@ -28963,6 +31716,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -28986,15 +31745,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:/9815634
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5372
+ PMID:/9815634
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5372
https://github.com/vaccineontology/VO/issues/389
11716682
5372
- Clinical trial
cancer vaccine
Gene name: tox1
- CTP-37-DT Vaccine
+ CTP-37-DT vaccine
@@ -29011,6 +31769,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -29035,11 +31799,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jie Zheng
Oliver He
NCT: https://clinicaltrials.gov/ct2/show/NCT01398124
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5139
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5139
https://github.com/vaccineontology/VO/issues/390
931
5139
- Clinical trial
cancer vaccine
Gene name: MS4A1
Cyclin B1 Peptide-pulsed Autologous Dendritic Cell Vaccine
@@ -29058,6 +31821,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -29075,12 +31844,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:23210562
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5070
+ PMID:23210562
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5070
https://github.com/vaccineontology/VO/issues/391
174
5070
- Clinical trial
cancer vaccine
Gene name: AFP
Cytokine-Induced Killer Cells Vaccine
@@ -29100,6 +31868,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -29123,11 +31897,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:15256471
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5163
+ PMID:15256471
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5163
https://github.com/vaccineontology/VO/issues/392
5163
- Clinical trial
cancer vaccine
Dendritic Cell Tumor Cell Lysate Vaccine
@@ -29146,6 +31919,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -29169,10 +31948,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5161
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5161
https://github.com/vaccineontology/VO/issues/393
5161
- Clinical trial
cancer vaccine
Dendritic Cell-Autologous Lung Tumor Vaccine
@@ -29191,6 +31969,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -29214,12 +31998,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:21187495
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5417
+ PMID:21187495
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5417
https://github.com/vaccineontology/VO/issues/394
1048
5417
- Clinical trial
cancer vaccine
Gene name: CEACAM5 (CEA)
Dendritic Cell-CEA Peptide Vaccine
@@ -29239,6 +32022,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -29262,15 +32051,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5067
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5067
https://github.com/vaccineontology/VO/issues/395
2315
6490
5067
- Clinical trial
cancer vaccine
- Gene name: gp100 (PMEL)|Gene name: MLANA
- Dendritic Cell-gp100-MART-1 Antigen Vaccine
+ Gene name: MLANA
+ Gene name: gp100 (PMEL)
+ dendritic cell-gp100-MART-1 Antigen vaccine
@@ -29287,6 +32076,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -29310,14 +32105,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5524
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5524
https://github.com/vaccineontology/VO/issues/396
2315
5524
- Clinical trial
cancer vaccine
Gene name: MLANA
- Dendritic Cell-MART-1 Peptide Vaccine
+ dendritic cell-MART-1 Peptide vaccine
@@ -29334,6 +32128,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -29357,11 +32157,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5000
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5000
https://github.com/vaccineontology/VO/issues/397
2346
5000
- Clinical trial
cancer vaccine
Gene name: Prostate-specific membrane antigen gene engineering:
Dendritic Cell-Recombinant Prostate-Specific Membrane Antigen Vaccine
@@ -29381,6 +32180,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -29404,12 +32209,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5493
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5493
https://www.cancer.gov/about-cancer/treatment/clinical-trials/search/v?id=NCI-2018-00926&r=1
https://github.com/vaccineontology/VO/issues/398
1485
5493
- Clinical trial
cancer vaccine
Gene name: NY-ESO-1
Dendritic Cell-targeting Lentiviral Vector ID-LV305 Vaccine
@@ -29429,6 +32233,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -29452,10 +32262,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5338
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5338
https://github.com/vaccineontology/VO/issues/400
5338
- Clinical trial
cancer vaccine
Dinitrophenyl-Modified Autologous Renal Cell Carcinoma Tumor cell Vaccine
@@ -29479,6 +32288,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -29496,15 +32311,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5016
+ DNA Plasmid Encoding Interleukin-12 INO-9012 Vaccine
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5016
https://jitc.bmj.com/content/9/7/e003019
https://github.com/vaccineontology/VO/issues/401
2902
5016
- Clinical trial
cancer vaccine
Gene name: GRIN1
- DNA Plasmid Encoding Interleukin-12 INO-9012 Vaccine
+ DNA plasmid-encoding Interleukin-12 INO-9012 vaccine
@@ -29526,6 +32341,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -29544,15 +32365,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jie Zheng
Oliver He
NCT: https://clinicaltrials.gov/ct2/show/NCT03439085
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5136
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5136
https://github.com/vaccineontology/VO/issues/402
1489078
1489079
5136
- Clinical trial
cancer vaccine
- Gene name: E7|Gene name: E6
- DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112
+ Gene name: E6
+ Gene name: E7
+ DNA plasmid-encoding Interleukin-12/HPV DNA plasmids therapeutic vaccine INO-3112
@@ -29575,6 +32396,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -29592,15 +32419,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:36129459
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5207
+ PMID:36129459
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5207
https://github.com/vaccineontology/VO/issues/403
1489078
1489079
5207
- Clinical trial
cancer vaccine
- Gene name: E7|Gene name: E6
+ Gene name: E6
+ Gene name: E7
DNA Vaccine VB10.16
@@ -29624,6 +32451,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -29642,14 +32475,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Jie Zheng
Oliver He
NCT: https://clinicaltrials.gov/ct2/show/NCT00423254
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5407
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5407
https://github.com/vaccineontology/VO/issues/404
2346
5407
- Research
cancer vaccine
Gene name: Prostate-specific membrane antigen
- DNA Vector pPRA-PSM Vaccine
+ DNA vector pPRA-PSM vaccine
@@ -29665,6 +32497,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -29688,14 +32526,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5378
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5378
https://github.com/vaccineontology/VO/issues/126
4582
1048
5378
- Clinical trial
cancer vaccine
- Gene name: CEACAM5|Gene name: MUC1
+ Gene name: CEACAM5
+ Gene name: MUC1
Falimarev vaccine
@@ -29712,6 +32550,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -29735,14 +32579,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5090
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5090
https://github.com/vaccineontology/VO/issues/456
7422
5090
- Clinical trial
cancer vaccine
Gene name: VEGFA
- hVEGF26-104/RFASE Peptide Vaccine
+ hVEGF26-104/RFASE peptide vaccine
@@ -29759,6 +32602,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -29788,14 +32637,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5464
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5464
https://github.com/vaccineontology/VO/issues/438
2829163
5464
- Clinical trial
cancer vaccine
Gene name: HPV6 E6
- HPV-6-targeting Immunotherapeutic Vaccine INO-3106
+ HPV-6-targeting immunotherapeutic vaccine INO-3106
@@ -29812,6 +32660,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -29841,14 +32695,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5103
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5103
https://github.com/vaccineontology/VO/issues/65
4582
5103
- Clinical trial
cancer vaccine
Gene name: MUC1
- Emepepimut-S Vaccine
+ Emepepimut-S vaccine
@@ -29865,6 +32718,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -29888,11 +32747,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5033
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5033
https://github.com/vaccineontology/VO/issues/209
7184
5033
- Clinical trial
cancer vaccine
Gene name: HSP90B1
gp96-secreting Allogeneic Bladder Cancer Cell Vaccine HS-410
@@ -29915,6 +32773,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -29956,14 +32820,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5300
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5300
https://github.com/vaccineontology/VO/issues/131
1485
5300
- Clinical trial
cancer vaccine
Gene name: NY-ESO-1
- Fowlpox-NY-ESO-1 Vaccine
+ fowlpox-NY-ESO-1 vaccine
@@ -29980,6 +32843,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -30003,11 +32872,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5096
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5096
https://github.com/vaccineontology/VO/issues/137
2548
5096
- Clinical trial
cancer vaccine
Gene name: GAA
Glioma-Associated Antigen Peptide-Pulsed Autologous Dendritic Cell Vaccine
@@ -30027,6 +32895,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -30050,11 +32924,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5073
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5073
https://github.com/vaccineontology/VO/issues/138
1956
5073
- Clinical trial
cancer vaccine
Gene name: EGFR
Glioma-associated Peptide-loaded Dendritic Cell Vaccine SL-701
@@ -30074,6 +32947,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -30096,11 +32975,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5202
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5202
https://github.com/vaccineontology/VO/issues/426
55553
5202
- Clinical trial
cancer vaccine
Gene name: SOX6
HLA-A2-Restricted Synthetic Glioma Antigen Peptides Vaccine
@@ -30120,6 +32998,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -30142,11 +33026,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5298
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5298
https://github.com/vaccineontology/VO/issues/458
3417
5298
- Clinical trial
cancer vaccine
Gene name: IDH1
IDH1R132H Mutation-targeting IDH1 Peptide Vaccine
@@ -30166,6 +33049,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -30189,11 +33078,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5461
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5461
https://github.com/vaccineontology/VO/issues/459
3417
5461
- Clinical trial
cancer vaccine
Gene name: IDH1
IDH1R132H-Specific Peptide Vaccine PEPIDH1M
@@ -30212,6 +33100,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -30223,13 +33117,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5215
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5215
https://github.com/vaccineontology/VO/issues/494
4100
6490
5215
cancer vaccine
- Gene name: MAGEA1|Gene name: gp100
+ Gene name: MAGEA1
+ Gene name: gp100
Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
@@ -30247,6 +33142,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -30270,11 +33171,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5531
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5531
https://github.com/vaccineontology/VO/issues/64
1100818972
5531
- Clinical trial
cancer vaccine
Gene name: EGFR
EGFRvIII Peptide Vaccine
@@ -30293,6 +33193,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -30309,10 +33215,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5151
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5151
https://github.com/vaccineontology/VO/issues/127
5151
- Clinical trial
cancer vaccine
Fas-Chimera Transgene-expressing Endothelial Tumor Cell-targeting Adenovector VB-111 Vaccine
@@ -30330,6 +33235,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -30347,11 +33258,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5277
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5277
https://github.com/vaccineontology/VO/issues/457
8842
5277
- Clinical trial
cancer vaccine
Gene name: PROM1
ICT-121 Dendritic Cell Vaccine
@@ -30377,6 +33287,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -30394,14 +33310,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5229
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5229
https://github.com/vaccineontology/VO/issues/174
4582
2760
5229
- Clinical trial
cancer vaccine
- Gene name: GM2A|Gene name: MUC1
+ Gene name: GM2A
+ Gene name: MUC1
Globo-H-GM2-Lewis-y-MUC1-32(aa)-sTn(c)-TF(c)-Tn(c)-KLH Conjugate Vaccine
@@ -30418,6 +33334,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -30435,11 +33357,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5237
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5237
https://github.com/vaccineontology/VO/issues/306
2064
5237
- Clinical trial
cancer vaccine
Gene name: ERBB2
HER2-pulsed Autologous Type-1 Polarized Dendritic Cell Vaccine
@@ -30459,6 +33380,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -30481,14 +33408,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4997
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4997
https://github.com/vaccineontology/VO/issues/447
1442
7494
4997
- Clinical trial
cancer vaccine
- Gene name: XBP1|Gene name: CSH1
+ Gene name: CSH1
+ Gene name: XBP1
hTERT/Survivin/CMV Multipeptide Vaccine
@@ -30512,6 +33439,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -30523,13 +33456,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5166
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5166
https://github.com/vaccineontology/VO/issues/495
4582
634
5166
cancer vaccine
- Gene name: CEACAM1|Gene name: MUC1
+ Gene name: CEACAM1
+ Gene name: MUC1
Mammaglobin-A DNA Vaccine
@@ -30546,6 +33480,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -30557,13 +33497,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5036
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5036
https://github.com/vaccineontology/VO/issues/530
2064
2315
5036
cancer vaccine
- Gene name: MLANA-Dupli|Gene name: ERBB2
+ Gene name: ERBB2
+ Gene name: MLANA-Dupli
Modified Vaccinia Ankara (Bavarian Nordic)-HER2 Vaccine
@@ -30580,6 +33521,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -30603,12 +33550,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4987
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4987
https://github.com/vaccineontology/VO/issues/51
4987
- Clinical trial
cancer vaccine
- E1M(184V) Peptide Vaccine
+ E1M(184V) peptide vaccine
@@ -30625,6 +33571,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -30654,14 +33606,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5121
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5121
https://github.com/vaccineontology/VO/issues/440
7015
5121
- Clinical trial
cancer vaccine
Gene name: TERT
- hTERT mRNA/Survivin Peptide-double-loaded Autologous Dendritic Cell Vaccine
+ hTERT mRNA/survivin peptide-double-loaded autologous dendritic cell vaccine
@@ -30677,6 +33628,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -30700,14 +33657,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5516
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5516
https://github.com/vaccineontology/VO/issues/441
7015
5516
- Clinical trial
cancer vaccine
Gene name: TERT
- hTERT Multipeptide/Montanide ISA-51 VG/Imiquimod Vaccine GX 301
+ hTERT multipeptide/montanide ISA-51 VG/Imiquimod vaccine GX 301
@@ -30722,6 +33678,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -30738,14 +33700,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5065
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5065
https://github.com/vaccineontology/VO/issues/445
7015
5065
- Clinical trial
cancer vaccine
Gene name: TERT
- hTERT Vaccine V934/V935
+ hTERT vaccine V934/V935
@@ -30763,7 +33724,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
+
+
+
+
+
+
@@ -30784,12 +33751,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5130
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5130
https://github.com/vaccineontology/VO/issues/465
5130
- Clinical trial
cancer vaccine
- Inactivated Vaccinia Virus Vaccine
+ inactivated vaccinia virus vaccine
@@ -30804,6 +33770,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -30821,15 +33793,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5099
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5099
https://github.com/vaccineontology/VO/issues/466
1048
4582
5099
- Clinical trial
cancer vaccine
- Gene name: CEACAM5|Gene name: MUC1
- Inalimarev Vaccine
+ Gene name: CEACAM5
+ Gene name: MUC1
+ inalimarev vaccine
@@ -30847,7 +33819,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
+
+
+
+
+
+
@@ -30868,12 +33846,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5258
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5258
https://github.com/vaccineontology/VO/issues/472
5258
- Clinical trial
cancer vaccine
- Live-attenuated Double-deleted Listeria monocytogenes Bacteria JNJ-64041809 Vaccine
+ live-attenuated double-deleted listeria monocytogenes bacteria JNJ-64041809 vaccine
@@ -30888,6 +33865,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -30905,12 +33888,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5146
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5146
https://github.com/vaccineontology/VO/issues/473
5146
- Clinical trial
cancer vaccine
- KLH-FITC Vaccine
+ KLH-FITC vaccine
@@ -30925,6 +33907,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -30942,14 +33930,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5538
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5538
https://github.com/vaccineontology/VO/issues/475
2064
5538
- Clinical trial
cancer vaccine
Gene name: ERBB2
- Lapuleucel-T Vaccine
+ Lapuleucel-T vaccine
@@ -30964,6 +33951,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -30975,13 +33968,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5187
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5187
https://github.com/vaccineontology/VO/issues/525
1234
5187
cancer vaccine
Gene name: CCR5
- Mesothelioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
+ mesothelioma tumor lysate-pulsed autologous dendritic cell vaccine
@@ -30996,6 +33989,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -31007,11 +34006,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5235
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5235
https://github.com/vaccineontology/VO/issues/526
5235
cancer vaccine
- Methanol Extraction Residue of BCG
+ methanol extraction residue of BCG
@@ -31027,6 +34026,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -31043,12 +34048,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5347
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5347
https://github.com/vaccineontology/VO/issues/529
5347
cancer vaccine
Gene name: P10
- Mimotope-P10s-PADRE Peptide Vaccine
+ Mimotope-P10s-PADRE peptide vaccine
@@ -31064,6 +34069,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -31081,13 +34092,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5286
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5286
https://github.com/vaccineontology/VO/issues/533
4240
5286
cancer vaccine
Gene name: MFGE8
- Monoclonal Antibody 11D10 Anti-Idiotype Vaccine
+ monoclonal antibody 11D10 anti-idiotype vaccine
@@ -31105,6 +34116,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -31140,13 +34157,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5452
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5452
https://github.com/vaccineontology/VO/issues/534
1048
5452
cancer vaccine
Gene name: CEACAM5
- Monoclonal Antibody 3H1 Anti-Idiotype Vaccine
+ monoclonal antibody 3H1 anti-idiotype vaccine
@@ -31164,6 +34181,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -31199,13 +34222,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5308
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5308
https://github.com/vaccineontology/VO/issues/536
2583
5308
cancer vaccine
Gene name: B4GALNT1
- Monoclonal Antibody A1G4 Anti-Idiotype Vaccine
+ monoclonal antibody A1G4 anti-idiotype vaccine
@@ -31223,6 +34246,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -31258,13 +34287,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5469
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5469
https://github.com/vaccineontology/VO/issues/537
6489
5469
cancer vaccine
Gene name: ST8SIA1
- Monoclonal Antibody GD2 Anti-Idiotype Vaccine
+ monoclonal antibody GD2 anti-idiotype vaccine
@@ -31280,6 +34309,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -31296,11 +34331,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5239
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5239
https://github.com/vaccineontology/VO/issues/538
5239
cancer vaccine
- Montanide ISA-51/Survivin Peptide Vaccine
+ Montanide ISA-51/survivin peptide vaccine
@@ -31315,6 +34350,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -31325,13 +34366,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5362
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5362
https://github.com/vaccineontology/VO/issues/544
4255
5362
cancer vaccine
Gene name: MGMT
- MSCV-MGMT(P140K) Vaccine
+ MSCV-MGMT(P140K) vaccine
@@ -31347,6 +34388,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -31364,13 +34411,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5517
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5517
https://github.com/vaccineontology/VO/issues/545
4582
5517
cancer vaccine
Gene name: MUC1
- MUC-1 Peptide Vaccine
+ MUC-1 peptide vaccine
@@ -31385,6 +34432,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -31396,13 +34449,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5169
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5169
https://github.com/vaccineontology/VO/issues/547
4583
5169
cancer vaccine
Gene name: MUC2
- MUC-2-KLH Vaccine
+ MUC-2-KLH vaccine
@@ -31418,6 +34471,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -31434,13 +34493,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5123
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5123
https://github.com/vaccineontology/VO/issues/548
4582
5123
cancer vaccine
Gene name: MUC1
- MUC1 Antigen/SB AS-2 Vaccine
+ MUC1 antigen/SB AS-2 vaccine
@@ -31465,6 +34524,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -31488,13 +34553,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5251
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5251
https://github.com/vaccineontology/VO/issues/549
4582
5251
cancer vaccine
Gene name: MUC1
- MUC1-KLH Conjugate Vaccine
+ MUC1-KLH conjugate vaccine
@@ -31509,6 +34574,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -31520,13 +34591,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5160
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5160
https://github.com/vaccineontology/VO/issues/550
4582
5160
cancer vaccine
Gene name: MUC1
- MUC1-KLH Vaccine/QS21
+ MUC1-KLH vaccine/QS21
@@ -31543,6 +34614,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -31565,13 +34642,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5068
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5068
https://github.com/vaccineontology/VO/issues/551
4582
5068
cancer vaccine
Gene name: MUC1
- MUC1-targeted Peptide GO-203-2C Vaccine
+ MUC1-targeted peptide GO-203-2C vaccine
@@ -31589,6 +34666,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -31611,13 +34694,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5522
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5522
https://github.com/vaccineontology/VO/issues/552
2348
5522
cancer vaccine
Gene name: FOLR1
- Multi-epitope Folate Receptor Alpha Peptide Vaccine
+ multi-epitope folate receptor alpha peptide vaccine
@@ -31633,6 +34716,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -31650,14 +34739,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5064
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5064
https://github.com/vaccineontology/VO/issues/556
10643
54742
5064
cancer vaccine
- Gene name: LY6K |Gene name: IGF2BP3
- Multipeptide Vaccine S-588210
+ Gene name: IGF2BP3
+ Gene name: LY6K
+ multipeptide vaccine S-588210
@@ -31673,6 +34763,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -31690,11 +34786,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5364
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5364
https://github.com/vaccineontology/VO/issues/559
5364
cancer vaccine
- Mutant p53 Peptide Pulsed Dendritic Cell Vaccine
+ mutant p53 peptide pulsed dendritic cell vaccine
@@ -31709,6 +34805,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -31720,13 +34822,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5091
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5091
https://github.com/vaccineontology/VO/issues/564
4582
5091
cancer vaccine
Gene name: MUC1
- MVA-MUC1-IL2 Vaccine
+ MVA-MUC1-IL2 vaccine
@@ -31742,6 +34844,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -31759,13 +34867,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5400
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5400
https://github.com/vaccineontology/VO/issues/566
2064
5400
cancer vaccine
Gene name: ERBB2
- MVF-HER-2(597-626)/MVF-HER-2 (266-296) Peptide Vaccine
+ MVF-HER-2(597-626)/MVF-HER-2 (266-296) peptide vaccine
@@ -31782,6 +34890,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -31805,10 +34919,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5449
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5449
https://github.com/vaccineontology/VO/issues/450
5449
- Clinical trial
cancer vaccine
Human Papilloma Virus L1 Virus-Like Particle V504 Vaccine
@@ -31827,6 +34940,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -31855,15 +34974,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5408
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5408
https://github.com/vaccineontology/VO/issues/478
1489079
2829163
5408
- Clinical trial
cancer vaccine
- Gene name: HPV6 E6|Gene name: E7
- Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101
+ Gene name: E7
+ Gene name: HPV6 E6
+ liposomal HPV-16 E6/E7 multipeptide vaccine PDS0101
@@ -31879,6 +34998,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -31896,13 +35021,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5195
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5195
https://github.com/vaccineontology/VO/issues/532
1604
5195
cancer vaccine
Gene name: CD55
- Monoclonal Antibody 105AD7 Anti-idiotype Vaccine
+ monoclonal antibody 105AD7 anti-idiotype vaccine
@@ -31919,6 +35044,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -31942,14 +35073,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5164
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5164
https://github.com/vaccineontology/VO/issues/486
54742
7422
5164
- Clinical trial
cancer vaccine
- Gene name: LY6K|Gene name: VEGFA
+ Gene name: LY6K
+ Gene name: VEGFA
LY6K/VEGFR1/VEGFR2 Multipeptide Vaccine
@@ -31970,6 +35101,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -32011,14 +35148,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5055
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5055
https://github.com/vaccineontology/VO/issues/172
11716682
5055
- Clinical trial
cancer vaccine
Gene name: tox1
- Globo H-DT Vaccine OBI-833
+ Globo H-DT vaccine OBI-833
@@ -32034,6 +35170,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -32057,15 +35199,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- PubMed:/2753158
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5432
+ PMID:/2753158
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5432
https://github.com/vaccineontology/VO/issues/63
297374825
5432
- Clinical trial
cancer vaccine
Gene name: CD22
- EF-2 Peptide Vaccine
+ EF-2 peptide vaccine
@@ -32081,6 +35222,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -32098,14 +35245,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5421
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5421
https://github.com/vaccineontology/VO/issues/554
4100
6490
5421
cancer vaccine
- Gene name: MAGEA1|Gene name: gp100
- Multi-glioblastoma-peptide-targeting Autologous Dendritic Cell Vaccine ICT-107
+ Gene name: MAGEA1
+ Gene name: gp100
+ multi-glioblastoma-peptide-targeting autologous dendritic cell vaccine ICT-107
@@ -32121,6 +35269,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -32138,10 +35292,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5168
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5168
https://github.com/vaccineontology/VO/issues/461
5168
- Clinical trial
cancer vaccine
IL-12-expressing Mesenchymal Stem Cell Vaccine GX-051
@@ -32158,6 +35311,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -32169,13 +35328,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5015
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5015
https://github.com/vaccineontology/VO/issues/528
5133
5015
cancer vaccine
Gene name: PDCD1
- MiHA-loaded PD-L1/L2-silenced Dendritic Cell Vaccine
+ MiHA-loaded PD-L1/L2-silenced dendritic cell vaccine
@@ -32198,6 +35357,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -32215,11 +35380,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5002
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5002
https://github.com/vaccineontology/VO/issues/304
3845
5002
- Clinical trial
cancer vaccine
Gene name: KRAS
HCV DNA Vaccine INO-8000
@@ -32238,6 +35402,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -32249,7 +35419,7 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5312
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5312
https://github.com/vaccineontology/VO/issues/563
5312
cancer vaccine
@@ -32270,6 +35440,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -32299,14 +35475,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5474
+ HPV 16 E6 (18-26) peptide vaccine
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5474
https://github.com/vaccineontology/VO/issues/429
1489078
5474
- Clinical trial
cancer vaccine
Gene name: E6
- HPV 16 E6 (18-26) peptide vaccine
+ human papillomavirus 16 E6 (18-26) peptide vaccine
@@ -32323,6 +35499,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -32352,14 +35534,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5184
+ HPV 16 E7:86-93 peptide vaccine
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5184
https://github.com/vaccineontology/VO/issues/431
1489079
5184
- Clinical trial
cancer vaccine
Gene name: E7
- HPV 16 E7:86-93 peptide vaccine
+ human papillomavirus 16 E7:86-93 peptide vaccine
@@ -32376,6 +35558,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -32405,14 +35593,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5520
+ HPV 16 L1-VLP vaccine
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5520
https://github.com/vaccineontology/VO/issues/432
25479185
5520
- Clinical trial
cancer vaccine
Gene name: L1
- HPV 16 L1-VLP vaccine
+ human papillomavirus 16 L1-VLP vaccine
@@ -32429,6 +35617,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -32458,12 +35652,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5159
+ HPV 18 E6:13-21 peptide vaccine
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5159
https://github.com/vaccineontology/VO/issues/433
5159
- Clinical trial
cancer vaccine
- HPV 18 E6:13-21 peptide vaccine
+ human papillomavirus 18 E6:13-21 peptide vaccine
@@ -32480,6 +35674,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -32509,12 +35709,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5247
+ HPV 18 L1-VLP vaccine
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5247
https://github.com/vaccineontology/VO/issues/434
5247
- Clinical trial
cancer vaccine
- HPV 18 L1-VLP vaccine
+ human papillomavirus 18 L1-VLP vaccine
@@ -32538,6 +35738,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -32567,15 +35773,16 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5226
+ HPV DNA plasmids therapeutic vaccine VGX-3100
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5226
https://github.com/vaccineontology/VO/issues/435
1489078
1489079
5226
- Clinical trial
cancer vaccine
- Gene name: E6|Gene name: E7
- HPV DNA plasmids therapeutic vaccine VGX-3100
+ Gene name: E6
+ Gene name: E7
+ human papillomavirus DNA plasmids therapeutic vaccine VGX-3100
@@ -32591,6 +35798,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -32614,12 +35827,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5227
+ HPV-11 Vaccine
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5227
https://github.com/vaccineontology/VO/issues/437
5227
- Clinical trial
cancer vaccine
- HPV-11 Vaccine
+ human papillomavirus -11 vaccine
@@ -32636,6 +35849,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -32665,14 +35884,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5162
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5162
https://github.com/vaccineontology/VO/issues/451
1489079
5162
- Clinical trial
cancer vaccine
Gene name: E7
- human Papillomavirus 16 E7 Peptide/Padre 965.10 Vaccine
+ human papillomavirus 16 E7 peptide/padre 965.10 vaccine
@@ -32689,6 +35907,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -32718,12 +35942,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5233
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5233
https://github.com/vaccineontology/VO/issues/452
5233
- Clinical trial
cancer vaccine
- Human Papillomavirus 16/18 L1 virus-like particle/AS04 vaccine
+ human papillomavirus 16/18 L1 virus-like particle/AS04 vaccine
@@ -32740,6 +35963,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -32769,15 +35998,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5279
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5279
https://github.com/vaccineontology/VO/issues/453
1489078
1489079
5279
- Clinical trial
cancer vaccine
- Gene name: E6|Gene name: E7
- Human Papillomavirus Tumor Antigen Vaccine
+ Gene name: E6
+ Gene name: E7
+ human papillomavirus tumor antigen vaccine
@@ -32794,6 +36023,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -32823,13 +36058,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5167
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5167
https://github.com/vaccineontology/VO/issues/454
5167
- Clinical trial
cancer vaccine
Gene name: major capsid protein L1
- Human Papillomavirus Vaccine V503
+ human papillomavirus vaccine V503
@@ -32852,6 +36086,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -32875,14 +36115,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5079
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5079
https://github.com/vaccineontology/VO/issues/430
1489079
5079
- Clinical trial
cancer vaccine
Gene name: E7
- HPV 16 E7:12-20 Peptide Vaccine
+ human papillomavirus 16 E7:12-20 peptide vaccine
@@ -32905,6 +36144,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -32928,15 +36173,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5083
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5083
https://github.com/vaccineontology/VO/issues/436
1489078
1489079
5083
- Clinical trial
cancer vaccine
- Gene name: E6|Gene name: E7
- HPV E6/E7 DNA Vaccine GX-188E
+ Gene name: E6
+ Gene name: E7
+ human papillomavirus E6/E7 DNA vaccine GX-188E
@@ -32959,6 +36204,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -32976,11 +36227,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5262
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5262
https://github.com/vaccineontology/VO/issues/455
2346
5262
- Clinical trial
cancer vaccine
Gene name: Prostate-specific membrane antigen
Human Prostate-Specific Membrane Antigen Plasmid DNA Vaccine
@@ -33006,6 +36256,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -33017,7 +36273,7 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5105
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5105
https://github.com/vaccineontology/VO/issues/540
5105
cancer vaccine
@@ -33037,6 +36293,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -33054,10 +36316,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5511
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5511
https://github.com/vaccineontology/VO/issues/449
5511
- Clinical trial
cancer vaccine
Human Myeloid Progenitor Cells CLT-008 vaccine
@@ -33075,6 +36336,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -33092,10 +36359,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5004
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5004
https://github.com/vaccineontology/VO/issues/476
5004
- Clinical trial
cancer vaccine
Leukemic Apoptotic Corpse-Pulsed Autologous Dendritic Cells Vaccine
@@ -33115,6 +36381,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -33137,14 +36409,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5200
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5200
https://github.com/vaccineontology/VO/issues/555
3077513
3077579
5200
cancer vaccine
- Gene name: UL83|Gene name: UL123
- Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
+ Gene name: UL123
+ Gene name: UL83
+ multi-peptide CMV-modified vaccinia ankara vaccine
@@ -33160,6 +36433,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -33177,11 +36456,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5453
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5453
https://github.com/vaccineontology/VO/issues/302
1437
5453
- Clinical trial
cancer vaccine
Gene name: GM-CSF
GVAX Lung Cancer Vaccine
@@ -33203,6 +36481,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -33250,14 +36534,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5112
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5112
https://github.com/vaccineontology/VO/issues/419
3791
5112
- Clinical trial
cancer vaccine
Gene name: KDR
- HLA-A*2402-Restricted VEGFR1 Peptide Vaccine
+ HLA-A*2402-Restricted VEGFR1 peptide vaccine
@@ -33276,6 +36559,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -33323,14 +36612,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5294
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5294
https://github.com/vaccineontology/VO/issues/420
3791
5294
- Clinical trial
cancer vaccine
Gene name: KDR
- HLA-A2402-Restricted VEGFR1/2 Multipeptide Vaccine
+ HLA-A2402-restricted VEGFR1/2 multipeptide vaccine
@@ -33347,6 +36635,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -33370,14 +36664,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5173
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5173
https://github.com/vaccineontology/VO/issues/462
6375
5173
- Clinical trial
cancer vaccine
Gene name: XCL1
- IL-2/Lptn Gene-Modified Allogeneic Neuroblastoma Tumor Cell Vaccine
+ IL-2/Lptn gene-modified allogeneic neuroblastoma tumor cell vaccine
@@ -33394,6 +36687,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -33417,14 +36716,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5343
+ Immunotherapeutic GSK1572932A
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5343
https://github.com/vaccineontology/VO/issues/463
4102
5343
- Clinical trial
cancer vaccine
Gene name: MAGEA3
- Immunotherapeutic GSK1572932A
+ immunotherapeutic GSK1572932A vaccine
@@ -33442,6 +36741,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -33471,15 +36776,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5211
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5211
https://github.com/vaccineontology/VO/issues/301
1493
354
5211
- Clinical trial
cancer vaccine
- Gene name: CTLA4|Gene name: KLK3
- GVAX Cancer Vaccine
+ Gene name: CTLA4
+ Gene name: KLK3
+ GVAX cancer vaccine
@@ -33496,6 +36801,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -33519,11 +36830,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5540
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5540
https://github.com/vaccineontology/VO/issues/470
2546420
5540
- Clinical trial
cancer vaccine
Gene name: WHcAg
Interferon-gamma-expressing Adenovirus Vaccine ASN-002
@@ -33542,6 +36852,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -33559,11 +36875,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5352
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5352
https://github.com/vaccineontology/VO/issues/471
5176180
5352
- Clinical trial
cancer vaccine
Gene name: gp72
Interleukin-2 Anti-Idiotype Vaccine
@@ -33582,6 +36897,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -33599,10 +36920,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5519
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5519
https://github.com/vaccineontology/VO/issues/474
5519
- Clinical trial
cancer vaccine
KLH-Lymphoma Ig Vaccine
@@ -33620,6 +36940,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -33643,14 +36969,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5212
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5212
https://github.com/vaccineontology/VO/issues/467
1048
5212
- Clinical trial
cancer vaccine
Gene name: CEACAM5
- Indium In 111-Labeled Autologous Peripheral Blood Mononuclear Cells Vaccine
+ indium in 111-labeled autologous peripheral blood mononuclear cells vaccine
@@ -33666,6 +36991,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -33689,12 +37020,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5273
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5273
https://github.com/vaccineontology/VO/issues/468
5273
- Clinical trial
cancer vaccine
- Indium In 111-Labeled Autologous Polymorphonuclear Leukocytes Vaccine
+ indium in 111-labeled autologous polymorphonuclear leukocytes vaccine
@@ -33710,6 +37040,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -33727,15 +37063,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5178
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5178
https://pubmed.ncbi.nlm.nih.gov/?term=ESO-1+Reactive+Autologous+Peripheral+Blood+Lymphocyte
https://github.com/vaccineontology/VO/issues/67
1485
5178
- Clinical trial
cancer vaccine
Gene name: NY-ESO-1
- ESO-1 Reactive Autologous Peripheral Blood Lymphocyte vaccine
+ ESO-1 reactive autologous peripheral blood lymphocyte vaccine
@@ -33752,6 +37087,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -33775,15 +37116,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5042
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5042
https://github.com/vaccineontology/VO/issues/130
4582
1048
5042
- Clinical trial
cancer vaccine
- Gene name: CEACAM5|Gene name: MUC1
- Fowlpox Virus Vector Vaccine
+ Gene name: CEACAM5
+ Gene name: MUC1
+ fowlpox virus vector vaccine
@@ -33800,6 +37141,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -33823,14 +37170,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5249
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5249
https://github.com/vaccineontology/VO/issues/135
2315
5249
- Clinical trial
cancer vaccine
Gene name: MLANA
- Gag:267-274 Peptide Vaccine
+ Gag:267-274 peptide vaccine
@@ -33846,6 +37192,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -33863,14 +37215,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5410
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5410
https://github.com/vaccineontology/VO/issues/136
1493
5410
- Clinical trial
cancer vaccine
Gene name: CTLA4
- GITRL RNA-transfected Autologous Dendritic Cell Vaccine
+ GITRL RNA-transfected autologous dendritic cell vaccine
@@ -33886,6 +37237,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -33909,10 +37266,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4061
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4061
https://github.com/vaccineontology/VO/issues/176
4061
- Clinical trial
cancer vaccine
GM-CSF, IL-12 and GM-CSF+IL-12 genetically modified tumor cell vaccine
@@ -33930,6 +37286,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -33947,10 +37309,9 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5111
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5111
https://github.com/vaccineontology/VO/issues/177
5111
- Clinical trial
cancer vaccine
GM-CSF-encoding Oncolytic Adenovirus CGTG-102 vaccine
@@ -33968,6 +37329,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -33991,11 +37358,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3993
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3993
https://github.com/vaccineontology/VO/issues/196
6490
3993
- Clinical trial
cancer vaccine
Gene name: gp100
gp100 + Mart-1 + Mart-3 vaccine
@@ -34015,6 +37381,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -34038,14 +37410,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5133
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5133
https://github.com/vaccineontology/VO/issues/197
6490
5133
- Clinical trial
cancer vaccine
Gene name: gp100
- gp100 Adenovirus Vaccine
+ gp100 Adenovirus vaccine
@@ -34068,6 +37439,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -34085,14 +37462,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5084
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5084
https://github.com/vaccineontology/VO/issues/198
6490
5084
- Clinical trial
cancer vaccine
Gene name: gp100
- gp100 and GM-CSF DNA/Gold Vaccine
+ gp100 and GM-CSF DNA/Gold vaccine
@@ -34108,6 +37484,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -34125,11 +37507,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5482
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5482
https://github.com/vaccineontology/VO/issues/199
6490
5482
- Clinical trial
cancer vaccine
Gene name: gp100
gp100 Protein (184V) vaccine
@@ -34148,6 +37529,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -34165,14 +37552,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5153
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5153
https://github.com/vaccineontology/VO/issues/200
6490
5153
- Clinical trial
cancer vaccine
Gene name: gp100
- gp100 Vaccinia Vaccine
+ gp100 Vaccinia vaccine
@@ -34188,6 +37574,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -34205,14 +37597,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5135
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5135
https://github.com/vaccineontology/VO/issues/201
6490
5135
- Clinical trial
cancer vaccine
Gene name: gp100
- gp100-Fowlpox Vaccine
+ gp100-Fowlpox vaccine
@@ -34228,6 +37619,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -34245,11 +37642,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5007
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5007
https://github.com/vaccineontology/VO/issues/202
6490
5007
- Clinical trial
cancer vaccine
Gene name: gp100
gp100-Pulsed Peripheral Blood Mononuclear Cell vaccine
@@ -34268,6 +37664,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -34285,11 +37687,10 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4990
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4990
https://github.com/vaccineontology/VO/issues/203
6490
4990
- Clinical trial
cancer vaccine
Gene name: gp100
gp100-Reactive Autologous Peripheral Blood Lymphocyte vaccine
@@ -34308,6 +37709,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -34332,11 +37739,10 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4078
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4078
https://github.com/vaccineontology/VO/issues/204
6490
4078
- Clinical trial
cancer vaccine
Gene name: gp100
gp100/IFA vaccine
@@ -34356,6 +37762,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -34379,11 +37791,10 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5095
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5095
https://github.com/vaccineontology/VO/issues/205
6490
5095
- Clinical trial
cancer vaccine
Gene name: gp100
gp100: ES209-217(210M) Peptide vaccine
@@ -34403,6 +37814,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -34426,14 +37843,13 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5145
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5145
https://github.com/vaccineontology/VO/issues/206
6490
5145
- Clinical trial
cancer vaccine
Gene name: gp100
- gp100:154-162 Peptide Vaccine
+ gp100:154-162 peptide vaccine
@@ -34450,6 +37866,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -34473,11 +37895,10 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5050
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5050
https://github.com/vaccineontology/VO/issues/207
6490
5050
- Clinical trial
cancer vaccine
Gene name: gp100
gp100:209-217 Peptide vaccine
@@ -34497,6 +37918,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -34520,14 +37947,13 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5526
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5526
https://github.com/vaccineontology/VO/issues/208
6490
5526
- Clinical trial
cancer vaccine
Gene name: gp100
- gp100:280-288 Peptide Vaccine
+ gp100:280-288 peptide vaccine
@@ -34544,6 +37970,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -34572,11 +38004,10 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3989
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3989
https://github.com/vaccineontology/VO/issues/307
6490
3989
- Clinical trial
cancer vaccine
Gene name: gp100
Hexapeptide melanoma vaccine
@@ -34596,6 +38027,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -34619,15 +38056,15 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5185
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5185
https://github.com/vaccineontology/VO/issues/423
4100
4102
5185
- Clinical trial
cancer vaccine
- Gene name: MAGEA3|Gene name: MAGEA1
- HLA-A1-Binding MAGE-1/MAGE-3 Multipeptide-Pulsed Autologous Dendritic Cell Vaccine
+ Gene name: MAGEA1
+ Gene name: MAGEA3
+ HLA-A1-binding MAGE-1/MAGE-3 multipeptide-pulsed autologous dendritic cell vaccine
@@ -34644,6 +38081,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -34667,15 +38110,15 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5034
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5034
https://github.com/vaccineontology/VO/issues/425
2315
6490
5034
- Clinical trial
cancer vaccine
- Gene name: gp100 |Gene name: MLANA
- HLA-A2-Binding TYR/MART-1/gp100 Multipeptide-Pulsed Autologous Dendritic Cell Vaccine
+ Gene name: MLANA
+ Gene name: gp100
+ HLA-A2-binding TYR/MART-1/gp100 multipeptide-pulsed autologous dendritic cell vaccine
@@ -34692,6 +38135,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -34715,14 +38164,13 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5270
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5270
https://github.com/vaccineontology/VO/issues/448
7015
5270
- Clinical trial
cancer vaccine
Gene name: TERT
- hTERT/Survivin/Melanoma Tumor Cell-Derived mRNA-Transfected Dendritic Cell Vaccine
+ hTERT/survivin/melanoma tumor cell-derived mRNA-transfected dendritic cell vaccine
@@ -34739,6 +38187,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -34762,15 +38216,15 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5143
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5143
https://github.com/vaccineontology/VO/issues/484
3845
7157
5143
- Clinical trial
cancer vaccine
- Gene name: TP53|Gene name: KRAS
- Long Peptide Vaccine 7
+ Gene name: KRAS
+ Gene name: TP53
+ long peptide vaccine 7
@@ -34787,6 +38241,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -34799,18 +38259,24 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
A synthetic peptide cancer vaccine consisting of human leukocyte antigen HLA-A1-restricted peptide derived from human melanoma antigen 3 (MAGE-3) with potential immunostimulating and antineoplastic activities. Upon administration, MAGE-3.A1 peptide vaccine may stimulate the immune system to mount a cytotoxic T-cell (CTL) response against tumor cells expressing MAGE-3, resulting in tumor cell lysis. MAGE-3, a tumor-associated antigen (TAA), is overexpressed by a variety of cancer cell types.
Jie Zheng
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5021
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5021
https://github.com/vaccineontology/VO/issues/489
4102
5021
cancer vaccine
Gene name: MAGEA3
- MAGE-3.A1 Peptide Vaccine
+ MAGE-3.A1 peptide vaccine
@@ -34826,6 +38292,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -34836,13 +38308,13 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4003
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4003
https://github.com/vaccineontology/VO/issues/497
6490
4003
cancer vaccine
Gene name: gp100
- MART-1 Vaccine
+ MART-1 vaccine
@@ -34859,6 +38331,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -34871,18 +38349,24 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
A vaccine consisting of recombinant adenovirus vector encoding MART-1 (melanoma antigen recognized by T-cells 1), an immunogenic protein of unknown function that is expressed by certain types of melanoma. Vaccination with MART-1 adenovirus vaccine may stimulate the host immune system to direct cytotoxic T lymphocytes (CTL) against MART-1 positive melanoma cells, resulting in an antitumor effect.
Jie Zheng
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5398
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5398
https://github.com/vaccineontology/VO/issues/498
2315
5398
cancer vaccine
Gene name: MLANA-Dupli
- MART-1 Adenovirus Vaccine
+ MART-1 Adenovirus vaccine
@@ -34898,24 +38382,36 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
+
+
+
+
+
+
A synthetic cancer vaccine derived from a melanoma-associated antigen, MART-1. Antigenic peptides derived from MART-1 are recognized by CD8+ T lymphocytes and have been used to immunize patients with advanced melanomas; prolonged immunization may result in a reduction in tumor size. Fowlpox virus is an attractive vector because its genome is easy to manipulate and it does not multiply in human tissues.
Jie Zheng
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5254
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5254
https://github.com/vaccineontology/VO/issues/502
2315
5254
cancer vaccine
Gene name: MLANA-Dupli
- MART-1 Fowlpox Vaccine
+ MART-1 Fowlpox vaccine
@@ -34931,24 +38427,36 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
+
+
+
+
+
+
A cancer vaccine consisting of an attenuated recombinant vaccinia virus expressing the melanoma-associated antigen MART-1. Vaccination with this agent may stimulate cytotoxic host immune responses to melanoma cells.
Jie Zheng
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5204
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5204
https://github.com/vaccineontology/VO/issues/503
2315
5204
cancer vaccine
Gene name: MLANA-Dupli
- MART-1 Vaccinia Vaccine
+ MART-1 Vaccinia vaccine
@@ -34965,6 +38473,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -34977,19 +38491,26 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
Irradiated allogeneic, HLA-A*0201 positive, plasmacytoid dendritic cells (pDCs) loaded with 4 melanoma peptides derived from the tumor associated antigens (TAAs) MelA/MART-1, gp100/pmel17, tyrosinase, and MAGE-A3, with potential immunostimulating and antineoplastic activities. Upon subcutaneous administration, the irradiated allogeneic pDCs may trigger functional multi-specific T cells from peripheral blood mononuclear cells and tumor-infiltrating lymphocytes, and activate the immune system to mount a cytotoxic T-lymphocyte response against HLA-A*0201 positive melanoma cancer cells expressing the TAAs MelA/MART-1, gp100/pmel17, tyrosinase, and MAGE-A3. These TAAs are upregulated in a variety of tumor cells. The pDCs are derived from a distinct subset of dendritic cells (DCs) with a plasma cell-like morphology and express a characteristic set of surface markers and may increase the anti-tumor immune responses.
Jie Zheng
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5028
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5028
https://github.com/vaccineontology/VO/issues/504
4100
6490
5028
cancer vaccine
- Gene name: gp100|Gene name: MAGEA3
- MART-1/gp100/Tyrosinase/MAGE-A3 Peptides-loaded Irradiated Allogeneic Plasmacytoid Dendritic Cells Vaccine
+ Gene name: MAGEA3
+ Gene name: gp100
+ MART-1/gp100/Tyrosinase/MAGE-A3 peptides-loaded irradiated allogeneic plasmacytoid dendritic cells vaccine
@@ -35006,6 +38527,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -35018,18 +38545,25 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
Jie Zheng
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5141
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5141
https://github.com/vaccineontology/VO/issues/505
2315
6490
5141
cancer vaccine
- Gene name: MLANA|Gene name: gp100
- MART-1:26-35(27L) Peptide Vaccine
+ Gene name: MLANA
+ Gene name: gp100
+ MART-1:26-35(27L) peptide vaccine
@@ -35046,6 +38580,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -35058,18 +38598,24 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
A natural or synthetic peptide cancer vaccine consisting of amino acid residues 27 through 35 of the melanoma-associated antigen MART-1 with potential antineoplastic activity. Vaccination with MART-1:27-35 peptide may induce cytotoxic host immune responses against melanoma cells that express this peptide
Jie Zheng
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5450
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5450
https://github.com/vaccineontology/VO/issues/506
2315
5450
cancer vaccine
Gene name: MLANA
- MART-1:27-35 Peptide Vaccine
+ MART-1:27-35 peptide vaccine
@@ -35085,24 +38631,36 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
+
+
+
+
+
+
A vaccine consisting of the melanocyte differentiation antigen Melan A (also called MART-1) encapsulated in noninfectious virus-like particles (VLP) with potential immunostimulating and antineoplastic activities. Upon administration, Melan-A VLP vaccine may activate the immune system to exert a specific cytotoxic T lymphocyte (CTL) response against cancer cells expressing the Melan A antigen, resulting in tumor cell lysis. Melan A is an antigen that is upregulated in most melanomas. VLP stimulates the immune system and promotes the CTL response.
Jie Zheng
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5142
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5142
https://github.com/vaccineontology/VO/issues/507
2315
5142
cancer vaccine
Gene name: MLANA
- Melan-A VLP Vaccine
+ Melan-A VLP vaccine
@@ -35119,6 +38677,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -35131,18 +38695,25 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
Jie Zheng
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5318
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5318
https://github.com/vaccineontology/VO/issues/508
2315
4102
5318
cancer vaccine
- Gene name: MLANA|Gene name: MAGEA3
- Melan-A/MAGE-3.DP4 Peptide Vaccine
+ Gene name: MAGEA3
+ Gene name: MLANA
+ Melan-A/MAGE-3.DP4 peptide vaccine
@@ -35175,24 +38746,37 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
+
+
+
+
+
+
A synthetic allogeneic cancer vaccine. Melanoma theraccine typically consists of lysed melanoma cells obtained from several melanoma cell lines combined with an adjuvant (such as DETOX or RIBI). This agent may be combined with immunomodulatory cytokines such as interferon alpha. Melanoma theraccine may induce a rise in the level of cytotoxic T-lymphocyte precursors.
Jie Zheng
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4989
+ Melanoma Theraccine
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4989
https://github.com/vaccineontology/VO/issues/522
282617
4989
cancer vaccine
Gene name: IFNL3
- Melanoma Theraccine
+ melanoma Theraccine vaccine
@@ -35208,22 +38792,34 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
+
+
+
+
+
+
A therapeutic melanoma vaccine consisting of autologous dendritic cells (DCs) pulsed with antigens from lethally irradiated autologous tumor cells derived from a patient-specific, continuously proliferating and melanoma-initiating cell line and suspended in a solution containing the cytokine granulocyte-macrophage colony stimulating factor (GM-CSF), with potential immunostimulatory and antineoplastic activities. Upon subcutaneous administration, melapuldencel-T may stimulate the immune system to exert a cytotoxic T-lymphocyte (CTL) immune response against the patient's repertoire of melanoma-associated antigens, particularly tumor stem cell antigens, found in the irradiated autologous cancer cells. As an immunostimulant, GM-CSF enhances the activation of dendritic cells (DCs) and promotes antigen presentation to both B- and T-lymphocytes.
Jie Zheng
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5014
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5014
https://github.com/vaccineontology/VO/issues/523
5014
cancer vaccine
- Melapuldencel-T Vaccine
+ Melapuldencel-T vaccine
@@ -35240,6 +38836,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -35252,19 +38854,26 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
A multipeptide cancer vaccine comprised of 12 melanoma peptides restricted by Class I MHC (12MP), plus a tetanus helper peptide
Jie Zheng
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5261
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5261
https://github.com/vaccineontology/VO/issues/524
22178
6490
5261
cancer vaccine
- Gene name: gp100|Gene name: TRP-1
- MELITAC 12.1 Peptide Vaccine
+ Gene name: TRP-1
+ Gene name: gp100
+ MELITAC 12.1 peptide vaccine
@@ -35280,24 +38889,36 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
+
+
+
+
+
+
A humanized anti-idiotypic (anti-Id) monoclonal antibody (MoAb) that mimics the disialoganglioside GD2 with potential immunostimulating and antineoplastic activities. Upon administration, monoclonal antibody 4B5 anti-idiotype vaccine may elicit both cellular and humoral immune responses against GD2- expressing tumor cells. GD2 is a glycosphingolipid (ceramide and oligosaccharide) that may be highly expressed by melanomas and other neuroectodermal tumors, while only minimally expressed by normal tissues.
Jie Zheng
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5039
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5039
https://github.com/vaccineontology/VO/issues/535
2064
5039
cancer vaccine
Gene name: ERBB2
- Monoclonal Antibody 4B5 Anti-Idiotype Vaccine
+ monoclonal antibody 4B5 anti-idiotype vaccine
@@ -35320,6 +38941,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -35331,13 +38958,13 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5386
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5386
https://github.com/vaccineontology/VO/issues/539
20431
5386
cancer vaccine
Gene name: Pmel17
- Mouse gp100 Plasmid DNA Vaccine
+ Mouse gp100 Plasmid DNA vaccine
@@ -35376,6 +39003,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -35387,13 +39020,13 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5310
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5310
https://github.com/vaccineontology/VO/issues/558
1638
5310
cancer vaccine
Gene name: DCT
- Murine TYRP2 Plasmid DNA Vaccine
+ Murine TYRP2 plasmid DNA vaccine
@@ -35410,6 +39043,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -35433,14 +39072,13 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5276
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5276
https://github.com/vaccineontology/VO/issues/446
7015
5276
- Clinical trial
cancer vaccine
Gene name: TERT
- hTERT-LAMP mRNA-loaded Autologous Dendritic Cell Vaccine GRNVAC1
+ hTERT-LAMP mRNA-loaded autologous dendritic cell vaccine GRNVAC1
@@ -35461,6 +39099,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -35508,14 +39152,13 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5264
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5264
https://github.com/vaccineontology/VO/issues/66
1485
5264
- Clinical trial
cancer vaccine
Gene name: NY-ESO-1
- ESO-1 (161-180) Peptide Vaccine
+ ESO-1 (161-180) peptide vaccine
@@ -35536,6 +39179,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -35583,15 +39232,14 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5473
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5473
https://pubmed.ncbi.nlm.nih.gov/?term=ESO-1%3A157-165%28165V%29+Peptide
https://github.com/vaccineontology/VO/issues/68
1485
5473
- Clinical trial
cancer vaccine
Gene name: NY-ESO-1
- ESO-1:157-165(165V) Peptide vaccine
+ ESO-1:157-165(165V) peptide vaccine
@@ -35608,6 +39256,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -35631,16 +39285,16 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- PubMed:15757474
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5031
+ PMID:15757474
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5031
https://github.com/vaccineontology/VO/issues/129
354
634
5031
- Clinical trial
cancer vaccine
- Gene name: CEACAM1|Gene name: KLK3
- Fowlpox Virus Vaccine
+ Gene name: CEACAM1
+ Gene name: KLK3
+ fowlpox virus vaccine
@@ -35657,6 +39311,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -35680,14 +39340,13 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5144
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5144
https://github.com/vaccineontology/VO/issues/469
3620
5144
- Clinical trial
cancer vaccine
Gene name: IDO1
- Indoleamine 2,3-dioxygenase Peptide Vaccine
+ Indoleamine 2,3-dioxygenase Peptide vaccine
@@ -35702,6 +39361,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -35719,12 +39384,11 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- PubMed:22855837
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5317
+ PMID:22855837
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5317
https://github.com/vaccineontology/VO/issues/128
2348
5317
- Clinical trial
cancer vaccine
Gene name: FOLR1
Folate-FITC vaccine
@@ -35742,6 +39406,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -35753,13 +39423,14 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5157
+ MAGE-1 Vaccinia Contaminated with BVDV
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5157
https://github.com/vaccineontology/VO/issues/488
4100
5157
cancer vaccine
Gene name: MAGEA1
- MAGE-1 Vaccinia Contaminated with BVDV
+ MAGE-1 Vaccinia contaminated with bovine viral diarrhea virus vaccine
@@ -35775,6 +39446,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -35792,13 +39469,13 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5395
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5395
https://github.com/vaccineontology/VO/issues/491
4102
5395
cancer vaccine
Gene name: MAGEA3
- MAGE-A3 Peptide Vaccine
+ MAGE-A3 peptide vaccine
@@ -35813,6 +39490,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -35824,13 +39507,13 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5336
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5336
https://github.com/vaccineontology/VO/issues/492
4102
5336
cancer vaccine
Gene name: MAGEA3
- MAGE-A3-expressing Adenovirus Type 5 Vaccine
+ MAGE-A3-expressing Adenovirus Type 5 vaccine
@@ -35848,6 +39531,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -35877,14 +39566,13 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5191
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5191
https://github.com/vaccineontology/VO/issues/439
7015
5191
- Clinical trial
cancer vaccine
Gene name: TERT
- hTERT I540/R572Y/D988Y Multipeptide Vaccine
+ hTERT I540/R572Y/D988Y multipeptide vaccine
@@ -35901,6 +39589,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -35924,12 +39618,11 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5344
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5344
https://github.com/vaccineontology/VO/issues/460
5344
- Clinical trial
cancer vaccine
- Idiotype-Pulsed Autologous Dendritic Cell Vaccine APC8020
+ Idiotype-pulsed autologous dendritic cell vaccine APC8020
@@ -35945,6 +39638,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -35956,13 +39655,14 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5460
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5460
https://github.com/vaccineontology/VO/issues/565
354
55
5460
cancer vaccine
- Gene name: KLK3|Gene name: ACP3
+ Gene name: ACP3
+ Gene name: KLK3
MVA-PSA/PAP Prostate Cancer Vaccine
@@ -35979,6 +39679,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -35996,14 +39702,14 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5314
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5314
https://github.com/vaccineontology/VO/issues/560
3783709
5698
5314
- Clinical trial
cancer vaccine
- Gene name: EBNA-1|Gene name: PSMB9
+ Gene name: EBNA-1
+ Gene name: PSMB9
MVA-EBNA1/LMP2 Vaccine
@@ -36021,6 +39727,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -36044,11 +39756,10 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5466
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5466
https://github.com/vaccineontology/VO/issues/482
5689
5466
- Clinical trial
cancer vaccine
Gene name: PSMB9
LMP-2:340-349 Peptide Vaccine
@@ -36068,6 +39779,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -36091,11 +39808,10 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5479
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5479
https://github.com/vaccineontology/VO/issues/483
5689
5479
- Clinical trial
cancer vaccine
Gene name: PSMB9
LMP-2:419-427 Peptide Vaccine
@@ -36114,6 +39830,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -36131,14 +39853,15 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5263
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5263
https://github.com/vaccineontology/VO/issues/490
4100
4102
5263
cancer vaccine
- Gene name: MAGEA3|Gene name: MAGEA1
- MAGE-A1/MAGE-A3/NY-ESO-1 Peptides Vaccine
+ Gene name: MAGEA1
+ Gene name: MAGEA3
+ MAGE-A1/MAGE-A3/NY-ESO-1 peptide vaccine
@@ -36160,6 +39883,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -36177,15 +39906,15 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5532
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5532
https://github.com/vaccineontology/VO/issues/178
117189
2760
5532
- Clinical trial
cancer vaccine
- Gene name: GM2A|Gene name: GRDX
- GM2/GD2/GD3 Lactone-KLH Conjugate Trivalent Vaccine
+ Gene name: GM2A
+ Gene name: GRDX
+ GM2/GD2/GD3 Lactone-KLH conjugate trivalent vaccine
@@ -36201,6 +39930,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -36224,15 +39959,15 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5429
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5429
https://github.com/vaccineontology/VO/issues/421
10953
3791
5429
- Clinical trial
cancer vaccine
- Gene name: KDR|Gene name: TOMM34
- HLA-A*2404-Restricted RNF43-TOMM34-VEGFR1-VEGFR2 Multipeptide Vaccine
+ Gene name: KDR
+ Gene name: TOMM34
+ HLA-A*2404-Restricted RNF43-TOMM34-VEGFR1-VEGFR2 multipeptide vaccine
@@ -36248,6 +39983,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -36271,13 +40012,13 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5120
+ HLA-A1, A2, B35-Restricted Survivin Peptides/Montanide ISA-51 Vaccine
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5120
https://github.com/vaccineontology/VO/issues/422
5120
- Clinical trial
cancer vaccine
Gene name: Survivin
- HLA-A1, A2, B35-Restricted Survivin Peptides/Montanide ISA-51 Vaccine
+ HLA-A1, A2, B35-restricted survivin peptide/montanide ISA-51 vaccine
@@ -36292,6 +40033,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -36309,14 +40056,13 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5246
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5246
https://github.com/vaccineontology/VO/issues/428
1489078
5246
- Clinical trial
cancer vaccine
Gene name: E6
- Host Dendritic Cell Vaccine-001 MSSM/BIIR
+ host dendritic cell vaccine-001 MSSM/BIIR
@@ -36331,6 +40077,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -36348,15 +40100,15 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5048
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5048
https://github.com/vaccineontology/VO/issues/464
10983
983
5048
- Clinical trial
cancer vaccine
- Gene name: CDK1|Gene name: CCNI
- IMT-1012 Immunotherapeutic Vaccine
+ Gene name: CCNI
+ Gene name: CDK1
+ IMT-1012 Immunotherapeutic vaccine
@@ -36372,6 +40124,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -36395,15 +40153,15 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5355
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5355
https://github.com/vaccineontology/VO/issues/309
2064
6490
5355
- Clinical trial
cancer vaccine
- Gene name: PMEL|Gene name: ERBB2
- HLA-A0201-Restricted TRP2-gp100-EphA2-HER2 multipeptide Vaccine
+ Gene name: ERBB2
+ Gene name: PMEL
+ HLA-A0201-Restricted TRP2-gp100-EphA2-HER2 multipeptide vaccine
@@ -36419,6 +40177,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -36442,15 +40206,15 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5017
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5017
https://github.com/vaccineontology/VO/issues/417
3791
54742
5017
- Clinical trial
cancer vaccine
- Gene name: KDR|Gene name: LY6K
- HLA-A*0201-Restricted URLC10-VEGFR1-VEGFR2 Multipeptide Vaccine
+ Gene name: KDR
+ Gene name: LY6K
+ HLA-A*0201-Restricted URLC10-VEGFR1-VEGFR2 multipeptide vaccine
@@ -36468,7 +40232,13 @@ Immunization Route: Intramuscular injection (i.m.)
-
+
+
+
+
+
+
+
@@ -36489,15 +40259,15 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4991
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4991
https://github.com/vaccineontology/VO/issues/480
1485
1956
4991
- Clinical trial
cancer vaccine
- Gene name: EGFR|Gene name: CTAG1B
- Live-attenuated Listeria monocytogenes-encoding EGFRvIII-NY-ESO-1 Vaccine ADU-623
+ Gene name: CTAG1B
+ Gene name: EGFR
+ live-attenuated Listeria monocytogenes-encoding EGFRvIII-NY-ESO-1 vaccine ADU-623
@@ -36519,6 +40289,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -36536,15 +40312,15 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5104
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5104
https://github.com/vaccineontology/VO/issues/173
4582
2760
5104
- Clinical trial
cancer vaccine
- Gene name: GM2A|Gene name: MUC1
- Globo H-GM2-Lewis-y-MUC1-32-mer-TF(c)-Tn(c)-KLH Conjugate Vaccine
+ Gene name: GM2A
+ Gene name: MUC1
+ Globo H-GM2-Lewis-y-MUC1-32-mer-TF(c)-Tn(c)-KLH conjugate vaccine
@@ -36560,6 +40336,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -36571,7 +40353,7 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5335
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5335
https://github.com/vaccineontology/VO/issues/541
4343
5335
@@ -36593,6 +40375,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -36616,13 +40404,12 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5385
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5385
https://github.com/vaccineontology/VO/issues/477
5385
- Clinical trial
cancer vaccine
Gene name: Tumor Associated Antigen
- Light-Emitting Oncolytic Vaccinia Virus GL-ONC1 Vaccine
+ light-emitting Oncolytic Vaccinia virus GL-ONC1 vaccine
@@ -36641,6 +40428,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -36688,14 +40481,13 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5413
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5413
https://github.com/vaccineontology/VO/issues/418
3791
5413
- Clinical trial
cancer vaccine
Gene name: KDR
- HLA-A*0201-Restricted VEGFR1 Peptide Vaccine
+ HLA-A*0201-Restricted VEGFR1 peptide vaccine
@@ -36711,6 +40503,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -36728,11 +40526,10 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5038
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5038
https://github.com/vaccineontology/VO/issues/132
354
5038
- Clinical trial
cancer vaccine
Gene name: KLK3
Fowlpox-PSA-TRICOM Vaccine
@@ -36752,6 +40549,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -36769,7 +40572,7 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5369
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5369
https://github.com/vaccineontology/VO/issues/542
26872
5369
@@ -36798,6 +40601,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -36808,7 +40617,7 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5126
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5126
https://github.com/vaccineontology/VO/issues/546
4583
5126
@@ -36834,6 +40643,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -36875,14 +40690,13 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5292
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5292
https://github.com/vaccineontology/VO/issues/194
7124
5292
- Clinical trial
cancer vaccine
Gene name: TNF
- Golnerminogene Pradenovec Vaccine
+ Golnerminogene Pradenovec vaccine
@@ -36899,6 +40713,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -36922,11 +40742,10 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5465
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5465
https://github.com/vaccineontology/VO/issues/424
2250
5465
- Clinical trial
cancer vaccine
Gene name: FGF5
HLA-A2, A3-Restricted FGF-5 Peptides/Montanide ISA-51 Vaccine
@@ -36946,6 +40765,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -36969,11 +40794,10 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5498
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5498
https://github.com/vaccineontology/VO/issues/134
4108
5498
- Clinical trial
cancer vaccine
Gene name: MAGEA9
G250 Peptide Vaccine
@@ -36993,6 +40817,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -37016,14 +40846,14 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5509
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5509
https://github.com/vaccineontology/VO/issues/52
253970502
100306940
5509
- Clinical trial
cancer vaccine
- Gene name: FL1|Gene name: EWSR1
+ Gene name: EWSR1
+ Gene name: FL1
EF-1 Peptide Vaccine
@@ -37041,6 +40871,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -37064,14 +40900,13 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5488
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5488
https://github.com/vaccineontology/VO/issues/479
4582
5488
- Clinical trial
cancer vaccine
Gene name: MUC1
- Liposomal MUC1/PET-lipid A Vaccine
+ liposomal MUC1/PET-lipid A vaccine
@@ -37087,6 +40922,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -37103,13 +40944,13 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5345
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5345
https://github.com/vaccineontology/VO/issues/493
4102
5345
cancer vaccine
Gene name: MAGEA3
- MAGE-A3/HPV 16 Peptide Vaccine
+ MAGE-A3/HPV 16 peptide vaccine
@@ -37126,6 +40967,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -37149,14 +40996,13 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5236
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5236
https://github.com/vaccineontology/VO/issues/133
7428
5236
- Clinical trial
cancer vaccine
Gene name: VHL
- FrSh61 (MEA) VHL33 Peptide Vaccine
+ FrSh61 (MEA) VHL33 peptide vaccine
@@ -37172,6 +41018,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -37195,14 +41047,13 @@ Immunization Route: Intramuscular injection (i.m.)
Justin Song
Oliver He
Yuanyi (Penny) Pan
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5442
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5442
https://github.com/vaccineontology/VO/issues/305
2064
5442
- Clinical trial
cancer vaccine
Gene name: ERBB2
- HER2 ECD+TM Virus-like Replicon Particles Vaccine AVX901
+ HER2 ECD+TM virus-like replicon particles vaccine AVX901
@@ -37217,6 +41068,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -37226,12 +41083,12 @@ Immunization Route: Intramuscular injection (i.m.)
A replication-competent oncolytic adenovirus encoding the murine pro-inflammatory cytokine interleukin-12 (IL-12) gene and two suicide fusion genes, a yeast cytosine deaminase (yCD) and a mutant form of herpes simplex virus type 1 thymidine kinase (HSV-1 TKSR39), with potential immunomodulating and antineoplastic activities. Upon intratumoral administration of Ad5-yCD/mutTKSR39rep-hIL12, the adenovirus selectively infects and replicates in tumor cells, which results in direct tumor cell lysis. Synergistically, IL-12 expressed by the adenovirus may activate the immune system by promoting the activation of natural killer cells (NKs), inducing secretion of interferon-gamma (IFN-g) and inducing cytotoxic T-lymphocyte (CTL) responses against tumor cells, which may result in immune-mediated tumor cell death, inhibition of tumor cell proliferation and inhibition of tumor angiogenesis. In addition, Ad5-yCD/mutTKSR39rep-hIL12-infected cancer cells express yCD and TKSR39; upon administration of the prodrugs 5-fluorocytosine (5-FC) and valganciclovir (vGCV), the yCD and HSV-1 TKSR39 activate these prodrugs to form 5-fluorouracil (5-FU) and ganciclovir, respectively. 5-FU gets converted to 5-fluoro-uridine monophosphate (5-FUMP) and subsequently to 5-fluoro-deoxyuridine monophosphate (5-FdUMP); 5-FdUMP irreversible inhibits thymidylate synthase, inhibits deoxythymidine triphosphate (dTTP) formation and halts DNA synthesis. Once phosphorylated intracellularly, ganciclovir triphosphate competitively inhibits deoxyguanosine triphosphate (dGTP) incorporation into DNA and inhibits DNA synthesis.
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5303
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5303
https://github.com/vaccineontology/VO/issues/89
5303
- Clinical trial
cancer vaccine
- Gene name: IL12B|Gene name: IL12A
+ Gene name: IL12A
+ Gene name: IL12B
Ad5-yCD/mutTKSR39rep-hIL12 vaccine
@@ -37247,6 +41104,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -37255,11 +41118,10 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5324
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5324
5324
- Clinical trial
cancer vaccine
- Ad5F35-LMP1/LMP2-Transduced Autologous Dendritic Cell vaccine
+ Ad5F35-LMP1/LMP2-Transduced autologous dendritic cell vaccine
@@ -37281,6 +41143,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -37289,11 +41157,10 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5534
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5534
5534
- Clinical trial
cancer vaccine
- Alpha Fetoprotein Plasmid DNA Vaccine
+ Alpha Fetoprotein Plasmid DNA vaccine
@@ -37308,6 +41175,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -37316,11 +41189,10 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4995
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4995
4995
- Clinical trial
cancer vaccine
- ALVAC-CEA (6D)-B7.1 Vaccine
+ ALVAC-CEA (6D)-B7.1 vaccine
@@ -37335,6 +41207,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -37343,9 +41221,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4051
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4051
4051
- Clinical trial
cancer vaccine
autologous dendritic cells (DCs) vaccine
@@ -37363,6 +41240,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -37377,9 +41260,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3981
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3981
3981
- Research
cancer vaccine
autologous monocyte-derived mature DCs pulsed with p53, survivin and telomerase-derived peptide vaccine
@@ -37397,6 +41279,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -37405,9 +41293,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4029
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4029
4029
- Research
cancer vaccine
Bacille Calmette Guerin for melanoma of lower extremity vaccine
@@ -37425,6 +41312,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -37439,14 +41332,11 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4028
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4028
+ https://github.com/vaccineontology/VO/issues/776
4028
- 19
- Licensed
- 40213271
- Bacillus Calmette-Guerin vaccine
cancer vaccine
- Bacillus Calmette-Guerin (BCG) vaccine
+ Bacillus Calmette-Guerin (BCG) vaccine for melanoma
@@ -37462,6 +41352,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -37470,11 +41366,11 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4036
+ Bacillus Calmette-Guerin (BCG), C. parvum vaccine
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4036
4036
- Research
cancer vaccine
- Bacillus Calmette-Guerin (BCG), C. parvum vaccine
+ Bacillus Calmette-Guerin (BCG), Corynebacterium parvum vaccine
@@ -37490,6 +41386,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -37498,9 +41400,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4035
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4035
4035
- Research
cancer vaccine
Bacillus Calmette-Guerin (BCG), dinitrochlorobenzene (DNCB) vaccine
@@ -37518,6 +41419,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -37526,11 +41433,10 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4034
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4034
4034
- Research
cancer vaccine
- bacillus Calmette-Guerin (MER) vaccine
+ Bacillus Calmette-Guerin (MER) vaccine
@@ -37546,6 +41452,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -37554,9 +41466,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4021
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4021
4021
- Research
cancer vaccine
BCG and chemotherapy for malignant melanoma vaccine
@@ -37574,6 +41485,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -37582,9 +41499,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4022
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4022
4022
- Clinical trial
cancer vaccine
BCG and Corynebacterium parvum for malignant melanoma vaccine
@@ -37602,6 +41518,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -37610,9 +41532,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4033
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4033
4033
- Clinical trial
cancer vaccine
BCG treatment after surgical tumor removal vaccine
@@ -37631,6 +41552,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -37645,9 +41572,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4017
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4017
4017
- Research
cancer vaccine
Biolistic DNA vaccine
@@ -37665,6 +41591,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -37673,9 +41605,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3984
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3984
3984
- Research
cancer vaccine
Canvaxin
@@ -37694,6 +41625,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -37708,9 +41645,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4072
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4072
4072
- Research
cancer vaccine
class I HLA-A0201-restricted gp100209-2M peptide vaccine
@@ -37727,6 +41663,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -37735,9 +41677,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5456
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5456
5456
- Clinical trial
cancer vaccine
Contusugene ladenovec vaccine
@@ -37754,6 +41695,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -37762,9 +41709,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3990
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3990
3990
- Research
cancer vaccine
CpG 7909/PF3512676 vaccine
@@ -37774,26 +41720,14 @@ Immunization Route: Intramuscular injection (i.m.)
-
-
-
-
-
-
-
-
-
-
-
-
-
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4170
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4170
+
4170
- Licensed
- cancer vaccine
- CVB4/p24(73(3)) vaccine
+ Recorded as licensed cancer vaccine without reference. Based on the vaccine name, it is not correct, see term:VO:0004719.
+ obsolete CVB4/p24(73(3)) vaccine
+ true
@@ -37808,6 +41742,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -37816,11 +41756,10 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5494
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5494
5494
- Clinical trial
cancer vaccine
- Dendritic Cell-Idiotype-Keyhole Limpet Hemocyanin Vaccine
+ dendritic cell-Idiotype-Keyhole Limpet Hemocyanin vaccine
@@ -37837,6 +41776,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -37851,11 +41796,10 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5346
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5346
5346
- Clinical trial
cancer vaccine
- DEPDC1/MPHOSH1 Peptide Vaccine
+ DEPDC1/MPHOSH1 peptide vaccine
@@ -37871,6 +41815,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -37885,11 +41835,10 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5116
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5116
5116
- Clinical trial
cancer vaccine
- DLK1/EPHA2/HBB/NRP1/RGS5/TEM1 Peptide-pulsed Alpha-type-1 Polarized Dendritic Cell Vaccine
+ DLK1/EPHA2/HBB/NRP1/RGS5/TEM1 peptide-pulsed alpha-type-1 polarized dendritic cell vaccine
@@ -37912,6 +41861,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -37920,11 +41875,10 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4060
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4060
4060
- Clinical trial
cancer vaccine
- DNA Vaccine encoding p42.3
+ DNA vaccine encoding p42.3
@@ -37939,6 +41893,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -37947,9 +41907,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3998
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3998
3998
- Research
cancer vaccine
DNP-modified autologous vaccine
@@ -37967,6 +41926,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -37975,9 +41940,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4076
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4076
4076
- Research
cancer vaccine
electroloading of mature dendritic cells with melanoma whole tumor cell lysate vaccine
@@ -37996,6 +41960,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -38010,9 +41980,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4067
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4067
4067
- Research
cancer vaccine
ESAT-6-gpi DNA vaccine combined with B16F10-ESAT-6-gpi/IL-21 vaccine
@@ -38029,6 +41998,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -38037,9 +42012,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4081
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4081
4081
- Research
cancer vaccine
Flagrp170 vaccine
@@ -38049,6 +42023,8 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
@@ -38056,17 +42032,28 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
+
+
+
+
+
+
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4018
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4018
4018
- Licensed
cancer vaccine
FVAX vaccine
@@ -38083,6 +42070,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -38091,9 +42084,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4047
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4047
4047
- Research
cancer vaccine
GM-CSF transfected cells vaccine
@@ -38110,6 +42102,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -38118,11 +42116,10 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4008
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4008
4008
- Research
cancer vaccine
- gp100 Vaccine
+ gp100 vaccine
@@ -38138,6 +42135,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -38152,9 +42155,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3974
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3974
3974
- Clinical trial
cancer vaccine
gp100:209-217(210M) peptide vaccine
@@ -38173,6 +42175,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -38187,11 +42195,10 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5438
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5438
5438
- Clinical trial
cancer vaccine
- gp100:280-288(288V) Peptide Vaccine
+ gp100:280-288(288V) peptide vaccine
@@ -38206,6 +42213,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -38214,11 +42227,10 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5062
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5062
5062
- Clinical trial
cancer vaccine
- GVAX Pancreatic Cancer Vaccine
+ GVAX pancreatic cancer vaccine
@@ -38234,6 +42246,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -38242,9 +42260,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4010
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4010
4010
- Research
cancer vaccine
hapten dinitrophenyl vaccine
@@ -38261,6 +42278,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -38269,9 +42292,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3992
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3992
3992
- Research
cancer vaccine
HCA587 protein vaccine
@@ -38289,6 +42311,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -38297,9 +42325,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4053
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4053
4053
- Clinical trial
cancer vaccine
hMART-IT vaccine
@@ -38318,6 +42345,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -38332,9 +42365,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3986
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3986
3986
- Research
cancer vaccine
HSP65-HER2 fusion peptide vaccine
@@ -38351,6 +42383,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -38359,9 +42397,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4058
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4058
4058
- Research
cancer vaccine
Hsp70 chaperone-based gel composition vaccine
@@ -38379,6 +42416,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -38387,9 +42430,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3982
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3982
3982
- Research
cancer vaccine
HSPPC-96 vaccine
@@ -38408,6 +42450,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -38422,9 +42470,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3980
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3980
3980
- Research
cancer vaccine
human leukocyte antigen class I-modified peptide vaccine
@@ -38442,6 +42489,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -38450,9 +42503,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4077
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4077
4077
- Research
cancer vaccine
HUVECs-OK432 vaccine
@@ -38470,6 +42522,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -38478,9 +42536,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3976
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3976
3976
- Clinical trial
cancer vaccine
IDD-3 vaccine
@@ -38498,6 +42555,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -38506,9 +42569,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4009
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4009
4009
- Research
cancer vaccine
IFN/tremem vaccine
@@ -38526,6 +42588,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -38534,9 +42602,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4062
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4062
4062
- Clinical trial
cancer vaccine
IL-12p70 vaccine
@@ -38554,6 +42621,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -38562,9 +42635,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3977
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3977
3977
- Research
cancer vaccine
IMM-101 vaccine
@@ -38582,6 +42654,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -38590,9 +42668,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4069
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4069
4069
- Clinical trial
cancer vaccine
Incomplete Freund's adjuvant (IFA) alone, or a melanoma vaccine in IFA
@@ -38610,6 +42687,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -38618,9 +42701,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4037
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4037
4037
- Research
cancer vaccine
intralesional bacile Calmette-Guerin (BCG) vaccine
@@ -38638,6 +42720,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -38646,9 +42734,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4038
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4038
4038
- Research
cancer vaccine
intralesional bacile Calmette-Guerin (BCG), DTIC, vincristine vaccine
@@ -38666,6 +42753,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -38674,11 +42767,10 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3975
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3975
3975
- Research
cancer vaccine
- Ipilimumab vaccine
+ ipilimumab vaccine
@@ -38694,6 +42786,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -38702,9 +42800,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4045
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4045
4045
- Research
cancer vaccine
ipilimumab, vemurafenib vaccine
@@ -38722,6 +42819,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -38730,9 +42833,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4012
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4012
4012
- Research
cancer vaccine
irradiated autologous cell vaccine
@@ -38750,6 +42852,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -38758,9 +42866,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4050
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4050
4050
- Clinical trial
cancer vaccine
irradiated melanoma cells plus BCG vaccine
@@ -38784,6 +42891,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -38792,11 +42905,10 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5472
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5472
5472
- Clinical trial
cancer vaccine
- KSA-KLH Conjugate Vaccine
+ KSA-KLH conjugate vaccine
@@ -38812,6 +42924,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -38820,9 +42938,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4000
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4000
4000
- Licensed
cancer vaccine
L612 HuMAb vaccine
@@ -38840,6 +42957,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -38848,9 +42971,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3968
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3968
3968
- Research
cancer vaccine
Large Multivalent Immunogen (LMI) vaccine
@@ -38869,6 +42991,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -38883,9 +43011,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4048
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4048
4048
- Research
cancer vaccine
long-peptide vaccine and mAb
@@ -38903,6 +43030,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -38911,9 +43044,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4066
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4066
4066
- Research
cancer vaccine
mAb PC61 and DC/tumor fusion vaccine
@@ -38931,6 +43063,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -38939,9 +43077,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4005
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4005
4005
- Research
cancer vaccine
MAGE-A12:170-178 vaccine
@@ -38959,6 +43096,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -38967,9 +43110,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4059
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4059
4059
- Clinical trial
cancer vaccine
MAGE-A3 + AS15 vaccine
@@ -38987,6 +43129,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -38995,9 +43143,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4039
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4039
4039
- Clinical trial
cancer vaccine
MAGE-A3-genetically modified lymphocyte vaccine
@@ -39015,6 +43162,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -39023,9 +43176,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4065
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4065
4065
- Research
cancer vaccine
MCMV-TRP2 vaccine
@@ -39042,6 +43194,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -39050,9 +43208,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4046
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4046
4046
- Research
cancer vaccine
mCRT-vGPCR-coated whole-cell vaccine
@@ -39070,6 +43227,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -39078,11 +43241,11 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3996
+ Melacine
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3996
3996
- Research
cancer vaccine
- Melacine
+ Melacine vaccine
@@ -39098,6 +43261,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -39106,9 +43275,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3985
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3985
3985
- Research
cancer vaccine
Melan-A/Mart-1 vaccine
@@ -39128,6 +43296,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -39148,11 +43322,11 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3979
+ Melanoma-specific Melan-A/Mart-1 peptide + virus-like nanoparticles
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3979
3979
- Research
cancer vaccine
- Melanoma-specific Melan-A/Mart-1 peptide + virus-like nanoparticles
+ melanoma-specific Melan-A/Mart-1 peptide + virus-like nanoparticles vaccine
@@ -39167,6 +43341,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -39175,11 +43355,10 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5412
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5412
5412
- Clinical trial
cancer vaccine
- Modified Vaccinia Virus Ankara Vaccine Expressing p53
+ modified Vaccinia virus ankara vaccine expressing p53
@@ -39196,6 +43375,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -39208,11 +43393,16 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4068
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4068
4068
- Licensed
cancer vaccine
mouse/human gp10025-33 peptide plus CpG adjuvant; mouse/human gp100; mouse/human gp10025-33 peptide-pulsed DCs vaccine
@@ -39231,6 +43421,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -39245,11 +43441,10 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5224
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5224
5224
- Clinical trial
cancer vaccine
- Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
+ multi-epitope folate receptor alpha-loaded dendritic cell vaccine
@@ -39266,6 +43461,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -39280,9 +43481,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4063
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4063
4063
- Clinical trial
cancer vaccine
Multipeptide melanoma vaccine
@@ -39300,6 +43500,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -39308,9 +43514,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4030
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4030
4030
- Research
cancer vaccine
Oral Bacille Calmette-Guerin for malignant melanoma vaccine
@@ -39328,6 +43533,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -39336,9 +43547,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=3983
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3983
3983
- Research
cancer vaccine
OVA-TEXO vaccine
@@ -39356,6 +43566,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -39364,9 +43580,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4032
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4032
4032
- Clinical trial
cancer vaccine
procarbazine, dactinomycin, velba vaccine
@@ -39384,6 +43599,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -39392,9 +43613,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4031
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4031
4031
- Research
cancer vaccine
Pulmonary BCG immunotherapy for malignant melanoma vaccine
@@ -39411,17 +43631,28 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
+
+
+
+
+
+
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=6075
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6075
6075
- Research
cancer vaccine
RIPO(H3.3) vaccine
@@ -39438,6 +43669,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -39446,9 +43683,8 @@ Immunization Route: Intramuscular injection (i.m.)
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=4011
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4011
4011
- Research
cancer vaccine
alpha-GalCer-loaded tumor-cell vaccine
@@ -39587,7 +43823,7 @@ Immunization Route: Intramuscular injection (i.m.)
A cancer vaccine that uses whole cells to deliver cancer antigen(s).
Oliver He
- PubMed:22595050
+ PMID:22595050
https://github.com/vaccineontology/VO/issues/683
cancer vaccine
whole cell cancer vaccine
@@ -39602,7 +43838,7 @@ Immunization Route: Intramuscular injection (i.m.)
A whole cell cancer vaccine that uses whole tumor cells to deliver cancer antigen(s).
Jie Zheng
Oliver He
- PubMed:37355722
+ PMID:37355722
https://github.com/vaccineontology/VO/issues/683
cancer vaccine
whole tumor cell cancer vaccine
@@ -39751,6 +43987,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -39785,12 +44027,11 @@ Immunization Route: Intramuscular injection (i.m.)
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:C7828795
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=1051
+ PMID:C7828795
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1051
https://github.com/vaccineontology/VO/issues/343
2064
1051
- Research
cancer vaccine
Gene name: ERBB2
Cancer Her-2/neu Protein Subunit Vaccine
@@ -39809,6 +44050,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -39843,15 +44090,14 @@ Immunization Route: Intramuscular injection (i.m.)
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:17266027
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=1052
+ PMID:17266027
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1052
https://github.com/vaccineontology/VO/issues/315
6528
1052
- Research
cancer vaccine
Gene name: SLC5A5
- Cancer DNA Vaccine MIDGE/hNIS encoding hNIS protein
+ cancer DNA vaccine MIDGE/hNIS encoding hNIS protein
@@ -39867,6 +44113,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -39901,15 +44153,14 @@ Immunization Route: Intramuscular injection (i.m.)
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:19526360
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=1053
+ PMID:19526360
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1053
https://github.com/vaccineontology/VO/issues/318
2315863
1053
- Research
cancer vaccine
Gene name: Survivin
- Cancer DNA Vaccine pSURV encoding Survivin
+ cancer DNA vaccine pSURV encoding Survivin
@@ -39925,6 +44176,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -39953,16 +44210,15 @@ Immunization Route: Intramuscular injection (i.m.)
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:21448901
- PubMed:31980914
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=1047
+ PMID:21448901
+ PMID:31980914
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1047
https://github.com/vaccineontology/VO/issues/368
1485
1047
- Research
cancer vaccine
Gene name: CTAG1B
- Cancer Subunit NY-ESO-1 Protein Vaccine
+ cancer subunit NY-ESO-1 protein vaccine
@@ -39978,6 +44234,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -40012,14 +44274,13 @@ Immunization Route: Intramuscular injection (i.m.)
Ibrahim Seleznev
Jie Zheng
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=1048
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1048
https://github.com/vaccineontology/VO/issues/314
13805
1048
- Research
cancer vaccine
Gene name: Eng
- Cancer DNA Vaccine encoding Endoglin Boosted with Recombinant Endoglin Protein
+ cancer DNA vaccine encoding Endoglin Boosted with recombinant Endoglin Protein
@@ -40036,6 +44297,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -40058,13 +44325,12 @@ Immunization Route: Intramuscular injection (i.m.)
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:10678354
- PubMed:8363286
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=1049
+ PMID:10678354
+ PMID:8363286
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1049
https://github.com/vaccineontology/VO/issues/345
14972
1049
- Research
cancer vaccine
Gene name: H2-K1
Cancer recombinant vector vaccine encoding H-2Kb
@@ -40083,6 +44349,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -40098,10 +44370,9 @@ Immunization Route: Intramuscular injection (i.m.)
An xenogenic DNA vaccine encoding human TEM8 carried by attenuated Salmonella typhimurium to help reduce tumor growth and suppress angiogenesis in the tumors.
Allen Xiang
Oliver He
- PubMed:19609240
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=1046
+ PMID:19609240
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1046
1046
- Research
cancer vaccine
cancer DNA vaccine encoding TEM8
@@ -40120,6 +44391,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -40154,13 +44431,12 @@ Immunization Route: Intramuscular injection (i.m.)
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:10881691
- PubMed:19188665
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=1064
+ PMID:10881691
+ PMID:19188665
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1064
https://github.com/vaccineontology/VO/issues/319
4072
1064
- Research
cancer vaccine
Gene name: EPCAM
Cancer EPCAM protein vaccine
@@ -40180,6 +44456,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -40208,13 +44490,12 @@ Immunization Route: Intramuscular injection (i.m.)
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:19034678
- PubMed:32164575
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=1066
+ PMID:19034678
+ PMID:32164575
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1066
https://github.com/vaccineontology/VO/issues/371
7422
1066
- Clinical trial
cancer vaccine
Gene name: VEGFA
Cancer VEGFA protein vaccine
@@ -40232,6 +44513,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -40246,10 +44533,10 @@ Immunization Route: Intramuscular injection (i.m.)
Allen Xiang
Oliver He
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=1058
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1058
1058
cancer vaccine
- cancer Retroviral vector vaccine encoding Cd40lg
+ cancer retroviral vector vaccine encoding Cd40lg
@@ -40266,6 +44553,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -40300,12 +44593,11 @@ Immunization Route: Intramuscular injection (i.m.)
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:/7533183
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=1059
+ PMID:/7533183
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1059
https://github.com/vaccineontology/VO/issues/317
12524
1059
- Research
cancer vaccine
Gene name: Cd86
Cancer DNA Vaccine pLXSHDmB7-2 encoding Cd86
@@ -40331,12 +44623,6 @@ Immunization Route: Intramuscular injection (i.m.)
-
-
-
-
-
-
@@ -40369,6 +44655,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -40391,12 +44683,11 @@ Immunization Route: Intramuscular injection (i.m.)
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:C5187854
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=891
+ PMID:C5187854
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=891
https://github.com/vaccineontology/VO/issues/367
7015
891
- Clinical trial
cancer vaccine
Gene name: TERT
Cancer Subunit GV1001 Protein Vaccine
@@ -40415,6 +44706,12 @@ Immunization Route: Intramuscular injection (i.m.)
+
+
+
+
+
+
@@ -40449,12 +44746,11 @@ Immunization Route: Intramuscular injection (i.m.)
Ibrahim Seleznev
Jie Zheng
Oliver He
- PubMed:wler=tru
- VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=894
+ PMID:wler=tru
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=894
https://github.com/vaccineontology/VO/issues/366
1084
894
- Research
cancer vaccine
Gene name: CEACAM3
Cancer Subunit DC (Tat-CEA) vaccine
diff --git a/CVX-VO/cvx-vo.owl b/CVX-VO/cvx-vo.owl
index 657453b..e6c8b28 100644
--- a/CVX-VO/cvx-vo.owl
+++ b/CVX-VO/cvx-vo.owl
@@ -17,7 +17,7 @@
xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#"
xmlns:ncbitaxon="http://purl.obolibrary.org/obo/ncbitaxon#">
-
+
en
Jie Zheng
Yongqun "Oliver" He (YH)
@@ -26,7 +26,7 @@
OWL-DL
Vaccine Ontology CVX code View
- 2024-12-29
+ 2025-02-26
@@ -223,6 +223,12 @@ We also have the outstanding issue of how to aim different definitions to differ
+
+
+
+
+
+
@@ -472,7 +478,9 @@ WHERE {
An annotation property that represents the proper name of a vaccine, which is defined in an official way such as one defined by FDA.
Kallan Roan
Oliver He
- vaccine proper name
+
+ obsolete vaccine proper name
+ true
@@ -561,7 +569,9 @@ Reference: https://www.fda.gov/biologicsbloodvaccines/vaccines/approvedproducts/
Jie Zheng
Oliver He
Penny Pan
- status of vaccine development
+
+ obsolete status of vaccine development
+ true
@@ -885,44 +895,6 @@ A continuant cannot have an occurrent as part: use 'participates in'.
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- occurs in
- b occurs_in c =def b is a process and c is a material entity or immaterial entity& there exists a spatiotemporal region r and b occupies_spatiotemporal_region r.& forall(t) if b exists_at t then c exists_at t & there exist spatial regions s and s’ where & b spatially_projects_onto s at t& c is occupies_spatial_region s’ at t& s is a proper_continuant_part_of s’ at t
- occurs_in
- unfolds in
- unfolds_in
- Paraphrase of definition: a relation between a process and an independent continuant, in which the process takes place entirely within the independent continuant
-
- occurs in
-
-
-
-
-
-
-
- site of
- [copied from inverse property 'occurs in'] b occurs_in c =def b is a process and c is a material entity or immaterial entity& there exists a spatiotemporal region r and b occupies_spatiotemporal_region r.& forall(t) if b exists_at t then c exists_at t & there exist spatial regions s and s’ where & b spatially_projects_onto s at t& c is occupies_spatial_region s’ at t& s is a proper_continuant_part_of s’ at t
- Paraphrase of definition: a relation between an independent continuant and a process, in which the process takes place entirely within the independent continuant
-
- contains process
-
-
-
-
@@ -1350,13 +1322,13 @@ Some currently missing phenomena that should be considered "about" are
-
+
This is redundant with the more specific 'independent and not spatial region' constraint. We leave in the redundant axiom for use with reasoners that do not use negation.
-
+
This is redundant with the more specific 'independent and not spatial region' constraint. We leave in the redundant axiom for use with reasoners that do not use negation.
@@ -1380,26 +1352,18 @@ Some currently missing phenomena that should be considered "about" are
-
+
-
+
- An object property that defines a relation between a vaccine and its component
- Asiyah Yu Lin
- Oliver He
- has vaccine component
-
-
-
-
-
-
-
- An object property that specifies a vaccine antigen
- This relation only works for those vaccine antigen that is physically part of a vaccine preparation. It does not include those antigens that are not part of vaccine. For example, a protein antigen expressed in a DNA vaccine is not a part of vaccine pe ser. In this case, the vaccine expresses the protein, but the gene is part of the vaccine, not the protein. For the case, we can use the relation 'DNA vaccine expresses protein antigen' under the relation 'expresses'.
- Asiyah Yu Lin
+
+ A shortcut relation that is equivalent to:
+('vaccine') and ('has component' some ('vaccine organism' and 'has quality' some 'organismal quality').
+The domain of this relation is a vaccine.
+The range of this relation is a organismal quality.
+ Jie Zheng
Oliver He
- has vaccine antigen
+ has vaccine organism with quality
@@ -1407,7 +1371,6 @@ Some currently missing phenomena that should be considered "about" are
-
A type of 'has vaccine antigen' relation that is specifically for vaccine protective protein antigen used in subunit vaccine development
Asiyah Yu Lin
Oliver He
@@ -1416,19 +1379,6 @@ Some currently missing phenomena that should be considered "about" are
-
-
-
-
-
- A type of 'has vaccine component' relation that is specifically for vaccine vector component
- Asiyah Yu Lin
- Oliver He
- has vaccine vector
-
-
-
-
@@ -1533,6 +1483,22 @@ Ranges: organism and 'has role' some 'pathogen role'
+
+
+
+
+ A shortcut relation that is equivalent to:
+('vaccine' and 'has function' some ('vaccine function' and ('is realized by' some ('vaccine immunization' and 'has participant' some ('organism' and 'has role' some 'laboratory animal model role'))))).
+The domain of this relation is a vaccine.
+The range of this relation is a organism.
+ Jie Zheng
+ Oliver He
+ test in laboratory model
+
+
+
+
@@ -3733,6 +3699,22 @@ Request that IAO either clarify these or change definitions not to use them
+
+
+
+
+
+ NCBITaxon:85055
+ GC_ID:1
+ house mouse
+ mouse
+ ncbi_taxonomy
+ Mus musculus
+
+
+
+
@@ -4573,7 +4555,6 @@ Request that IAO either clarify these or change definitions not to use them
- NCBITaxon:31968
GC_ID:11
PMID:10555317
PMID:11034484
@@ -4589,10 +4570,6 @@ Request that IAO either clarify these or change definitions not to use themBacillota corrig. Gibbons and Murray 2021
Bacillus/Clostridium group
Clostridium group firmicutes
- Firmacutes
- Firmicuteota
- Firmicutes
- Firmicutes corrig. Gibbons and Murray 1978 (Approved Lists 1980)
Low G+C firmicutes
clostridial firmicutes
firmicutes
@@ -5034,12 +5011,21 @@ Request that IAO either clarify these or change definitions not to use them
-
+
+ NCBITaxon:31968
+ NCBITaxon:3376104
GC_ID:11
PMID:18988685
PMID:23851394
+ Terrabacteria group
ncbi_taxonomy
- Terrabacteria group
+ Firmacutes
+ Firmicuteota
+ Firmicutes
+ Firmicutes corrig. Gibbons and Murray 1978 (Approved Lists 1980)
+ Terrabacteria
+ Terrabacterida
+ Bacillati
@@ -5486,6 +5472,7 @@ Request that IAO either clarify these or change definitions not to use them
GC_ID:1
+ Tombus-Noda-like virus sp.
ncbi_taxonomy
Kitrinoviricota
@@ -5734,6 +5721,23 @@ Request that IAO either clarify these or change definitions not to use them
+
+
+
+
+
+ GC_ID:1
+ PMID:11214319
+ PMID:12082125
+ PMID:15522813
+ Rodents and rabbits
+ ncbi_taxonomy
+ Glires
+
+
+
+
@@ -5870,6 +5874,20 @@ Request that IAO either clarify these or change definitions not to use them
+
+
+
+
+
+ NCBITaxon:109679
+ GC_ID:1
+ ncbi_taxonomy
+ Murinae
+
+
+
+
@@ -6562,6 +6580,21 @@ Request that IAO either clarify these or change definitions not to use them
+
+
+
+
+
+ GC_ID:1
+ rodent
+ ncbi_taxonomy
+ rodents
+ Rodentia
+
+
+
+
@@ -7617,9 +7650,9 @@ https://sourceforge.net/p/obi/obi-terms/738/
Melanie Courtot
Oliver He
Ronak Sutariya
+ MeSH: D014612
vaccine
vaccine
- MeSH: D014612
@@ -7747,32 +7780,38 @@ https://sourceforge.net/p/obi/obi-terms/738/
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -7813,10 +7852,11 @@ https://sourceforge.net/p/obi/obi-terms/738/
Kallan Roan
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=96
http://purl.bioontology.org/ontology/RXNORM/833083
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm180810.htm
+ 96
ACAM2000
- Smallpox (Vaccinia) Vaccine, Live
Active immunization against smallpox disease for persons determined to be at high risk for smallpox infection.
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM142572.pdf
BL 125158
@@ -7842,48 +7882,55 @@ https://sourceforge.net/p/obi/obi-terms/738/
+
-
-
+
+
-
-
+
+
-
-
+
+
-
+
-
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -7920,16 +7967,17 @@ https://sourceforge.net/p/obi/obi-terms/738/
Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&keywords=
Kallan Roan
Oliver He
+ PMID:1517908
+ PMID:1735812
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm174743.htm
+ 157
ActHIB
- Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)
ActHIB vaccine is indicated for the active immunization of infants and children 2 months through 5 years of age for the prevention of invasive disease caused by H influenzae type b.
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM109841.pdf
103935
vaccine
ActHIB vaccine
- PMID:1517908
- PMID:1735812
@@ -7950,79 +7998,86 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -8081,10 +8136,15 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
Kallan Roan
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=371
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=383
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=774
http://purl.bioontology.org/ontology/RXNORM/605718
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm172481.htm
+ 371
+ 383
+ 774
Adacel
- Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed
Booster immunization against tetanus, diphtheria and pertussis as a single dose in individuals 10 through 64 years of age.
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM142764.pdf
BL 125111
@@ -8109,31 +8169,33 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
+
+
-
-
+
+
-
-
+
+
-
+
-
-
+
+
@@ -8148,6 +8210,12 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
+
+
+
+
+
+
@@ -8192,10 +8260,11 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
Kallan Roan
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=325
WEB: http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/appendices/B/excipient-table-2.pdf
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094043.htm
+ 325
AFLURIA
- Influenza Virus Vaccine
For active immunization of persons ages 6 months of age and older against influenza disease caused by influenza virus subtypes A and type B present in the vaccine.
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM263239.pdf
BL 125254
@@ -8220,12 +8289,13 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
+
-
-
+
+
@@ -8234,6 +8304,12 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
+
+
+
+
+
+
@@ -8253,9 +8329,9 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
Oliver He
+ Attenuvax
vaccine
Product Name: Measles Virus Vaccine, Live
- Trade Name: Attenuvax
Attenuvax vaccine
@@ -8291,9 +8367,9 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
A vaccine that protects against Bacillus anthrax that causes anthrax.
Oliver He
anthrax vaccine
+ MeSH: D022122
vaccine
Bacillus anthracis vaccine
- MeSH: D022122
@@ -8313,35 +8389,43 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -8382,10 +8466,11 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
Kallan Roan
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=15
http://purl.bioontology.org/ontology/RXNORM/404894
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm133822.htm
+ 15
Biothrax
- Anthrax Vaccine Adsorbed
For the active immunization for the prevention of disease caused by Bacillus anthracis in persons between 18 and 65 years of age at high risk of exposure.
https://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/UCM074923.pdf
BL 103821
@@ -8411,73 +8496,80 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -8536,10 +8628,15 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
Kallan Roan
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=372
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=385
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=772
http://purl.bioontology.org/ontology/RXNORM/583411
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm172925.htm
+ 372
+ 385
+ 772
Boostrix
- Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed
Booster immunization against tetanus, diphtheria and pertussis as a single dose in individuals 10 years of age and older.
https://www.fda.gov/downloads/BiologicsBloodVaccines/UCM152842.pdf
BL 125106
@@ -8564,31 +8661,38 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -8610,10 +8714,14 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3180
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=368
http://purl.bioontology.org/ontology/RXNORM/139056
+ 3180
+ 368
+ Comvax
vaccine
Product Name: Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) & Hepatitis B Vaccine (Recombinant)
- Trade Name: Comvax
Comvax vaccine
@@ -8635,78 +8743,85 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -8766,10 +8881,15 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
Vaccine components see http://www.vaccinesafety.edu/components-DTaP.htm
Kallan Roan
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=356
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=363
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=775
http://purl.bioontology.org/ontology/RXNORM/352572
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM241874.pdf
+ 356
+ 363
+ 775
DAPTACEL
- Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed
Indicated for active immunization against diphtheria, tetanus and pertussis as a five dose series in infants and children 6 weeks through 6 years of age (prior to 7th birthday).
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM103037.pdf
103666
@@ -8794,9 +8914,16 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
+
+
+
+
+
+
+
@@ -8822,9 +8949,13 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=369
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=386
+ 369
+ 386
+ DECAVAC
vaccine
Product Name: Tetanus & Diphtheria Toxoids Adsorbed for Adult Use
- Trade Name: DECAVAC
Decavac vaccine
@@ -8846,55 +8977,65 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
+
+
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -8942,10 +9083,13 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
A vaccine for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type b. MENHIBRIX is approved for use in children 6 weeks of age through 18 months of age.
Kallan Roan
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3832
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3833
http://purl.bioontology.org/ontology/RXNORM/1437912
https://www.fda.gov/biologicsbloodvaccines/vaccines/approvedproducts/ucm308566.htm
+ 3832
+ 3833
MenHibrix
- Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine
Indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type b for children 6 weeks of age through 18 months of age.
BL 125363/0
vaccine
@@ -9001,6 +9145,12 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
+
+
+
+
+
+
@@ -9025,13 +9175,13 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
- a vaccinia virus vaccine that is a freeze-dried calf lymph smallpox vaccine, specifically, Dryvax is a live-virus preparation of vaccinia prepared from calf lymph.
+ A vaccinia virus vaccine that is a freeze-dried calf lymph smallpox vaccine, specifically, Dryvax is a live-virus preparation of vaccinia prepared from calf lymph.
Dryvax is a freeze-dried calf lymph smallpox vaccine. It is the world's oldest smallpox vaccine, created in the late 19th century by American Home Products, a predecessor of Wyeth. By the 1940s, Wyeth was the leading US manufacturer of the vaccine and the only manufacturer by the 1960s. After world health authorities declared smallpox had been eradicated from nature in 1980, Wyeth stopped making the vaccine.
Oliver He
http://en.wikipedia.org/wiki/Dryvax
+ Dryvax
vaccine
Product Name: Smallpox Vaccine, Dried, Calf Lymph Type
- Trade Name: Dryvax
Dryvax vaccine
@@ -9060,31 +9210,33 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
+
+
-
-
+
+
-
-
+
+
-
+
-
-
+
+
@@ -9093,6 +9245,12 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
+
+
+
+
+
+
@@ -9125,9 +9283,10 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
Kallan Roan
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=327
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm112845.htm
+ 327
FluLaval
- Influenza Virus Vaccine
Active immunization for the prevention of disease caused by influenza A subtype viruses and type B virus contained in the vaccine. FLULAVAL is approved for use in persons 6 months of age and older.
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM112904.pdf
BL 125163
@@ -9142,14 +9301,16 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
+
+
-
-
+
+
@@ -9170,6 +9331,12 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
+
+
+
+
+
+
@@ -9220,10 +9387,11 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
Kallan Roan
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=328
WEB: http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/appendices/B/excipient-table-2.pdf
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094047.htm
+ 328
FluMist
- Influenza Vaccine Live, Intranasal
For the active immunization of individuals 2-49 years of age against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine.
BL 125020
vaccine
@@ -9247,31 +9415,39 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
+
+
-
-
+
+
-
-
+
+
-
+
-
-
+
+
+
+
+
+
+
+
@@ -9312,9 +9488,10 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
Kallan Roan
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=326
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm112850.htm
+ 326
Fluarix
- Influenza Virus Vaccine
For active immunization of persons 3 years of age and older for the prevention of disease caused by influenza virus subtypes A and type B contained in the vaccine.
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM335392.pdf
BL 125127
@@ -9328,31 +9505,33 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
+
+
-
-
+
+
-
-
+
+
-
+
-
-
+
+
@@ -9361,6 +9540,12 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
+
+
+
+
+
+
@@ -9399,9 +9584,10 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
Kallan Roan
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=329
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm112852.htm
+ 329
Fluvirin
- Influenza Virus Vaccine
For active immunization of persons 4 years of age and older against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine.
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM123694.pdf
BL 103837
@@ -9416,31 +9602,33 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
+
+
-
-
+
+
-
-
+
+
-
+
-
-
+
+
@@ -9449,6 +9637,12 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
+
+
+
+
+
+
@@ -9481,9 +9675,10 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
Kallan Roan
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=330
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm112854.htm
+ 330
Fluzone
- Influenza Virus Vaccine
Fluzone is indicated for active immunization of persons 6 months of age and older against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine.
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM619664.pdf
BL 103914
@@ -9509,67 +9704,75 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -9602,15 +9805,16 @@ Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&
- Gardasil is a quadrivalent vaccine meaning it protects against 4 strains of virus (types 6, 11, 16, and 18). The vaccine was made using genetic engineering techniques. The genes that encode a specific protein from each of these strains are expressed in yeast in large-scale fermentation cultures. Protein purification methods are then used to isolate the proteins and make the vaccine.
+ Quadrivalent vaccine meaning it protects against 4 strains of virus (types 6, 11, 16, and 18). The vaccine was made using genetic engineering techniques. The genes that encode a specific protein from each of these strains are expressed in yeast in large-scale fermentation cultures. Protein purification methods are then used to isolate the proteins and make the vaccine.
Cited from:
-http://biotech.about.com/b/2008/09/03/gardasil-safety-of-genetically-engineered-hpv-vaccine-still-in-question.htm
+http://biotech.about.com/b/2008/09/03/gardasil-safety-of-genetically-engineered-hpv-vaccine-still-in-question.htm
Kallan Roan
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=337
http://purl.bioontology.org/ontology/RXNORM/659877
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094042.htm
+ 337
Gardasil
- Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant
- Prevention of vulvar and vaginal cancer
- Vaccination in females 9 through 26 years of age for prevention of the following diseases caused by Human Papillomavirus (HPV) Types 6, 11, 16, and 18:
- Cervical Cancer
@@ -9645,8 +9849,15 @@ http://biotech.about.com/b/2008/09/03/gardasil-safety-of-genetically-engineered-
+
+
+
+
+
+
+
@@ -9691,8 +9902,9 @@ http://biotech.about.com/b/2008/09/03/gardasil-safety-of-genetically-engineered-
OHDSI Vaccine WG
Havrix
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=320
+ 320
HAVRIX
- Hepatitis A Vaccine
HAVRIX is indicated for active immunization against disease caused by hepatitis A virus (HAV). HAVRIX is approved for use in persons 12 months of age and older. Primary immunization should be administered at least 2 weeks prior to expected exposure to HAV.
https://www.fda.gov/media/119388/download?attachment
BL 103475
@@ -9726,9 +9938,9 @@ http://biotech.about.com/b/2008/09/03/gardasil-safety-of-genetically-engineered-
A bacterial vaccine that prevents Neisseria meningitidis infection.
Oliver He
Meningococcal vaccine
+ MeSH: D022401
vaccine
Neisseria meningitidis vaccine
- MeSH: D022401
@@ -9748,55 +9960,62 @@ http://biotech.about.com/b/2008/09/03/gardasil-safety-of-genetically-engineered-
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
+
+
+
+
+
+
+
-
-
+
+
-
-
+
+
@@ -9832,10 +10051,11 @@ http://biotech.about.com/b/2008/09/03/gardasil-safety-of-genetically-engineered-
IPOL, Poliovirus Vaccine Inactivated is a sterile suspension of three types of poliovirus: Type 1 (Mahoney), Type 2 (MEF-1), and Type 3 (Saukett). IPOL vaccine is a highly purified, inactivated poliovirus vaccine with enhanced potency.
Kallan Roan
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=338
http://purl.bioontology.org/ontology/RXNORM/287617
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm180053.htm
+ 338
IPOL
- Poliovirus Vaccine Inactivated (Monkey Kidney Cell)
IPOL vaccine is indicated for active immunization of infants (as young as 6 weeks of age), children and adults for the prevention of poliomyelitis caused by poliovirus Types 1, 2, and 3.
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM133479.pdf
103930
@@ -9861,85 +10081,92 @@ http://biotech.about.com/b/2008/09/03/gardasil-safety-of-genetically-engineered-
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -9998,10 +10225,15 @@ http://biotech.about.com/b/2008/09/03/gardasil-safety-of-genetically-engineered-
Kallan Roan
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=355
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=361
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=776
http://purl.bioontology.org/ontology/RXNORM/224903
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm101568.htm
+ 355
+ 361
+ 776
INFANRIX
- Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed
For active immunization against diphtheria, tetanus, and pertussis as a 5-dose series in infants and children 6 weeks to 7 years of age.
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM124514.pdf
BL 103647
@@ -10026,19 +10258,14 @@ http://biotech.about.com/b/2008/09/03/gardasil-safety-of-genetically-engineered-
+
-
-
-
-
-
-
-
-
+
+
@@ -10059,6 +10286,18 @@ http://biotech.about.com/b/2008/09/03/gardasil-safety-of-genetically-engineered-
+
+
+
+
+
+
+
+
+
+
+
+
@@ -10094,7 +10333,6 @@ http://biotech.about.com/b/2008/09/03/gardasil-safety-of-genetically-engineered-
Oliver He
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm179149.htm
JE-Vax
- Japanese Encephalitis Virus Vaccine Inactivated
Indicated for Active Immunization against JE for persons one year age and older.
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM123761.pdf
vaccine
@@ -10118,6 +10356,7 @@ http://biotech.about.com/b/2008/09/03/gardasil-safety-of-genetically-engineered-
+
@@ -10129,98 +10368,104 @@ http://biotech.about.com/b/2008/09/03/gardasil-safety-of-genetically-engineered-
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -10290,10 +10535,17 @@ http://biotech.about.com/b/2008/09/03/gardasil-safety-of-genetically-engineered-
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=358
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=365
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5551
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5581
http://purl.bioontology.org/ontology/RXNORM/801721
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm172495.htm
+ 358
+ 365
+ 5551
+ 5581
KINRIX
- Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine
Active immunization against diphtheria, tetanus, pertussis, and poliomyelitis as the fifth dose in the diphtheria, tetanus, and acellular pertussis (DTaP) vaccine series and the fourth dose in the inactivated poliovirus vaccine (IPV) series in children 4 through 6 years of age whose previous DTaP vaccine doses have been with INFANRIX(R) and/or PEDIARIX(R) for the first three doses and INFANRIX(R) for the fourth dose.
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM241453.pdf
BL 125260
@@ -10320,55 +10572,62 @@ http://biotech.about.com/b/2008/09/03/gardasil-safety-of-genetically-engineered-
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -10429,9 +10688,14 @@ http://biotech.about.com/b/2008/09/03/gardasil-safety-of-genetically-engineered-
Kallan Roan
Oliver He
MMR II
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=374
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=375
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=601
https://www.fda.gov/biologicsbloodvaccines/vaccines/approvedproducts/ucm094050.htm
+ 374
+ 375
+ 601
M-M-R II
- Measles, Mumps, and Rubella Virus Vaccine, Live
M-M-R II is indicated for simultaneous vaccination against measles, mumps, and rubella in individuals 12 months of age or older.For active immunization against invasive meningococcal disease caused by Neisseria meningiditis serogroups A, C, Y, and W-135. Menomune – A/C/Y/W-135 vaccine is approved for use in persons 2 years of age and older.
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM123789.pdf
BL 101069
@@ -10456,60 +10720,64 @@ http://biotech.about.com/b/2008/09/03/gardasil-safety-of-genetically-engineered-
+
+
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
@@ -10518,6 +10786,12 @@ http://biotech.about.com/b/2008/09/03/gardasil-safety-of-genetically-engineered-
+
+
+
+
+
+
@@ -10545,9 +10819,10 @@ http://biotech.about.com/b/2008/09/03/gardasil-safety-of-genetically-engineered-
Kallan Roan
Oliver He
Menomune A C Y W135
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=316
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm179991.htm
+ 316
Menomune-A/C/Y/W-135
- Meningococcal Polysaccharide Vaccine, Groups A, C, Y, W-135 Combined
For active immunization against invasive meningococcal disease caused by Neisseria meningiditis serogroups A, C, Y, and W-135. Menomune - A/C/Y/W-135 vaccine is approved for use in persons 2 years of age and older.
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM308370.pdf
BL 103926
@@ -10572,24 +10847,31 @@ http://biotech.about.com/b/2008/09/03/gardasil-safety-of-genetically-engineered-
+
-
-
+
+
-
+
+
+
+
+
+
+
-
-
+
+
@@ -10611,9 +10893,9 @@ http://biotech.about.com/b/2008/09/03/gardasil-safety-of-genetically-engineered-
Oliver He
+ Meruvax II
vaccine
Product Name: Rubella Virus Vaccine Live
- Trade Name: Meruvax II
Meruvax II vaccine
@@ -10634,7 +10916,14 @@ http://biotech.about.com/b/2008/09/03/gardasil-safety-of-genetically-engineered-
+
+
+
+
+
+
+
@@ -10660,9 +10949,9 @@ http://biotech.about.com/b/2008/09/03/gardasil-safety-of-genetically-engineered-
Oliver He
+ Mumpsvax
vaccine
Product Name: Mumps Virus Vaccine Live
- Trade Name: Mumpsvax
Mumpsvax vaccine
@@ -10674,26 +10963,32 @@ http://biotech.about.com/b/2008/09/03/gardasil-safety-of-genetically-engineered-
-
-
+
+
-
-
+
+
-
+
-
-
+
+
+
+
+
+
+
+
@@ -10729,10 +11024,10 @@ http://biotech.about.com/b/2008/09/03/gardasil-safety-of-genetically-engineered-
an influenza vaccine that is similar to Fluzone but has high dose.
Kallan Roan
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=754
WEB: http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM305079.pdf
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm112854.htm
- Fluzone High-Dose
- Influenza Virus Vaccine
+ 754
Fluzone High-Dose is indicated for active immunization of persons 65 years of age and older against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine.
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM619541.pdf
BL 103914
@@ -10758,6 +11053,7 @@ http://biotech.about.com/b/2008/09/03/gardasil-safety-of-genetically-engineered-
+
@@ -10769,98 +11065,104 @@ http://biotech.about.com/b/2008/09/03/gardasil-safety-of-genetically-engineered-
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -10943,10 +11245,19 @@ http://biotech.about.com/b/2008/09/03/gardasil-safety-of-genetically-engineered-
Kallan Roan
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=357
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=364
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=610
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=611
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=760
http://purl.bioontology.org/ontology/RXNORM/352877
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm146759.htm
+ 357
+ 364
+ 610
+ 611
+ 760
Pediarix
- Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined
For active immunization against diphtheria, tetanus, pertussis, infection caused by all known subtypes of hepatitis B virus, and poliomyelitis. PEDIARIX is approved for use as a three-dose series in infants born of hepatitis B surface antigen (HBsAg)-negative mothers. PEDIARIX may be given as early as 6 weeks of age through 6 years of age (prior to the 7th birthday).
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM241874.pdf
BL 103907
@@ -10972,17 +11283,12 @@ http://biotech.about.com/b/2008/09/03/gardasil-safety-of-genetically-engineered-
+
-
-
-
-
-
-
-
-
+
+
@@ -11003,6 +11309,18 @@ http://biotech.about.com/b/2008/09/03/gardasil-safety-of-genetically-engineered-
+
+
+
+
+
+
+
+
+
+
+
+
@@ -11037,15 +11355,16 @@ http://biotech.about.com/b/2008/09/03/gardasil-safety-of-genetically-engineered-
influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an outer membrane protein complex (OMPC) of the B11 strain of Neisseria meningitidis serogroup B.
Kallan Roan
Oliver He
+ PMID:2791073
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=161
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm253644.htm
+ 161
Liquid PedvaxHIB
- Haemophilus B Conjugate Vaccine (Meningococcal Protein Conjugate)
Liquid PedvaxHIB is indicated for routine vaccination against invasive disease caused by Haemophilus influenzae type b in infants and children 2 to 71 months of age.
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM253652.pdf
BL 103237/5285
vaccine
PedvaxHIB vaccine
- PMID:2791073
@@ -11070,98 +11389,104 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -11244,10 +11569,19 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
Kallan Roan
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=359
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=367
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=613
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=614
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=765
http://purl.bioontology.org/ontology/RXNORM/674453
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm172502.htm
+ 359
+ 367
+ 613
+ 614
+ 765
Pentacel
- Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine
For active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease caused by Haemophilus influenzae type b when administered to infants and children 6 weeks through 4 years of age (prior to fifth birthday).
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM109810.pdf
125145
@@ -11273,172 +11607,179 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
+
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
-
+
-
+
-
+
-
+
-
+
-
+
-
+
-
+
-
+
-
+
-
+
-
+
-
+
-
+
-
+
-
+
-
+
-
+
-
+
-
+
-
+
-
+
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+
+
@@ -11473,9 +11814,10 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
Kallan Roan
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=317
https://www.fda.gov/biologicsbloodvaccines/vaccines/approvedproducts/ucm179996.htm
+ 317
Pneumovax 23
- Pneumococcal Vaccine, Polyvalent
PNEUMOVAX 23 is indicated for active immunization against pneumococcal disease caused by those pneumococcal types included in the vaccine in persons 50 years of age or older and persons greater than or equal to 2 years of age who are at increased risk for pneumococcal disease.
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM257088.pdf
BLA 101094
@@ -11503,16 +11845,11 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
+
-
-
-
-
-
-
-
-
+
+
@@ -11539,6 +11876,18 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
+
+
+
+
+
+
+
+
+
+
+
+
@@ -11570,10 +11919,11 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=318
https://www.fda.gov/biologicsbloodvaccines/vaccines/approvedproducts/ucm180017.htm
https://www.prevnar13.com/
+ 318
Prevnar
- Pneumococcal 7-valent Conjugate Vaccine (Diphtheria CRM197 Protein)
- Immunization of infants 2, 4, 6 and 12-15 months of age to prevent invasive pneumococcal disease.
- Immunization of infants and toddlers against otitis media caused by vaccine serotypes.
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM137038.pdf
@@ -11581,7 +11931,6 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
Product Name: Pneumococcal 7-valent Conjugate Vaccine (Diphtheria CRM197 Protein)
STN: BLA 101094
Prevnar vaccine
- VIOLIN Vaccine ID: 1114
@@ -11601,47 +11950,54 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -11725,10 +12081,17 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
A Measles-Mumps-Rubella-Vericella vaccine that is live and manufactured by Merck & Co, Inc.
Kallan Roan
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=376
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=377
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=378
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=379
WEB: http://www.merck.com/product/usa/pi_circulars/p/proquad/proquad_pi.pdf
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm188806.htm
+ 376
+ 377
+ 378
+ 379
PROQUAD
- Measles, Mumps, Rubella and Varicella Virus Vaccine Live
For vaccination against measles, mumps, rubella, and varicella in children 12 months to 12 years of age.
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM123793.pdf
125108
@@ -11753,12 +12116,13 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
+
-
-
+
+
@@ -11779,6 +12143,12 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
+
+
+
+
+
+
@@ -11818,11 +12188,12 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
RabAvert Rabies Vaccine is a sterile, freeze-dried vaccine obtained by growing the fixed-virus strain Flury Low Egg Passage (LEP) in primary cultures of chicken fibroblasts.
Kallan Roan
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6181
WEB: http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/appendices/B/excipient-table-2.pdf
http://purl.bioontology.org/ontology/RXNORM/219579
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm133517.htm
+ 6181
RabAvert
- Rabies Vaccine
Pre-exposure and post-exposure immunization of children and adults
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM312931.pdf
BL 103334
@@ -11837,29 +12208,36 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
+
-
-
+
+
-
-
+
+
-
+
-
-
+
+
+
+
+
+
+
+
@@ -11889,8 +12267,9 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
Kallan Roan
Oliver He
Samantha G. Sayers
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3116
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm247508.htm
- Adenovirus Type 4 and Type 7 Vaccine, Live, Oral
+ 3116
Indicated for active immunization for the prevention of febrile acute respiratory disease caused by Adenovirus Type 4 and Type 7.
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM247515.pdf
BL 125296/0
@@ -11898,10 +12277,10 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
40213264
Adenovirus, type 4 and type 7, live, oral
Adenovirus types 4 and 7
+ SNOMEDCT: 442561000
+ UMLS_CUI: C0695130
vaccine
Adenovirus Type 4 and Type 7 Vaccine, Live, Oral
- SNOMEDCT: 442561000
- UMLS_CUI: C0695130
@@ -11921,67 +12300,75 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -12016,10 +12403,11 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
Kallan Roan
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=344
http://purl.bioontology.org/ontology/RXNORM/496892
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094063.htm
+ 344
RotaTeq
- Rotavirus Vaccine, Live, Oral, Pentavalent
For prevention of rotavirus gastroenteritis in infants 6 weeks to 32 weeks of age caused by types G1, G2, G3, G4, and G9.
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM142288.pdf
BL 125122
@@ -12044,21 +12432,17 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
+
+
-
-
-
-
-
-
-
-
+
+
@@ -12085,6 +12469,18 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
+
+
+
+
+
+
+
+
+
+
+
+
@@ -12130,9 +12526,12 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
Kallan Roan
Oliver He
Tenivac
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=370
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=384
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm152800.htm
+ 370
+ 384
TENIVAC
- Tetanus and Diphtheria Toxoids Adsorbed For Adult Use
Indicated for active immunization for the prevention of tetanus and diphtheria in persons 7 years of age and older.
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM152826.pdf
103171
@@ -12157,19 +12556,14 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
+
-
-
-
-
-
-
-
-
+
+
@@ -12190,6 +12584,18 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
+
+
+
+
+
+
+
+
+
+
+
+
@@ -12223,10 +12629,11 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
Typhim Vi, Typhoid Vi Polysaccharide Vaccine, for intramuscular use, is a sterile solution containing the cell surface Vi polysaccharide extracted from Salmonella enterica serovar Typhi, S typhi Ty2 strain.
Kallan Roan
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=352
http://purl.bioontology.org/ontology/RXNORM/114883
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094072.htm
+ 352
Typhim Vi
- Typhoid Vi Polysaccharide Vaccine
For active immunization against typhoid fever for persons two years of age or older.
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM142811.pdf
103936
@@ -12255,20 +12662,26 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
-
-
+
+
-
+
+
+
+
+
+
+
-
-
+
+
@@ -12290,9 +12703,15 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=354
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=366
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=777
+ 354
+ 366
+ 777
+ Tripedia
vaccine
Product Name: Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed
- Trade Name: Tripedia
Tripedia vaccine
@@ -12313,7 +12732,9 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
+
+
@@ -12322,14 +12743,8 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
-
-
-
-
-
-
-
-
+
+
@@ -12362,6 +12777,18 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
+
+
+
+
+
+
+
+
+
+
+
+
@@ -12406,9 +12833,12 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
Kallan Roan
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=349
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=350
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094035.htm
+ 349
+ 350
Twinrix
- Hepatitis A Inactivated & Hepatitis B (Recombinant) Vaccine
Active immunization of persons 18 years of age or older against disease caused by hepatitis A virus and infection by all known subtypes of hepatitis B virus.
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM110079.pdf
BL 103850
@@ -12434,16 +12864,12 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
+
+
-
-
-
-
-
-
-
-
+
+
@@ -12464,6 +12890,18 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
+
+
+
+
+
+
+
+
+
+
+
+
@@ -12508,9 +12946,9 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
Kallan Roan
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=347
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094073.htm
- Varicella Virus Vaccine Live
- Varivax
+ 347
Indicated for active immunization for the prevention of varicella in individuals 12 months of age and older
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM142812.pdf
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM142813.pdf
@@ -12553,7 +12991,6 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
yellow fever vaccine
vaccine
yellow fever virus vaccine
- MeSH: D022341
@@ -12574,16 +13011,12 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
+
+
-
-
-
-
-
-
-
-
+
+
@@ -12604,6 +13037,18 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
+
+
+
+
+
+
+
+
+
+
+
+
@@ -12648,9 +13093,10 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
Kallan Roan
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=348
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm136941.htm
+ 348
Zostavax
- Zoster Vaccine, Live
For prevention of herpes zoster (shingles) in individuals 50 years of age and older.
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM132831.pdf
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM285015.pdf
@@ -12661,6 +13107,35 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ a vaccine organism that is live and attenuated
+ Oliver He
+ organism
+ live attenuated vaccine organism
+
+
+
+
@@ -12689,8 +13164,8 @@ influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an ou
-
- a vaccine component role that inheres in a recombinant vaccine vector as a vaccine component. The combination of a recombinant vaccine vector and a heterogenous protective antigen(s) inserted inside the vector for a recombinant vector vaccine.
+
+ A vaccine vector role that inheres in a recombinant vaccine vector as a vaccine component. The combination of a recombinant vaccine vector and a heterogenous protective antigen(s) inserted inside the vector for a recombinant vector vaccine.
Asiyah Yu Lin
Oliver He
role
@@ -12772,9 +13247,9 @@ An adjuvant is a substance that helps and enhances the pharmacological effect of
A vaccine that targets against a bacterial disease.
Oliver He
+ MeSH: D001428
vaccine
bacterial vaccine
- MeSH: D001428
@@ -12812,6 +13287,12 @@ An adjuvant is a substance that helps and enhances the pharmacological effect of
+
+
+
+
+
+
Vaccine that prevents or treats cancer.
Anna Maria Masci
Barry Smith
@@ -12944,6 +13425,18 @@ An adjuvant is a substance that helps and enhances the pharmacological effect of
+
+
+
+
+ A vaccine role that is not licensed or in clinical trial; instead, it has been experimently approved to induce protection or treatment effect in vivo in at least an experimental animal model.
+ Oliver He
+ role
+ vaccine in research role
+
+
+
+
@@ -13044,7 +13537,6 @@ http://sourceforge.net/tracker/?func=detail&aid=2873643&group_id=76834&a
HIV
vaccine
human immunodeficiency virus vaccine
- MeSH: D016915
@@ -13102,7 +13594,7 @@ http://sourceforge.net/tracker/?func=detail&aid=2873643&group_id=76834&a
-
+
@@ -13111,7 +13603,7 @@ http://sourceforge.net/tracker/?func=detail&aid=2873643&group_id=76834&a
-
+
@@ -13243,7 +13735,7 @@ http://sourceforge.net/tracker/?func=detail&aid=2873643&group_id=76834&a
-
+
@@ -13252,7 +13744,7 @@ http://sourceforge.net/tracker/?func=detail&aid=2873643&group_id=76834&a
-
+
@@ -13265,6 +13757,38 @@ http://sourceforge.net/tracker/?func=detail&aid=2873643&group_id=76834&a
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ Allen Xiang
+ Asiyah Yu Lin
+ Oliver He
+ a vaccine organism that is inactived/killed
+ killed vaccine organism
+ organism
+ inactivated vaccine organism
+
+
+
+
@@ -13279,24 +13803,31 @@ http://sourceforge.net/tracker/?func=detail&aid=2873643&group_id=76834&a
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -13326,7 +13857,9 @@ http://sourceforge.net/tracker/?func=detail&aid=2873643&group_id=76834&a
Pandemrix is an influenza vaccine for influenza pandemics, such as the H1N1 2009 flu pandemic colloquially called the swine flu. The vaccine was developed by GlaxoSmithKline and patented in September 2006.
Asiyah Yu Lin
Pandemrix H1N1
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3957
http://en.wikipedia.org/wiki/Pandemrix
+ 3957
vaccine
ATC code:J07BB02
As well as the active antigen derived from A/California/7/2009 (H1N1), the vaccine contains an immunologic adjuvant AS03 which consists of DL-alpha-tocopherol (vitamin E), squalene and polysorbate 80. Thiomersal (thimerosal) is added as a preservative. Being manufactured in chicken eggs, it contains trace amounts of egg proteins. Additional important non-medicinal ingredients are formaldehyde, sodium deoxycholate, and sucrose. (http://en.wikipedia.org/wiki/Pandemrix)
@@ -13387,9 +13920,9 @@ http://sourceforge.net/tracker/?func=detail&aid=2873643&group_id=76834&a
Oliver He
parasite vaccine
parasitic vaccine
+ MeSH: D016052
vaccine
protozoan vaccine
- MeSH: D016052
@@ -13401,7 +13934,7 @@ http://sourceforge.net/tracker/?func=detail&aid=2873643&group_id=76834&a
-
+
@@ -13409,8 +13942,6 @@ http://sourceforge.net/tracker/?func=detail&aid=2873643&group_id=76834&a
Oliver He
vaccine
Varicella-zoster virus live vaccine
- SNOMEDCT: 412530002
- ULMS_CUI: C0770687
@@ -13482,24 +14013,31 @@ http://sourceforge.net/tracker/?func=detail&aid=2873643&group_id=76834&a
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -13528,24 +14066,31 @@ http://sourceforge.net/tracker/?func=detail&aid=2873643&group_id=76834&a
+
-
-
+
+
-
+
+
+
+
+
+
+
-
-
+
+
@@ -13586,8 +14131,6 @@ http://sourceforge.net/tracker/?func=detail&aid=2873643&group_id=76834&a
parainfluenza-3
vaccine
Parainfluenza 3 virus vaccine
- SNOMEDCT: 82867008
- UMLS_CUI: C0310756
@@ -13639,12 +14182,6 @@ http://sourceforge.net/tracker/?func=detail&aid=2873643&group_id=76834&a
-
-
-
-
-
-
a vaccine that is used for prevention against a disease.
Oliver He
vaccine
@@ -13717,14 +14254,14 @@ http://sourceforge.net/tracker/?func=detail&aid=2873643&group_id=76834&a
-
-
+
+
-
-
+
+
A vaccine that uses a modified virus or bacterium as the vector to deliver vaccine antigen(s) to the cells of the host body.
@@ -13751,12 +14288,13 @@ http://sourceforge.net/tracker/?func=detail&aid=2873643&group_id=76834&a
+
-
-
+
+
@@ -13765,6 +14303,12 @@ http://sourceforge.net/tracker/?func=detail&aid=2873643&group_id=76834&a
+
+
+
+
+
+
@@ -13778,8 +14322,6 @@ http://sourceforge.net/tracker/?func=detail&aid=2873643&group_id=76834&a
typhoid vaccine, live, oral
vaccine
typhoid live oral vaccine
- SNOMEDCT: 346696005
- UMLS_CUI: C0359940
@@ -13914,7 +14456,7 @@ http://sourceforge.net/tracker/?func=detail&aid=2873643&group_id=76834&a
-
+
@@ -13923,7 +14465,7 @@ http://sourceforge.net/tracker/?func=detail&aid=2873643&group_id=76834&a
-
+
an organism that is used as part of a vaccine
@@ -14027,16 +14569,41 @@ http://sourceforge.net/tracker/?func=detail&aid=2873643&group_id=76834&a
+ A vaccine that is used for treatment for a disease.
+ Oliver He
+ vaccine
+ therapeutic vaccine
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
-
-
+
+
- A vaccine that is used for treatment for a disease.
+ a vaccine that is designed to immunize against two or more strains of the same microorganism, or against two or more microorganisms.
+ Ningxian Fan
Oliver He
+ WEB: http://coastalcarolinaresearch.com/?p=679
vaccine
- therapeutic vaccine
+ multivalent vaccine
@@ -14232,6 +14799,52 @@ http://sourceforge.net/tracker/?func=detail&aid=2873643&group_id=76834&a
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ a multivalent vaccine that is designed to immunize against at least one bacterial disease and one viral disease.
+ Ningxian Fan
+ Oliver He
+ vaccine
+ multivalent vaccine against bacterial and viral diseases
+
+
+
+
@@ -14322,14 +14935,16 @@ http://sourceforge.net/tracker/?func=detail&aid=2873643&group_id=76834&a
-
+
+ Vaccine vector that is a genetically engineered virus or bacterium used to deliver genetic code into the cells within the body.
a vaccine component that uses a microbe (e.g., bacterium, virus, and parasitic organism) as a vector that is inserted with the DNA(s) of a heterologous protective antigen(s) to generate a "recombinant vector vaccine". The microorganism used as a vector generally has a stable non or low pathogenic phenotype for the species the vaccine is intended for.
+ Jie Zheng
Oliver He
recombinant vector
WEB: http://en.wikipedia.org/wiki/Vaccine
@@ -14383,9 +14998,9 @@ http://sourceforge.net/tracker/?func=detail&aid=2873643&group_id=76834&a
A vaccine that targets against a viral disease.
Oliver He
+ MeSH: D014765
vaccine
viral vaccine
- MeSH: D014765
@@ -14477,12 +15092,25 @@ http://sourceforge.net/tracker/?func=detail&aid=2873643&group_id=76834&a
-
+
+
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
@@ -14499,12 +15127,15 @@ http://sourceforge.net/tracker/?func=detail&aid=2873643&group_id=76834&a
A vaccine used to prevent infection by Haemophilus influenzae type b (Hib) bacteria. The vaccine works by causing your body to produce its own protection (antibodies) against the disease.
Oliver He
+ H. influenzae Type b capsular polysaccharide vaccine
Hib polysaccharide vaccine
+ PMID:335348
+ PMID:6387614
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=165
https://www.mayoclinic.org/drugs-supplements/haemophilus-b-polysaccharide-vaccine-intramuscular-route-injection-route/description/drg-20064142
+ 165
vaccine
- H. influenzae Type b capsular polysaccharide vaccine
- PMID:335348
- PMID:6387614
+ Haemophilus influenzae type b capsular polysaccharide vaccine
@@ -14630,6 +15261,46 @@ http://sourceforge.net/tracker/?func=detail&aid=2873643&group_id=76834&a
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ 2
+
+
+
+ Combination vaccine is a vaccine that induces protection against multiple infectious diseases or several different serotypes of the same organism. The anitgens contained in combination vaccines are either formulated together by the manufacturer or physically mixed by a health care provider just prior to administration. Both approaches require licensure.
+Ref: Baylor NW and Midthum K. Regulation and testing of vaccines. In: Vaccines (Editors: Plotkin S, Orenstein W, and Offit P). 2008. p1624.
+ Oliver He
+ combo vaccine
+ https://github.com/vaccineontology/VO/issues/621
+ MeSH: D017778
+ vaccine
+ combination vaccine
+
+
+
+
@@ -14653,9 +15324,6 @@ http://sourceforge.net/tracker/?func=detail&aid=2873643&group_id=76834&a
('unidentified influenza virus' or 'Influenzavirus A' or 'Influenzavirus B' or 'Influenzavirus C')
However, even this may not be comprehensive.
influenza virus vaccine
- MeSH: D007252
- SNOMEDCT: 46233009
- UMLS_CUI: C0021403
@@ -14687,7 +15355,6 @@ However, even this may not be comprehensive.
https://en.wikipedia.org/wiki/Hepatitis_B_vaccine
vaccine
Hepatitis B virus vaccine
- MeSH: D017325
@@ -14718,7 +15385,6 @@ However, even this may not be comprehensive.
hepatitis A vaccine
vaccine
Hepatitis A virus vaccine
- MeSH: D022362
@@ -14742,9 +15408,6 @@ However, even this may not be comprehensive.
plague
vaccine
Yersinia pestis vaccine
- MeSH: D010931
- SNOMEDCT: 11866009
- UMLS_CUI:C0032066
@@ -14781,9 +15444,6 @@ However, even this may not be comprehensive.
rabies vaccine
vaccine
Rabies virus vaccine
- MeSH: D011819
- SNOMEDCT: 333606008
- UMLS_CUI:C0034496
@@ -14821,7 +15481,6 @@ However, even this may not be comprehensive.
smallpox vaccine
vaccine
Smallpox virus vaccine
- MeSH: D012900
@@ -14852,7 +15511,6 @@ However, even this may not be comprehensive.
measles vaccine
vaccine
Measles virus vaccine
- MeSH: D008458
@@ -14889,7 +15547,6 @@ However, even this may not be comprehensive.
mumps vaccine
vaccine
Mumps virus vaccine
- MeSH: D009108
@@ -14925,9 +15582,6 @@ However, even this may not be comprehensive.
Oliver He
vaccine
Rotavirus vaccine
- MeSH: D022243
- SNOMEDCT: 116077000
- UMLS_CUI: C0597418
@@ -14961,10 +15615,12 @@ However, even this may not be comprehensive.
In most cases HibTITER was administered concomitantly with other vaccines including DTP, DTaP, hepatitis B vaccine, IPV, OPV, pneumococcal 7-valent conjugate vaccine, MMR, and/or meningococcal group C conjugate vaccine (not licensed in the US).
Oliver He
+ PMID:2057256
+ PMID:9353019
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=160
+ 160
vaccine
HIBTITER vaccine
- PMID:2057256
- PMID:9353019
@@ -14998,9 +15654,11 @@ However, even this may not be comprehensive.
Ref: http://www.rxlist.com/prohibit-drug.htm
Oliver He
+ PMID:2057256
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=162
+ 162
vaccine
ProHIBiT vaccine
- PMID:2057256
@@ -15029,9 +15687,9 @@ However, even this may not be comprehensive.
A bacterial vaccine that protects against infection with Haemophilus.
Oliver He
https://en.wikipedia.org/wiki/Haemophilus
+ MeSH: D018073
vaccine
Haemophilus vaccine
- MeSH: D018073
@@ -15080,10 +15738,12 @@ However, even this may not be comprehensive.
A live attenuated Shigella flexneri 2a vaccine that carries deletions of the plasmid-borne virulence gene icsA (mediating intra- and intercellular spread) and the chromosomal locus iuc (encoding aerobactin).
Oliver He
+ SC602
PMID:10377124
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=259
+ 259
vaccine
- SC602
- PMID:10377124
+ SC602 vaccine
@@ -15136,7 +15796,6 @@ However, even this may not be comprehensive.
polio vaccine
vaccine
Poliovirus vaccine
- MeSH: D023321
@@ -15173,7 +15832,6 @@ However, even this may not be comprehensive.
Japanese encephalitis vaccine
vaccine
Japanese encephalitis virus vaccine
- MeSH: D022321
@@ -15201,10 +15859,10 @@ However, even this may not be comprehensive.
a vaccine against human papillomavirus infection
Oliver He
+ SNOMEDCT: 424519000
+ UMLS_CUI: C1512511
vaccine
human papillomavirus vaccine
- SNOMEDCT: 424519000
- UMLS_CUI: C1512511
@@ -15227,8 +15885,6 @@ However, even this may not be comprehensive.
chickenpox and shingles virus vaccine
vaccine
Varicella-zoster virus vaccine
- SNOMEDCT: 108729007
- UMLS_CUI: C0078048
@@ -15336,7 +15992,7 @@ However, even this may not be comprehensive.
-
+
@@ -15346,7 +16002,7 @@ However, even this may not be comprehensive.
-
+
@@ -15434,7 +16090,6 @@ However, even this may not be comprehensive.
Dengue vaccine
vaccine
Dengue virus vaccine
- MeSH: D053059
@@ -15465,7 +16120,6 @@ However, even this may not be comprehensive.
Ebola vaccine
vaccine
Ebola virus vaccine
- MeSH: D046129
@@ -15484,7 +16138,6 @@ However, even this may not be comprehensive.
Oliver He
vaccine
Herpesvirus vaccine
- MeSH: D022283
@@ -15504,10 +16157,17 @@ However, even this may not be comprehensive.
+
+
+
+
+
+
+
@@ -15622,8 +16282,8 @@ However, even this may not be comprehensive.
-
-
+
+
@@ -15632,6 +16292,12 @@ However, even this may not be comprehensive.
+
+
+
+
+
+
@@ -15660,10 +16326,17 @@ However, even this may not be comprehensive.
+
+
+
+
+
+
+
@@ -15693,8 +16366,6 @@ However, even this may not be comprehensive.
DTP
vaccine
Diphtheria-Tetanus-Pertussis vaccine
- SNOMEDCT: 421245007
- UMLS_CUI: C0012559
@@ -15713,6 +16384,7 @@ However, even this may not be comprehensive.
+
@@ -15746,12 +16418,6 @@ However, even this may not be comprehensive.
-
-
-
-
-
-
@@ -15770,6 +16436,12 @@ However, even this may not be comprehensive.
+
+
+
+
+
+
@@ -15885,7 +16557,6 @@ However, even this may not be comprehensive.
parainfluenza vaccine
vaccine
Parainfluenza virus vaccine
- MeSH: D022241
@@ -15915,7 +16586,6 @@ However, even this may not be comprehensive.
Oliver He
vaccine
Respiratory syncytial virus vaccine
- MeSH: D022261
@@ -15926,9 +16596,9 @@ However, even this may not be comprehensive.
A vaccine that is used in conjunction with diagnostic tests to differentiate vaccinated animals from carrier animals. It can be a subunit or a gene-deleted vaccine.
Oliver He
+ MeSH: D022581
vaccine
marker vaccine
- MeSH: D022581
@@ -15956,9 +16626,9 @@ However, even this may not be comprehensive.
A vaccine that is edible and derived from an edible plant. The transgenic plant is used as recombinant protein production system. The edible plant tissue functions as an oral vaccine.
Oliver He
+ MeSH: D022462
vaccine
edible vaccine
- MeSH: D022462
@@ -16006,7 +16676,6 @@ However, even this may not be comprehensive.
malaria
vaccine
malaria vaccine
- MeSH: D017780
@@ -16041,7 +16710,6 @@ However, even this may not be comprehensive.
leishmaniasis
vaccine
Leishmania vaccine
- MeSH: D054332
@@ -16078,7 +16746,6 @@ However, even this may not be comprehensive.
cholera vaccine
vaccine
Vibrio cholerae vaccine
- MeSH: D022121
@@ -16100,9 +16767,9 @@ However, even this may not be comprehensive.
40213167
Lyme disease vaccine
Lyme disease
+ MeSH: D022123
vaccine
Lyme disease vaccine
- MeSH: D022123
@@ -16135,14 +16802,12 @@ However, even this may not be comprehensive.
A bacterial vaccine that prevents against Bordetella pertussis infection that causes pertussis or whooping cough.
+ Khadeejah Khan
Oliver He
+ Acellular Pertussis Vaccine
Pertussis vaccine
- 8080
- pertussis vaccine
- 19033193
vaccine
Bordetella pertussis vaccine
- MeSH: D010567
@@ -16171,9 +16836,9 @@ However, even this may not be comprehensive.
A bacterial vaccine that protects against infections by various Salmonella species.
Oliver He
https://en.wikipedia.org/wiki/Salmonella
+ MeSH: D022562
vaccine
Salmonella vaccine
- MeSH: D022562
@@ -16201,9 +16866,9 @@ However, even this may not be comprehensive.
A bacterial vaccine that protects against infections with Shigella species.
Oliver He
+ MeSH: D022281
vaccine
Shigella vaccine
- MeSH: D022281
@@ -16233,9 +16898,9 @@ However, even this may not be comprehensive.
Oliver He
Staph vaccine
Staphylococcus vaccine
+ MeSH: D013209
vaccine
Staphylococcal vaccine
- MeSH: D013209
@@ -16265,9 +16930,9 @@ However, even this may not be comprehensive.
Oliver He
Streptococcus vaccine
https://en.wikipedia.org/wiki/Streptococcus
+ MeSH: D022541
vaccine
Streptococcal vaccine
- MeSH: D022541
@@ -16317,7 +16982,7 @@ However, even this may not be comprehensive.
- a vaccine component that is added to the immunogen by the vaccine manufacturer for a specific purpose. Additives include adjuvants, preservatives and stablizers, as well as materials that are added to affect pH and isotonicity.
+ Vaccine component that is added to the immunogen by the vaccine manufacturer for a specific purpose. Additives include adjuvants, preservatives and stablizers, as well as materials that are added to affect pH and isotonicity.
Oliver He
Finn TM and Egan W, in Vaccines fifth edition, 2008. Page 73.
vaccine component
@@ -16347,7 +17012,7 @@ However, even this may not be comprehensive.
- vaccine preservative is an vaccine additive that is added to a vaccine formulation to prevent the growth of bacteria or fungi that inadvertently may be introduced into the vaccine during use.
+ Vaccine additive that is added to a vaccine formulation to prevent the growth of bacteria or fungi that inadvertently may be introduced into the vaccine during use.
Ref: Finn TM and Egan W, in Vaccines fifth edition, 2008. Page 73.
Oliver He
antimicrobial agent in vaccine
@@ -16378,7 +17043,7 @@ Ref: Finn TM and Egan W, in Vaccines fifth edition, 2008. Page 73.
- a vaccine additive that helps to protect the vaccine from adverse conditions such as the freeze-drying process (for those vaccines that are freeze-dried) or heat.
+ Vaccine additive that helps to protect the vaccine from adverse conditions such as the freeze-drying process (for those vaccines that are freeze-dried) or heat.
Oliver He
Finn TM and Egan W, in Vaccines fifth edition, 2008. Page 75.
vaccine component
@@ -16391,7 +17056,7 @@ Ref: Finn TM and Egan W, in Vaccines fifth edition, 2008. Page 73.
- a vaccine component that remains from the vaccine manufacturing process.
+ A vaccine component that remains from the vaccine manufacturing process.
Although no all manufacturing residuals may be identified and quantified, their presence and quantity is assumed to be constant because of the constancy of the manufacturing process.
Oliver He
Finn TM and Egan W, in Vaccines fifth edition, 2008. Page 73.
@@ -16600,7 +17265,7 @@ of minimal anatomy terminology and NCBI taxonomy... Eventually, this term chicke
- the vaccine component that is used as antigen to produce an immune responce protect against the specific pathogen or disease.
+ Vaccine component that is used as antigen to produce an immune responce protect against the specific pathogen or disease.
This is a modified or partial form of the virus, bacteria or the toxin that causes the disease against which the vaccine protects. The vaccine antigen is altered from its original form so it no longer causes disease but it can produce an immune response.(Vaccine components FactSheet of NCIRS)
Asiyah Yu Lin
Oliver He
@@ -16707,31 +17372,32 @@ of minimal anatomy terminology and NCBI taxonomy... Eventually, this term chicke
+
-
-
+
+
-
-
+
+
-
+
-
+
@@ -16740,6 +17406,18 @@ of minimal anatomy terminology and NCBI taxonomy... Eventually, this term chicke
+
+
+
+
+
+
+
+
+
+
+
+
@@ -16787,8 +17465,15 @@ of minimal anatomy terminology and NCBI taxonomy... Eventually, this term chicke
+
+
+
+
+
+
+
@@ -16840,12 +17525,14 @@ of minimal anatomy terminology and NCBI taxonomy... Eventually, this term chicke
+
+
-
-
+
+
@@ -16860,6 +17547,12 @@ of minimal anatomy terminology and NCBI taxonomy... Eventually, this term chicke
+
+
+
+
+
+
@@ -16892,9 +17585,10 @@ of minimal anatomy terminology and NCBI taxonomy... Eventually, this term chicke
Kallan Roan
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5555
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm335836.htm
+ 5555
Flublok
- Influenza Vaccine
For active immunization against disease caused by influenza virus subtypes A and type B contained in the vaccine. Flublok is approved for use in persons 18 years of age and older.
125285
vaccine
@@ -16907,31 +17601,39 @@ of minimal anatomy terminology and NCBI taxonomy... Eventually, this term chicke
+
+
-
-
+
+
-
-
+
+
-
+
-
-
+
+
+
+
+
+
+
+
@@ -16966,9 +17668,10 @@ of minimal anatomy terminology and NCBI taxonomy... Eventually, this term chicke
Kallan Roan
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5560
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm328629.htm
+ 5560
FLUCELVAX
- Influenza Vaccine
For active immunization of persons 4 years of age and older for the prevention of influenza disease caused by influenza virus subtypes A and type B contained in the vaccine.
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM329134.pdf
125408
@@ -16993,13 +17696,14 @@ of minimal anatomy terminology and NCBI taxonomy... Eventually, this term chicke
+
-
-
+
+
@@ -17014,6 +17718,12 @@ of minimal anatomy terminology and NCBI taxonomy... Eventually, this term chicke
+
+
+
+
+
+
@@ -17057,8 +17767,9 @@ of minimal anatomy terminology and NCBI taxonomy... Eventually, this term chicke
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5564
+ 5564
FluMist Quadrivalent
- Influenza Vaccine
For active immunization for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. FluMist Quadrivalent is approved for use in persons 2 through 49 years of age
https://www.fda.gov/media/160349/download?attachment
125020
@@ -17072,31 +17783,38 @@ of minimal anatomy terminology and NCBI taxonomy... Eventually, this term chicke
+
-
-
+
+
-
-
+
+
-
+
-
-
+
+
+
+
+
+
+
+
@@ -17130,7 +17848,8 @@ of minimal anatomy terminology and NCBI taxonomy... Eventually, this term chicke
Oliver He
- Influenza Vaccine
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5565
+ 5565
FLUARIX QUADRIVALENT is a vaccine indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.FLUARIX QUADRIVALENT is approved for use in persons aged 6 months and older
https://www.fda.gov/media/79278/download?attachment
BL 125127
@@ -17140,64 +17859,6 @@ of minimal anatomy terminology and NCBI taxonomy... Eventually, this term chicke
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- a live attenuated quality of a bacterial vaccine strain.
- Oliver He
- quality
- bacterial vaccine organism live attenuated
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- a live attenuated quality of a virus vaccine strain.
- Oliver He
- quality
- viral vaccine organism live attenuated
-
-
-
-
@@ -17230,11 +17891,13 @@ of minimal anatomy terminology and NCBI taxonomy... Eventually, this term chicke
+
+
-
-
+
+
@@ -17255,6 +17918,12 @@ of minimal anatomy terminology and NCBI taxonomy... Eventually, this term chicke
+
+
+
+
+
+
@@ -17287,9 +17956,10 @@ of minimal anatomy terminology and NCBI taxonomy... Eventually, this term chicke
Kallan Roan
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=753
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm192126.htm
+ 753
Agriflu
- Influenza Virus Vaccine
Active immunization of adults 18 years of age and older against influenza disease caused by influenza virus subtypes A and type B present in the vaccine.
BL 125297/32
vaccine
@@ -17319,7 +17989,7 @@ of minimal anatomy terminology and NCBI taxonomy... Eventually, this term chicke
-
+
@@ -17329,7 +17999,7 @@ of minimal anatomy terminology and NCBI taxonomy... Eventually, this term chicke
-
+
@@ -17349,7 +18019,7 @@ of minimal anatomy terminology and NCBI taxonomy... Eventually, this term chicke
-
+
@@ -17359,7 +18029,7 @@ of minimal anatomy terminology and NCBI taxonomy... Eventually, this term chicke
-
+
@@ -17371,25 +18041,6 @@ of minimal anatomy terminology and NCBI taxonomy... Eventually, this term chicke
-
-
-
-
-
-
-
-
-
-
- a vaccination that occurs in the intramuscular route.
- Asiyah Yu Lin
- Oliver He
- vaccination
- intramuscular vaccination
-
-
-
-
@@ -17398,7 +18049,7 @@ of minimal anatomy terminology and NCBI taxonomy... Eventually, this term chicke
-
+
@@ -17408,7 +18059,7 @@ of minimal anatomy terminology and NCBI taxonomy... Eventually, this term chicke
-
+
@@ -17428,7 +18079,7 @@ of minimal anatomy terminology and NCBI taxonomy... Eventually, this term chicke
-
+
@@ -17438,7 +18089,7 @@ of minimal anatomy terminology and NCBI taxonomy... Eventually, this term chicke
-
+
@@ -17458,7 +18109,7 @@ of minimal anatomy terminology and NCBI taxonomy... Eventually, this term chicke
-
+
@@ -17468,18 +18119,13 @@ of minimal anatomy terminology and NCBI taxonomy... Eventually, this term chicke
-
+
a viral vaccine that is live attenuated
Oliver He
vaccine
- This term has an equivalent class:
-'viral vaccine' and ('has quality at some time' some 'vaccine organism live attenuated')
-
-However, running the reasoner takes time. As a way to reducing the time, I have tentatively made tern two subclasses instead of equivalent class. If needed, the equivalent class can be used in SPARQL or converted back in VO. --Oliver
-
live attenuated viral vaccine
@@ -17541,112 +18187,119 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
-
+
-
+
-
+
-
+
-
+
-
+
-
+
-
+
-
+
-
+
-
+
-
+
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+
+
@@ -17682,10 +18335,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Allen Xiang
Kallan Roan
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1115
https://www.fda.gov/biologicsbloodvaccines/vaccines/approvedproducts/ucm201667.htm
https://www.prevnar13.com/
+ 1115
Prevnar 13
- Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein)
- Active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F in children 6 weeks through 5 years of age (prior to the 6th birthday).
- Active immunization for the prevention of otitis media caused by S. pneumoniae serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F. No otitis media efficacy data are available for serotypes 1, 3, 5, 6A, 7F, and 19A In children 6 weeks through 5 years of age (prior to the 6th birthday).
- Active immunization for the prevention of invasive disease caused by S. pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F in children 6 years through 17 years of age (prior to the 18th birthday).
@@ -17695,7 +18349,6 @@ However, running the reasoner takes time. As a way to reducing the time, I have
125324
vaccine
Prevnar 13 vaccine
- VIOLIN Vaccine ID: 1114
@@ -17714,11 +18367,17 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
-
+
+
+
+
+
+
+
@@ -17736,10 +18395,11 @@ However, running the reasoner takes time. As a way to reducing the time, I have
SYNFLORIX is indicated for active immunization of infants and children from 6 weeks up to 5 years of age against Streptococcus pneumoniae serotypes 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F and 23F and invasive disease caused by these serotypes (including sepsis, meningitis, bacteraemic pneumonia, pleural empyema and bacteraemia).
Allen Xiang
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1114
WEB: http://www.gsk.ca/english/docs-pdf/product-monographs/Synflorix.pdf
+ 1114
vaccine
Synflorix vaccine
- VIOLIN Vaccine ID: 1115
@@ -17758,22 +18418,36 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1117
+ 1117
vaccine
Intanza vaccine
- VIOLIN Vaccine ID: 1117
@@ -17976,31 +18650,32 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
-
-
+
+
-
-
+
+
-
+
-
-
+
+
@@ -18021,6 +18696,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -18052,15 +18733,14 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5554
WEB: https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM518295.pdf
- http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5554
5554
- Influenza Vaccine
+ Afluria Quadrivalent
Active immunization against influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. Afluria Quadrivalent is approved for use in persons 6 months of age and older.
https://www.fda.gov/media/117022/download?attachment
BL 125254
vaccine
- Trade Name: Afluria Quadrivalent
Afluria Quadrivalent
@@ -18097,42 +18777,6 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
-
-
-
-
-
-
-
-
-
- vaccination process that occurs in oral route.
- Asiyah Yu Lin
- vaccination
- oral vaccination
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- vaccination process that occurs in the subcutaneous route
- Asiyah Yu Lin
- vaccination
- subcutaneous vaccination
-
-
-
-
@@ -18268,23 +18912,6 @@ However, running the reasoner takes time. As a way to reducing the time, I have
-
-
-
-
-
-
-
-
-
-
- Administration of a drug by the way of absorption through the skin, usually for systemic action. The route allows sustained therapeutic plasma drug levels and avoids first pass effect. Simplicity of administration tends to result in high patient compliance.|YL
- vaccination
- percutaneous vaccination
-
-
-
-
@@ -18300,61 +18927,64 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
@@ -18363,6 +18993,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -18396,17 +19032,17 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Kallan Roan
Oliver He
Omar Tibi
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5576
http://purl.bioontology.org/ontology/RXNORM/1601403
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm431374.htm
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM431447.pdf
+ 5576
BEXSERO
- Meningococcal Group B Vaccine
Active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B in individuals 10 through 25 years of age.
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM431447.pdf
BL 125546
vaccine
Bexsero vaccine
- VIOLIN Vaccine ID: 5576
@@ -18416,12 +19052,13 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
-
-
+
+
@@ -18442,6 +19079,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -18474,15 +19117,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Oliver He
Omar Tibi
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5556
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM524684.pdf
- Influenza Vaccine
+ 5556
+ Flublok Quadrivalent
For active immunization against disease caused by influenza A subtype viruses and influenza type B viruses contained in the vaccine. Flublok Quadrivalent is approved for use in persons 18 years of age and older.
https://www.fda.gov/vaccines-blood-biologics/vaccines/flublok-quadrivalent
125285
vaccine
- Trade Name: Flublok Quadrivalent
Flublok Quadrivalent
- VIOLIN Vaccine ID: 5556
@@ -18491,37 +19134,44 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -18556,15 +19206,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Oliver He
Omar Tibi
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5561
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM502899.pdf
- Influenza Vaccine
+ 5561
+ Flucelvax Quadrivalent
For active immunization for the prevention of influenza disease caused by influenza virus subtypes A and types B contained in the vaccine
https://www.fda.gov/media/115862/download?attachment
BL 125408
vaccine
- Trade Name: Flucelvax Quadrivalent
Flucelvax Quadrivalent
- VIOLIN Vaccine ID: 5561
@@ -18573,37 +19223,38 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
@@ -18612,6 +19263,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -18650,16 +19307,16 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Kallan Roan
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5562
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm366061.htm
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM404086.pdf
+ 5562
FluLaval
- Influenza Virus Vaccine
For active immunization of persons 6 months of age and older for the prevention of disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM619548.pdf
BL 125163
vaccine
FluLaval Quadrivalent
- VIOLIN Vaccine ID: 5562
@@ -18668,44 +19325,45 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
-
-
+
+
-
-
+
+
-
-
+
+
-
+
-
-
+
+
-
-
+
+
@@ -18714,6 +19372,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
+
+
+
+
@@ -18746,15 +19410,15 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Kallan Roan
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5566
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm356091.htm
+ 5566
Fluzone Quadrivalent
- Influenza Virus Vaccine
For active immunization of persons 6 months of age and older for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM356094.pdf
BL 103914
vaccine
Fluzone Quadrivalent
- VIOLIN Vaccine ID: 5566
@@ -18774,104 +19438,112 @@ However, running the reasoner takes time. As a way to reducing the time, I have
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -18908,11 +19580,12 @@ However, running the reasoner takes time. As a way to reducing the time, I have
Khadeejah Khan
Oliver He
Omar Tibi
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5546
http://purl.bioontology.org/ontology/RXNORM/1597095
https://www.cancer.org/latest-news/fda-approves-gardasil-9-hpv-vaccine.html
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm426445.htm
+ 5546
Gardasil 9
- Human Papillomavirus 9-valent Vaccine, Recombinant
Indicated in girls and women 9 through 45 years of age for the prevention of the following diseases:
- Cervical, vulvar, vaginal, and anal cancer caused by Human Papillomavirus (HPV) types 16, 18, 31, 33, 45, 52, and 58. (1.1)
Genital warts (condyloma acuminata) caused by HPV types 6 and 11. (1.1)
@@ -18934,7 +19607,6 @@ And the following precancerous or dysplastic lesions caused by HPV types 6, 11,
125508
vaccine
Gardasil 9 vaccine
- VIOLIN Vaccine ID: 5546
@@ -18953,18 +19625,24 @@ And the following precancerous or dysplastic lesions caused by HPV types 6, 11,
-
+
-
-
+
+
-
+
+
+
+
+
+
+
@@ -18981,10 +19659,11 @@ And the following precancerous or dysplastic lesions caused by HPV types 6, 11,
Oliver He
Omar Tibi
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5578
http://www.pfizer.ca/sites/g/files/g10028126/f/201604/Nimenrix_PM_184020_23Mar2016_E.pdf
+ 5578
vaccine
Nimenrix vaccine
- VIOLIN Vaccine ID: 5578
@@ -19004,42 +19683,50 @@ And the following precancerous or dysplastic lesions caused by HPV types 6, 11,
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -19074,16 +19761,16 @@ And the following precancerous or dysplastic lesions caused by HPV types 6, 11,
Kallan Roan
Oliver He
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5577
http://purl.bioontology.org/ontology/RXNORM/1593136
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm421020.htm
+ 5577
TRUMENBA
- Meningococcal Group B Vaccine
Indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B. Trumenba is approved for use in individuals 10 through 25 years of age.
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM421139.pdf
BL 125549
vaccine
Trumenba vaccine
- VIOLIN Vaccine ID: 5577
@@ -19104,34 +19791,41 @@ And the following precancerous or dysplastic lesions caused by HPV types 6, 11,
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -19166,16 +19860,16 @@ And the following precancerous or dysplastic lesions caused by HPV types 6, 11,
Oliver He
Omar Tibi
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5569
http://purl.bioontology.org/ontology/RXNORM/1812946
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM506235.pdf
+ 5569
VAXCHORA
- Cholera Vaccine, Live, Oral
VAXCHORA is a vaccine indicated for active immunization against disease caused by Vibrio cholerae serogroup O1. VAXCHORA is approved for use in persons 2 through 64 years of age traveling to cholera-affected areas.
https://www.fda.gov/media/179631/download?attachment
125597
vaccine
Vaxchora vaccine
- VIOLIN Vaccine ID: 5569
@@ -19200,14 +19894,14 @@ And the following precancerous or dysplastic lesions caused by HPV types 6, 11,
-
-
+
+
-
-
+
+
@@ -19228,15 +19922,6 @@ And the following precancerous or dysplastic lesions caused by HPV types 6, 11,
https://www.medicines.org.uk/emc/files/pil.5581.pdf
https://www.medicines.org.uk/emc/product/5581/smpc
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166496/
- Dose: 0.5-mL suspension for injection in a pre-filled syringe
-Active ingredients:
-Purified diphtheria toxoid >=2 IU (5 Lf)
-Purified tetanus toxoid >=20 IU (10 Lf)
-Inactivated poliovirus type 1 40 DU
-Inactivated poliovirus type 2 8 DU
-Inactivated poliovirus type 3 32 DU
-Adsorbant:
-Aluminum hydroxide. 0.35 mg (as aluminum)
vaccine
Revaxis is used for preventing diphtheria, tetanus and polio in children from six years of age, adolescents and adults. Revaxis is used for a booster vaccination against these diseases. It is given to teenagers at 14 years of age as part of the British childhood immunisation schedule.
Revaxis vaccine
@@ -19258,20 +19943,33 @@ Aluminum hydroxide. 0.35 mg (as aluminum)
-
+
+
-
-
+
+
-
+
+
+
+
+
+
+
+
+
+
+
+
+
@@ -19314,20 +20012,33 @@ Aluminum hydroxide. 0.35 mg (as aluminum)
+
-
+
-
-
+
+
-
+
+
+
+
+
+
+
+
+
+
+
+
+
@@ -19423,41 +20134,48 @@ Aluminum hydroxide. 0.35 mg (as aluminum)
+
-
-
+
+
-
-
+
+
-
-
+
+
-
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -19497,23 +20215,30 @@ Aluminum hydroxide. 0.35 mg (as aluminum)
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -19539,8 +20264,6 @@ Aluminum hydroxide. 0.35 mg (as aluminum)
Randi Vita
ACWYVax
http://www.mhra.gov.uk/home/groups/comms-ic/documents/drugsafetymessage/con425089.pdf
- Meningococcal polysaccharides (groups A, C, W135 and Y polysaccharides)
- Lactose
vaccine
ACWY Vax vaccine
@@ -19590,7 +20313,14 @@ Aluminum hydroxide. 0.35 mg (as aluminum)
+
+
+
+
+
+
+
@@ -19599,7 +20329,7 @@ Aluminum hydroxide. 0.35 mg (as aluminum)
-
+
@@ -19617,10 +20347,10 @@ Aluminum hydroxide. 0.35 mg (as aluminum)
797752
hepatitis B surface antigen vaccine
528323
+ CUI: C0062527
+ RXAUI: 2850925
+ TUI: T116, T129, T121
vaccine
- CUI: C0062527
- RXAUI: 2850925
- TUI: T116, T129, T121
Hepatitis B surface antigen vaccine
@@ -19641,12 +20371,13 @@ Aluminum hydroxide. 0.35 mg (as aluminum)
+
-
-
+
+
@@ -19673,6 +20404,12 @@ Aluminum hydroxide. 0.35 mg (as aluminum)
+
+
+
+
+
+
@@ -19710,7 +20447,6 @@ Aluminum hydroxide. 0.35 mg (as aluminum)
HBsAg-1018
http://purl.bioontology.org/ontology/RXNORM/1994348
https://www.ncbi.nlm.nih.gov/pubmed/22342916
- Hepatitis B Vaccine (Recombinant), Adjuvanted
For prevention of infection caused by all known subtypes of hepatitis B virus. HEPLISAV-B is approved for use in adults 18 years of age and older
https://www.fda.gov/media/108745/download?attachment
125428
@@ -19723,8 +20459,15 @@ Aluminum hydroxide. 0.35 mg (as aluminum)
+
+
+
+
+
+
+
@@ -19733,7 +20476,7 @@ Aluminum hydroxide. 0.35 mg (as aluminum)
-
+
@@ -19763,6 +20506,12 @@ Aluminum hydroxide. 0.35 mg (as aluminum)
+
+
+
+
+
+
@@ -19794,25 +20543,39 @@ Aluminum hydroxide. 0.35 mg (as aluminum)
+
+
-
-
+
+
-
-
+
+
-
+
+
+
+
+
+
+
+
+
+
+
+
+
@@ -19826,11 +20589,13 @@ Aluminum hydroxide. 0.35 mg (as aluminum)
An oral vaccine against adenovirus serotype 4.
+ Kallan Roan
+ Oliver He
+ Adenovirus Type 4
https://health.mil/Military-Health-Topics/Health-Readiness/Immunization-Healthcare/Vaccine-Preventable-Diseases/Adenovirus
vaccine
- Kallan Roan, Oliver He
The vaccine is in a form of white enteric-coated tablets. It is typically administered with Adenovirus type 7 vaccine.
- Adenovirus Type 4
+ Adenovirus Type 4 vaccine
@@ -19839,25 +20604,39 @@ Aluminum hydroxide. 0.35 mg (as aluminum)
+
+
-
-
+
+
-
-
+
+
-
+
+
+
+
+
+
+
+
+
+
+
+
+
@@ -19871,11 +20650,12 @@ Aluminum hydroxide. 0.35 mg (as aluminum)
An oral vaccine against adenovirus serotype 7.
+ Adenovirus Type 7
Kallan Roan, Oliver He
The vaccine is in a form of peach-colored enteric-coated tablets. It is typically administered with Adenovirus type 4 vaccine.
https://health.mil/Military-Health-Topics/Health-Readiness/Immunization-Healthcare/Vaccine-Preventable-Diseases/Adenovirus
vaccine
- Adenovirus Type 7
+ Adenovirus Type 7 vaccine
@@ -19883,7 +20663,14 @@ Aluminum hydroxide. 0.35 mg (as aluminum)
+
+
+
+
+
+
+
@@ -19925,14 +20712,14 @@ Aluminum hydroxide. 0.35 mg (as aluminum)
-
-
+
+
-
-
+
+
@@ -19946,7 +20733,6 @@ Aluminum hydroxide. 0.35 mg (as aluminum)
798302
acellular pertussis vaccine, inactivated
529218
- VO:0003390
vaccine
inactivated acellular pertussis vaccine
@@ -19956,11 +20742,12 @@ Aluminum hydroxide. 0.35 mg (as aluminum)
+
-
-
+
+
@@ -19969,6 +20756,12 @@ Aluminum hydroxide. 0.35 mg (as aluminum)
+
+
+
+
+
+
@@ -19986,12 +20779,13 @@ Aluminum hydroxide. 0.35 mg (as aluminum)
+
-
-
+
+
@@ -20006,6 +20800,12 @@ Aluminum hydroxide. 0.35 mg (as aluminum)
+
+
+
+
+
+
@@ -20027,7 +20827,7 @@ Aluminum hydroxide. 0.35 mg (as aluminum)
-
+
@@ -20040,11 +20840,12 @@ Aluminum hydroxide. 0.35 mg (as aluminum)
+
-
-
+
+
@@ -20053,6 +20854,12 @@ Aluminum hydroxide. 0.35 mg (as aluminum)
+
+
+
+
+
+
@@ -20072,8 +20879,15 @@ Aluminum hydroxide. 0.35 mg (as aluminum)
+
+
+
+
+
+
+
@@ -20113,24 +20927,31 @@ Aluminum hydroxide. 0.35 mg (as aluminum)
+
-
-
+
+
-
+
+
+
+
+
+
+
-
-
+
+
@@ -20167,8 +20988,15 @@ over.
+
+
+
+
+
+
+
@@ -20198,8 +21026,15 @@ over.
+
+
+
+
+
+
+
@@ -20229,8 +21064,15 @@ over.
+
+
+
+
+
+
+
@@ -20260,8 +21102,15 @@ over.
+
+
+
+
+
+
+
@@ -20291,8 +21140,15 @@ over.
+
+
+
+
+
+
+
@@ -20322,8 +21178,15 @@ over.
+
+
+
+
+
+
+
@@ -20353,8 +21216,15 @@ over.
+
+
+
+
+
+
+
@@ -20384,8 +21254,15 @@ over.
+
+
+
+
+
+
+
@@ -20415,8 +21292,15 @@ over.
+
+
+
+
+
+
+
@@ -20446,8 +21330,15 @@ over.
+
+
+
+
+
+
+
@@ -20477,8 +21368,15 @@ over.
+
+
+
+
+
+
+
@@ -20508,8 +21406,15 @@ over.
+
+
+
+
+
+
+
@@ -20539,8 +21444,15 @@ over.
+
+
+
+
+
+
+
@@ -20570,8 +21482,15 @@ over.
+
+
+
+
+
+
+
@@ -20601,8 +21520,15 @@ over.
+
+
+
+
+
+
+
@@ -20632,8 +21558,15 @@ over.
+
+
+
+
+
+
+
@@ -20663,8 +21596,15 @@ over.
+
+
+
+
+
+
+
@@ -20694,8 +21634,15 @@ over.
+
+
+
+
+
+
+
@@ -20725,8 +21672,15 @@ over.
+
+
+
+
+
+
+
@@ -20756,8 +21710,15 @@ over.
+
+
+
+
+
+
+
@@ -20788,10 +21749,11 @@ over.
+
-
-
+
+
@@ -20800,6 +21762,12 @@ over.
+
+
+
+
+
+
@@ -20850,7 +21818,7 @@ over.
Khadeejah Khan
Oliver He
vaccine
- L1 protein, Human papillomavirus Vaccine
+ L1 protein, Human papillomavirus vaccine
@@ -20859,8 +21827,15 @@ over.
+
+
+
+
+
+
+
@@ -20889,12 +21864,13 @@ over.
+
-
-
+
+
@@ -20903,6 +21879,12 @@ over.
+
+
+
+
+
+
@@ -20925,8 +21907,15 @@ over.
+
+
+
+
+
+
+
@@ -20955,8 +21944,15 @@ over.
+
+
+
+
+
+
+
@@ -20985,8 +21981,15 @@ over.
+
+
+
+
+
+
+
@@ -21015,8 +22018,15 @@ over.
+
+
+
+
+
+
+
@@ -21045,8 +22055,15 @@ over.
+
+
+
+
+
+
+
@@ -21075,8 +22092,15 @@ over.
+
+
+
+
+
+
+
@@ -21105,8 +22129,15 @@ over.
+
+
+
+
+
+
+
@@ -21147,54 +22178,55 @@ over.
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
@@ -21242,7 +22274,6 @@ over.
Kallan Roan
Oliver He
SHINGRIX
- Zoster Vaccine Recombinant, Adjuvanted
Indicated for prevention of herpes zoster (shingles) in adults aged 50 years and older.
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM581605.pdf
125614
@@ -21256,8 +22287,15 @@ over.
+
+
+
+
+
+
+
@@ -21292,8 +22330,15 @@ over.
+
+
+
+
+
+
+
@@ -21328,8 +22373,15 @@ over.
+
+
+
+
+
+
+
@@ -21364,8 +22416,15 @@ over.
+
+
+
+
+
+
+
@@ -21400,8 +22459,15 @@ over.
+
+
+
+
+
+
+
@@ -21436,8 +22502,15 @@ over.
+
+
+
+
+
+
+
@@ -21472,8 +22545,15 @@ over.
+
+
+
+
+
+
+
@@ -21508,8 +22588,15 @@ over.
+
+
+
+
+
+
+
@@ -21544,8 +22631,15 @@ over.
+
+
+
+
+
+
+
@@ -21580,8 +22674,15 @@ over.
+
+
+
+
+
+
+
@@ -21616,8 +22717,15 @@ over.
+
+
+
+
+
+
+
@@ -21652,8 +22760,15 @@ over.
+
+
+
+
+
+
+
@@ -21688,8 +22803,15 @@ over.
+
+
+
+
+
+
+
@@ -21724,7 +22846,14 @@ over.
+
+
+
+
+
+
+
@@ -21764,13 +22893,14 @@ over.
+
-
-
+
+
@@ -21791,6 +22921,12 @@ over.
+
+
+
+
+
+
@@ -21825,7 +22961,6 @@ over.
Oliver He
https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094070.htm
Vivotif
- Typhoid Vaccine Live Oral Ty21a
For immunization of adults and children greater than 6 years of age against disease caused by Salmonella typhi.
https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM142807.pdf
103123
@@ -21864,7 +22999,14 @@ over.
+
+
+
+
+
+
+
@@ -21907,8 +23049,15 @@ over.
+
+
+
+
+
+
+
@@ -21940,13 +23089,14 @@ over.
+
-
-
+
+
@@ -21961,6 +23111,12 @@ over.
+
+
+
+
+
+
@@ -22005,7 +23161,14 @@ over.
+
+
+
+
+
+
+
@@ -22039,8 +23202,16 @@ over.
+
+
+
+
+
+
+
+
@@ -22075,6 +23246,18 @@ over.
+
+
+
+
+ Vaccine component role inheres in a vaccine vector.
+ Jie Zheng
+ role
+ vaccine vector role
+
+
+
+
@@ -22082,16 +23265,17 @@ over.
-
+
A trivalent influenza vaccine containing two strains of influenza A and one strain of influenza B for use in people 18 years to 64 years for use during the 2012-2013 season.
Kallan Roan
Oliver He
+ Fluzone Intradermal Trivalent
http://www.news.sanofi.us/2014-12-12-Sanofi-Pasteur-Announces-FDA-Approval-of-Fluzone-R-Intradermal-Quadrivalent-Influenza-Vaccine-for-Adults
vaccine
- Fluzone Intradermal Trivalent
+ Fluzone Intradermal Trivalent vaccine
@@ -22110,25 +23294,42 @@ over.
+
+
+
+
+
-
-
+
+
-
-
+
+
-
+
+
+
+
+
+
+
+
+
+
+
+
+
@@ -22187,13 +23388,14 @@ over.
+
-
-
+
+
@@ -22208,6 +23410,12 @@ over.
+
+
+
+
+
+
@@ -22404,8 +23612,15 @@ over.
+
+
+
+
+
+
+
@@ -22521,8 +23736,15 @@ over.
+
+
+
+
+
+
+
@@ -22632,8 +23854,9 @@ over.
Khadeejah Khan
Oliver He
+ human influenza B-like virus
vaccine
- human influenza B-like virus
+ human influenza B-like virus vaccine
@@ -22642,8 +23865,15 @@ over.
+
+
+
+
+
+
+
@@ -22684,13 +23914,14 @@ over.
+
-
-
+
+
@@ -22699,6 +23930,12 @@ over.
+
+
+
+
+
+
@@ -22727,8 +23964,15 @@ over.
+
+
+
+
+
+
+
@@ -22993,9 +24237,9 @@ over.
Oliver He
vaccine against Papillomaviridae
https://en.wikipedia.org/wiki/Papillomaviridae
+ MeSH: D053918
vaccine
Papillomaviridae vaccine
- MeSH: D053918
@@ -23440,8 +24684,15 @@ over.
+
+
+
+
+
+
+
@@ -23486,44 +24737,50 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -23547,10 +24804,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1427028
+ CUI: C3645245
+ RXAUI: 5473440
+ TUI: T116, T121
vaccine
- CUI: C3645245
- RXAUI: 5473440
- TUI: T116, T121
Fluzone Quadrivalent 2013-2014 Formula vaccine
@@ -23571,6 +24828,12 @@ over.
+
+
+
+
+
+
@@ -23613,10 +24876,10 @@ over.
1658713
influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone 2015-2016]
46275396
+ CUI: C4033789
+ RXAUI: 7253479
+ TUI: T200
vaccine
- CUI: C4033789
- RXAUI: 7253479
- TUI: T200
Fluzone 2015-2016 High-Dose vaccine Prefilled Syringe
@@ -23640,26 +24903,32 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -23683,10 +24952,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1801179
+ CUI: C4271565
+ RXAUI: 8237155
+ TUI: T116, T129, T121
vaccine
- CUI: C4271565
- RXAUI: 8237155
- TUI: T116, T129, T121
Fluzone 2016-2017 vaccine
@@ -23708,6 +24977,12 @@ over.
+
+
+
+
+
+
@@ -23756,10 +25031,10 @@ over.
1801181
influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone 2016-2017]
36249508
+ CUI: C4271674
+ RXAUI: 8237157
+ TUI: T200
vaccine
- CUI: C4271674
- RXAUI: 8237157
- TUI: T200
Fluzone 2016-2017 High-Dose vaccine Prefilled Syringe
@@ -23783,26 +25058,32 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -23826,10 +25107,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1928340
+ CUI: C4490427
+ RXAUI: 9198824
+ TUI: T116
vaccine
- CUI: C4490427
- RXAUI: 9198824
- TUI: T116
Fluzone 2017-2018 vaccine
@@ -23851,6 +25132,12 @@ over.
+
+
+
+
+
+
@@ -23899,10 +25186,10 @@ over.
1928342
influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone 2017-2018]
1593355
+ CUI: C4490429
+ RXAUI: 9198826
+ TUI: T200
vaccine
- CUI: C4490429
- RXAUI: 9198826
- TUI: T200
Fluzone 2017-2018 high-dose vaccine Prefilled Syringe
@@ -23926,26 +25213,32 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -23969,10 +25262,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/2050419
+ CUI: C4719042
+ RXAUI: 10289780
+ TUI: T109
vaccine
- CUI: C4719042
- RXAUI: 10289780
- TUI: T109
Fluzone 2018-2019 vaccine
@@ -24012,6 +25305,12 @@ over.
+
+
+
+
+
+
@@ -24060,10 +25359,10 @@ over.
2050421
influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone 2018-2019]
35200034
+ CUI: C4719044
+ RXAUI: 10289782
+ TUI: T200
vaccine
- CUI: C4719044
- RXAUI: 10289782
- TUI: T200
Fluzone 2018-2019 high-dose vaccine Prefilled Syringe
@@ -24137,8 +25436,15 @@ over.
+
+
+
+
+
+
+
@@ -24180,8 +25486,15 @@ over.
+
+
+
+
+
+
+
@@ -24229,8 +25542,15 @@ over.
+
+
+
+
+
+
+
@@ -24293,44 +25613,50 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -24354,10 +25680,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1537557
+ CUI: C3817309
+ RXAUI: 6338534
+ TUI: T116, T121
vaccine
- CUI: C3817309
- RXAUI: 6338534
- TUI: T116, T121
Fluzone Quadrivalent 2014-2015 Formula vaccine
@@ -24380,32 +25706,38 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -24423,10 +25755,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1659725
+ CUI: C4026655
+ RXAUI: 7255357
+ TUI: T116, T129, T121
vaccine
- CUI: C4026655
- RXAUI: 7255357
- TUI: T116, T129, T121
Fluzone Quadrivalent 2015-2016 vaccine
@@ -24450,32 +25782,38 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -24499,10 +25837,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1801071
+ CUI: C4224224
+ RXAUI: 8236907
+ TUI: T116, T129, T121
vaccine
- CUI: C4224224
- RXAUI: 8236907
- TUI: T116, T129, T121
Fluzone Quadrivalent 2016-2017 vaccine
@@ -24526,32 +25864,38 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -24575,10 +25919,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1928313
+ CUI: C4325215
+ RXAUI: 9198781
+ TUI: T116, T129, T121
vaccine
- CUI: C4325215
- RXAUI: 9198781
- TUI: T116, T129, T121
Fluzone Quadrivalent 2017-2018 vaccine
@@ -24602,32 +25946,38 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -24651,15 +26001,44 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/2050773
+ CUI: C4719179
+ RXAUI: 10290520
+ TUI: T116, T129, T121
vaccine
- CUI: C4719179
- RXAUI: 10290520
- TUI: T116, T129, T121
Fluzone Quadrivalent 2018-2019 vaccine
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ Vaccine component that is used to deliver genetic code into the cells to produce antigen.
+ Jie Zheng
+ vaccine component
+ vaccine vector
+
+
+
+
@@ -24677,26 +26056,32 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -24714,10 +26099,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1657326
+ CUI: C4026630
+ RXAUI: 7251220
+ TUI: T116, T129, T121
vaccine
- CUI: C4026630
- RXAUI: 7251220
- TUI: T116, T129, T121
Fluvirin 2015-2016 vaccine
@@ -24741,26 +26126,32 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -24784,10 +26175,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1801153
+ CUI: C4224219
+ RXAUI: 8237127
+ TUI: T116, T129, T121
vaccine
- CUI: C4224219
- RXAUI: 8237127
- TUI: T116, T129, T121
Fluvirin 2016-2017 vaccine
@@ -24811,26 +26202,32 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -24854,10 +26251,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1928970
+ CUI: C4325210
+ RXAUI: 9199995
+ TUI: T116, T129, T121
vaccine
- CUI: C4325210
- RXAUI: 9199995
- TUI: T116, T129, T121
Fluvirin 2017-2018 vaccine
@@ -24880,32 +26277,38 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -24923,10 +26326,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1657232
+ CUI: C4026648
+ RXAUI: 7251209
+ TUI: T116, T129, T121
vaccine
- CUI: C4026648
- RXAUI: 7251209
- TUI: T116, T129, T121
Fluarix Quadrivalent 2015-2016 vaccine
@@ -24950,32 +26353,38 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -24999,10 +26408,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1799119
+ CUI: C4224221
+ RXAUI: 8233865
+ TUI: T116, T129, T121
vaccine
- CUI: C4224221
- RXAUI: 8233865
- TUI: T116, T129, T121
Fluarix Quadrivalent 2016-2017 vaccine
@@ -25026,32 +26435,38 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -25075,10 +26490,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1928303
+ CUI: C4490400
+ RXAUI: 9198769
+ TUI: T116, T129, T121
vaccine
- CUI: C4490400
- RXAUI: 9198769
- TUI: T116, T129, T121
Fluarix Quadrivalent 2017-2018 vaccine
@@ -25102,32 +26517,38 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -25151,10 +26572,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/2048962
+ CUI: C4704189
+ RXAUI: 10279939
+ TUI: T116, T129, T121
vaccine
- CUI: C4704189
- RXAUI: 10279939
- TUI: T116, T129, T121
Fluarix Quadrivalent 2018-2019 vaccine
@@ -25193,26 +26614,32 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -25230,10 +26657,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1661803
+ CUI: C4020099
+ RXAUI: 7264715
+ TUI: T129, T121
vaccine
- CUI: C4020099
- RXAUI: 7264715
- TUI: T129, T121
Afluria 2015-2016 vaccine
@@ -25257,26 +26684,32 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -25300,10 +26733,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1799399
+ CUI: C4224216
+ RXAUI: 8234382
+ TUI: T116, T129, T121
vaccine
- CUI: C4224216
- RXAUI: 8234382
- TUI: T116, T129, T121
Afluria 2016-2017 vaccine
@@ -25327,26 +26760,32 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -25370,10 +26809,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1942128
+ CUI: C4325193
+ RXAUI: 9267473
+ TUI: T129, T121
vaccine
- CUI: C4325193
- RXAUI: 9267473
- TUI: T129, T121
Afluria 2017-2018 vaccine
@@ -25397,26 +26836,32 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -25440,10 +26885,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/2050767
+ CUI: C4719173
+ RXAUI: 10290502
+ TUI: T116, T129, T121
vaccine
- CUI: C4719173
- RXAUI: 10290502
- TUI: T116, T129, T121
Afluria 2018-2019 vaccine
@@ -25467,32 +26912,38 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -25516,10 +26967,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1858959
+ CUI: C4293360
+ RXAUI: 8698883
+ TUI: T116, T129, T121
vaccine
- CUI: C4293360
- RXAUI: 8698883
- TUI: T116, T129, T121
Afluria Quadrivalent 2016-2017 Formula vaccine
@@ -25543,32 +26994,38 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -25592,10 +27049,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1942162
+ CUI: C4325196
+ RXAUI: 9267495
+ TUI: T129, T121
vaccine
- CUI: C4325196
- RXAUI: 9267495
- TUI: T129, T121
Afluria Quadrivalent 2017-2018 vaccine
@@ -25619,32 +27076,38 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -25668,10 +27131,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/2050791
+ CUI: C4719195
+ RXAUI: 10290555
+ TUI: T116, T129, T121
vaccine
- CUI: C4719195
- RXAUI: 10290555
- TUI: T116, T129, T121
Afluria Quadrivalent 2018-2019 vaccine
@@ -25695,32 +27158,38 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -25744,10 +27213,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1799102
+ CUI: C4224220
+ RXAUI: 8233849
+ TUI: T116, T129, T121
vaccine
- CUI: C4224220
- RXAUI: 8233849
- TUI: T116, T129, T121
Flulaval Quadrivalent 2016-2017 vaccine
@@ -25770,32 +27239,38 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -25813,10 +27288,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1657335
+ CUI: C4026650
+ RXAUI: 7251229
+ TUI: T116, T129, T121
vaccine
- CUI: C4026650
- RXAUI: 7251229
- TUI: T116, T129, T121
FluLaval Quadrivalent 2015-2016 vaccine
@@ -25840,32 +27315,38 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -25889,10 +27370,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1928325
+ CUI: C4325209
+ RXAUI: 9198793
+ TUI: T116, T129, T121
vaccine
- CUI: C4325209
- RXAUI: 9198793
- TUI: T116, T129, T121
Flulaval Quadrivalent 2017-2018 vaccine
@@ -25916,32 +27397,38 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -25965,10 +27452,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/2048970
+ CUI: C4704197
+ RXAUI: 10279949
+ TUI: T116, T129, T121
vaccine
- CUI: C4704197
- RXAUI: 10279949
- TUI: T116, T129, T121
Flulaval Quadrivalent 2018-2019 vaccine
@@ -25991,26 +27478,32 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -26028,10 +27521,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1657140
+ CUI: C4026649
+ RXAUI: 7251081
+ TUI: T116, T129, T121
vaccine
- CUI: C4026649
- RXAUI: 7251081
- TUI: T116, T129, T121
Flucelvax 2015-2016 vaccine
@@ -26055,32 +27548,38 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -26104,10 +27603,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1801607
+ CUI: C4276115
+ RXAUI: 8238453
+ TUI: T129, T121
vaccine
- CUI: C4276115
- RXAUI: 8238453
- TUI: T129, T121
Flucelvax Quadrivalent 2016-2017 vaccine
@@ -26147,32 +27646,38 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -26196,10 +27701,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1928533
+ CUI: C4325207
+ RXAUI: 9199341
+ TUI: T116, T129, T121
vaccine
- CUI: C4325207
- RXAUI: 9199341
- TUI: T116, T129, T121
Flucelvax Quadrivalent 2017-2018 vaccine
@@ -26271,32 +27776,38 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -26311,10 +27822,10 @@ over.
+ CUI: C4026651
+ RXAUI: 7266972
+ TUI: T116, T129, T121
vaccine
- CUI: C4026651
- RXAUI: 7266972
- TUI: T116, T129, T121
FluMist 2015-2016 vaccine
@@ -26338,32 +27849,38 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -26387,10 +27904,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1801825
+ CUI: C4276113
+ RXAUI: 8238995
+ TUI: T116, T129, T121
vaccine
- CUI: C4276113
- RXAUI: 8238995
- TUI: T116, T129, T121
Flumist Quadrivalent 2016-2017 vaccine
@@ -26414,32 +27931,38 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -26463,10 +27986,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1946970
+ CUI: C4529647
+ RXAUI: 9278624
+ TUI: T116, T129, T121
vaccine
- CUI: C4529647
- RXAUI: 9278624
- TUI: T116, T129, T121
Flumist Quadrivalent 2017-2018 vaccine
@@ -26522,32 +28045,38 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -26571,10 +28100,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/2054182
+ CUI: C4719703
+ RXAUI: 10329701
+ TUI: T116, T129, T121
vaccine
- CUI: C4719703
- RXAUI: 10329701
- TUI: T116, T129, T121
Flumist Quadrivalent 2018-2019 vaccine
@@ -26599,12 +28128,13 @@ over.
+
-
-
+
+
@@ -26613,6 +28143,12 @@ over.
+
+
+
+
+
+
@@ -26636,8 +28172,8 @@ over.
-
-
+
+
@@ -26646,6 +28182,12 @@ over.
+
+
+
+
+
+
@@ -26658,10 +28200,10 @@ over.
763096
poliovirus vaccine inactivated, type 1 (Mahoney)
523283
+ CUI: C2242156
+ RXAUI: 5026693
+ TUI: T129, T121
vaccine
- CUI: C2242156
- RXAUI: 5026693
- TUI: T129, T121
poliovirus vaccine inactivated, type 1 (Mahoney)
@@ -26674,8 +28216,8 @@ over.
-
-
+
+
@@ -26684,6 +28226,12 @@ over.
+
+
+
+
+
+
@@ -26696,10 +28244,10 @@ over.
763098
poliovirus vaccine inactivated, type 2 (MEF-1)
523365
+ CUI: C2242158
+ RXAUI: 5026694
+ TUI: T129, T121
vaccine
- CUI: C2242158
- RXAUI: 5026694
- TUI: T129, T121
poliovirus vaccine inactivated, type 2 (MEF-1)
@@ -26712,8 +28260,8 @@ over.
-
-
+
+
@@ -26722,6 +28270,12 @@ over.
+
+
+
+
+
+
@@ -26734,10 +28288,10 @@ over.
763100
poliovirus vaccine inactivated, type 3 (Saukett)
523367
+ CUI: C2242160
+ RXAUI: 5026695
+ TUI: T129, T121
vaccine
- CUI: C2242160
- RXAUI: 5026695
- TUI: T129, T121
poliovirus vaccine inactivated, type 3 (Saukett)
@@ -26747,8 +28301,15 @@ over.
+
+
+
+
+
+
+
@@ -26767,10 +28328,10 @@ over.
807219
typhoid Vi polysaccharide vaccine, S typhi Ty2 strain
532881
+ CUI: C0078221
+ RXAUI: 2863812
+ TUI: T116, T129, T121
vaccine
- CUI: C0078221
- RXAUI: 2863812
- TUI: T116, T129, T121
Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain
@@ -26780,7 +28341,14 @@ over.
+
+
+
+
+
+
+
@@ -26799,10 +28367,10 @@ over.
830457
rabies virus vaccine flury-lep strain
544411
+ CUI: C2586798
+ RXAUI: 2939884
+ TUI: T129, T121
vaccine
- CUI: C2586798
- RXAUI: 2939884
- TUI: T129, T121
rabies virus vaccine flury-lep strain
@@ -26826,26 +28394,32 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -26869,10 +28443,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1367001
+ CUI: C3531472
+ RXAUI: 5048926
+ TUI: T116, T121
vaccine
- CUI: C3531472
- RXAUI: 5048926
- TUI: T116, T121
Flublok 2012-2013 Formula vaccine
@@ -26896,26 +28470,32 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -26939,10 +28519,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1442206
+ CUI: C3692550
+ RXAUI: 5532833
+ TUI: T116, T121
vaccine
- CUI: C3692550
- RXAUI: 5532833
- TUI: T116, T121
Flublok 2013-2014 Formula vaccine
@@ -26966,26 +28546,32 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -27009,10 +28595,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1537517
+ CUI: C3817315
+ RXAUI: 6338485
+ TUI: T116, T121
vaccine
- CUI: C3817315
- RXAUI: 6338485
- TUI: T116, T121
Flublok 2014-2015 Formula vaccine
@@ -27035,26 +28621,32 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -27072,10 +28664,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1660925
+ CUI: C4020135
+ RXAUI: 7258098
+ TUI: T129, T121
vaccine
- CUI: C4020135
- RXAUI: 7258098
- TUI: T129, T121
Flublok 2015-2016 vaccine
@@ -27099,26 +28691,32 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -27142,10 +28740,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1803020
+ CUI: C4224215
+ RXAUI: 8241253
+ TUI: T116, T129, T121
vaccine
- CUI: C4224215
- RXAUI: 8241253
- TUI: T116, T129, T121
Flublok 2016-2017 vaccine
@@ -27169,26 +28767,32 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -27212,10 +28816,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1928876
+ CUI: C4490679
+ RXAUI: 9199818
+ TUI: T116, T129, T121
vaccine
- CUI: C4490679
- RXAUI: 9199818
- TUI: T116, T129, T121
Flublok 2017-2018 vaccine
@@ -27239,32 +28843,38 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -27288,10 +28898,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/2050378
+ CUI: C4719023
+ RXAUI: 10289675
+ TUI: T200
vaccine
- CUI: C4719023
- RXAUI: 10289675
- TUI: T200
Flublok Quadrivalent 2018-2019 vaccine
@@ -27315,26 +28925,32 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -27352,10 +28968,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1724002
+ CUI: C4060062
+ RXAUI: 7710863
+ TUI: T116, T121
vaccine
- CUI: C4060062
- RXAUI: 7710863
- TUI: T116, T121
FLUAD 2015-2016 vaccine
@@ -27380,26 +28996,32 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -27423,10 +29045,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1801078
+ CUI: C4271566
+ RXAUI: 8236918
+ TUI: T116, T129, T121
vaccine
- CUI: C4271566
- RXAUI: 8236918
- TUI: T116, T129, T121
Fluad 2016-2017 vaccine
@@ -27451,26 +29073,32 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -27494,10 +29122,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1928961
+ CUI: C4325205
+ RXAUI: 9199981
+ TUI: T116, T129, T121
vaccine
- CUI: C4325205
- RXAUI: 9199981
- TUI: T116, T129, T121
Fluad 2017-2018 vaccine
@@ -27522,26 +29150,32 @@ over.
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -27565,10 +29199,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/2050759
+ CUI: C4719165
+ RXAUI: 10290487
+ TUI: T116, T129, T121
vaccine
- CUI: C4719165
- RXAUI: 10290487
- TUI: T116, T129, T121
Fluad 2018-2019 vaccine
@@ -27594,6 +29228,12 @@ over.
+
+
+
+
+
+
@@ -27609,10 +29249,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1301885
+ CUI: C2724165
+ RXAUI: 4627784
+ TUI: T116, T121
vaccine
- CUI: C2724165
- RXAUI: 4627784
- TUI: T116, T121
Human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine
@@ -27622,6 +29262,12 @@ over.
+
+
+
+
+
+
@@ -27637,10 +29283,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1301887
+ CUI: C2724167
+ RXAUI: 4627786
+ TUI: T116, T129, T121
vaccine
- CUI: C2724167
- RXAUI: 4627786
- TUI: T116, T129, T121
Human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine
@@ -27650,12 +29296,13 @@ over.
+
-
-
+
+
@@ -27664,6 +29311,12 @@ over.
+
+
+
+
+
+
@@ -27676,10 +29329,10 @@ over.
845525
Japanese encephalitis virus vaccine, inactivated
19047598
+ CUI: C1579318
+ RXAUI: 2963098
+ TUI: T129, T121
vaccine
- CUI: C1579318
- RXAUI: 2963098
- TUI: T129, T121
Japanese encephalitis virus vaccine, inactivated
@@ -27691,8 +29344,8 @@ over.
-
-
+
+
@@ -27701,6 +29354,12 @@ over.
+
+
+
+
+
+
@@ -27710,10 +29369,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/1300779
+ CUI: C3474322
+ RXAUI: 4626258
+ TUI: T129, T121
vaccine
- CUI: C3474322
- RXAUI: 4626258
- TUI: T129, T121
Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated
@@ -27742,8 +29401,15 @@ over.
+
+
+
+
+
+
+
@@ -27782,13 +29448,14 @@ over.
+
-
-
+
+
@@ -27797,6 +29464,12 @@ over.
+
+
+
+
+
+
@@ -27812,13 +29485,14 @@ over.
Ningxian Fan
Oliver He
Ronak Sutariya
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=184
+ 184
80
40213253
Venezuelan equine encephalitis, live, attenuated
VEE, live
vaccine
Live attenuated VEE vaccines
- violinID: 184
@@ -27856,14 +29530,27 @@ over.
+
+
+
+
+
+
+
+
+
+
+
+
+
@@ -27885,9 +29572,10 @@ over.
Ningxian Fan
Oliver He
Ronak Sutariya
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3286
+ 3286
vaccine
Fluad vaccine
- violinID: 3286
@@ -27896,6 +29584,12 @@ over.
+
+
+
+
+
+
@@ -27905,10 +29599,11 @@ over.
An Ebola virus vaccine that uses a recombinant vesicular stomatitis virus (rVSV) vector expressing an Ebola filovirus glycoprotein
Kallan Roan
Oliver He
- http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4140
+ rVSV-EBOV
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4140
+ 4140
vaccine
- rVSV-EBOV
- violinID: 4140
+ rVSV-EBOV vaccine
@@ -27916,7 +29611,14 @@ over.
+
+
+
+
+
+
+
quadrivalent influenza vaccine
@@ -27926,12 +29628,13 @@ over.
+
-
-
+
+
@@ -27940,6 +29643,12 @@ over.
+
+
+
+
+
+
@@ -27950,10 +29659,10 @@ over.
805573
rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain
19032599
+ CUI: C2364569
+ RXAUI: 2861602
+ TUI: T129, T121
vaccine
- CUI: C2364569
- RXAUI: 2861602
- TUI: T129, T121
Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain
@@ -27963,7 +29672,14 @@ over.
+
+
+
+
+
+
+
@@ -27983,10 +29699,10 @@ over.
human-bovine reassortant rotavirus strain G4 vaccine
human rotavirus A type G4P7(5) strain BRB live antigen
529214
+ CUI: C2344315
+ RXAUI: 2851375
+ TUI: T116, T129, T121
vaccine
- CUI: C2344315
- RXAUI: 2851375
- TUI: T116, T129, T121
Human-Bovine Reassortant Rotavirus Strain G4 Vaccine
@@ -27996,7 +29712,14 @@ over.
+
+
+
+
+
+
+
@@ -28016,10 +29739,10 @@ over.
human-bovine reassortant rotavirus strain P1A[8] vaccine
human rotavirus A type G6P1A(8) strain WI79 live antigen
529216
+ CUI: C2344317
+ RXAUI: 2851377
+ TUI: T116, T129, T121
vaccine
- CUI: C2344317
- RXAUI: 2851377
- TUI: T116, T129, T121
Human-Bovine Reassortant Rotavirus Strain P1A[8] Vaccine
@@ -28029,7 +29752,14 @@ over.
+
+
+
+
+
+
+
@@ -28049,10 +29779,10 @@ over.
human-bovine reassortant rotavirus strain G2 vaccine
human rotavirus A type G2P7(5) strain SC2 live antigen
529180
+ CUI: C2344311
+ RXAUI: 2851371
+ TUI: T116, T129, T121
vaccine
- CUI: C2344311
- RXAUI: 2851371
- TUI: T116, T129, T121
Human-Bovine Reassortant Rotavirus Strain G2 Vaccine
@@ -28062,7 +29792,14 @@ over.
+
+
+
+
+
+
+
@@ -28082,10 +29819,10 @@ over.
human-bovine reassortant rotavirus strain G3 vaccine
human rotavirus A type G3P7(5) strain WI78 live antigen
529212
+ CUI: C2344313
+ RXAUI: 2851373
+ TUI: T116, T129, T121
vaccine
- CUI: C2344313
- RXAUI: 2851373
- TUI: T116, T129, T121
Human-Bovine Reassortant Rotavirus Strain G3 Vaccine
@@ -28095,7 +29832,14 @@ over.
+
+
+
+
+
+
+
@@ -28115,10 +29859,10 @@ over.
human-bovine reassortant rotavirus strain G1 vaccine
human rotavirus A type G1P7(5) strain WI79 live antigen
529176
+ CUI: C2344309
+ RXAUI: 2851369
+ TUI: T116, T129, T121
vaccine
- CUI: C2344309
- RXAUI: 2851369
- TUI: T116, T129, T121
Human-Bovine Reassortant Rotavirus Strain G1 Vaccine
@@ -28130,8 +29874,8 @@ over.
-
-
+
+
@@ -28140,6 +29884,12 @@ over.
+
+
+
+
+
+
@@ -28149,10 +29899,10 @@ over.
Kallan Roan
Oliver He
http://purl.bioontology.org/ontology/RXNORM/833079
+ CUI: C2608637
+ RXAUI: 2944708
+ TUI: T116, T121
vaccine
- CUI: C2608637
- RXAUI: 2944708
- TUI: T116, T121
smallpox vaccine live vaccinia virus
@@ -28181,7 +29931,14 @@ over.
+
+
+
+
+
+
+
@@ -28200,10 +29957,10 @@ over.
314725
meningococcal polysaccharide vaccine group Y
514015
+ CUI: C0982276
+ RXAUI: 1473942
+ TUI: T109, T129, T121
vaccine
- CUI: C0982276
- RXAUI: 1473942
- TUI: T109, T129, T121
MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y
@@ -28244,8 +30001,8 @@ over.
-
-
+
+
@@ -28254,6 +30011,12 @@ over.
+
+
+
+
+
+
@@ -28272,10 +30035,10 @@ over.
54
adenovirus vaccine, type 4, live, oral
adenovirus, type 4
+ CUI: C3207956
+ RXAUI: 3814359
+ TUI: T200
vaccine
- CUI: C3207956
- RXAUI: 3814359
- TUI: T200
Adenovirus Type 4 Vaccine Live Oral Product
@@ -28288,8 +30051,8 @@ over.
-
-
+
+
@@ -28298,6 +30061,12 @@ over.
+
+
+
+
+
+
@@ -28316,10 +30085,10 @@ over.
55
adenovirus vaccine, type 7, live, oral
adenovirus, type 7
+ CUI: C3207958
+ RXAUI: 3814361
+ TUI: T200
vaccine
- CUI: C3207958
- RXAUI: 3814361
- TUI: T200
Adenovirus Type 7 Vaccine Live Oral Product
@@ -28329,7 +30098,14 @@ over.
+
+
+
+
+
+
+
@@ -28346,10 +30122,10 @@ over.
314724
meningococcal polysaccharide vaccine group W-135
514012
+ CUI: C0982275
+ RXAUI: 1473937
+ TUI: T200
vaccine
- CUI: C0982275
- RXAUI: 1473937
- TUI: T200
MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135
@@ -28386,13 +30162,14 @@ over.
+
-
-
+
+
@@ -28401,6 +30178,12 @@ over.
+
+
+
+
+
+
@@ -28417,7 +30200,6 @@ over.
Oliver He
Randi Vita
https://www.ncbi.nlm.nih.gov/pubmed/26148331
- Influenza A virus (A/California/7/2009(H1N1)), Influenza A virus (A/Victoria/361/2011(H3N2)), Influenza B virus (B/Massachusetts/02/2012
vaccine
Fluenz vaccine
@@ -28555,7 +30337,14 @@ over.
+
+
+
+
+
+
+
@@ -28576,7 +30365,7 @@ over.
-
+
@@ -28623,14 +30412,15 @@ over.
BNT162b2
PF-07302048
Tozinameran
- PubMed: 32839784
+ PMID: 32839784
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5784
http://www.violinet.org/cov19vaxkb/authorizedcov19vax.php
https://en.wikipedia.org/wiki/Tozinameran
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/Pfizer-BioNTech.html
https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/pfizer-biontech-covid-19-vaccine
https://www.fda.gov/media/144246/download
+ 5784
COMIRNATY
- COVID-19 Vaccine, mRNA
For active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 years of age and older.
https://www.fda.gov/media/151707/download?attachment
125742
@@ -28665,7 +30455,14 @@ over.
+
+
+
+
+
+
+
@@ -28674,8 +30471,8 @@ over.
-
-
+
+
@@ -28702,9 +30499,11 @@ over.
Rohit Goru
BBV152
COVAXIN
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5795
http://www.violinet.org/cov19vaxkb/authorizedcov19vax.php
https://en.wikipedia.org/wiki/BBV152
https://go.drugbank.com/drugs/DB15847
+ 5795
502
702666
SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (COVAXIN)
@@ -28718,7 +30517,14 @@ over.
+
+
+
+
+
+
+
@@ -28747,6 +30553,8 @@ over.
Philip Huang
CoVLP
NCT04636697
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5796
+ 5796
512
778259
SARS-COV-2 COVID-19 Virus Like Particle (VLP) Non-US Vaccine Product (Medicago, Covifenz)
@@ -28760,7 +30568,14 @@ over.
+
+
+
+
+
+
+
@@ -28769,7 +30584,7 @@ over.
-
+
@@ -28794,7 +30609,9 @@ over.
A SARS-CoV-2 vaccine that includes a protein antigen, SARS-CoV-2 Spike RBD, adsorbed to the adjuvant Alhydrogel (Alum), in combination with another approved adjuvant, CpG 1018
Philip Huang
Corbevax
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5802
https://www.biologicale.com/news.html
+ 5802
517
778264
SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Biological E Limited, Corbevax)
@@ -28808,7 +30625,14 @@ over.
+
+
+
+
+
+
+
@@ -28817,8 +30641,8 @@ over.
-
-
+
+
@@ -28844,7 +30668,9 @@ over.
Philip Huang
KCONVAC
NCT04852705
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5805
http://www.violinet.org/cov19vaxkb/authorizedcov19vax.php
+ 5805
516
778263
SARS-COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)
@@ -28858,7 +30684,14 @@ over.
+
+
+
+
+
+
+
@@ -28887,7 +30720,9 @@ over.
Philip Huang
EpiVacCorona
NCT04527575
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5794
http://www.violinet.org/cov19vaxkb/authorizedcov19vax.php
+ 5794
509
702671
SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (EpiVacCorona)
@@ -28901,7 +30736,14 @@ over.
+
+
+
+
+
+
+
@@ -28910,8 +30752,8 @@ over.
-
-
+
+
@@ -28937,7 +30779,9 @@ over.
QazCovid-in
QazVac
NCT04691908
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5810
http://www.violinet.org/cov19vaxkb/authorizedcov19vax.php
+ 5810
501
702665
SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (QAZCOVID-IN)
@@ -28951,7 +30795,14 @@ over.
+
+
+
+
+
+
+
@@ -28960,8 +30811,8 @@ over.
-
-
+
+
@@ -28985,7 +30836,9 @@ over.
A SARS-CoV-2 inactivated, Vero-cell based vaccine adjuvanted with aluminum and CpG 1018. It uses the manufacturing platform of Valneva's commercial Japanese encephalitis (JE) vaccine
Philip Huang
VLA2001
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5816
https://valneva.com/research-development/covid-19-vla2001/
+ 5816
518
716023
SARS-COV-2 COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)
@@ -28999,7 +30852,14 @@ over.
+
+
+
+
+
+
+
@@ -29008,8 +30868,8 @@ over.
-
-
+
+
@@ -29030,6 +30890,12 @@ over.
+
+
+
+
+
+
A SARS-CoV-2 whole virus vaccine made from a purified inactivated SARS-CoV-2 virus.
Anthony Huffman
Oliver He
@@ -29037,17 +30903,17 @@ over.
Rohit Goru
CoronaVac
PiCoVacc
- VIOLIN: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5761
+ PMID:32376603
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5761
http://www.violinet.org/cov19vaxkb/authorizedcov19vax.php
https://en.wikipedia.org/wiki/CoronaVac
+ 5761
511
702673
SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac)
COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac)
vaccine
- PubMed ID:32376603
CoronaVac vaccine
- VIOLIN ID: 5761
@@ -29055,22 +30921,23 @@ over.
+
-
-
+
+
-
-
+
+
-
+
@@ -29097,7 +30964,9 @@ over.
Philip Huang
Covovax
Nuvaxovid
- PubMed:32376603
+ PMID:32376603
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5791
+ 5791
211
SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL dose
COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL
@@ -29110,7 +30979,14 @@ over.
+
+
+
+
+
+
+
@@ -29119,13 +30995,13 @@ over.
-
+
-
+
@@ -29153,8 +31029,10 @@ over.
AZD1222
COVID-19 Vaccine AstraZeneca
ChAdOx1 nCoV-19
- PubMed:32702298
+ PMID:32702298
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5774
https://en.wikipedia.org/wiki/AZD1222
+ 5774
Covishield
210
724905
@@ -29162,7 +31040,6 @@ over.
COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL
vaccine
Oxford-AstraZeneca COVID-19 vaccine
- violinID:2020-001072-15, 2020-001228-32, ISRCTN89951424
@@ -29170,7 +31047,14 @@ over.
+
+
+
+
+
+
+
@@ -29179,14 +31063,14 @@ over.
-
-
+
+
-
-
+
+
@@ -29221,8 +31105,10 @@ over.
Ad26COVS1
JNJ-78436735
Johnson & Johnson COVID-19 vaccine
- PubMed:32731257
+ PMID:32731257
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5782
http://www.violinet.org/cov19vaxkb/authorizedcov19vax.php
+ 5782
212
SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL
COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL
@@ -29235,7 +31121,14 @@ over.
+
+
+
+
+
+
+
@@ -29244,7 +31137,7 @@ over.
-
+
@@ -29269,7 +31162,9 @@ over.
A SARS-CoV-2 plasmid DNA vaccine that encodes the envelope protein.
Anthony Huffman
ZyCoV-D
- PubMed:32800805
+ PMID:32800805
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5778
+ 5778
514
778261
SARS-COV-2 COVID-19 DNA Non-US Vaccine Product (Zydus Cadila, ZyCoV-D)
@@ -29283,7 +31178,14 @@ over.
+
+
+
+
+
+
+
@@ -29298,21 +31200,20 @@ over.
-
-
-
-
-
-
-
-
-
+
+
-
-
+
+
+
+
+
+
+
+
@@ -29339,10 +31240,11 @@ over.
Philip Huang
Rohit Goru
Sputnik V
- PubMed:32896291
+ PMID:32896291
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5777
http://www.violinet.org/cov19vaxkb/authorizedcov19vax.php
https://en.wikipedia.org/wiki/Gam-COVID-Vac
- Gam-COVID-Vac
+ 5777
505
702668
SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik V)
@@ -29356,7 +31258,14 @@ over.
+
+
+
+
+
+
+
@@ -29365,8 +31274,8 @@ over.
-
-
+
+
@@ -29392,9 +31301,11 @@ over.
Philip Huang
BBIBP-CorV
ChiCTR2000032459, ChiCTR2000034780
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5776
http://www.violinet.org/cov19vaxkb/authorizedcov19vax.php
https://en.wikipedia.org/wiki/BBIBP-CorV
https://go.drugbank.com/drugs/DB15807
+ 5776
510
702672
SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm)
@@ -29433,8 +31344,15 @@ over.
+
+
+
+
+
+
+
@@ -29463,6 +31381,8 @@ over.
Philip Huang
COVI-VAC
NCT04619628
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5824
+ 5824
503
702680
SARS-COV-2 COVID-19 Live Attenuated Virus Non-US Vaccine Product (COVIVAC)
@@ -29476,7 +31396,14 @@ over.
+
+
+
+
+
+
+
@@ -29485,7 +31412,7 @@ over.
-
+
@@ -29523,6 +31450,8 @@ over.
Philip Huang
MVC-COV1901
NCT04487210
+ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5828
+ 5828
515
778262
SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Medigen, MVC-COV1901)
@@ -29610,7 +31539,7 @@ over.
-
+
@@ -29666,7 +31595,7 @@ over.
-
+
@@ -29777,14 +31706,14 @@ over.
-
-
+
+
-
-
+
+
Oliver He
@@ -29994,6 +31923,12 @@ over.
+
+
+
+
+
+
@@ -30020,6 +31955,12 @@ over.
+
+
+
+
+
+
@@ -30052,6 +31993,12 @@ over.
+
+
+
+
+
+
@@ -30086,6 +32033,12 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
@@ -30124,6 +32077,12 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
@@ -30167,6 +32126,12 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
@@ -30213,8 +32178,15 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -30241,6 +32213,12 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
@@ -30266,6 +32244,12 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
@@ -30299,6 +32283,12 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
@@ -30324,6 +32314,12 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
@@ -30350,6 +32346,12 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
@@ -30375,6 +32377,12 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
@@ -30402,6 +32410,12 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
@@ -30428,6 +32442,12 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
@@ -30453,6 +32473,12 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
@@ -30477,10 +32503,17 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -30527,6 +32560,7 @@ administered prior to exposure or within two weeks after exposure.
+
@@ -30574,6 +32608,12 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
@@ -30609,7 +32649,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -30649,8 +32696,15 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -30697,6 +32751,12 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
@@ -30733,6 +32793,12 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
@@ -30767,7 +32833,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -30809,30 +32882,37 @@ administered prior to exposure or within two weeks after exposure.
+
-
-
+
+
-
-
+
+
-
+
-
-
+
+
+
+
+
+
+
+
@@ -30870,6 +32950,7 @@ administered prior to exposure or within two weeks after exposure.
+
@@ -30877,8 +32958,8 @@ administered prior to exposure or within two weeks after exposure.
-
-
+
+
@@ -30893,6 +32974,12 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
@@ -30921,14 +33008,15 @@ administered prior to exposure or within two weeks after exposure.
+
-
-
+
+
@@ -30943,6 +33031,12 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
@@ -30971,14 +33065,15 @@ administered prior to exposure or within two weeks after exposure.
+
-
-
+
+
@@ -30993,6 +33088,12 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
@@ -31015,12 +33116,13 @@ administered prior to exposure or within two weeks after exposure.
+
-
-
+
+
@@ -31029,6 +33131,12 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
@@ -31065,7 +33173,9 @@ administered prior to exposure or within two weeks after exposure.
+
+
@@ -31076,8 +33186,8 @@ administered prior to exposure or within two weeks after exposure.
-
-
+
+
@@ -31104,6 +33214,12 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
@@ -31158,7 +33274,7 @@ administered prior to exposure or within two weeks after exposure.
- a grouping class for vaccines for specific diseases
+ Vaccine that prevents or treats specific disease.
Barry Smith
Charles Tapley Hoyt
Jie Zheng
@@ -31240,7 +33356,13 @@ administered prior to exposure or within two weeks after exposure.
- a grouping class for vaccines for specific platforms
+ Vaccine that is developed and produced by specific technology or method.
+ Barry Smith
+ Charles Tapley Hoyt
+ Jie Zheng
+ Oliver He
+ Xingxian Li
+ https://github.com/vaccineontology/VO/issues/619
vaccine
vaccine by platform type
@@ -31265,7 +33387,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -31298,8 +33427,15 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -31331,7 +33467,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -31364,7 +33507,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -31401,14 +33551,14 @@ administered prior to exposure or within two weeks after exposure.
-
-
-
-
+
+
+
+
@@ -31416,12 +33566,13 @@ administered prior to exposure or within two weeks after exposure.
+
-
-
+
+
@@ -31430,6 +33581,12 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
@@ -31456,8 +33613,15 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -31490,7 +33654,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -31530,7 +33701,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -31569,12 +33747,13 @@ administered prior to exposure or within two weeks after exposure.
+
-
-
+
+
@@ -31583,6 +33762,12 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
@@ -31609,7 +33794,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -31642,7 +33834,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -31675,7 +33874,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -31708,7 +33914,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -31741,8 +33954,15 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -31781,7 +34001,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -31814,7 +34041,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -31889,8 +34123,15 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -31938,7 +34179,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -31971,7 +34219,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -32004,7 +34259,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -32038,7 +34300,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -32071,7 +34340,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -32104,7 +34380,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -32137,8 +34420,15 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -32192,7 +34482,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -32225,7 +34522,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -32258,7 +34562,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -32291,7 +34602,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -32325,7 +34643,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -32364,7 +34689,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -32398,8 +34730,15 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -32445,7 +34784,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -32484,8 +34830,15 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -32518,8 +34871,15 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -32552,13 +34912,14 @@ administered prior to exposure or within two weeks after exposure.
+
-
-
+
+
@@ -32567,6 +34928,12 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
@@ -32593,8 +34960,15 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -32628,7 +35002,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -32668,7 +35049,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -32708,7 +35096,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -32748,7 +35143,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -32787,7 +35189,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -32820,7 +35229,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -32853,8 +35269,15 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -32887,8 +35310,15 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -32921,7 +35351,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -32942,7 +35379,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -32975,12 +35419,13 @@ administered prior to exposure or within two weeks after exposure.
+
-
-
+
+
@@ -32989,6 +35434,12 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
@@ -33015,8 +35466,15 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -33061,8 +35519,15 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -33108,7 +35573,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -33146,7 +35618,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -33184,7 +35663,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -33222,7 +35708,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -33260,7 +35753,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -33298,7 +35798,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -33336,7 +35843,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -33374,7 +35888,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -33412,7 +35933,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -33450,7 +35978,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -33488,7 +36023,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -33526,7 +36068,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -33564,7 +36113,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -33602,7 +36158,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -33636,7 +36199,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -33675,7 +36245,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -33714,7 +36291,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -33747,7 +36331,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -33786,7 +36377,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -33825,7 +36423,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -33864,7 +36469,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+
+
+
+
+
@@ -33897,7 +36509,14 @@ administered prior to exposure or within two weeks after exposure.
+
+
+